
<html lang="en"     class="pb-page"  data-request-id="8f6148ed-7f84-4d23-abb0-a7deedef3fec"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.7b01052;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties" /></meta><meta name="dc.Creator" content="Martina  Gobec" /></meta><meta name="dc.Creator" content="Tihomir  Tomašič" /></meta><meta name="dc.Creator" content="Adela  Štimac" /></meta><meta name="dc.Creator" content="Ruža  Frkanec" /></meta><meta name="dc.Creator" content="Jurij  Trontelj" /></meta><meta name="dc.Creator" content="Marko  Anderluh" /></meta><meta name="dc.Creator" content="Irena  Mlinarič-Raščan" /></meta><meta name="dc.Creator" content="Žiga  Jakopin" /></meta><meta name="dc.Description" content="Muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, has long been known as the smallest fragment possessing adjuvant activity, on the basis of its agonistic action on the nucleotide-bin..." /></meta><meta name="Description" content="Muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, has long been known as the smallest fragment possessing adjuvant activity, on the basis of its agonistic action on the nucleotide-bin..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01052" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01052" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01052" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01052" /></link>
        
    
    

<title>Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01052" /></meta><meta property="og:title" content="Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0011.jpeg" /></meta><meta property="og:description" content="Muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, has long been known as the smallest fragment possessing adjuvant activity, on the basis of its agonistic action on the nucleotide-binding oligomerization domain-containing protein 2 (NOD2). There is a pressing need for novel adjuvants, and NOD2 agonists provide an untapped source of potential candidates. Here, we report the design, synthesis, and characterization of a series of novel acyl tripeptides. A pivotal structural element for molecular recognition by NOD2 has been identified, culminating in the discovery of compound 9, the most potent desmuramylpeptide NOD2 agonist to date. Compound 9 augmented pro-inflammatory cytokine release from human peripheral blood mononuclear cells in synergy with lipopolysaccharide. Furthermore, it was able to induce ovalbumin-specific IgG titers in a mouse model of adjuvancy. These findings provide deeper insights into the structural requirements of desmuramylpeptides for NOD2-activation and highlight the potential use of NOD2 agonists as adjuvants for vaccines." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01052"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01052">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01052&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01052&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01052&amp;href=/doi/10.1021/acs.jmedchem.7b01052" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 2707-2724</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01282" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01312" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Martina Gobec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martina Gobec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martina++Gobec">Martina Gobec</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tihomir Tomašič</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tihomir Tomašič</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tihomir++Toma%C5%A1i%C4%8D">Tihomir Tomašič</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adela Štimac</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adela Štimac</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Rockefellerova 10, 10000 Zagreb, Croatia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adela++%C5%A0timac">Adela Štimac</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruža Frkanec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruža Frkanec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Rockefellerova 10, 10000 Zagreb, Croatia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ru%C5%BEa++Frkanec">Ruža Frkanec</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jurij Trontelj</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jurij Trontelj</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jurij++Trontelj">Jurij Trontelj</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marko Anderluh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marko Anderluh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marko++Anderluh">Marko Anderluh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Irena Mlinarič-Raščan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Irena Mlinarič-Raščan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Irena++Mlinari%C4%8D-Ra%C5%A1%C4%8Dan">Irena Mlinarič-Raščan</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Žiga Jakopin</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Žiga Jakopin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +386 1 4769 646. Fax: + 386 1 4258 031. E-mail: <a href="/cdn-cgi/l/email-protection#fc86959b9dd2969d97938c9592bc9a9a9dd2899295d19096d28f95"><span class="__cf_email__" data-cfemail="aad0c3cdcb84c0cbc1c5dac3c4eacccccb84dfc4c387c6c084d9c3">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=%C5%BDiga++Jakopin">Žiga Jakopin</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9384-0858" title="Orcid link">http://orcid.org/0000-0001-9384-0858</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01052&amp;href=/doi/10.1021%2Facs.jmedchem.7b01052" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 2707–2724</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 15, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 September 2017</li><li><span class="item_label"><b>Published</b> online</span>15 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01052" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01052</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2707%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartina%2BGobec%252C%2BTihomir%2BToma%25C5%25A1i%25C4%258D%252C%2BAdela%2B%25C5%25A0timac%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D7%26contentID%3Dacs.jmedchem.7b01052%26title%3DDiscovery%2Bof%2BNanomolar%2BDesmuramylpeptide%2BAgonists%2Bof%2Bthe%2BInnate%2BImmune%2BReceptor%2BNucleotide-Binding%2BOligomerization%2BDomain-Containing%2BProtein%2B2%2B%2528NOD2%2529%2BPossessing%2BImmunostimulatory%2BProperties%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2724%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01052"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1261</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">12</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01052" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Nanomolar Desmuramylpeptide Agonists of the Innate Immune Receptor Nucleotide-Binding Oligomerization Domain-Containing Protein 2 (NOD2) Possessing Immunostimulatory Properties&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martina&quot;,&quot;last_name&quot;:&quot;Gobec&quot;},{&quot;first_name&quot;:&quot;Tihomir&quot;,&quot;last_name&quot;:&quot;Tomašič&quot;},{&quot;first_name&quot;:&quot;Adela&quot;,&quot;last_name&quot;:&quot;Štimac&quot;},{&quot;first_name&quot;:&quot;Ruža&quot;,&quot;last_name&quot;:&quot;Frkanec&quot;},{&quot;first_name&quot;:&quot;Jurij&quot;,&quot;last_name&quot;:&quot;Trontelj&quot;},{&quot;first_name&quot;:&quot;Marko&quot;,&quot;last_name&quot;:&quot;Anderluh&quot;},{&quot;first_name&quot;:&quot;Irena&quot;,&quot;last_name&quot;:&quot;Mlinarič-Raščan&quot;},{&quot;first_name&quot;:&quot;Žiga&quot;,&quot;last_name&quot;:&quot;Jakopin&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2707-2724&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01052&quot;},&quot;abstract&quot;:&quot;Muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, has long been known as the smallest fragment possessing adjuvant activity, on the basis of its agonistic action on the nucleotide-binding oligomerization domain-containing protein 2 (NOD2). There is a pressing need for novel adjuvants, and NOD2 agonists provide an untapped source of potential candidates. Here, we report the design, synthesis, and characterization of a series of novel acyl tripeptides. A pivotal structural element for molecular recognition by NOD2 has been identified, culminating in the discovery of compound 9, the most potent desmuramylpeptide NOD2 agonist to date. Compound 9 augmented pro-inflammatory cytokine release from human peripheral blood mononuclear cells in synergy with lipopolysaccharide. Furthermore, it was able to induce ovalbumin-specific IgG titers in a mouse model of adjuvancy. These findings provide deeper insights into the structural requirements of desmuramylpeptides for NOD2-activation and highlight the potent&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01052&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01052" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01052&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01052" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01052&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01052" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01052&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01052&amp;href=/doi/10.1021/acs.jmedchem.7b01052" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01052" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01052" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01052%26sid%3Dliteratum%253Aachs%26pmid%3D29543461%26genre%3Darticle%26aulast%3DGobec%26date%3D2018%26atitle%3DDiscovery%2Bof%2BNanomolar%2BDesmuramylpeptide%2BAgonists%2Bof%2Bthe%2BInnate%2BImmune%2BReceptor%2BNucleotide-Binding%2BOligomerization%2BDomain-Containing%2BProtein%2B2%2B%2528NOD2%2529%2BPossessing%2BImmunostimulatory%2BProperties%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D7%26spage%3D2707%26epage%3D2724%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292317" title="Ethyl groups">Ethyl groups</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/jmcmar.2018.61.issue-7/20180412/jmcmar.2018.61.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Muramyl dipeptide (MDP), a fragment of bacterial peptidoglycan, has long been known as the smallest fragment possessing adjuvant activity, on the basis of its agonistic action on the nucleotide-binding oligomerization domain-containing protein 2 (NOD2). There is a pressing need for novel adjuvants, and NOD2 agonists provide an untapped source of potential candidates. Here, we report the design, synthesis, and characterization of a series of novel acyl tripeptides. A pivotal structural element for molecular recognition by NOD2 has been identified, culminating in the discovery of compound <b>9</b>, the most potent desmuramylpeptide NOD2 agonist to date. Compound <b>9</b> augmented pro-inflammatory cytokine release from human peripheral blood mononuclear cells in synergy with lipopolysaccharide. Furthermore, it was able to induce ovalbumin-specific IgG titers in a mouse model of adjuvancy. These findings provide deeper insights into the structural requirements of desmuramylpeptides for NOD2-activation and highlight the potential use of NOD2 agonists as adjuvants for vaccines.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Innate immunity, once assumed to be the redundant remnant of an ancient antimicrobial system, is in fact the cornerstone of the body’s ability to combat infection.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Pattern recognition receptors (PRRs) comprise a constellation of evolutionarily conserved immune sensors that possess the ability, not only to sense invading pathogens via the detection of their specific molecular signatures but also to orchestrate the initial defense response as part of the innate immune process.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Nucleotide-binding oligomerization domain-containing protein 2 (NOD2), which belongs to a major cytosolic class of PRRs, the NOD-like receptors (NLR), is of utmost importance since it has an important task within the innate immune response.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> It is predominantly expressed in immune cells and, to a lesser degree, in Paneth cells and certain epithelial cells.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> The structure of NOD2 protein is assembled from the following structural units: two caspase activation and recruitment domains (CARDs), a nucleotide-binding oligomerization domain (NOD), and multiple leucine-rich repeats (LRRs). It has been suggested that it typically exists in an autoinhibited state.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Muramyl dipeptide (MDP), a conserved constituent of the cell wall of the majority of types of bacteria, is the smallest structural subunit of bacterial peptidoglycan capable of eliciting NOD2 activation;<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> direct contact between MDP and NOD2 has recently been proven by both biophysical and biochemical assays.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> On recognition of MDP, NOD2 undergoes self-oligomerization and activates the serine-threonine kinase receptor-interacting protein 2 (RIP2). Subsequently, the nuclear factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways are initiated, resulting in the production of cytokines and certain antimicrobial peptides and the induction of additional processes, which characterize a proinflammatory/antimicrobial response.<a onclick="showRef(event, 'ref3 ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref3 ref7 ref9">(3,7,9)</a> Of note, a number of regulatory proteins closely control the downstream signaling pathways underlying NOD2 activation.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">Activation of NOD2 itself is sufficient to shape adaptive immune responses,<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> but more importantly, NOD2 agonist synergistically augments the adjuvant capacity of other PRR ligands such as Toll-like receptor (TLR) ligands. This NLR-TLR crosstalk has been proved to be essential for adaptive immunity and underlines the importance of NLRs.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> Interestingly, in spite of innate immunity not being known to possess memory, NOD2 ligands have been shown to induce epigenetic reprogramming of monocytes, resulting in nonspecific protection against reinfection; this phenomenon has been termed “trained immunity”.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> Recently gained insight into the crosstalk between innate and adaptive immune responses is of significant clinical importance and has opened up new avenues for development of novel vaccines.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Currently, only four adjuvants are approved for human vaccines in the US and Europe. Although MDP was long ago identified as the smallest component underlying the efficacy of Freund’s complete adjuvant, thus opening up a new era in immunology, it has proved to be too pyrogenic for clinical application, while it also suffers from rapid elimination.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> Therefore, MDP has been limited to veterinary vaccines.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Besides their adjuvant properties, NOD2 agonists have been shown to possess indirect antimicrobial properties as well as the ability to act synergistically in combination with antibiotics and to stimulate the nonspecific resistance against infections and tumors.<a onclick="showRef(event, 'ref18 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref21 ref22">(18,21,22)</a></div><div class="NLM_p">Recent decades have witnessed the discovery of diverse nonpyrogenic MDP analogs, either chemically modified MDP derivatives or conjugated with carriers, with preserved adjuvant/immunostimulatory activity.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26 ref27 ref28 ref29 ref30 ref31 ref32">(23−32)</a> Certain lipophilic derivatives of MDP have exhibited stronger adjuvant activity than that of the parent structure, showing that MDP can be tailored to increase the adjuvant activity.<a onclick="showRef(event, 'ref20 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref20 ref30 ref31">(20,30,31)</a> Thus, mifamurtide has been tested as part of an influenza vaccine in a number of clinical trials.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">The term “desmuramylpeptides” refers to MDP derivatives lacking the sugar <i>N</i>-acetylmuramyl moiety (Mur<i>N</i>Ac). It has been shown unequivocally that the presence of Mur<i>N</i>Ac is not mandatory for NOD2 recognition, as evidenced by recently developed desmuramylpeptides possessing NOD2 agonistic activity.<a onclick="showRef(event, 'ref24 ref25 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref33 ref34">(24,25,33,34)</a> Here, we describe the design, synthesis, and characterization of a series of novel acyl tripeptides as a continuation of our efforts to generate desmuramylpeptides with potent NOD2 agonistic activity. The NOD2-dependent NF-κB activation capacity of the synthesized library of fourth generation desmuramylpeptides has been determined on HEK293 cells overexpressing the NOD2 gene. The pivotal structural elements of acyl tripeptides for molecular recognition by NOD2 were identified. Compound <b>9</b>, in which the carbohydrate moiety was replaced by a <i>trans</i>-feruloyl moiety, has been identified as the strongest desmuramylpeptide NOD2 agonist to date, being twice as potent as MDP. Its immunostimulatory properties have been determined in <i>in vitro</i> experiments that revealed the capacity of <b>9</b> to augment pro-inflammatory cytokine release from human peripheral blood mononuclear cells (PBMC), by itself and in synergy with lipopolysaccharide (LPS). Furthermore, when coadministered subcutaneously with the model antigen, ovalbumin (OVA), it induced OVA-specific IgG titers in a mouse model of adjuvancy. These findings provide deeper insights into the structural requirements of desmuramylpeptides for NOD2-activation and point out the potential utility of NOD2 agonists as adjuvants for vaccines.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">2.1.  Design</h3><div class="NLM_p">The SLC15 family of peptide transporters, outer membrane vesicles, and endocytosis have all been suggested as a potential entry route for MDP into the cytoplasm,<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35−38)</a> while desmuramylpeptides were shown to cross the membrane via passive absorption.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In accordance with this, the introduction of lipophilic groups into the structures of NOD agonists, as well as the use of lipophilic delivery carrier systems, strongly enhanced the cellular immunity and strikingly increased the adjuvant activity of compounds, further reinforcing this suggestion.<a onclick="showRef(event, 'ref31 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref31 ref40 ref41">(31,40,41)</a> Similarly, previous studies of the structure–activity relationships (SARs) of MDP derivatives established that introduction of a lipophilic moiety into MDP can increase its adjuvant activity.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42−44)</a> Although the molecular nature of the interaction between MDP and NOD2 is not known, in our previous research, cinnamoyl-Gly (i.e., compound <b>II</b>) and 6-Ph-indole-Gly (i.e., compound <b>I</b>) moieties were highlighted as appropriate surrogates for the Mur<i>N</i>Ac group. Leads <b>I</b> and <b>II</b> were identified as effective NOD2 agonists and were selected for further optimization (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref24 ref25 ref34'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref34">(24,25,34)</a> The structural requirements thus elucidated for NOD2 agonist activity also include the presence of ethyl ester groups at the <span class="smallcaps smallerCapital">d</span>-Glu moiety.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of acylated tripeptide analogs and structural modifications of leads <b>I</b> and <b>II</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we explored the chemical space of our leads <b>I</b> and <b>II</b> (shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and investigated how modifications of the amino acid type and the acyl moiety affect their NOD2-agonistic activity. The underlying principle that guided our design was the previously reported promising immunostimulatory effect of lipophilic derivatives. In the light of this, we decided to modify the tripeptide and carbohydrate moiety so that the analogs bear the features of leads <b>I</b> and <b>II</b> while differing from each other in subtle substitutions. The first group of modifications involved replacement of the <span class="smallcaps smallerCapital">l</span>-Ala residue with its more lipophilic counterparts, <span class="smallcaps smallerCapital">l</span>-Val and <span class="smallcaps smallerCapital">l</span>-Phe, since only limited variations of the essential <span class="smallcaps smallerCapital">l</span>-Ala-<span class="smallcaps smallerCapital">d</span>-<i>iso</i>Gln pharmacophore are allowed.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> Also, a previous study has suggested that, by designing MDP derivatives harboring <span class="smallcaps smallerCapital">l</span>-Val, it should be possible to decouple the inflammation-inducing capacity from the ability to induce adaptive immunity.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The second group of modifications includes replacement of the aforementioned acyl moieties by a careful selection of their closely related mimetics. As the analogs needed to be synthetically accessible, we focused more intensively on modifications of the cinnamoyl rather than the 6-phenylindole fragment. Unsubstituted and substituted cinnamoyl moieties are present in many natural products and drugs. The feruloyl (4-hydroxy-3-methoxycinnamoyl) moiety, for example, is considered to be a privileged fragment and has found application as a component of the drug cyclovalone.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> In addition, the cyclopropyl ring system has been introduced into the cinnamoyl moieties as a bioisosteric replacement of the alkene bond. It is worth noting that cyclopropane has increasingly been featured in a wide array of drugs with the aim of preventing the isomerization of the <i>E</i>/<i>Z</i> alkene bond and/or facilitating the projection of the attached groups in a desirable <i>trans</i>-geometry.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Finally, minor modifications were also introduced into the <span class="smallcaps smallerCapital">d</span>-Glu residue of the tripeptides by equipping this moiety with rigid mimetics. The previously reported conformationally constrained mimetics of <span class="smallcaps smallerCapital">d</span>-glutamic acid<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> were incorporated into the structure of <b>9</b>, used as the starting point, with the aim of potentiating its NOD2-agonistic activity. This optimization approach has been well-known among medicinal chemists for decades. These combined efforts afforded several novel desmuramyldipeptides, which were tested for their NOD2-agonistic properties on the commercially available HEK-Blue NOD2 cell line.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.2.  Chemistry</h3><div class="NLM_p">Preparation of tripeptides was guided by the desire to establish a reproducible and convenient route suitable for multigram production. Thus, a four-step synthesis of the key intermediates Boc-Gly-<span class="smallcaps smallerCapital">l</span>-Val-<span class="smallcaps smallerCapital">d</span>-Glu(OEt)<sub>2</sub> (<b>3a</b>) and Boc-Gly-<span class="smallcaps smallerCapital">l</span>-Phe-<span class="smallcaps smallerCapital">d</span>-Glu(OEt)<sub>2</sub> (<b>3b</b>) was executed as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The starting <span class="smallcaps smallerCapital">d</span>-glutamic acid was first esterified via acid-catalyzed esterification, using SOCl<sub>2</sub> in ethanol, to yield the corresponding diethyl ester <b>1a</b>. The crude diethyl ester was then coupled with Boc-<span class="smallcaps smallerCapital">l</span>-Val or Boc-<span class="smallcaps smallerCapital">l</span>-Phe, using dicyclohexylcarbodiimide (DCC)/1-hydroxybenzotriazole (HOBt) methodology, thus giving the corresponding dipeptides Boc-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamic acid diethyl ester (<b>2a</b>) and Boc-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">d</span>-glutamic acid diethyl ester (<b>2b</b>). The Boc-protecting group was then removed from <b>2a/2b</b> under acidolytic conditions using trifluoroacetic acid (TFA), followed instantly by coupling with Boc-Gly, thus affording the Boc-protected tripeptides Boc-Gly-<span class="smallcaps smallerCapital">l</span>-Val-<span class="smallcaps smallerCapital">d</span>-Glu(OEt)<sub>2</sub> (<b>3a</b>) and Boc-Gly-<span class="smallcaps smallerCapital">l</span>-Phe-<span class="smallcaps smallerCapital">d</span>-Glu(OEt)<sub>2</sub> (<b>3b</b>). The Boc-protecting group was removed from tripeptides <b>3a</b> and <b>3b</b>, using TFA, giving the corresponding trifluoroacetate salts of the tripeptides. Having prepared intermediates that enable acylation of the free amino group of Gly at a late-stage, we generated several compounds with diverse functionalities in order to ascertain how minimal modifications of the cinnamoyl moiety affect the NOD2-agonistic activities of the compounds. By coupling of the commercially available acids with the key intermediates <b>3a</b> and <b>3b</b>, using standard 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide (EDC)/HOBt coupling methodology, corresponding <i>N</i>-acyl Gly-<span class="smallcaps smallerCapital">l</span>-Val-<span class="smallcaps smallerCapital">d</span>-Glu(OEt)<sub>2</sub> analogs <b>4</b>–<b>9</b> and <i>N</i>-acyl Gly-<span class="smallcaps smallerCapital">l</span>-Phe-<span class="smallcaps smallerCapital">d</span>-Glu(OEt)<sub>2</sub> analogs <b>10</b>–<b>15</b> (see <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) were afforded.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acylated Tripeptide Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Boc-<span class="smallcaps smallerCapital">l</span>-Val or Boc-<span class="smallcaps smallerCapital">l</span>-Phe, DCC, HOBt, DIPEA, DMAP, EtOAc; (ii) TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:5); (iii) Boc-Gly, DCC, HOBt, DIPEA, DMAP, EtOAc; (iv) R′COOH, EDC, HOBt, DIPEA, DMAP, DMF. *a mixture of two diastereomers; <i>**</i>a mixture of four diastereomers.</p></p></figure><div class="NLM_p">Similarly, an <span class="smallcaps smallerCapital">l</span>-Ala carrying congener of <b>9</b>, compound <b>16</b>, was prepared by coupling <i>trans</i>-ferulic acid with Boc-Gly-<span class="smallcaps smallerCapital">l</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Glu(OEt)<sub>2</sub> prepared as described.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Further, compound <b>9</b> was converted to its free acid analog <b>17</b> via alkaline hydrolysis (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Derivatives of Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF; (ii) 1 M NaOH, EtOH, rt.</p></p></figure><div class="NLM_p">It has been reported that only minuscule variations of the second amino acid of the essential <span class="smallcaps smallerCapital">l</span>-Ala-<span class="smallcaps smallerCapital">d</span>-Glu moiety are allowed.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> In order to determine how the incorporation of rigidified <span class="smallcaps smallerCapital">d</span>-Glu mimetics affects the NOD2-agonistic activity, derivatives harboring modified <span class="smallcaps smallerCapital">d</span>-Glu moiety were prepared by introducing previously reported constrained mimetics of <span class="smallcaps smallerCapital">d</span>-glutamic acid<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> into the structure of compound <b>9</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The glycine was first esterified via acid-catalyzed esterification, using SOCl<sub>2</sub> in ethanol, to yield the corresponding ethyl ester <b>1c</b>. The crude ester was then coupled with <i>trans</i>-ferulic acid, using EDC/HOBt methodology, affording the corresponding <i>N</i>-feruloyl derivative <b>18</b>. In the succeeding synthetic step, the ethyl ester was hydrolyzed under alkaline conditions, furnishing the free acid <b>19</b>, which was coupled with HCl × <span class="smallcaps smallerCapital">l</span>-Val-OEt (<b>1b</b>) to generate <i>N</i>-feruloyl dipeptide <b>20</b>. On alkaline hydrolysis of the latter, the intermediate free acid <b>21</b> was coupled with the commercially available amines using the established EDC/HOBt procedure, resulting in the desired rigidified mimetics of <b>9</b>, compounds <b>22</b>–<b>24</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Finally, in order to investigate in what manner the forced planarity, a direct consequence of the introduced aromatic ring, affects NOD2 recognition, <i>N</i>-feruloyl glycine <b>19</b> was also linked to aromatic mimetics of the <span class="smallcaps smallerCapital">l</span>-Val-<span class="smallcaps smallerCapital">d</span>-Glu dipeptide <b>25b</b>, <b>26b</b>, and <b>27b</b> (prepared as described in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Supporting Information</a>) affording compounds <b>28</b>–<b>30</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Exploration of the Chemical Space of <span class="smallcaps smallerCapital">d</span>-Glutamic Acid<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF; (ii) 1 M NaOH, EtOH, rt; (iii) <b>1b</b>, EDC, HOBt, DIPEA, DMAP, DMF; (iv) ethyl isonipecotate or ethyl (1<i>R</i>,2<i>S</i>)-2-aminocyclohexane-1-carboxylate or ethyl (1<i>S</i>,2<i>S</i>)-2-aminocyclohexane-1-carboxylate, EDC, HOBt, DIPEA, DMAP, DMF; (v) <b>25b</b> or <b>26b</b> or <b>27b</b>, EDC, HOBt, DIPEA, DMAP, DMF. Constrained mimetics of <span class="smallcaps smallerCapital">d</span>-glutamic acid are highlighted in dashed red rectangles. Core structure of <b>9</b> is highlighted in dashed blue rectangles.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.3.  Biological Studies</h3><div id="sec2_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">2.3.1.  Evaluation of the Cytotoxicity of the Synthesized Compounds</h4><div class="NLM_p last">The cytotoxic potential of MDP and the novel desmuramylpeptides was first established by measuring the proliferation rates of HEK-Blue NOD2 cells treated with these compounds, using the standard metabolic activity assay. Cells were treated for 18 h with MDP and desmuramylpeptides at 20 μM concentration and their measured metabolic activities compared with that of the untreated control. The compounds proved to be noncytotoxic to HEK-Blue NOD2 cells since none of the residual metabolic activities were less than 80% at the tested concentration (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S12</a>).</div></div><div id="sec2_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">2.3.2.  Evaluation of NOD2-Agonistic Activity of the Synthesized Compounds</h4><div class="NLM_p">The ability of the synthesized desmuramylpeptides to activate NOD2 at the cell level was investigated employing a validated, commercially available HEK-Blue NOD2-dependent NF-κB-inducible secreted embryonic alkaline phosphatase (SEAP) reporter gene assay. NOD2 agonistic activity of a compound is directly related to the elicited NF-κB transcriptional activity and, in turn, the production of SEAP. HEK-Blue NOD2 cells were treated with desmuramylpeptides, and with MDP as the reference compound, for 18 h at 2 or 20 μM. The results were normalized to that of the untreated control (NT). Since all tested compounds initially exhibited maximal NOD2 activation at 20 μM (data not shown), the biological evaluation was repeated at the 10-fold lower concentration of 2 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Table S1</a>). Of the 20 synthesized MDP-derived compounds, most belong to two parallel series of acyl tripeptides harboring modifications at the second amino acid and carrying slightly different acyl moieties. The ability of the synthesized acyl tripeptides <b>4</b> to <b>15</b> (the <span class="smallcaps smallerCapital">l</span>-Val and the <span class="smallcaps smallerCapital">l</span>-Phe series), with MDP as reference compound, to activate NOD2 at the level of the cell led to several interesting observations (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). The majority of the compounds feature a cinnamoyl structural motif, previously employed successfully in the preparation of lead <b>II</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and, surprisingly, in the recently disclosed MDP-derived NOD2 antagonists<a onclick="showRef(event, 'ref48 cit49a'); return false;" href="javascript:void(0);" class="ref ref48 cit49a">(48,49a)</a> and dual NOD1/NOD2 antagonists revealed in a paper by Wang et al.<a onclick="showRef(event, 'cit49b'); return false;" href="javascript:void(0);" class="ref cit49b">(49b)</a> The SAR analysis offered some explanation on how slight structural variations of the cinnamoyl moiety linked to the glycine amino group affect NOD2 activation, reflected by NF-κB transcriptional activity, with respect to untreated cells (1.0-fold) and MDP (5.6-fold NOD2 activation). It has been suggested that the 6-phenylindole fragment, as a surrogate of Mur<i>N</i>Ac, is a pivotal structural element for NOD2 recognition, as evidenced by our lead <b>I</b>.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Surprisingly, the 6-phenylindole-incorporating compound <b>4</b> was in fact a weaker NOD2 activator (3.9-fold) than all the cinnamoyl moiety-bearing analogs. All the tested variations of the substituted cinnamoyl derivatives were tolerated. Introduction of two fluorine atoms on the phenyl ring of <b>5</b> (5.7-fold), yielding the 3,4-difluorosubstituted <b>7</b> (5.6-fold), did not enhance the activity of the parent compound. Analogously, the 3-methoxy-4-hydroxy substituted derivative <b>9</b> proved to be as strong as the unsubstituted derivative <b>5</b>, with a 5.6-fold NOD2 activation. Cyclopropanation of the alkene moieties of <b>5</b> and <b>7</b> resulted in the corresponding cyclopropane-carrying derivatives <b>6</b> and <b>8</b> with NOD2 agonist activities of 4.4-fold and 5.8-fold. The minor drop in NOD2 activation capacity, as compared to that of the parent compound, is probably a result of the different spatial orientations of the diastereomers composing <b>6</b>. A similar trend was observed with the <span class="smallcaps smallerCapital">l</span>-Phe series. The 3,4-difluorosubstituted <b>13</b> (5.4-fold) and the 3-methoxy-4-hydroxy <b>15</b> (5.7-fold) exhibited activities comparable to that of <b>11</b> (5.3-fold), harboring the unsubstituted cinnamoyl moiety. Compounds <b>12</b> and <b>14</b>, which represent the cyclopropanated congeners of <b>11</b> and <b>13</b>, retained the NOD2 agonistic activity of the parent compounds, exhibiting 5.2-fold and 5.3-fold activation. Again, the fact that <b>12</b> and <b>14</b> are mixtures of diastereomers has to be taken into account. Finally, in agreement with the <span class="smallcaps smallerCapital">l</span>-Val series, the 6-phenylindole-incorporating <b>10</b> proved to be a weaker NOD2 activator (4.8-fold) than any of the cinnamoyl moiety-featuring analogs.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Effects of desmuramylpeptides <b>4</b>–<b>15</b> on NF-κB transcriptional activity. (B) Effects of desmuramylpeptides <b>16</b>, <b>17</b>, <b>22</b>–<b>24</b>, and <b>28</b>–<b>30</b> on NF-κB transcriptional activity. SEAP activities were measured in both NOD2-specific and NOD1-specific HEK-Blue cells after incubation for 18 h with compounds of interest (2 μM), MDP (2 μM), or C12-iE-DAP (100 nM). The data are shown relative to that of the control (NT). Columns represent the means of duplicates of three independent experiments. Error bars indicate ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In an effort to improve the SAR of synthesized desmuramylpeptides and to enable comparison with the previously reported compounds, the <span class="smallcaps smallerCapital">l</span>-Ala-incorporating congener of <b>9</b>, compound <b>16</b>, was prepared. Introduction of the <span class="smallcaps smallerCapital">l</span>-Ala moiety still allowed for NOD2 activation, although to a lesser extent, as evidenced by the 4.5-fold activation. Previous experiments suggested that the increased NOD2 activation was a result of facilitated entry of desmuramylpeptide esters into the cytosol.<a onclick="showRef(event, 'ref25 ref34'); return false;" href="javascript:void(0);" class="ref ref25 ref34">(25,34)</a> The influence of modifications of the <span class="smallcaps smallerCapital">d</span>-Glu moiety was therefore further addressed by investigating the effect of removing the diethyl ester moieties on NOD2 stimulatory activity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). Replacement of the diethyl ester groups of <b>9</b> by free carboxyl groups gave compound <b>17</b>, which exhibited significantly diminished (2.7-fold) NOD2 stimulatory capacity. This observation suggests that the presence of ester moieties is a critical factor contributing to the NOD2-agonistic activity of the compound.</div><div class="NLM_p">Replacement of the <span class="smallcaps smallerCapital">d</span>-glutamic acid moiety by its custom-made mimetics provided some additional information concerning the ability of these compounds to activate NOD2. It has been speculated that both the carboxylate groups of <span class="smallcaps smallerCapital">d</span>-Glu form important interactions with the receptor.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50,51)</a> We thus anticipated that amines carrying only one carboxylate group (incorporated into <b>22</b>–<b>24</b>) would act as poor mimetics of glutamic acid. Nevertheless, a slightly better activity was expected of compounds <b>29</b> and <b>30</b>, which carry two COOMe groups at various positions on the aromatic ring. Unfortunately, the mimetic carrying the 4-amino-1,3-dicarboxyl substitution pattern on the phenyl ring could not be prepared due to difficulties in synthesis. Nevertheless, the results of the activation assay substantiate the importance of the <span class="smallcaps smallerCapital">d</span>-glutamic acid moiety for NOD2 recognition since its replacements with rigidified mimetics completely abolished the NOD2 agonistic capacity of the compounds. This shows that the <span class="smallcaps smallerCapital">d</span>-Glu fragment is an important structural characteristic for NOD2 recognition.</div><div class="NLM_p">The selectivity against NOD1 of all synthesized desmuramylpeptides was also established, employing commercially available HEK-Blue NOD1-dependent NF-κB-inducible SEAP reporter gene assay. These cells were incubated with synthesized desmuramylpeptides (20 μM) for 18 h, followed by the SEAP activity determination in the supernatant. The results that were normalized to that of the control (NT) have shown that none of the desmuramylpeptides nor MDP induced any NF-κB activity relative to the untreated cells (data shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).</div><div class="NLM_p">The specificities of all the synthesized compounds on NOD2 were evaluated in parallel, using HEK-Blue NOD2 cells in the presence or absence of GSK-669, a known NOD2 antagonist.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> HEK-Blue NOD2 cells were preincubated with NOD2 antagonist (10 μM) and then stimulated with synthesized desmuramylpeptides or MDP (2 μM) for 18 h, followed by the SEAP activity determination in the supernatant. The control cells were stimulated only with synthesized desmuramylpeptides and MDP (2 μM). The results that were normalized to those of the control cells, indicate that the induced NF-κB activity is indeed a consequence of the NOD2 agonistic activity of desmuramylpeptides and MDP (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S13</a>).</div><div class="NLM_p">The marginal differences in NOD2 activation observed for most compounds belonging to the <span class="smallcaps smallerCapital">l</span>-Val and <span class="smallcaps smallerCapital">l</span>-Phe series in the single-point assay, however, make it impossible to draw any clear conclusions regarding SAR. For this reason, the dose-dependent effect of selected compounds was investigated. The selection of desmuramylpeptides was based on the results obtained from the preliminary screening on HEK-Blue NOD2 cells at a concentration of 2 μM. At this concentration several of the synthesized desmuramylpeptides exhibited NOD2 agonistic capacities slightly better than, or comparable to, that of MDP, thus proving that all compounds are full agonists of NOD2. MDP and the selected compounds were then tested over a range of concentrations in order to guarantee that the activation experiments were conducted at an effective concentration and to determine their EC<sub>50</sub> values.</div><div class="NLM_p">NF-κB transcriptional activity was induced using 11 concentrations of compounds and MDP (ranging from 0.001 μM to 20 μM) allowing for a precise calculation of their EC<sub>50</sub> values (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Table S2</a>). As expected, the results indicate that increasing concentrations of desmuramylpeptides and MDP have an impact on the activation of NOD2. All the tested desmuramylpeptides, as well as MDP (EC<sub>50</sub> = 92 nM), induced a dose-dependent stimulatory effect on NOD2 activation (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Several conclusions can be drawn in terms of structural requirements for stimulation of the receptor. Comparison of the EC<sub>50</sub> values of three compounds harboring only modifications of the second amino acid residue of the tripeptide moiety, compounds <b>9</b> (<span class="smallcaps smallerCapital">l</span>-Val; EC<sub>50</sub> = 46 nM), <b>15</b> (<span class="smallcaps smallerCapital">l</span>-Phe; EC<sub>50</sub> = 121 nM), and <b>16</b> (<span class="smallcaps smallerCapital">l</span>-Ala; EC<sub>50</sub> = 2.79 μM), revealed an important contribution of the bulkiness and lipophilicity of the amino acid side chain to NOD2 agonism. The methyl side chain of <span class="smallcaps smallerCapital">l</span>-Ala (<b>16</b>) lacks the ability to form strong hydrophobic interactions, in contrast to the isopropyl side chain (<b>9</b>), which resulted in approximately 60-fold loss in activity. The benzyl side chain of <b>15</b>, however, possesses the potential to form hydrophobic interactions but is possibly too large to fit appropriately inside the pocket of the NOD2 receptor. Compound <b>15</b> was indeed less active, presumably due to steric hindrance. This finding suggests that a hydrophobic moiety of the appropriate size serves to greatly increase NOD2 stimulation activity. In line with these results, comparison of compound <b>10</b> (EC<sub>50</sub> = 777 nM), carrying the <span class="smallcaps smallerCapital">l</span>-Phe moiety, with its <span class="smallcaps smallerCapital">l</span>-Ala incorporating counterpart lead <b>I</b> (EC<sub>50</sub> = 2.88 μM) revealed the importance of the amino acid side chain. Compounds <b>5</b> (EC<sub>50</sub> = 223 nM) and <b>11</b> (EC<sub>50</sub> = 388 nM), incorporating the cinnamoyl moiety, exhibited potent NOD2 agonist activity, so we examined the chemical space around the phenyl core. Introduction of two fluorine atoms at positions 3 and 4 resulted in compounds <b>7</b> and <b>13</b> (EC<sub>50</sub> = 172 nM). The 3,4-difluorosubstitution slightly increased (2.3-fold) the activity relative to its unsubstituted counterpart. The <i>trans</i>-feruloyl acyl moiety featured in <b>9</b> and <b>15</b> proved to be the most advantageous in both series of compounds (<span class="smallcaps smallerCapital">l</span>-Val and <span class="smallcaps smallerCapital">l</span>-Phe), thus highlighting this fragment as the most effective mimetic of the carbohydrate portion of the MDP known to date. Replacement of the cinnamoyl moiety (compound <b>11</b>; EC<sub>50</sub> = 388 nM) with its cyclopropane-incorporating bioisostere <b>12</b> (EC<sub>50</sub> = 472 nM) did not affect the NOD2 agonistic activity very much. However, it still has to be borne in mind that <b>12</b> is, in fact, a mixture of two diastereomers, indicating that one of them could adopt a conformation with the most favorable interactions with the receptor. Interestingly, cyclopropanation of the 3,4-difluoro derivative <b>13</b> (EC<sub>50</sub> = 172 nM) diminished the capacity for NOD2 activation, as shown in the case of compound <b>14</b> (EC<sub>50</sub> = 276 nM). However, in analogy to <b>8</b> (EC<sub>50</sub> = 247 nM) from the <span class="smallcaps smallerCapital">l</span>-Val series, <b>14</b> is a mixture consisting of four diastereomers of which only one is likely to bind ideally to NOD2. These compounds were isolated as mixtures of four diastereomers, as confirmed by HPLC chromatography. The stereochemistry on the cyclopropane ring presumably has a role in mimicking the preferred spatial orientation of the appended groups. This makes compounds <b>14</b> and <b>8</b> interesting for further investigations to identify the most potent diastereomer. Evidently, desmuramylpeptides carrying the <span class="smallcaps smallerCapital">l</span>-Val moiety are more effective, in terms of NOD2 recognition, than their <span class="smallcaps smallerCapital">l</span>-Phe counterparts. Finally, conversion of the diethyl ester functionalities of the most potent compound <b>9</b> into free carboxylic acid groups resulted in compound <b>17</b>, which displays an EC<sub>50</sub> value of 6.98 μM, indicating a significant 152-fold drop in activity.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration-dependent activation of NOD2 by selected desmuramylpeptides and by MDP. SEAP activity was measured in NOD2-specific HEK-Blue cells after incubation for 18 h with MDP or with the compound of interest at concentrations ranging from 0.001 to 20 μM. Data points represent means of duplicates of three independent experiments; error bars indicate ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">2.3.3.  Determination of Stability and Cell Uptake of Compound <b>9</b> and Its Hydrolyzed Analog <b>17</b></h4><div class="NLM_p">The higher activity of the diester may be related to improved passive uptake of the ligands, which would result in greater availability of the ligand for the NOD2 receptor. The incorporation of ester linkages has been shown to result in increased internalization of the compounds.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Our preliminary results suggest that diethyl ester derivatives are merely prodrugs since introduction of two 1,2,4-oxadiazole moieties as nonhydrolyzable, bioisosteric replacements of the two diethyl ester moieties<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> resulted in complete loss of NOD2-agonistic activity.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Compounds incorporating ester functionalities are most often cleaved with carboxylic ester hydrolases, particularly carboxylesterases. Most mammalian carboxylesterases belong to the CES1 and CES2 families, which are differentiated on the basis of substrate specificity and tissue distribution. CES1, which preferentially catalyzes hydrolysis of substrates carrying a small alcohol group and a large acyl moiety, is expressed predominantly in human liver and monocytes/macrophages, including the THP-1 cell line.<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55,56)</a> For example, the ethyl ester, once absorbed, is rapidly and predominantly hydrolyzed by the human carboxylesterase 1 (CES1/hCE-1) in the liver.<a onclick="showRef(event, 'ref57 ref58'); return false;" href="javascript:void(0);" class="ref ref57 ref58">(57,58)</a> In contrast, the CES2 (hCE-2) isozyme is the dominant component in the small intestine, where it catalyzes primarily the hydrolysis of compounds carrying a small acyl group and a large alcohol group.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> This raises important questions about the fate of compound <b>9</b>, namely, which is the precise active moiety that is recognized by the receptor and which are the diethyl esters hydrolyzed under the conditions employed, thus converting <b>9</b> into <b>17</b>. HEK293 cells are not particularly known to express carboxylesterase enzymes,<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60,61)</a> so we speculated that the diester moieties of <b>9</b> remain intact, suggesting that the diester is not a prodrug <i>per se</i>, but in fact contributes to NOD2 recognition. Use of a highly sensitive LC–MS method enabled us to shed some light on the fates of compounds <b>9</b> and <b>17</b> under the conditions employed. First, both compounds, at a concentration of 2 μM, remained stable in culture medium for at least 18 h (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S11</a>). Next, we addressed the stability of compound <b>9</b> toward the cell enzymatic system. We collected the extracellular media from an HEK293-NOD2 cell culture treated by incubation with 2 μM concentrations of both compounds for 18 h. Cell lysates obtained from the same experiment were also collected in order to quantify the amount of the tested compound that moved into the cytosol and, also, to examine the extent of compound <b>9</b> intracellular ester hydrolysis. First, the extracellular concentrations measured indicate that ca. 40% of compound <b>9</b> entered the cytosol, while <b>17</b> presumably crossed the membrane to a much lesser extent. The lysate concentrations, which were found to be 0.13 (compound <b>9</b>) and 0.40 μM (compound <b>17</b>), further confirm that both species enter the cytosol (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In light of the strikingly high lysate concentration of compound <b>17</b>, it should be noted that the determined lysate concentrations are not as accurate as the determined extracellular concentrations. Further, compound <b>9</b> has proven to be susceptible to hydrolysis by the cells’ enzyme machinery, shown by approximately 65% of internalized compound <b>9</b> being converted to compound <b>17</b> after an 18 h incubation (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), thus actually supporting the hypothesis that the diester moieties predominantly allow for successful internalization and most likely contribute to binding to NOD2 only to a minor extent.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentrations of compounds <b>9</b> and <b>17</b> in cell supernatant (CS) and cell lysate (LYS) determined in the cell uptake and stability experiment performed by 18 h incubations in the presence of 2 μM compound <b>9</b> (A) and 2 μM compound <b>17</b> (B) in cell incubation media. Dark gray bars represent compound <b>9</b>, and light gray bars represent compound <b>17</b>. Columns represent means of two independent experiments performed in duplicates. Error bars represent SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">2.3.4.  Docking Studies of Compounds <b>9</b>, <b>17</b> and MDP into the Crystal Structure of NOD2</h4><div class="NLM_p">During the course of our study, the crystal structure of rabbit NOD2 was determined in the inactive ADP-bound state. A hydrophobic pocket on the concave surface of the LRR domain has been proposed as a potential MDP-binding site.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Recent experiments involving docking MDP to a homology model of zebrafish NOD2-LRR have shown that the Mur<i>N</i>Ac moiety is responsible for holding the ligand in its correct orientation, suggesting that MDP requires a hydrophobic pocket for its Mur<i>N</i>Ac moiety and a positively charged pocket for its <span class="smallcaps smallerCapital">l</span>-Ala-<span class="smallcaps smallerCapital">d</span>-<i>i</i>Gln part.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Further, using surface plasmon resonance methodology, Lauro et al. recently established that the molecular recognition of MDP indeed occurs in the LRR domain, and they defined the critical residues responsible for NOD2 recognition. In addition, they showed that both the dipeptide and the carbohydrate moiety contribute to the binding.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The putative binding residues for the NOD2-MDP interaction, namely, Arg857, Trp911, and Ser913, were highlighted in all models and are thus presumed to be critical for binding. Aromatic residues such as Trp911 are markedly involved in carbohydrate-binding sites, in line with recent findings showing that aromatic rings of the receptor often contribute to carbohydrate recognition in spite of the highly hydrophilic characters of most sugars.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63,64)</a> Compound <b>9</b>, incorporating the <i>trans</i>-feruloyl mimetic of Mur<i>N</i>Ac, displayed the most potent NOD2 agonistic activity, suggesting that the 4-hydroxy-3-methoxycinnamoyl fragment is a pivotal structural feature for NOD2 recognition. However, stability and cell uptake studies suggest that its carboxylic acid derivative <b>17</b>, which is the result of hydrolysis of compound <b>9</b> after uptake, could be the active compound. Therefore, a proposed model for the orientation of MDP and compounds <b>9</b> and <b>17</b> in the putative binding pocket was developed using the crystal structure of rabbit NOD2 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN">5IRN</a>) and GOLD software. The recognition is predicted to take place in the center of the LRR horseshoe fold. This model shows that Arg857 makes hydrogen bonding interactions with both the carbohydrate portion of MDP and the dipeptide (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a), as observed previously.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> However, there are certain differences in the predicted MDP binding modes to NOD2, which can be attributed to flexibility of the proposed binding pocket. This was partially addressed by making selected side chains flexible in the study of Lauro et al, while in our docking protocol the protein was kept rigid. Nevertheless, the MDP sugar moiety was found to occupy the same hydrophobic pocket and the dipeptide was predicted to be in contact with the Arg857 side chain in both studies. The stability of the NOD2-MDP complex was evaluated through molecular dynamics simulation in which the orientation of MDP slightly changed, but it still remained in contact with relevant residues (i.e., Arg857 and Trp911, <a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S1</a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted binding modes of (a) MDP (magenta sticks) and (b) <b>17</b> (green sticks) in the putative binding pocket on the concave surface of the LRR domain of NOD2 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN">5IRN</a>). The protein is shown in surface presentation, and for clarity, only amino acid side chains interacting with the ligands are shown as gray sticks. Hydrogen bonds are shown as black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Docking of compound <b>17</b> suggests its similar orientation to that of MDP (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b) in the putative binding pocket on the concave surface of the LRR domain of NOD2. The 4-hydroxy-3-methoxycinnamoyl moiety of <b>17</b> was suggested to mimic the sugar moiety of MDP since it binds to the same hydrophobic pocket, where it forms π–π stacking with Trp911 side chain and cation−π interaction with Arg857, while its methoxy group interacts with Ser913 side chain. Additional interaction is predicted between the hydroxy group of the 4-hydroxy-3-methoxycinnamoyl moiety and backbone NH of Trp887. Tripeptide moiety of <b>17</b> forms several hydrogen bonds with NOD2 residues. In detail, Gly carbonyl oxygen of <b>17</b> is hydrogen bonded to Arg803 side chain, while α-carboxylate of the <span class="smallcaps smallerCapital">d</span>-Glu of <b>17</b> interacts with the Tyr801 side chain and γ-carboxylate with the Lys827 and Arg857 side chains. The stability of the proposed binding mode of <b>17</b> was tested with molecular dynamics simulation in which only slight reorientation of the tripeptide portion of <b>17</b> was observed (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S2</a>).</div><div class="NLM_p">Compound <b>9</b> was predicted to bind in two different orientations to NOD2; the first similar to that of compound <b>17</b> and the second in a different orientation in relation to MDP (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S3</a>). However, when NOD2 in complex with <b>9</b> was studied by molecular dynamics simulations neither of these poses proved stable (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figures S4 and S5</a>), which is in agreement with the docking studies that predicted more extensive hydrogen bonding network of the carboxylate <b>17</b> than its ester derivative <b>9</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">S3</a>).</div><div class="NLM_p last">Taken together, our docking model thus suggests good complementarity of MDP and compound <b>17</b> and the binding pocket in the NOD2 LRR domain. Additional structural insights have thus been provided into the pharmacophores required for NOD2 activation.</div></div><div id="sec2_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">2.3.5.  Immunostimulatory Properties of Desmuramylpeptide <b>9</b> and MDP on PBMCs</h4><div class="NLM_p">The immunostimulatory activity of the best compound <b>9</b> was investigated on human peripheral blood mononuclear cells (PBMC) using the Human Th1/Th2/Th17 cytokine kit in order to extend the analysis beyond reporter gene assays (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Desmuramylpeptide <b>9</b> and MDP were evaluated for their ability to modulate pro- and anti-inflammatory cytokine production in PBMCs, alone or in combination with LPS. PBMCs constitute a physiologically relevant model system for investigating the immunomodulatory properties of a broad range of innate immune stimulants.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> The immunostimulatory capacity of NOD2 agonists is grounded mainly on stimulation of monocytes/macrophages. Similarly, LPS acts as an effective stimulus for the induction of Th1-type cytokines and mainly stimulates monocytes.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Unstimulated PBMCs produce few or no cytokines spontaneously, and as expected, stimulation of PBMCs with MDP and <b>9</b> alone (2 μM concentration) produced modest amounts of cytokines. Nevertheless, the release of TNF-α, IL-6 and IL-10 was increased significantly by both compounds (compared to untreated cells).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of MDP and compound <b>9</b> on cytokine release in PBMCs. Cells were treated with 2 μM MDP or <b>9</b> in the presence or absence of 10 ng/mL LPS. Cytokine release was determined after 18 h. Columns represent means of duplicates ± SEM of two independent experiments (data are representative of two independent donors); *<i>p</i> < 0.05 vs untreated (NT) or LPS-treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, stimulation with LPS brought about a considerable increase in cytokine release. This effect was evidently potentiated by the presence of MDP or compound <b>9</b> for all cytokines tested. The LPS-evoked release of the anti-inflammatory cytokine IL-10 was significantly amplified 5-fold by MDP or compound <b>9</b>. This effect was also observed in the case of the release of proinflammatory cytokines. Namely, the TNF-α release was increased 3-fold by compound <b>9</b> and 3.6-fold by MDP, while IL-6 release was increased 4-fold by both compounds.</div><div class="NLM_p last">The results are in agreement with those in studies that identified a powerful amplification effect of MDP on TLR4-induced cytokine production from isolated PBMCs while, on its own, inducing only low levels cytokines.<a onclick="showRef(event, 'ref14 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref14 ref67 ref68">(14,67,68)</a> The capacity of MDP to synergize with LPS and other TLR ligands, resulting in an amplified proinflammatory cytokine response, is well documented.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Such a synergy can be of great physiological importance since, during bacterial infection, MDP and LPS are likely to be present in the same tissues.</div></div><div id="sec2_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">2.3.6.  Adjuvant Properties of Liposome-Encapsulated <b>9</b> and MDP in OVA-Induced Antibody Response</h4><div class="NLM_p">An evident correlation between NOD2-stimulating capacities as well as adjuvant and antimicrobial properties of MDP derivatives has been shown;<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> so, desmuramylpeptide <b>9</b> was investigated further to evaluate its usefulness as an adjuvant. First, we established that <b>9</b> was devoid of any pyrogenic activity due to potential endotoxin contamination using a standard bacterial endotoxin test (data not shown).</div><div class="NLM_p">NOD2 induces a predominant Th2 polarized response, while a combination of PRR ligands such as NLR/TLR evokes a Th1 and Th17 response. Also, Tukhvatulin et al. showed that, by employing a multi-PRR activation approach as part of a standard alum-based vaccine formulation, activation of both cellular and humoral immunity was significantly increased. In fact, it proved to be superior to alum or a combination of alum and an individual PRR ligand.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The adjuvanticity of MDP was also shown to depend on the mode of administration; thus, MDP evoked a potent response when delivered with lipophilic carrier systems, such as liposomes.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Liposomes have long been used as carriers of antigens and adjuvants to enhance the immune response.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> The aim of this experiment was to evaluate liposome-encapsulated MDP and <b>9</b> for their immunoadjuvant activity in a well-defined mouse model. Specifically, their effect on the induction of a humoral immune response specific for protein antigen ovalbumin (OVA) as well as their capacity to skew the immune response toward Th1/Th2 were investigated. The group treated with OVA alone acted as a negative control. Both MDP and <b>9</b> increased anti-OVA IgG levels in sera relative to those in the control (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the adjuvant effects of MDP and <b>9</b> on the production of total anti-OVA IgGs in the sera of three experimental groups of NIH/OlaHsd female mice (<i>n</i> = 6) after the second booster. OVA in liposomes (50 μg of OVA in sterile PBS); OVA + MDP in liposomes (50 μg of OVA with 200 μg/mouse of MDP); OVA + <b>9</b> in liposomes (50 μg of OVA with 200 μg/mouse of <b>9</b>). ○ Denotes each mouse separately; −–– denotes group mean value; *<i>p</i> < 0.05 (Kruskal–Wallis ANOVA, followed by multiple Mann–Whitney U-nonparametric tests) in comparison to the group not treated by adjuvant or in comparison with the group connected with dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is well-known that vaccine adjuvants can modulate the Th1/Th2-bias of an induced immune response. In our study, the nature of the immune response produced was estimated indirectly by quantification of antigen-specific IgG1 (Th2-associated isotype) and IgG2a (Th1-associated isotype) and calculation of their ratio (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The immune response specific for OVA was Th2-biased with an IgG1/IgG2a ratio of 44.3 (log IgG1/IgG2a = 1.69) as demonstrated by Habjanec,<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73,74)</a> while the adjuvanticity of MDP depends on the administration context. Administration in saline increased the humoral immunity, while its incorporation into liposomes resulted in cell-mediated immunity.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> In addition, hydrophilic MDP derivatives are known to induce a Th2-type response as opposed to lipophilic derivatives, which augment the Th-1 type immune response. Of note, it was shown that coadministration of MDP and alum skews the immune response toward the Th1 type. IgG1 was the predominant IgG subclass for all groups, while only MDP, albeit weakly, induced an IgG2 response, resulting in an IgG1/IgG2a ratio of 133 (log IgG1/IgG2a = 2.37). In contrast, <b>9</b> displayed an IgG1/IgG2a ratio of 258 (log IgG1/IgG2a = 2.62) indicating a slight shift of the immune reaction toward the Th2 type of response. The result of this preliminary experiment sheds some light on the immunoadjuvant activity of both MDP and <b>9</b>. Compound <b>9</b> could function as an adjuvant, as evidenced by the OVA-specific serum IgG1 antibodies detected after a prime-boost immunization regimen with OVA + <b>9</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Ratio of Anti-OVA IgG1 and Anti-OVA IgG2a Levels Following a Second Booster</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">experimental group</th><th class="colsep0 rowsep0" align="center" char="±">log<sub>10</sub> (anti-OVA IgG1/anti-OVA IgG2a)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">OVA in liposomes</td><td class="colsep0 rowsep0" align="char" char="±">1.69 ± 0.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(OVA + MDP) in liposomes</td><td class="colsep0 rowsep0" align="char" char="±">2.37 ± 0.39<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(OVA + <b>9</b>) in liposomes</td><td class="colsep0 rowsep0" align="char" char="±">2.62 ± 0.55<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The IgG1/IgG2a ratio was calculated after the second booster for each mouse serum. The results for each experimental group (<i>n</i> = 6; females) are reported as the means ± SD.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">*<i>p</i> ≤ 0.01 in comparison to the first group.</p></div></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">3.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78586" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78586" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of fourth-generation desmuramylpeptides have been designed and prepared. Diverse variations were incorporated into the parent molecules providing further insights into the structure–activity relationship. The obtained results significantly increase our understanding of the structural requirements of desmuramylpeptides for NOD2-activation. In particular, compound <b>9</b> was identified as the, so far, most potent NOD2 agonist of the desmuramylpeptide structural class. Compound <b>9</b> also possesses the ability to augment LPS-induced pro-inflammatory cytokine release from PBMCs as well as to increase OVA-specific IgG titers in a mouse model of adjuvancy. Together, our results indicate that <b>9</b> can induce both innate and adaptive immune responses and thus demonstrate the potential utility of NOD2 agonists as adjuvants for vaccines.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51310" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51310" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.1.  General</h3><div class="NLM_p last">Chemicals were obtained from Acros, Aldrich Chemical Co., Molekula, Enamine, and Fluka, and used without further purification. MDP and LPS (from <i>E. coli</i> O111:B4) were obtained from Invivogen, Inc., (San Diego, CA). NOD2 antagonist was synthesized as described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Analytical TLC was performed on Merck 60 F254 silica gel plates (0.25 mm), using visualization with ultraviolet light and ninhydrin. Column chromatography was carried out on silica gel 60 (particle size 240–400 mesh). Melting points were determined on a Reichert hot stage microscope and are uncorrected. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 400 and 100 MHz, respectively, on a Bruker AVANCE III spectrometer in CDCl<sub>3</sub>, acetone-<i>d</i><sub>6</sub>, or MeOD solution with tetramethylsilane (TMS) as the internal standard. Spectra were assigned using gradient HSQC and HMBC. IR spectra were recorded on a PerkinElmer 1600 FT-IR spectrometer. Mass spectra were obtained using a VG-Analytical Autospec Q mass spectrometer. HPLC analyses for determination of purity were performed on an Agilent Technologies HP 1100 instrument with G1365B UV–vis detector (254 nm), using a Luna C18 column (4.6 × 150 mm) at a flow rate of 1 mL/min. The eluent was a mixture of 0.1% TFA in water (A) and acetonitrile (B), with a gradient of 30% B to 80% B from 0 to 30 min and 80% B to 90% B from 30 to 33 min. The purity of all biologically tested compounds is ≥95%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">4.2.  General Procedures</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">4.2.1.  TFA-Mediated Acidolysis</h4><div class="NLM_p last">Boc-protected compound (5 mmol) was added to an ice-chilled stirred mixture of trifluoroacetic acid and dichloromethane (5/1, 10 mL), and the mixture was allowed to warm to room temperature. After 3 h the reaction was completed. The solvent was evaporated <i>in vacuo</i>. The residue was washed three times with diethyl ether and used immediately for the next step.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22">4.2.2.  DCC-Mediated Coupling</h4><div class="NLM_p last">To a stirred solution of the corresponding carboxylic acid derivative (5.5 mmol) and amine (5 mmol) in dry ethyl acetate, diisopropylethylamine (DIPEA) (12.5 mmol) was added at 0 °C. After stirring for 15 min, DCC (5.5 mmol), HOBt (5.5 mmol), and a catalytic amount of 4-dimethylaminopyridine (DMAP) were added, and the mixture was allowed to warm to room temperature with stirring, the latter being continued overnight. The reaction mixture was filtered, and the filtrate was diluted with ethyl acetate (50 mL) and washed twice with a solution of 1 M HCl (2 × 20 mL), water (20 mL), saturated NaHCO<sub>3</sub> solution (2 × 20 mL), and water (20 mL), then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated <i>in vacuo</i>. If necessary, the residues were additionally purified using column chromatography to afford sufficiently pure products.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23">4.2.3.  EDC-Mediated Coupling</h4><div class="NLM_p last">To a stirred solution of the corresponding carboxylic acid derivative (0.33 mmol) and amine (0.3 mmol) in dry dichloromethane, DIPEA (0.75 mmol) was added at 0 °C. After stirring for 15 min, EDC (0.33 mmol), HOBt (0.33 mmol), and a catalytic amount of DMAP were added, and the mixture was allowed to warm to room temperature. Stirring was continued overnight. On completion, the reaction mixture was diluted with dichloromethane (30 mL) and then washed with 1 M HCl (2 × 10 mL), water (20 mL), saturated NaHCO<sub>3</sub> solution (2 × 10 mL), and water (20 mL), then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated <i>in vacuo</i>. If necessary, the products were further purified using column chromatography to afford sufficiently pure products.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24">4.2.4.  Alkaline Hydrolysis</h4><div class="NLM_p last">To a solution of ethyl ester (2 mmol) in ethanol was added 1 M NaOH (4 mL), and the mixture stirred for 24 h at room temperature. Upon completion of the reaction, as monitored by TLC, the ethanol was evaporated, and the remaining water phase acidified with 1 M HCl to pH ≈ 3. The obtained precipitate was filtered off and dried at 75 °C in an oven to afford compounds.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">4.3.  Characterization of Compounds</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26">4.3.1.  Diethyl (6-Phenyl-1<i>H</i>-indole-2-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>4</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. Yellow-white amorphous solid, yield 66 mg (38%); mp 150–153 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.17 (d, 3H, <i>J</i> = 6.8 Hz, C<u class="uu">H</u><sub>3</sub>-Val), 1.20 (d, 3H, <i>J</i> = 6.8 Hz, C<u class="uu">H</u><sub>3</sub>-Val), 1.32–1.40 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 2.31–2.38 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 2.43–2.51 (m, 2H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu and C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.58–2.67 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 4.19–4.37 (m, 4H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 4.47–4.52 (m, 1H, NHC<u class="uu">H</u><sub>2<u class="uu">A</u></sub>), 4.76–4.81 (m, 1H, NHC<u class="uu">H</u><sub>2<u class="uu">B</u></sub>), 4.85–4.93 (m, 2H, α-C<u class="uu">H</u>-Val and α-C<u class="uu">H</u>-Glu), 7.26 (s, 1H, <u class="uu">H</u>-Ar), 7.50–7.61 (m, 4H, 4 × <u class="uu">H</u>-Ar), 7.81–7.85 (m, 4H, 4 × <u class="uu">H</u>-Ar), 8.02 (d, 1H, <i>J</i> = 7.2 Hz, NH), 8.23 (s, 1H, N<u class="uu">H</u>CH<sub>2</sub>), 8.51 (d, 1H, <i>J</i> = 9.2 Hz, NH), 10.76 (s, 1H, indole-N<u class="uu">H</u>) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.08, 17.97, 19.35, 26.95, 30.48, 31.39, 43.79, 52.29, 58.50, 60.93, 61.79, 103.45, 110.63, 120.26, 122.17, 126.86, 126.92, 127.28, 128.73, 130.70, 137.48, 141.95, 162.39, 169.82, 171.67, 171.97, 173.03 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 577.3 (M – H)<sup>−</sup>. IR (ATR): ν = 3262, 2961, 1714, 1675, 1633, 1547, 1373, 1332, 1285, 1204, 1113, 1019, 825, 741, 693 cm<sup>–1</sup>. HPLC (254 nm): 100.0%, <i>t</i><sub>r</sub> = 19.64 min. HRMS Calcd for C<sub>31</sub>H<sub>37</sub>N<sub>4</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 577.2662 (M – H)<sup>−</sup>, found 577.2664. [α]<sub>D</sub><sup>20</sup> = −14.8° (<i>c</i> 0.22, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27">4.3.2.  Diethyl Cinnamoylglycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>5</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 88 mg (60%); mp 157–160 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.94–0.99 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.18–1.24 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.99–2.08 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 2.14–2.23 (m, 2H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu in C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.33–2.47 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 4.04–4.32 (m, 6H, NHC<u class="uu">H</u><sub>2</sub> and 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 4.53–4.62 (m, 2H, α-C<u class="uu">H</u>-Val and α-C<u class="uu">H</u>-Glu), 6.63 (d, 1H, <i>J</i> = 15.6 Hz, CH═C<u class="uu">H</u>), 7.32–7.34 (m, 4H, 3 × <u class="uu">H</u>-Ar in N<u class="uu">H</u>CH<sub>2</sub>), 7.45 (d, 1H, <i>J</i> = 8.8 Hz, N<u class="uu">H</u>), 7.49–7.51 (m, 2H, 2 × <u class="uu">H</u>-Ar), 7.62–7.66 (m, 2H, C<u class="uu">H</u>═CH and N<u class="uu">H</u>) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.11, 14.14, 17.95, 19.33, 26.90, 30.40, 31.23, 43.63, 51.86, 58.50, 60.74, 61.59, 120.22, 127.92, 128.81, 129.76, 134.82, 141.55, 166.61, 169.44, 171.32, 171.59, 172.79 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 488.2 (M – H)<sup>−</sup>. IR (ATR): ν = 3266, 3069, 2965, 1730, 1689, 1640, 1612, 1528, 1448, 1392, 1213, 1162, 1110, 1022, 977, 861, 766, 733, 694, 664 cm<sup>–1</sup>. HPLC (254 nm): 100.0%, <i>t</i><sub>r</sub> = 12.68 min. HRMS Calcd for C<sub>25</sub>H<sub>34</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 488.2397 (M – H)<sup>−</sup>, found 488.2393. [α]<sub>D</sub><sup>20</sup> = +17.7° (<i>c</i> 0.12, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28">4.3.3.  Diethyl (<i>trans</i>-2-Phenylcyclopropane-1-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>6</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 101 mg (67%); mp 159–162 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.90–0.94 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.19–1.24 (m, 7H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub> and PhCHC<u class="uu">H</u><sub>2<u class="uu">A</u></sub>CH), 1.54–1.59 (m, 1H, PhCHC<u class="uu">H</u><sub>2<u class="uu">B</u></sub>CH), 1.84–1.89 (m, 1H, PhCHCH<sub>2</sub>C<u class="uu">H</u>), 1.93–2.02 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 2.08–2.18 (m, 2H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu and C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.31–2.36 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 2.44–2.48 (m, 1H, PhC<u class="uu">H</u>CH<sub>2</sub>CH), 4.00–4.23 (m, 6H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NHC<u class="uu">H</u><sub>2</sub>), 4.47–4.54 (m, 2H, α-C<u class="uu">H</u>-Val and α-C<u class="uu">H</u>-Glu), 7.06–7.08 (m, 2H, 2 × <u class="uu">H</u>-Ar), 7.13–7.18 (m, 1H, <u class="uu">H</u>-Ar), 7.22–7.33 (m, 4H, 2 × <u class="uu">H</u>-Ar and N<u class="uu">H</u>CH<sub>2</sub> and NH), 7.53–7.58 (m, 1H, NH) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.11, 14.16, 16.06, 17.88, 17.94, 19.22, 25.30, 25.90, 25.97, 26.94, 30.39, 31.22, 31.29, 43.62, 43.72, 51.76, 51.80, 58.26, 60.76, 61.57, 126.11, 126.14, 126.25, 126.28, 128.41, 128.43, 140.68, 169.33, 171.19, 171.58, 171.61, 172.81, 172.84 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 502.3 (M – H)<sup>−</sup>. IR (ATR): ν = 3271, 2965, 1734, 1624, 1530, 1446, 1374, 1262, 1207, 1176, 1094, 1023, 935, 857, 757, 696 cm<sup>–1</sup>. HPLC (254 nm): 58.0% (<i>t</i><sub>r</sub> = 13.95 min), 42.0% (<i>t</i><sub>r</sub> = 14.21 min); total: 100% (mixture of 2 diastereomers). HRMS Calcd for C<sub>26</sub>H<sub>36</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 502.2553 (M – H)<sup>−</sup>, found 502.2555. [α]<sub>D</sub><sup>20</sup> = −1.8° (<i>c</i> 0.25, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29">4.3.4.  Diethyl ((<i>E</i>)-3-(3,4-Difluorophenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>7</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 96 mg (61%); mp 163–166 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.93–0.98 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.18–1.27 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.99–2.08 (m, 1H, C<u class="uu">H</u><sub>2A</sub>-β-Glu), 2.12–2.23 (m, 2H, C<u class="uu">H</u><sub>2B</sub>-β-Glu and C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.33–2.47 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 4.05–4.30 (m, 6H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NH-C<u class="uu">H</u><sub>2</sub>), 4.48–4.61 (m, 2H, α-C<u class="uu">H</u>-Glu and α-C<u class="uu">H</u>-Val), 6.55 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH), 7.19–7.23 (m, 1H, <u class="uu">H</u>-Ar), 7.10–7.16 (m, 1H, <u class="uu">H</u>-Ar), 7.22–7.25 (m, 2H, <u class="uu">H</u>-Ar and N<u class="uu">H</u>), 7.46 (d, 1H, <i>J</i> = 8.0 Hz, N<u class="uu">H</u>), 7.54 (d, 1H, <i>J</i> = 15.6 Hz, CH═C<u class="uu">H</u>), 7.63 (d, 1H, <i>J</i> = 8.0 Hz, N<u class="uu">H</u>) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.10, 14.11, 17.96, 19.29, 26.86, 30.38, 31.18, 51.89, 58.55, 60.81, 61.65, 116.13 (d, <i>J</i> = 20.1 Hz), 117.70 (d, <i>J</i> = 17.4 Hz), 121.20, 124.67, 132.08 (d, <i>J</i> = 8.1 Hz), 139.35, 139.38, 166.03, 169.32, 171.30, 171.66, 172.83 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 526.2 (M + H)<sup>+</sup>. IR (ATR): ν = 3287, 2930, 1735, 1636, 1515, 1376, 1275, 1202, 1113, 1023, 970, 855, 818, 774, 669 cm<sup>–1</sup>. HPLC (254 nm): 98.0%, <i>t</i><sub>r</sub> = 13.22 min. HRMS Calcd for C<sub>25</sub>H<sub>34</sub>F<sub>2</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 526.2365 (M + H)<sup>+</sup>, found 526.2360. [α]<sub>D</sub><sup>20</sup> = +2.8° (<i>c</i> 0.15, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30">4.3.5.  Diethyl (2-(3,4-Difluorophenyl)cyclopropane-1-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>8</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 105 mg (61%); mp 164–167 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.91–0.94 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.20–1.25 (m, 7H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub> and PhCHC<u class="uu">H</u><sub>2<u class="uu">A</u></sub>CH), 1.53–1.58 (m, 1H, PhCHC<u class="uu">H</u><sub>2<u class="uu">B</u></sub>CH), 1.82–1.84 (m, 1H, PhCHCH<sub>2</sub>C<u class="uu">H</u>), 1.95–2.00 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 2.11–2.17 (m, 2H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu and C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.26–2.49 (m, 3H, C<u class="uu">H</u><sub>2</sub>-γ-Glu and PhC<u class="uu">H</u>CH<sub>2</sub>CH), 4.03–4.21 (m, 6H, NHC<u class="uu">H</u><sub>2</sub> and 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 4.50–4.51 (m, 2H, α-C<u class="uu">H</u>-Val and α-C<u class="uu">H</u>-Glu), 6.82–6.91 (m, 2H, 2 × <u class="uu">H</u>-Ar), 7.00–7.07 (m, 1H, <u class="uu">H</u>-Ar), 7.26–7.29 (m, 2H, 2 × NH), 7.53–7.54 (m, 1H, NH) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.07, 14.14, 16.02, 17.88, 17.91, 19.21, 24.35, 25.90, 26.90, 26.94, 30.35, 31.28, 43.61, 51.80, 51.83, 58.28, 60.82, 61.63, 114.93 (d, <i>J</i> = 4.4 Hz), 115.10 (d, <i>J</i> = 4.3 Hz), 117.20 (d, <i>J</i> = 3.3 Hz), 122.38, 137.72–137.82 (m), 148.37 (dd, <i>J</i> = 129.5 Hz, <i>J</i> = 14.5 Hz), 150.76 (dd, <i>J</i> = 141.1 Hz, <i>J</i> = 9.8 Hz), 169.20, 171.12, 171.58, 172.28, 172.81 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 538.2 (M – H)<sup>−</sup>. IR (ATR): ν = 3280, 2923, 1732, 1631, 1546, 1522, 1454, 1381, 1268, 1219, 1165, 1116, 1064, 1023, 910, 862, 812, 771, 715, 668, 613 cm<sup>–1</sup>. HPLC (254 nm): 18.06% (<i>t</i><sub>r</sub> = 14,46 min), 56.27% (<i>t</i><sub>r</sub> = 15,80 min), 23.25% (<i>t</i><sub>r</sub> = 16,46 min); total: 97.58% (mixture of 4 diastereomers). HRMS Calcd for C<sub>26</sub>H<sub>34</sub>F<sub>2</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 538.2365 (M – H)<sup>−</sup>, found 538.2353. [α]<sub>D</sub><sup>20</sup> = +39.3° (<i>c</i> 0.15, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">4.3.6.  Diethyl ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>9</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. Yellow-white amorphous solid, yield 58 mg (36%); mp 117–120 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.93 (d, 3H, <i>J</i> = 6.8 Hz, C<u class="uu">H</u><sub>3</sub>-Val), 0.97 (d, 3H, <i>J</i> = 6.8 Hz, C<u class="uu">H</u><sub>3</sub>-Val), 1.21–1.29 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.99–2.08 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 2.15–2.30 (m, 2H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu and C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.32–2.47 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 3.92 (s, 3H, OCH<sub>3</sub>), 4.05–4.22 (m, 6H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NHC<u class="uu">H</u><sub>2</sub>), 4.38–4.44 (m, 1H, α-C<u class="uu">H</u>), 4.51–4.56 (m, 1H, α-C<u class="uu">H</u>), 5.87 (br s, 1H, OH), 6.34 (d, 1H, <i>J</i> = 15.6 Hz, CH═C<u class="uu">H</u>), 6.59 (t, 1H, <i>J</i> = 5.2 Hz, N<u class="uu">H</u>CH<sub>2</sub>), 6.81 (d, 1H, <i>J</i> = 8.4 Hz, N<u class="uu">H</u>), 6.90 (d, 1H, <i>J</i> = 8.0 Hz, <u class="uu">H</u>-Ar), 7.02 (d, 1H, <i>J</i> = 1.2 Hz, <u class="uu">H</u>-Ar), 7.05–7.09 (m, 2H, <u class="uu">H</u>-Ar and N<u class="uu">H</u>), 7.57 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.09, 14.14, 17.87, 19.34, 26.81, 30.42, 30.92, 43.61, 51.90, 55.93, 58.58, 60.76, 61.62, 110.09, 114.82, 117.54, 122.14, 127.23, 141.68, 146.83, 147.58, 167.04, 169.76, 171.45, 171.73, 172.84 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 534.2 (M – H)<sup>−</sup>. IR (ATR): ν = 3287, 2963, 1725, 1635, 1513, 1452, 1374, 1265, 1192, 1122, 1025, 976, 844, 814, 680 cm<sup>–1</sup>. HPLC (254 nm): 96.3%, <i>t</i><sub>r</sub> = 7.45 min. HRMS Calcd for C<sub>26</sub>H<sub>36</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 534.2452 (M – H)<sup>−</sup>, found 534.2458. [α]<sub>D</sub><sup>20</sup> = +15.4° (<i>c</i> 0.22, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">4.3.7.  Diethyl (6-Phenyl-1<i>H</i>-indole-2-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>10</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. Yellow amorphous solid, yield 83 mg (44%); mp 63–67 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.16–1.25 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.90–2.01 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 2.04–2.20 (m, 2H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu and C<u class="uu">H</u><sub>2</sub>-γ-Glu), 3.14 (d, 1H, <i>J</i> = 7.6 Hz, C<u class="uu">H</u><sub>2</sub>-Phe), 3.99–4.23 (m, 5H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NHC<u class="uu">H</u><sub>2<u class="uu">A</u></sub>), 4.41–4.50 (m, 1H, NHC<u class="uu">H</u><sub>2<u class="uu">B</u></sub>), 4.58–4.63 (m, 1H, α-C<u class="uu">H</u>), 5.04 (q, 1H, <i>J</i> = 7.6 Hz, α-C<u class="uu">H</u>), 7.04 (s, 1H, <u class="uu">H</u>-Ar), 7.07–7.10 (m, 1H, <u class="uu">H</u>-Ar), 7.10–7.22 (m, 4H, 4 × <u class="uu">H</u>-Ar), 7.31–7.45 (m, 4H, 4 × <u class="uu">H</u>-Ar), 7.49 (d, 1H, <i>J</i> = 7.6 Hz, NH), 7.65–7.69 (m, 3H, 3 × <u class="uu">H</u>-Ar), 7.74 (t, 1H, <i>J</i> = 4.8 Hz, N<u class="uu">H</u>CH<sub>2</sub>), 8.29 (d, 1H, <i>J</i> = 8.4 Hz, NH), 10.57 (s, 1H, indole-N<u class="uu">H</u>) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.05, 14.14, 26.89, 28.32, 30.06, 39.02, 43.59, 52.07, 54.72, 60.82, 61.69, 61.80, 110.64, 120.36, 122.23, 126.93, 126.97, 127.30, 128.58, 128.76, 129.35, 130.61, 136.42, 137.51, 141.95, 162.22, 169.24, 171.16, 171.78, 172.95 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 627.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3279, 1731, 1647, 1513, 1448, 1375, 1334, 1199, 1122, 1027, 830, 743, 698 cm<sup>–1</sup>. HPLC (254 nm): 96.8%, <i>t</i><sub>r</sub> = 21.99 min. HRMS Calcd for C<sub>35</sub>H<sub>39</sub>N<sub>4</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 627.2819 (M + H)<sup>+</sup>, found 627.2814. [α]<sub>D</sub><sup>20</sup> = −13.1° (<i>c</i> 0.16, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">4.3.8.  Diethyl Cinnamoylglycyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>11</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 119 mg (74%); mp 115–117 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.18–1.23 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.84–1.94 (m, 1H, <u class="uu">H</u>-β-Glu), 1.97–2.13 (m, 3H, <u class="uu">H</u>-β-Glu and C<u class="uu">H</u><sub>2</sub>-γ-Glu), 3.10 (d, 2H, <i>J</i> = 7.2 Hz, C<u class="uu">H</u><sub>2</sub>-Phe), 4.04–4.23 (m, 6H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NHC<u class="uu">H</u><sub>2</sub>), 4.52–4.57 (m, 1H, α-C<u class="uu">H</u>), 4.98–5.04 (m, 1H, α-C<u class="uu">H</u>), 6.63 (d, 1H, <i>J</i> = 16.0 Hz, CH═C<u class="uu">H</u>), 7.13–7.22 (m, 5H, Ar-<u class="uu">H</u>), 7.33–7.35 (m, 3H, Ar-<u class="uu">H</u> and CON<u class="uu">H</u>CH<sub>2</sub>), 7.49–7.51 (m, 2H, Ar-<u class="uu">H</u> and N<u class="uu">H</u>), 7.59–7.67 (m, 2H, C<u class="uu">H</u>═CH in NH) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.09, 14.19, 26.87, 30.01, 39.04, 43.51, 51.70, 54.49, 60.62, 61.58, 120.33, 126.96, 127.94, 128.59, 128.82, 129.42, 129.74, 134.90, 136.35, 141.53, 166.55, 169.15, 170.93, 171.50, 172.68 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 538.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3258, 1734, 1691, 1645, 1612, 1552, 1523, 1450, 1392, 1328, 1254, 1195, 1106, 1075, 1033, 989, 774, 732, 695, 671, 622 cm<sup>–1</sup>. HPLC (254 nm): 99.0%, <i>t</i><sub>r</sub> = 15.66 min. HRMS Calcd for C<sub>29</sub>H<sub>36</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 538.2553 (M + H)<sup>+</sup>, found 538.2560. [α]<sub>D</sub><sup>20</sup> = −9.6° (<i>c</i> 0.15, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">4.3.9.  Diethyl (<i>trans</i>-2-Phenylcyclopropane-1-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>12</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 98 mg (59%); mp 107–108 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.23–1.27 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.56–1.62 (m, 1H, PhCHC<u class="uu">H</u><sub>2<u class="uu">A</u></sub>CH), 1.69–1.75 (m, 1H, PhCHC<u class="uu">H</u><sub>2<u class="uu">B</u></sub>CH), 1.80–1.90 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 1.97–2.06 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu), 2.08–2.21 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 2.45–2.51 (m, 1H, PhC<u class="uu">H</u>CH<sub>2</sub>CH), 3.03–3.13 (m, 2H, C<u class="uu">H</u><sub>2</sub>-Phe), 3.88–4.04 (m, 2H, NHC<u class="uu">H</u><sub>2</sub>), 4.06–4.17 (m, 4H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 4.43–4.48 (m, 1H, α-C<u class="uu">H</u>), 4.77 (q, 1H, <i>J</i> = 7.2 Hz, α-C<u class="uu">H</u>), 6.64 (s, 1H, <u class="uu">H</u>-Ar), 6.77–6.81 (m, 1H, <u class="uu">H</u>-Ar), 6.90 (t, 1H, <i>J</i> = 7.2 Hz, NH), 7.07–7.09 (m, 2H, <u class="uu">H</u>-Ar), 7.18–7.29 (m, 6H, 4 × <u class="uu">H</u>-Ar and 2 × N<u class="uu">H</u>) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.13, 14.19, 16.28, 25.43, 26.13, 26.7730.07, 38.38, 43.57, 51.84, 54.33, 60.76, 61.67, 126.09, 126.38, 127.12, 128.47, 128.73, 129.30, 136.23, 140.40, 168.86, 170.53, 171.44, 172.68, 172.86, 172.89 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 552.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3273, 1729, 1628, 1525, 1498, 1445, 1377, 1267, 1179, 1114, 1026, 743, 697 cm<sup>–1</sup>. HPLC (254 nm): 100.0%, <i>t</i><sub>r</sub> = 16.93 min (mixture of 2 diastereomers). HRMS Calcd for C<sub>30</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 552.2710 (M + H)<sup>+</sup>, found 552.2714. [α]<sub>D</sub><sup>20</sup> = +6.6° (<i>c</i> 0.14, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">4.3.10.  Diethyl ((<i>E</i>)-3-(3,4-Difluorophenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>13</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 131 mg (76%); mp 122–124 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.18–1.25 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.83–1.93 (m, 1H, C<u class="uu">H</u><sub>2</sub>-β-Glu), 1.97–2.17 (m, 3H, C<u class="uu">H</u><sub>2</sub>-β-Glu and C<u class="uu">H</u><sub>2</sub>-γ-Glu), 3.09 (d, <i>J</i> = 7.2 Hz, CH<sub>2</sub>–Phe), 4.03–4.25 (m, 5H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NH-C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>), 4.20–4.25 (m, 1H, NH-C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>), 4.49–4.54 (m, 1H, α-C<u class="uu">H</u>), 5.00 (q, 1H, <i>J</i> = 7.2 Hz, α-C<u class="uu">H</u>), 6.55 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH), 7.11–7.24 (m, 6H, <u class="uu">H</u>-Ar), 7.33–7.38 (m, 2H, <u class="uu">H</u>-Ar), 7.52–7.56 (m, 2H, N<u class="uu">H</u> and CH═C<u class="uu">H</u>), 7.61 (d, 1H, <i>J</i> = 7.6 Hz, NH) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.07, 14.17, 26.86, 29.99, 39.07, 43.44, 51.74, 54.49, 60.69, 61.64, 116.18 (d, <i>J</i> = 17.5 Hz), 117.70 (d, <i>J</i> = 17.3 Hz), 121.32 (d, <i>J</i> = 2.5 Hz), 124.64, 127.02, 128.61, 129.38, 136.27, 139.36, 144.94 (d, <i>J</i> = 109.5 Hz), 145.45 (d, <i>J</i> = 93.4 Hz), 165.96, 168.95, 170.87, 171.52, 172.69 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 574.2 (M + H)<sup>+</sup>. IR (ATR): ν = 3305, 1735, 1647, 1608, 1514, 1434, 1375, 1334, 1297, 1273, 1184, 1114, 1024, 985, 968, 858, 823, 777, 739, 697, 647 cm<sup>–1</sup>. HPLC (254 nm): 99.2%, <i>t</i><sub>r</sub> = 17.25 min. HRMS Calcd for C<sub>29</sub>H<sub>34</sub>F<sub>2</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 574.2365 (M + H)<sup>+</sup>, found 574.2360. [α]<sub>D</sub><sup>20</sup> = −17.7° (<i>c</i> 0.12, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">4.3.11.  Diethyl (2-(3,4-Difluorophenyl)cyclopropane-1-carbonyl)glycyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>14</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 92 mg (52%); mp 89–92 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.15–1.27 (m, 7H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub> and PhCHC<u class="uu">H</u><sub>2<u class="uu">A</u></sub>CH), 1.51–1.57 (m, 1H, PhCHC<u class="uu">H</u><sub>2<u class="uu">B</u></sub>CH), 1.74–1.87 (m, 2H, PhCHCH<sub>2</sub>C<u class="uu">H</u> and C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 1.90–2.08 (m, 3H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu and C<u class="uu">H</u><sub>2</sub>-γ-Glu), 2.38–2.49 (m, 1H, PhC<u class="uu">H</u>CH<sub>2</sub>CH), 2.99–3.10 (m, 2H, PhC<u class="uu">H</u><sub>2</sub>), 3.95–4.17 (m, 6H, NHC<u class="uu">H</u><sub>2</sub> and 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 4.40–4.46 (m, 1H, α-C<u class="uu">H</u>), 4.90–4.97 (m, 1H, α-C<u class="uu">H</u>), 6.82–6.84 (m, 1H, <u class="uu">H</u>-Ar), 6.87–6.92 (m, 1H, <u class="uu">H</u>-Ar), 7.00–7.06 (m, 1H, <u class="uu">H</u>-Ar), 7.15–7.26 (m, 6H, 5 × <u class="uu">H</u>-Ar and N<u class="uu">H</u>), 7.33–7.44 (m, 2H, 2 × N<u class="uu">H</u>) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.07, 14.19, 16.02, 24.27, 24.34, 24.94, 25.67, 26.85, 29.92, 33.92?, 39.13, 42.65?, 43.43, 51.61, 54.36, 60.71, 61.65, 115.13 (d, <i>J</i> = 18.2 Hz), 117.11 (d, <i>J</i> = 17.0 Hz), 122.37, 127.05, 128.59, 129.37, 136.19, 137.83, 148.36 (dd, <i>J</i> = 127.0 Hz, <i>J</i> = 12.5 Hz), 150.77 (dd, <i>J</i> = 117.6 Hz, <i>J</i> = 10.2 Hz), 168.82, 170.73, 171.48, 172.21, 172.65 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 588.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3283, 1735, 1646, 1518, 1436, 1376, 1334, 1273, 1192, 1115, 1024, 858, 819, 776, 741, 698 cm<sup>–1</sup>. HPLC (254 nm): 17.4% (<i>t</i><sub>r</sub> = 17.25 min), 82.6% (<i>t</i><sub>r</sub> = 18.41 min); total: 100.0% (mixture of 4 diastereomers). HRMS Calcd for C<sub>30</sub>H<sub>36</sub>F<sub>2</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 588.2521 (M + H)<sup>+</sup>, found 588.2526. [α]<sub>D</sub><sup>20</sup> = +29.1° (<i>c</i> 0.20, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">4.3.12.  Diethyl ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-phenylalanyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>15</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. Yellow-white amorphous solid, yield 84 mg (48%); mp 70–73 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.18–1.22 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.83–1.93 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 1.98–2.06 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu), 2.09–2.14 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 3.02–3.14 (m, 2H, C<u class="uu">H</u><sub>2</sub>-Phe), 3.83 (s, 3H, OCH<sub>3</sub>), 4.03–4.13 (m, 6H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NHC<u class="uu">H</u><sub>2</sub>), 4.47–4.52 (m, 1H, α-CH), 4.86–4.92 (m, 1H, α-CH), 6.36 (d, 1H, <i>J</i> = 15.6 Hz, CH═C<u class="uu">H</u>CO), 6.85 (d, 1H, <i>J</i> = 8.0 Hz, <u class="uu">H</u>-Ar), 6.92–7.23 (m, 8H, 6 × <u class="uu">H</u>-Ar and N<u class="uu">H</u>CH<sub>2</sub> and NH), 7.46–7.66 (m, 3H, C<u class="uu">H</u>═CHCO and NH and <u class="uu">H</u>-Ar) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.09, 14.18, 26.77, 30.06, 38.56, 43.48, 51.82, 54.58, 55.92, 55.96, 60.67, 61.66, 110.24, 114.90, 117.56, 122.08, 126.94, 127.24, 128.60, 129.35, 136.48, 141.72, 146.90, 147.08, 147.62, 167.02, 169.48, 171.12, 171.73, 172.75 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 584.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3279, 1729, 1649, 1509, 1452, 1376, 1257, 1197, 1120, 1028, 980, 846, 815, 700 cm<sup>–1</sup>. HPLC (254 nm): 96.5%, <i>t</i><sub>r</sub> = 11.34 min. HRMS Calcd for C<sub>26</sub>H<sub>36</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 584.2608 (M + H)<sup>+</sup>, found 584.2605. [α]<sub>D</sub><sup>20</sup> = −14.8° (<i>c</i> 0.15, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">4.3.13.  Diethyl ((<i>E</i>)-3-(4-hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-alanyl-<span class="smallcaps smallerCapital">d</span>-glutamate (<b>16</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 66 mg (43%); mp 86–89 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.21–1.28 (m, 6H, 2 × CH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.42 (d, 3H, <i>J</i> = 7.2 Hz, C<u class="uu">H</u><sub>3</sub>-Ala) 1.99–2.08 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 2.17–2.25 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu), 2.33–2.45 (m, 2H, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 3.91 (s, 3H, OCH<sub>3</sub>), 4.00–4.22 (m, 6H, 2 × C<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and NHC<u class="uu">H</u><sub>2</sub>), 4.51–4.62 (m, 1H, α-CH-Glu and α-CH-Ala), 5.91 (br s, 1H, OH), 6.33 (d, 1H, <i>J</i> = 15.6 Hz, CH═C<u class="uu">H</u>), 6.61 (t, 1H, <i>J</i> = 5.2 Hz, N<u class="uu">H</u>CH<sub>2</sub>), 6.88–6.92 (m, 2H, <u class="uu">H</u>-Ar and N<u class="uu">H</u>), 7.01 (d, 1H, <i>J</i> = 1.2 Hz, <u class="uu">H</u>-Ar), 7.06 (dd, 1H, <i>J</i> = 8.4 Hz, <i>J</i> = 1.5 Hz, <u class="uu">H</u>-Ar), 7.18 (d, 1H, <i>J</i> = 7.6 Hz, N<u class="uu">H</u>), 7.54 (d, 1H, <i>J</i> = 15.6 Hz, CH═C<u class="uu">H</u>) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.13, 14.16, 18.10, 26.74, 30.38, 43.61, 48.94, 51.99, 55.95, 60.86, 61.75, 109.70, 122.42, 127.12, 146.72, 147.62, 162.92, 165.09, 169.08, 171.81, 172.13, 173.09, 173.25 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 508.2 (M + H)<sup>+</sup>. IR (ATR): ν = 3297, 1730, 1641, 1603, 1515, 1448, 1376, 1268, 1192, 1120, 1021, 977, 845, 813, 637 cm<sup>–1</sup>. HPLC (254 nm): 95.8%, <i>t</i><sub>r</sub> = 4.95 min. HRMS Calcd for C<sub>24</sub>H<sub>34</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 508.2295 (M – H)<sup>−</sup>, found 508.2281. [α]<sub>D</sub><sup>20</sup> = +3.0° (<i>c</i> 0.09, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">4.3.14.  ((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl-<span class="smallcaps smallerCapital">d</span>-glutamic Acid (<b>17</b>)</h4><div class="NLM_p last">Synthesized from <b>9</b> according to the <a class="ref internalNav" href="#sec4_2_4" aria-label="General Procedure for Alkaline Hydrolysis">General Procedure for Alkaline Hydrolysis</a>. Ochre amorphous solid, yield 21 mg (86%); mp 100–104 °C. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ = 0.83 (d, 3H, <i>J</i> = 6.8 Hz, C<u class="uu">H</u><sub>3</sub>-Val), 0.85 (d, 3H, <i>J</i> = 6.8 Hz, C<u class="uu">H</u><sub>3</sub>-Val), 1.73–1.83 (m, 1H, C<u class="uu">H</u><sub>2<u class="uu">A</u></sub>-β-Glu), 1.91–2.01 (m, 2H, C<u class="uu">H</u><sub>2<u class="uu">B</u></sub>-β-Glu and C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.26 (t, 2H, <i>J</i> = 7.6 Hz, C<u class="uu">H</u><sub>2</sub>-γ-Glu), 3.80 (s, 3H, OCH<sub>3</sub>), 3.88 (d, 2H, <i>J</i> = 5.6 Hz, NHC<u class="uu">H</u><sub>2</sub>), 4.20–4.30 (m, 2H, α-C<u class="uu">H-Glu</u> and α-C<u class="uu">H</u>-Val), 6.56 (d, 1H, <i>J</i> = 15.6 Hz, CH═C<u class="uu">H</u>), 6.79 (d, 1H, <i>J</i> = 8.0 Hz, <u class="uu">H</u>-Ar), 7.00 (dd, 1H, <i>J</i> = 8.4 Hz, <i>J</i> = 1.5 Hz, <u class="uu">H</u>-Ar), 7.14 (d, 1H, <i>J</i> = 1.2 Hz, <u class="uu">H</u>-Ar), 7.32 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH), 7.87 (d, 1H, <i>J</i> = 8.8 Hz, N<u class="uu">H</u>), 8.19 (t, 1H, <i>J</i> = 5.6 Hz, N<u class="uu">H</u>CH<sub>2</sub>), 8.29 (d, 1H, <i>J</i> = 7.6 Hz, N<u class="uu">H</u>), 9.45 (s, 1H, OH) ppm. <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 100 MHz): δ = 17.69, 19.10, 29.88, 55.47, 123.64, 124.69, 127.77, 139.00, 147.77, 170.87, 173.15, 173.69 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 480.2 (M + H)<sup>+</sup>. IR (ATR): ν = 3292, 2924, 1648, 1513, 1429, 1371, 1204, 1125, 1030, 979, 845, 815 cm<sup>–1</sup>. HPLC (254 nm): 100%, <i>t</i><sub>r</sub> = 2.14 min. HRMS Calcd for C<sub>22</sub>H<sub>30</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 480.1982 (M + H)<sup>+</sup>, found 480.1986. [α]<sub>D</sub><sup>20</sup> = +8.8° (<i>c</i> 0.25, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">4.3.15.  Ethyl (<i>E</i>)-1-((<i>E</i>)-(3-(4-Hydroxy-3-methoxyphenyl)acryloyl)glycyl-<span class="smallcaps smallerCapital">l</span>-valyl)piperidine-4-carboxylate (<b>22</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 92 mg (63%); mp 90–94 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.85–0.94 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.23 (t, 3H, <i>J</i> = 7.6 Hz, OCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.52–1.77 (m, 2H, NCH<sub>2</sub>C<u class="uu">H</u><sub>2</sub>), 1.89–2.00 (m, 3H, NCH<sub>2</sub>C<u class="uu">H</u><sub>2</sub> in C<u class="uu">H</u>COO), 2.49–2.54 (m, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.86 (t, 1H, <i>J</i> = 10.8 Hz, NC<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>), 3.17 (t, 1H, <i>J</i> = 12.0 Hz, NC<u class="uu">H</u><sub>2</sub>CH<sub>2</sub>), 3.80 (s, 3H, OC<u class="uu">H</u><sub>3</sub>), 3.93–3.99 (m, 1H, NHC<u class="uu">H</u><sub>2</sub>), 4.07–4.15 (m, 2H, OC<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>), 4.31–4.39 (m, 1H, NHC<u class="uu">H</u><sub>2</sub>), 4.81–4.85 (m, 1H, α-CH), 6.28 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH), 6.81–6.94 (m, 3H, 2 × <u class="uu">H</u>-Ar), 7.04–7.10 (t, 1H, <i>J</i> = Hz, N<u class="uu">H</u>CH<sub>2</sub>), 7.32–7.39 (m, 1H, NH), 7.48 (dd, 1H, J = 15.6 Hz, <i>J</i> = 3.2 Hz, C<u class="uu">H</u>═CH) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.18, 17.45, 17.49, 19.63, 19.75, 27.72, 27.92, 28.41, 28.56, 30.96, 31.49, 31.51, 40.64, 40.87, 41.49, 41.62, 43.11, 43.49, 45.06, 45.37, 53.56, 53.61, 55.89, 60.75, 109.99, 114.92, 117.44, 122.22, 122.27, 127.13, 127.16, 141.57, 146.93, 147.65, 166.73, 169.22, 169.36, 169.92, 169.99, 173.87, 174.08 ppm* (*doubling of peaks is observed as this compound is a mixture of two diastereomers). MS (ESI): <i>m</i>/<i>z</i> (%) = 490.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3293, 2964, 1725, 1619, 1513, 1449, 1372, 1270, 1179, 1123, 1035, 979, 846, 817, 635 cm<sup>–1</sup>. HPLC (254 nm): 97.5%, <i>t</i><sub>r</sub> = 7.04 min. HRMS Calcd for C<sub>25</sub>H<sub>36</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 490.2553 (M + H)<sup>+</sup>, found 490.2561. [α]<sub>D</sub><sup>20</sup> = +21.9° (<i>c</i> 0.08, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">4.3.16.  Ethyl (1<i>R</i>,2<i>S</i>)-2-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)cyclohexane-1-carboxylate (<b>23</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 115 mg (76%); mp 93–97 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.85–0.95 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.18–1.26 (m, 3H, OCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 1.28–1.42 (m, 3H, C<u class="uu">H</u><sub>2</sub> and C<u class="uu">H</u><sub>2A</sub>), 1.55–1.65 (m, 3H, C<u class="uu">H</u><sub>2</sub> and C<u class="uu">H</u><sub>2B</sub>), 1.72–1.87 (m, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 1.95–2.13 (m, 2H, C<u class="uu">H</u><sub>2</sub>), 2.70–2.78 (m, 1H, C<u class="uu">H</u>COO), 3.85 (s, 3H, OC<u class="uu">H</u><sub><u class="uu">3</u></sub>), 4.03–4.24 (m, 5H, OC<u class="uu">H</u><sub>2</sub>CH<sub>3</sub>, NHC<u class="uu">H</u><sub>2</sub> and NHC<u class="uu">H</u>), 4.30–4.42 (m, 1H, α-CH), 6.36–6.43 (m, 1H, C<u class="uu">H</u>═CH), 6.86 (dd, 1H, <i>J</i> = 8.0 Hz, J = 2.0 Hz, <u class="uu">H</u>-Ar), 6.96 (s, 1H, <u class="uu">H</u>-Ar), 7.00–7.02 (m, 1H, N<u class="uu">H</u>CH<sub>2</sub>), 7.12–7.15 (m, 1H, <u class="uu">H</u>-Ar), 7.28–7.33 (m, 1H, <i>J</i> = 8.4 Hz, N<u class="uu">H</u>), 7.56 (dd, 1H, <i>J</i> = 15.6 Hz, J = 6.0 Hz, C<u class="uu">H</u>═CH) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 14.15, 14.17, 18.04, 18.23, 19.14, 22.64, 29.17, 29.57, 31.36, 31.44, 43.39, 44.25, 44.31, 47.89, 55.91, 58.66, 58.72, 60.55, 60.65, 109.96, 110.02, 114.85, 117.55, 117.64, 122.09, 122.16, 127.26, 127.31, 141.61, 141.66, 146.84, 147.59, 166.75, 166.81, 169.32, 169.39, 170.07, 170.23, 173.92, 174.00 ppm* (*doubling of certain peaks is observed as this compound is a mixture of two diastereomers). MS (ESI): <i>m</i>/<i>z</i> (%) = 504.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3275, 2939, 2360, 2341, 1646, 1515, 1449, 1374, 1251, 1124, 1032, 983, 669 cm<sup>–1</sup>. HPLC (254 nm): 98.7%, <i>t</i><sub>r</sub> = 8.85 (and 9.25)* min. HRMS Calcd for C<sub>26</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 504.2717 (M + H)<sup>+</sup>, found 504.2710. [α]<sub>D</sub><sup>20</sup> = −17.0° (<i>c</i> 0.07, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">4.3.17.  Ethyl (1<i>S</i>,2<i>S</i>)-2-((<i>S</i>)-2-(2-((<i>E</i>)-3-(4-Hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)cyclohexane-1-carboxylate (<b>24</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 131 mg (87%); mp 108–112 °C. <sup>1</sup>H NMR (MeOD, 400 MHz): δ = 0.92–0.97 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.19–1.40 (m, 6H, OCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>, C<u class="uu">H</u><sub>2</sub> and C<u class="uu">H</u><sub>2A</sub>), 1.47–1.56 (m, 1H, C<u class="uu">H</u><sub>2B</sub>), 1.75–1.77 (m, 2H, C<u class="uu">H</u><sub>2</sub>), 1.84–2.13 (m, 3H, CH<sub>2</sub>, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 2.39–2.52 (m, 1H, C<u class="uu">H</u>COO), 3.86–4.18 (m, 9H, OC<u class="uu">H</u><sub>3</sub>, OC<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>, NHC<u class="uu">H</u><sub>2</sub>, NHC<u class="uu">H</u> and α-CH), 6.53 (dd, 1H, <i>J</i> = 15.8 Hz, <i>J</i> = 0.8 Hz, C<u class="uu">H</u>═CH), 6.82 (dd, 1H, <i>J</i> = 8.0 Hz, <i>J</i> = 1.6 Hz, <u class="uu">H</u>-Ar), 7.06 (dd, 1H, <i>J</i> = 8.8 Hz, <i>J</i> = 0.8 Hz, <u class="uu">H</u>-Ar), 7.16 (t, 1H, <i>J</i> = 1.6 Hz, <u class="uu">H</u>-Ar), 7.51 (dd, 1H, <i>J</i> = 15.6 Hz, <i>J</i> = 6.0 Hz, C<u class="uu">H</u>═CH) ppm. <sup>13</sup>C NMR (MeOD, 100 MHz): δ = 14.50, 14.57, 18.33, 18.41, 19.70, 19.74, 25.72, 25.87, 30.30, 30.52, 32.00, 32.24, 33.22, 33.40, 43.82, 44.01, 50.22, 50.39, 50.91, 50.98, 56.41, 60.15, 60.24, 61.72, 61.76, 111.59, 116.51, 118.06, 118.12, 123.45, 128.13, 142.87, 142.94, 149.33, 150.08, 169.62, 171.58, 171.74, 172.42, 175.83, 175.86 ppm* (*doubling of certain peaks is observed as this compound is a mixture of two diastereomers). MS (ESI): <i>m</i>/<i>z</i> (%) = 504.3 (M + H)<sup>+</sup>. IR (ATR): ν = 3276, 2937, 2360, 2342, 1725, 1645, 1513, 1449, 1374, 1268, 1124, 1031, 979, 845, 812, 669 cm<sup>–1</sup>. HPLC (254 nm): 96.3%, <i>t</i><sub>r</sub> = 7.04 (and 7.94)* min. HRMS Calcd for C<sub>26</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub><i>m</i>/<i>z</i>: 504.2715 (M + H)<sup>+</sup>, found 504.2710. [α]<sub>D</sub><sup>20</sup> = −39.9° (<i>c</i> 0.18, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">4.3.18.  Ethyl (<i>S</i>,<i>E</i>)-5-Hydroxy-2-(2-(2-(3-(4-hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)benzoate (<b>28</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 86 mg (56%); mp 116–120 °C. <sup>1</sup>H NMR (MeOD, 400 MHz): δ = 0.96–1.00 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 1.32 (t, 3H, <i>J</i> = 7.2 Hz, OCH<sub>2</sub>C<u class="uu">H</u><sub>3</sub>), 2.27–2.36 (m, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 3.83 (s, 3H, OC<u class="uu">H</u><sub>3</sub>), 4.18 (s, 2H, NHC<u class="uu">H</u><sub>2</sub>), 4.28–4.35 (m, 3H, OC<u class="uu">H</u><sub>2</sub>CH<sub>3</sub> and α-CH), 6.48 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH), 6.74 (d, 1H, <i>J</i> = 8.4 Hz, <u class="uu">H</u>-Ar), 6.95–7.00 (m, 2H, 2 × <u class="uu">H</u>-Ar), 7.08 (d, 1H, <i>J</i> = 2.0 Hz, <u class="uu">H</u>-Ar), 7.39 (d, 1H, <i>J</i> = 3.2 Hz, <u class="uu">H</u>-Ar), 7.43 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH), 8.30 (d, 1H, <i>J</i> = 9.2 Hz, <u class="uu">H</u>-Ar) ppm. <sup>13</sup>C NMR (MeOD, 100 MHz): δ = 14.47, 18.07, 19.84, 31.29, 43.80, 56.38, 61.75, 62.77, 111.57, 116.47, 117.59, 118.20, 119.25, 122.21, 123.38, 123.42, 128.14, 133.65, 142.76, 149.30, 150.02, 154.53, 169.12, 169.57, 171.63, 172.51 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 514.2 (M + H)<sup>+</sup>. IR (ATR): ν = 3286, 2361, 2342, 1652, 1589, 1513, 1436, 1229, 1123, 1078, 1028, 977, 820, 787, 754, 669, 609 cm<sup>–1</sup>. HPLC (254 nm): 96.3%, <i>t</i><sub>r</sub> = 8.02 min. HRMS Calcd for C<sub>26</sub>H<sub>32</sub>N<sub>3</sub>O<sub>8</sub><i>m</i>/<i>z</i>: 514.2189 (M + H)<sup>+</sup>, found 514.2178. [α]<sub>D</sub><sup>20</sup> = +43.9° (<i>c</i> 0.09, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">4.3.19.  Dimethyl (<i>S</i>,<i>E</i>)-5-(2-(2-(3-(4-Hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)isophthalate (<b>29</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 119 mg (73%); mp 122–126 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 0.97–1.25 (m, 6H, 2 × C<u class="uu">H</u><sub><u class="uu">3</u></sub>-Val), 2.21–2.33 (m, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 3.77 (s, 3H, OC<u class="uu">H</u><sub><u class="uu">3</u></sub>), 3.84 (s, 6H, 2 × OC<u class="uu">H</u><sub>3</sub>), 4.22–4.27 (m, 1H, NHC<u class="uu">H</u><sub>2A</sub>), 4.37–4.42 (m, 1H, NHC<u class="uu">H</u><sub>2B</sub>), 4.79–4.83 (m, 1H, α-CH), 6.52 (d, 1H, <i>J</i> = 16.0 Hz, C<u class="uu">H</u>═CH), 6.76 (d, 1H, <i>J</i> = 8.0 Hz, N<u class="uu">H</u>), 6.90–6.97 (m, 2H, 2 × <u class="uu">H</u>-Ar), 7.61 (d, 1H, <i>J</i> = 16.4 Hz, C<u class="uu">H</u>═CH), 7.68 (s, 1H, <u class="uu">H</u>-Ar), 7.81 (d, 1H, <i>J</i> = 8.8 Hz, N<u class="uu">H</u>), 8.35 (s, 1H, <u class="uu">H</u>-Ar), 8.57–8.59 (m, 2H, 2 × <u class="uu">H</u>-Ar), 9.96 (s, 1H, N<u class="uu">H</u>-Ar) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 18.53, 19.28, 28.05, 32.01, 52.42, 55.71, 59.27, 110.27, 114.64, 117.69, 121.73, 125.12, 126.23, 127.31, 131.13, 131.25, 138.62, 141.68, 146.58, 147.36, 165.80, 165.93, 167.39, 169.91, 170.66 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 542.2 (M + H)<sup>+</sup>. IR (ATR): ν = 3276, 2361, 1725, 1651, 1601, 1513, 1436, 1340, 1244, 1123, 1031, 812, 756, 721, 669 cm<sup>–1</sup>. HPLC (254 nm): 94.7%, <i>t</i><sub>r</sub> = 10.67 min. HRMS Calcd for C<sub>27</sub>H<sub>32</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 542.2139 (M + H)<sup>+</sup>, found 542.2128. [α]<sub>D</sub><sup>20</sup> = −23.1° (<i>c</i> 0.26, CH<sub>2</sub>Cl<sub>2</sub>).</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">4.3.20.  Dimethyl (<i>S</i>,<i>E</i>)-2-(2-(2-(3-(4-Hydroxy-3-methoxyphenyl)acrylamido)acetamido)-3-methylbutanamido)terephthalate (<b>30</b>)</h4><div class="NLM_p last">Synthesized according to the <a class="ref internalNav" href="#sec4_2_3" aria-label="General Procedure for EDC-Mediated Coupling">General Procedure for EDC-Mediated Coupling</a>. White amorphous solid, yield 44 mg (27%); mp 109–113 °C. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ = 1.00–1.04 (m, 6H, 2 × C<u class="uu">H</u><sub>3</sub>-Val), 2.36–2.44 (m, 1H, C<u class="uu">H</u>(CH<sub>3</sub>)<sub>2</sub>), 3.85 (s, 3H, OC<u class="uu">H</u><sub>3</sub>), 3.88 (s, 3H, OC<u class="uu">H</u><sub>3</sub>), 3.90 (s, 3H, OC<u class="uu">H</u><sub>3</sub>), 4.27–4.38 (m, 1H, NHC<u class="uu">H</u><sub>2</sub>), 4.52–4.56 (m, 1H, α-CH), 6.32 (d, 1H, <i>J</i> = 15.6 Hz, C<u class="uu">H</u>═CH), 6.83 (d, 1H, <i>J</i> = 8.0 Hz, <u class="uu">H</u>-Ar), 6.92–6.96 (m, 2H, H–Ar), 7.07–7.09 (m, 1H, N<u class="uu">H</u>CH<sub>2</sub>), 7.50 (d, 1H, J = 15.6 Hz, C<u class="uu">H</u>═CH), 7.59 (d, 1H, <i>J</i> = 7.6 Hz, N<u class="uu">H</u>), 7.68 (dd, 1H, <i>J</i> = 8.0 Hz, <i>J</i> = 2.0 Hz, <u class="uu">H</u>-Ar), 7.98 (d, 1H, <i>J</i> = 8.8 Hz, <u class="uu">H</u>-Ar), 9.31 (s, 1H, OH), 11.44 (s, 1H, N<u class="uu">H</u>-Ar) ppm. <sup>13</sup>C NMR (CDCl<sub>3</sub>, 100 MHz): δ = 17.66, 19.45, 30.68, 43.82, 52.61, 52.81, 55.92, 60.08, 109.58, 114.70, 117.22, 118.33, 121.11, 122.40, 123.59, 127.05, 130.91, 135.31, 140.76, 141.87, 146.73, 147.61, 166.01, 166.93, 167.99, 170.06, 170.28 ppm. MS (ESI): <i>m</i>/<i>z</i> (%) = 542.2 (M + H)<sup>+</sup>. IR (ATR): ν = 3287, 2361, 2341, 1647, 1582, 1514, 1418, 1247, 1110, 1082, 1030, 984, 848, 811, 754, 669 cm<sup>–1</sup>. HPLC (254 nm): 96.7%, <i>t</i><sub>r</sub> = 12.11 min. HRMS Calcd for C<sub>27</sub>H<sub>32</sub>N<sub>3</sub>O<sub>9</sub><i>m</i>/<i>z</i>: 542.2139 (M + H)<sup>+</sup>, found 542.2129. [α]<sub>D</sub><sup>20</sup> = −28.5° (<i>c</i> 0.24, CH<sub>2</sub>Cl<sub>2</sub>).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46">4.4.  Cell Culture</h3><div class="NLM_p last">Human PBMC from healthy blood donors were isolated by density gradient centrifugation with Ficoll-Paque (Pharmacia, Sweden). The cells were cultured in RPMI 1640 (Sigma, Germany) supplemented with 100 U/mL penicillin (Sigma), 100 μg/mL streptomycin (Sigma), 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Sigma), 50 μM 2-mercaptoethanol (Sigma), and 10% heat-inactivated fetal bovine serum (Gibco, USA). 10<sup>6</sup> cells were plated on 24-well culture plates (Nunc, Denmark) and cultivated at 37 °C in a humidified atmosphere of 5% CO<sub>2</sub> in air.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47">4.5.  Cytotoxicity Assay</h3><div class="NLM_p last">HEK-Blue NOD2 cells (Invivogen, San Diego, CA, USA) were cultured in accordance with the manufacturer’s instructions. HEK-Blue NOD2 cells (1 × 10<sup>5</sup> cells/mL) were treated with the appropriate amounts of compounds or with the corresponding vehicle (control cells), then seeded in duplicate in 96-well plates. After 18 h, metabolic activity was assessed using the CellTiter 96 Aqueous One Solution Cell Proliferation Assay (Promega, Madison, WI, USA), in accordance with the manufacturer’s instructions. The results are expressed as means of duplicates ± SEM of three independent experiments.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48">4.6.  Measurement of NF-κB Transcriptional Activity (Quanti-blue Assay)</h3><div class="NLM_p last">HEK-Blue NOD2 cells and NOD1 cells (Invivogen, San Diego, CA, USA) were cultured in accordance with the manufacturer’s instructions. HEK-Blue NOD2 cells and NOD1 cells were assayed for changes in NF-κB transcriptional activity upon incubation (5 × 10<sup>5</sup> cells/mL) with MDP and other NOD2 agonistic compounds (2 and 20 μM) for 18 h. Secreted embryonic alkaline phosphatase (SEAP) activity was determined in the supernatant in accordance with the manufacturer’s instructions. Absorbance was measured on a BioTek Synergy microplate reader (VT, USA) at 640 nm. The results are expressed as means of duplicates ± SEM of three independent experiments.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49">4.7.  Multiplexed Cytokine Assays</h3><div class="NLM_p last">PBMCs were treated with MDP or the compound of interest in the presence or absence of 10 ng/mL LPS. Cell-free supernatants were collected at 18 h and stored at −78 °C before being evaluated for cytokines by a commercially available kit. Cytokine production was assessed by BD Cytometric Bead Array (CBA) Human Th1/Th2/Th17 Kit (Content: IL-2, IL-4, IL-6, IL-10, TNF-α, IFNγ, IL-17A). Flow cytometric analyses were performed using a FACSCalibur flow cytometer with Sorting Option: 4-Color and CELLQuest software (BD Biosciences; San Diego, CA, USA). Standard curves were generated using recombinant cytokines provided in the kit. The data were analyzed with FlowJo software (Tree Star, Inc., Ashland, OR). Results are expressed in pg/mL. The results are expressed as means of duplicates ± SEM of two independent experiments.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50">4.8.  Preparation of Liposomes</h3><div class="NLM_p last">Multilamellar liposomes were prepared by the modified thin lipid film method following previously described methods.<a onclick="showRef(event, 'ref76 ref77'); return false;" href="javascript:void(0);" class="ref ref76 ref77">(76,77)</a> Egg-phosphatidylcholine, cholesterol, and dicetylphosphate (total mass of lipid was 4 mg/mL in a molar ratio of 7:5:1) were dissolved in chloroform/methanol (2:1). For incorporation of MDP or compound <b>9</b> in liposomes, the lipid solution was mixed with a solution of MDP or compound <b>9</b> in methanol or chloroform/methanol. After rotary evaporation of the solvent, the remaining lipid film was dried in vacuum for an hour and then dispersed by gentle hand shaking in 0.1 mg/mL OVA solution in saline. The concentration of MDP and compound <b>9</b> in the liposome suspension was 2 mM. The latter was left overnight at 4 °C to swell and stabilize. Liposome size was reduced by sequential extrusion of the multilamellar vesicles through polycarbonate membranes of 800 and 200 nm using the 0.5 mL extruder (LiposoFast, Avestin Inc., Canada). Nonentrapped material was not separated from liposome, and the complete liposome suspension was used for immunizations.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51">4.9.  Materials, Antigen, and Antibodies</h3><div class="NLM_p last">Bovine serum albumin (BSA), Tween 20, tris(hydroxymethyl)aminomethane, monoclonal antichicken egg albumin (clone OVA-14 mouse IgG1 isotype), <i>o</i>-phenylenediamine dihydrochloride (OPD), MDP, and avidin–peroxidase were from Sigma, USA. Horseradish peroxidase conjugated goat antimouse IgG (HRP-antimouse IgG) was from Bio-Rad Laboratories, USA. Biotin-conjugated rat antimouse IgG1 and antimouse IgG2a monoclonal antibodies and streptavidin–peroxidase were purchased from PharMingen, Becton Dickinson (USA). Chemicals for buffers and solutions were from Kemika, Croatia. Ovalbumin (OVA) was from Serva, Germany. <span class="smallcaps smallerCapital">l</span>-α-Phosphatidylcholine, type XI-E, from fresh egg yolk (egg-PC), was from Avanti Polar Lipids. Cholesterol from porcine liver (CHL) and dicetyl phosphate (DCPh) were purchased from Sigma (USA).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52">4.10.  Experimental Mice</h3><div class="NLM_p last">NIH/OlaHsd inbred mice were raised at the Institute of Immunology, Croatia. All mice used were females from 2 to 2.5 months old. During the experimental period animals were housed in the Animal Facility of the Institute of Immunology. Commercial food and water were provided ad libitum. All animal work was performed according to the Croatian Law on Animal Welfare (NN 135/06).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53">4.11.  Immunizations</h3><div class="NLM_p last">Experimental groups of six female mice were immunized and boosted two times subcutaneously (s.c.) into the tail base at 28-day intervals. The doses used per mouse were OVA, 10 μg, MDP, and compound <b>9</b>, 100 μg. The amount of lipids administered to each mouse was 400 μg. The injection volume in all experimental groups was 0.1 mL per mouse. Mice were anaesthetized prior to blood collection from axillary’s plexus on the seventh day after second booster. Individual sera from each animal was decomplemented at 56 °C for 30 min and then stored at −20 °C until tested.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54">4.12.  ELISA for Anti-OVA IgG</h3><div class="NLM_p last">Microtiter plates, flat-bottomed high binding (Costar, USA), were coated with 100 μL of 15 μg/mL OVA solution in carbonate buffer, pH 9.6, and left overnight at room temperature (RT). Nonspecific antibody binding was blocked by incubation with 0.5% (w/v) BSA in PBS-T (0.05% (v/v) Tween 20 in PBS) buffer (200 μL per well) for 2 h at 37 °C. Mice sera to be tested and standard preparation (100 μL per well) were added in five serial dilutions and left overnight at room temperature (RT). All samples were analyzed in duplicates. Plates were washed and 100 μL/well of HRP-antimouse IgG (4000× diluted) was added and incubated for 2 h at 37 °C. After washing, the substrate solution consisting of 0.6 mg/mL OPD solution in citrate–phosphate buffer, pH 5.0, with 0.5 μL of 30% H<sub>2</sub>O<sub>2</sub> /mL was added (100 μL per well) and incubated for 30 min at RT in the dark. The enzyme reaction was stopped with 50 μL per well of 12.5% H<sub>2</sub>SO<sub>4</sub>, and absorbance at 492 nm (<i>A</i><sub>492</sub>) was measured using a microplate reader (Thermoscientific Fisher, Finland). All washings (three times after each step) utilized PBS-T buffer in microplate washer (Multiwash; Labsystems, Finland). The relative quantity of anti-OVA IgGs was calculated by parallel line assay, where each serum was compared to the standard preparation, monoclonal antichicken egg albumin, to which we voluntarily assigned 20000 arbitrary units per mL (AU/mL).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55">4.13.  ELISA for Anti-OVA IgG1 and IgG2a</h3><div class="NLM_p last">For quantification of OVA specific immunoglobulin G subclasses, IgG1 and IgG2a, plates were coated with OVA and incubated with sera samples as described above. After washing, biotinylated rat antimouse IgG1 0.05 μg/mL or biotinylated rat antimouse IgG2a 0.5 μg/mL was added, 100 μL to each well, and incubated for 2 h at 37 °C. For IgG1 determination, streptavidin–peroxidase (100,000× diluted) and, for IgG2a determination, avidin–peroxidase (50,000× diluted) were added (100 μL/well) and incubated for another 2 h at 37 °C. Plates were washed, and the substrate solution of 100 μL per well was added and incubated for 30 min at RT in the dark as described above. The enzymatic reaction was stopped with 12.5% H<sub>2</sub>SO<sub>4</sub> (50 μL/well), and <i>A</i><sub>492</sub> was measured using a microplate reader. The relative quantities of antibody isotypes were determined by parallel line assay using appropriate standard preparations for anti-OVA IgG1 and anti-OVA IgG2a.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The monoclonal anti-OVA IgG1 was a standard for relative quantification of anti-OVA IgG1 to which 400,000 AU/mL was assigned, while polyclonal mouse serum containing high levels of anti-OVA IgG2a was used as a standard for relative quantification of IgG2a specific antibodies with voluntarily assigned 5000 AU/mL. The ratio of anti-OVA IgG1 and anti-OVA IgG2a (IgG1/IgG2a) was used as an indication of the Th1/Th2-bias of induced immune response. The IgG1/IgG2a ratio was calculated after the second booster for each mouse serum. The results for each experimental group (<i>n</i> = 6; females) are expressed as means ± SD; *<i>p</i> ≤ 0.01.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56">4.14.  Molecular Modeling</h3><div id="sec4_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">4.14.1.  Ligand and Protein Preparation</h4><div class="NLM_p last">Three-dimensional models of compounds were built in ChemBio3D Ultra 16.0.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Their geometries were optimized using MMFF94<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> force field, and partial atomic charges were added. Energy was minimized until the gradient value was smaller than 0.001 kcal/(mol Å). The optimized structure was further refined with GAMESS interface in ChemBio3D Ultra 16.0 using the semiempirical PM3 method, QA optimization algorithm, and Gasteiger Hückel charges for all atoms for 100 steps.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Molecular docking calculations were performed using GOLD Suite v5.4,<a onclick="showRef(event, 'ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref81 ref82">(81,82)</a> running on four octal core AMD Opteron CPU processors, 16 GB RAM, and two 750 GB hard drives, running 64-bit Scientific Linux 6.0. Receptor was prepared in a GOLD graphical user interface. Hydrogen atoms were added to the protein, and correct tautomers and protonation states were assigned. Water molecules were deleted from the crystal structure. The binding site on the concave surface of NOD2 LRR domain was defined by selecting amino acid residues within a radius of 12 Å around Arg857 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN">5IRN</a><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a>).</div></div><div id="sec4_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">4.14.2.  Ligand Docking</h4><div class="NLM_p last">Compounds were docked to the defined binding site in 25 independent genetic algorithm (GA) runs by applying different GA parameters (population size = 100, selection pressure = 1.1, number of operations = 100,000, number of islands = 5, niche size = 2, crossover frequency = 95, mutation frequency = 95, migration frequency = 10) and scoring functions (GoldScore, ChemScore, CHEMPLP). The most representative results were obtained using GoldScore as a scoring function. Ligands with rmsd value less than 1.5 Å were joined in clusters, and early termination was allowed if the top three solutions were within 1.0 Å of the rmsd value. Proposed binding modes of the top five highest scored docking poses per ligand were evaluated, and the highest ranked binding pose was used for graphical representation in PyMOL.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59">4.15.  Screening against PAINS</h3><div class="NLM_p last">All tested compounds were screened against the PAINS filter as available in CANVAS (Schrödinger Release 2017–1: Canvas, Schrödinger, LLC, New York, NY, 2017). All compounds passed the PAINS filter.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60">4.16.  Liquid Chromatography with Tandem Mass Spectrometry (LC–MS/MS)</h3><div class="NLM_p">For LC–MS/MS quantitation of compounds <b>9</b> and <b>17</b> in cell incubation media and lysate samples, an Agilent 1290 Infinity/6460 Triple Quadrupole detector (Agilent Technologies, Santa Clara, USA) was used. The chromatographic separation was achieved on a Kinetex C18 50 × 2.1 mm, 2.6 μm column (Phenomenex, Torrance, USA) operated at 50 °C and using a gradient elution with a flow rate of 0.65 mL/min and consisted of 0.1% formic acid in water (mobile phase A) and 99.8% acetonitrile (mobile phase B) with the following steps (min, %B): (0.5, 10), (2.5, 18), (3.0–3.5, 82), (3.75, 10). Total run time was 5 min. The injection volume was 1 and 2 μL for the quantification in extracellular medium and cell lysate samples, respectively. Quantification was performed in negative ESI mode using the multiple reaction monitoring with the widest (2.5 amu) resolution. The parameters of JetStream ion source were as follows: gas flow (and temperature) = 10 L/min (275 °C), nebulizer pressure = 45 psi, sheath gas flow (and temperature) = 11 L/min (350 °C), capillary voltage = 3500 V. For compound <b>9</b>, the following <i>m</i>/<i>z</i> transitions were used: 535.3 → 134.5 at 40 eV and 535.3 → 150.6 at 45 eV for quantifier and qualifier ion, respectively. For compound <b>17</b>, <i>m</i>/<i>z</i> 479.2 → 128.4 at 35 eV and 479.2 → 111.0 at 25 eV were used for quantifier and qualifier ion, respectively. The retention times of compounds <b>9</b> and <b>17</b> were 3.53 and 2.88 min, respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S7</a>). The method was evaluated for selectivity, working range, accuracy, precision, and sensitivity (limit of quantification). The method’s limit of quantification has been proven to be 0.0625 μM for compounds <b>9</b> and <b>17</b>, based on the signal/noise ratio criterion of more than 30:1 (area, peak-to-peak) and based on bias of less than ±20% and precision better than 20% RSD (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S8 and Table S5</a>). The calibration lines for compound <b>9</b> and compound <b>17</b> that cover the concentration range of both analytes from 0.0625 to 4.00 μM are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S9</a>. The results are expressed as means of duplicates ± SEM of two independent experiments measured in two parallels.</div><div id="sec4_16_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">4.16.1.  Determination of Extra- and Intracellular Concentrations</h4><div class="NLM_p last">HEK-Blue NOD2 cells (Invivogen, San Diego/CA, USA) were treated with 2 μM of compound <b>9</b> or <b>17</b> for 18 h. Afterward, supernatants were collected, and cells were lysed in water. The lysates were sonicated, rocked on ice for 30 min, and centrifuged at 13,000 rpm at 4 °C for 15 min. Supernatants were collected and stored at −80 °C. The intracellular molarity of compounds <b>9</b> and <b>17</b> was determined based on the concentration found in the supernatant after centrifugation of methanol-treated cell lysate. The recovery of both compounds from the cell lysate was determined in a separate experiment.</div></div><div id="sec4_16_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">4.16.2.  Recovery and Matrix Effect</h4><div class="NLM_p last">The analyte recovery and possible matrix effects were determined by spiking the known amounts of compounds <b>9</b> and <b>17</b> into blank incubation medium, cell supernatant, and cell lysate. After the sample preparation and LC–MS analysis, the obtained responses were compared to the responses from matrix-free methanolic solution at the same nominal analyte concentration (2 μM) and expressed as percentage (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S10</a>). The values close to 100% show that the method has negligible matrix effects and complete recovery from all the tested media.</div></div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63">4.17.  Statistics</h3><div class="NLM_p"><i>In vitro</i> evaluations of cytotoxicity (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S12</a>), NOD2/NOD1 agonistic action (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), specificity of compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">Figure S13</a>), and dose-dependent NOD2 agonistic action (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) were each performed in three independent experiments, with average values expressed as means of duplicates ± SEM (the data was analyzed using descriptive statistics). <i>In vitro</i> evaluation of cell uptake and stability (shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) was performed in two independent experiments, with average values expressed as means of duplicates ± SEM (the data was analyzed using descriptive statistics). <i>In vitro</i> experiment on PBMCs (shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) was performed twice (two independent donors) with average values expressed as means of duplicates ± SEM (the data was analyzed using descriptive statistics). Statistical significance was determined by Student <i>t</i> test (two-tailed; unpaired). Differences were considered significant for <i>p</i> < 0.05.</div><div class="NLM_p last">The <i>in vivo</i> experiment in mice was performed in three experimental groups consisting of six female mice (as described in detail in <a class="ref internalNav" href="#sec4_11" aria-label="section 4.11">section 4.11</a>). Statistical difference between experimental groups in the production of total anti-OVA IgGs (shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) was determined by Kruskal–Wallis ANOVA, followed by multiple Mann–Whitney U-nonparametric tests. Differences were considered significant for <i>p</i> < 0.05. Statistical difference between experimental groups in terms of the anti-OVA IgG1/anti-OVA IgG2a ratio (listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was determined by Kruskal–Wallis ANOVA, followed by multiple Mann–Whitney U-nonparametric tests. The results for each experimental group (<i>n</i> = 6; females) are expressed as means ± SD. Differences were considered highly significant for <i>p</i> < 0.01. Analyses were performed using Statistica 6.0 for Windows, StatSoft Inc.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01052" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01052" class="ext-link">10.1021/acs.jmedchem.7b01052</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Synthesis details for compounds <b>1a</b>–<b>1c</b>, <b>25a</b>–<b>b</b>, <b>26a</b>–<b>b</b>, and <b>27a</b>–<b>b</b>; analytical data/characterization of intermediate compounds <b>3a</b>–<b>b</b>, <b>18</b>–<b>21</b>, <b>25a</b>, <b>26a</b>, and <b>27a</b>; Supporting Schemes, Figures, and Tables; experimental procedure for molecular dynamics simulation; experimental procedure for bacterial endotoxin test; <sup>1</sup>H and <sup>13</sup>C NMR spectra of representative tested compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">PDB-ID code of file used for docking experiments: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN">5IRN</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_003.zip" class="ext-link">ZIP</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_001.csv">jm7b01052_si_001.csv (1.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf">jm7b01052_si_002.pdf (8.64 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_003.zip">jm7b01052_si_003.zip (916.69 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01052" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Žiga Jakopin</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9384-0858" title="Orcid link">http://orcid.org/0000-0001-9384-0858</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#374d5e5056195d565c58475e59775151561942595e1a5b5d19445e"><span class="__cf_email__" data-cfemail="bfc5d6d8de91d5ded4d0cfd6d1ffd9d9de91cad1d692d3d591ccd6">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martina Gobec</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tihomir Tomašič</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adela Štimac</span> - <span class="hlFld-Affiliation affiliation">Centre
for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Rockefellerova 10, 10000 Zagreb, Croatia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruža Frkanec</span> - <span class="hlFld-Affiliation affiliation">Centre
for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Rockefellerova 10, 10000 Zagreb, Croatia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jurij Trontelj</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marko Anderluh</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irena Mlinarič-Raščan</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The study was designed by Ž.J and M.G. The synthetic work was conducted by Ž.J. and M.A. In vitro assays of cytotoxicity, NOD1 and NOD2 stimulation, and PBMC isolation and stimulation were conducted by M.G. Characterization of selected compounds, preparation of experimental liposomal formulations and in vivo experiments (immunization experiments, analysis of sera) were conducted by A.Š. and R.F. The in vitro stability and cell uptake experiments were conducted by M.G., J.T., and Ž.J. The in silico experiments (docking, MD simulation) were conducted by T.T. Ž.J., M.G., and T.T. wrote the manuscript. Ž.J., M.G., T.T., A.Š., R.F., M.A., I.M.R., and J.T. analyzed the data, read the manuscript, and gave approval to the final version.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d89e6273-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the Slovenian Research Agency (Grant No. 0787-P208) and the Croatian Science Foundation (HrZZ) (Project No. 7387). We thank Roger Pain for proofreading the manuscript and Izidor Sosič for meaningful discussions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS USED</td></tr><tr><td class="NLM_term">CARD</td><td class="NLM_def"><p class="first last">caspase activation and recruitment domain</p></td></tr><tr><td class="NLM_term">CES</td><td class="NLM_def"><p class="first last">human carboxylesterase</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last">dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">EDC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">LRR</td><td class="NLM_def"><p class="first last">leucine-rich repeats</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MDP</td><td class="NLM_def"><p class="first last">muramyl dipeptide</p></td></tr><tr><td class="NLM_term">Mur<i>N</i>Ac</td><td class="NLM_def"><p class="first last"><i>N</i>-acetylmuramyl</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κB</p></td></tr><tr><td class="NLM_term">NLR</td><td class="NLM_def"><p class="first last">NOD-like receptor</p></td></tr><tr><td class="NLM_term">NOD</td><td class="NLM_def"><p class="first last">nucleotide-binding oligomerization domain</p></td></tr><tr><td class="NLM_term">OVA</td><td class="NLM_def"><p class="first last">ovalbumin</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">PRR</td><td class="NLM_def"><p class="first last">pattern recognition receptors</p></td></tr><tr><td class="NLM_term">RIP2</td><td class="NLM_def"><p class="first last">receptor-interacting serine-threonine kinase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SEAP</td><td class="NLM_def"><p class="first last">secreted embryonic alkaline phosphatase</p></td></tr><tr><td class="NLM_term">TLR</td><td class="NLM_def"><p class="first last">toll-like receptor</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 83 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janeway, C. A.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Innate immune recognition</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.20.083001.084359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1146%2Fannurev.immunol.20.083001.084359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=11861602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=197-216&author=C.+A.+Janewayauthor=R.+Medzhitov&title=Innate+immune+recognition&doi=10.1146%2Fannurev.immunol.20.083001.084359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immune recognition</span></div><div class="casAuthors">Janeway, Charles A., Jr.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-216</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The innate immune system is a universal and ancient form of host defense against infection.  Innate immune recognition relies on a limited no. of germline-encoded receptors.  These receptors evolved to recognize conserved products of microbial metab. produced by microbial pathogens, but not by the host.  Recognition of these mol. structures allows the immune system to distinguish infectious nonself from noninfectious self.  Toll-like receptors play a major role in pathogen recognition and initiation of inflammatory and immune responses.  Stimulation of Toll-like receptors by microbial products leads to the activation of signaling pathways that result in the induction of antimicrobial genes and inflammatory cytokines.  In addn., stimulation of Toll-like receptors triggers dendritic cell maturation and results in the induction of costimulatory mols. and increased antigen-presenting capacity.  Thus, microbial recognition by Toll-like receptors helps to direct adaptive immune responses to antigens derived from microbial pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Ee-TeDKpobVg90H21EOLACvtfcHk0liXPxR4_ihR0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D&md5=0c4bd7dbf690ad61e6b81324be227d8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.20.083001.084359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.20.083001.084359%26sid%3Dliteratum%253Aachs%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DInnate%2520immune%2520recognition%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D20%26spage%3D197%26epage%3D216%26doi%3D10.1146%2Fannurev.immunol.20.083001.084359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbara, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croitoru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">NOD proteins: regulators of inflammation in health and disease</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1038/nri3565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnri3565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=24336102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=9-23&author=D.+J.+Philpottauthor=M.+T.+Sorbaraauthor=S.+J.+Robertsonauthor=K.+Croitoruauthor=S.+E.+Girardin&title=NOD+proteins%3A+regulators+of+inflammation+in+health+and+disease&doi=10.1038%2Fnri3565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">NOD proteins: regulators of inflammation in health and disease</span></div><div class="casAuthors">Philpott, Dana J.; Sorbara, Matthew T.; Robertson, Susan J.; Croitoru, Kenneth; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-23</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Entry of bacteria into host cells is an important virulence mechanism.  Through peptidoglycan recognition, the nucleotide-binding oligomerization domain (NOD) proteins NOD1 and NOD2 enable detection of intracellular bacteria and promote their clearance through initiation of a pro-inflammatory transcriptional program and other host defense pathways, including autophagy.  Recent findings have expanded the scope of the cellular compartments monitored by NOD1 and NOD2 and have elucidated the signalling pathways that are triggered downstream of NOD activation.  In vivo, NOD1 and NOD2 have complex roles, both during bacterial infection and at homeostasis.  The assocn. of alleles that encode constitutively active or constitutively inactive forms of NOD2 with different diseases highlights this complexity and indicates that a balanced level of NOD signalling is crucial for the maintenance of immune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHe0P1JHOtJ7Vg90H21EOLACvtfcHk0liXPxR4_ihR0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO&md5=4de699679859f47003bceeea35012b34</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri3565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3565%26sid%3Dliteratum%253Aachs%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSorbara%26aufirst%3DM.%2BT.%26aulast%3DRobertson%26aufirst%3DS.%2BJ.%26aulast%3DCroitoru%26aufirst%3DK.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DNOD%2520proteins%253A%2520regulators%2520of%2520inflammation%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D9%26epage%3D23%26doi%3D10.1038%2Fnri3565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">NOD1 and NOD2: signaling, host defense, and inflammatory disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.immuni.2014.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=25526305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=898-908&author=R.+Carusoauthor=N.+Warnerauthor=N.+Inoharaauthor=G.+Nu%C3%B1ez&title=NOD1+and+NOD2%3A+signaling%2C+host+defense%2C+and+inflammatory+disease&doi=10.1016%2Fj.immuni.2014.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease</span></div><div class="casAuthors">Caruso, Roberta; Warner, Neil; Inohara, Naohiro; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">898-908</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The nucleotide-binding oligomerization domain (NOD) proteins NOD1 and NOD2, the founding members of the intracellular NOD-like receptor family, sense conserved motifs in bacterial peptidoglycan and induce proinflammatory and antimicrobial responses.  Here, we discuss recent developments about the mechanisms by which NOD1 and NOD2 are activated by bacterial ligands, the regulation of their signaling pathways, and their role in host defense and inflammatory disease.  Several routes for the entry of peptidoglycan ligands to the host cytosol to trigger activation of NOD1 and NOD2 have been elucidated.  Furthermore, genetic screens and biochem. analyses have revealed mechanisms that regulate NOD1 and NOD2 signaling.  Finally, recent studies have suggested several mechanisms to account for the link between NOD2 variants and susceptibility to Crohn's disease.  Further understanding of NOD1 and NOD2 should provide new insight into the pathogenesis of disease and the development of new strategies to treat inflammatory and infectious disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTC-ne46_MPrVg90H21EOLACvtfcHk0lhY9UumijPDlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislyqsg%253D%253D&md5=da20e3b76c185e91da9168b011bc0b78</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DR.%26aulast%3DWarner%26aufirst%3DN.%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DNOD1%2520and%2520NOD2%253A%2520signaling%252C%2520host%2520defense%252C%2520and%2520inflammatory%2520disease%26jtitle%3DImmunity%26date%3D2014%26volume%3D41%26spage%3D898%26epage%3D908%26doi%3D10.1016%2Fj.immuni.2014.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzenbacher, R.</span></span> <span> </span><span class="NLM_article-title">The Nod-like receptor (NLR) family: a tale of similarities and differences</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e2119</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0002119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1371%2Fjournal.pone.0002119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2119&author=M.+Proellauthor=S.+J.+Riedlauthor=J.+H.+Fritzauthor=A.+M.+Rojasauthor=R.+Schwarzenbacher&title=The+Nod-like+receptor+%28NLR%29+family%3A+a+tale+of+similarities+and+differences&doi=10.1371%2Fjournal.pone.0002119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002119%26sid%3Dliteratum%253Aachs%26aulast%3DProell%26aufirst%3DM.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DRojas%26aufirst%3DA.%2BM.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26atitle%3DThe%2520Nod-like%2520receptor%2520%2528NLR%2529%2520family%253A%2520a%2520tale%2520of%2520similarities%2520and%2520differences%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2119%26doi%3D10.1371%2Fjournal.pone.0002119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamaillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labigne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansonetti, P. J.</span></span> <span> </span><span class="NLM_article-title">Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">8869</span>– <span class="NLM_lpage">8872</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200651200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.C200651200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=12527755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=8869-8872&author=S.+E.+Girardinauthor=I.+G.+Bonecaauthor=J.+Vialaauthor=M.+Chamaillardauthor=A.+Labigneauthor=G.+Thomasauthor=D.+J.+Philpottauthor=P.+J.+Sansonetti&title=Nod2+is+a+general+sensor+of+peptidoglycan+through+muramyl+dipeptide+%28MDP%29+detection&doi=10.1074%2Fjbc.C200651200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection</span></div><div class="casAuthors">Girardin, Stephen E.; Boneca, Ivo G.; Viala, Jerome; Chamaillard, Mathias; Labigne, Agnes; Thomas, Gilles; Philpott, Dana J.; Sansonetti, Philippe J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8869-8872</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod2 activates the NF-κB pathway following intracellular stimulation by bacterial products.  Recently, mutations in Nod2 have been shown to be assocd. with Crohn's disease, suggesting a role for bacteria-host interactions in the etiol. of this disorder.  The authors show here that Nod2 is a general sensor of peptidoglycan through the recognition of muramyl dipeptide (MDP), the minimal bioactive peptidoglycan motif common to all bacteria.  Moreover, the 3020insC frameshift mutation, the most frequent Nod2 variant assocd. with Crohn's disease patients, fully abrogates Nod2-dependent detection of peptidoglycan and MDP.  Together, these results impact on the understanding of Crohn's disease development.  Addnl., the characterization of Nod2 as the first pathogen-recognition mol. that detects MDP will help to unravel the well known biol. activities of this immunomodulatory compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOYkWjlEqR7Vg90H21EOLACvtfcHk0lhY9UumijPDlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D&md5=220b5b27786d90179dca20566d643bf6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200651200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200651200%26sid%3Dliteratum%253Aachs%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DViala%26aufirst%3DJ.%26aulast%3DChamaillard%26aufirst%3DM.%26aulast%3DLabigne%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSansonetti%26aufirst%3DP.%2BJ.%26atitle%3DNod2%2520is%2520a%2520general%2520sensor%2520of%2520peptidoglycan%2520through%2520muramyl%2520dipeptide%2520%2528MDP%2529%2520detection%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D8869%26epage%3D8872%26doi%3D10.1074%2Fjbc.C200651200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontalba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Luna, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">Host recognition of bacterial muramyl dipeptide mediated through NOD2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">5509</span>– <span class="NLM_lpage">5512</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200673200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.C200673200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=5509-5512&author=N.+Inoharaauthor=Y.+Oguraauthor=A.+Fontalbaauthor=O.+Gutierrezauthor=F.+Ponsauthor=J.+Crespoauthor=K.+Fukaseauthor=S.+Inamuraauthor=S.+Kusumotoauthor=M.+Hashimotoauthor=S.+J.+Fosterauthor=A.+P.+Moranauthor=J.+L.+Fernandez-Lunaauthor=G.+Nu%C3%B1ez&title=Host+recognition+of+bacterial+muramyl+dipeptide+mediated+through+NOD2&doi=10.1074%2Fjbc.C200673200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200673200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200673200%26sid%3Dliteratum%253Aachs%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DFontalba%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DO.%26aulast%3DPons%26aufirst%3DF.%26aulast%3DCrespo%26aufirst%3DJ.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInamura%26aufirst%3DS.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DS.%2BJ.%26aulast%3DMoran%26aufirst%3DA.%2BP.%26aulast%3DFernandez-Luna%26aufirst%3DJ.%2BL.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DHost%2520recognition%2520of%2520bacterial%2520muramyl%2520dipeptide%2520mediated%2520through%2520NOD2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D5509%26epage%3D5512%26doi%3D10.1074%2Fjbc.C200673200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monie, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, J. A.</span></span> <span> </span><span class="NLM_article-title">Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23057</span>– <span class="NLM_lpage">23067</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.344283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.M112.344283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=22549783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23057-23067&author=J.+Moauthor=J.+P.+Boyleauthor=C.+B.+Howardauthor=T.+P.+Monieauthor=B.+K.+Davisauthor=J.+A.+Duncan&title=Pathogen+sensing+by+nucleotide-binding+oligomerization+domain-containing+protein+2+%28NOD2%29+is+mediated+by+direct+binding+to+muramyl+dipeptide+and+ATP&doi=10.1074%2Fjbc.M112.344283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP</span></div><div class="casAuthors">Mo, Jinyao; Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.; Davis, Beckley K.; Duncan, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">23057-23067</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide binding and oligomerization domain-contg. protein 2 (NOD2/Card15) is an intracellular protein that is involved in the recognition of bacterial cell wall-derived muramyl dipeptide.  Mutations in the gene encoding NOD2 are assocd. with inherited inflammatory disorders, including Crohn disease and Blau syndrome.  NOD2 is a member of the nucleotide-binding domain and leucine-rich repeat-contg. protein gene (NLR) family.  Nucleotide binding is thought to play a crit. role in signaling by NLR family members.  However, the mol. mechanisms underlying signal transduction by these proteins remain largely unknown.  Mutations in the nucleotide-binding domain of NOD2 have been shown to alter its signal transduction properties in response to muramyl dipeptide in cellular assays.  Using purified recombinant protein, we now demonstrate that NOD2 binds and hydrolyzes ATP.  Addnl., we have found that the purified recombinant protein is able to bind directly to muramyl dipeptide and can assoc. with known NOD2-interacting proteins in vitro.  Binding of NOD2 to muramyl dipeptide and homo-oligomerization of NOD2 are enhanced by ATP binding, suggesting a model of the mol. mechanism for signal transduction that involves binding of nucleotide followed by binding of muramyl dipeptide and oligomerization of NOD2 into a signaling complex.  These findings set the stage for further studies into the mol. mechanisms that underlie detection of muramyl dipeptide and assembly of NOD2-contg. signaling complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHB17K-Mn8MrVg90H21EOLACvtfcHk0liihyTCWidAqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D&md5=79080d42bc5db467360658170bde4caf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.344283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.344283%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DHoward%26aufirst%3DC.%2BB.%26aulast%3DMonie%26aufirst%3DT.%2BP.%26aulast%3DDavis%26aufirst%3DB.%2BK.%26aulast%3DDuncan%26aufirst%3DJ.%2BA.%26atitle%3DPathogen%2520sensing%2520by%2520nucleotide-binding%2520oligomerization%2520domain-containing%2520protein%25202%2520%2528NOD2%2529%2520is%2520mediated%2520by%2520direct%2520binding%2520to%2520muramyl%2520dipeptide%2520and%2520ATP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23057%26epage%3D23067%26doi%3D10.1074%2Fjbc.M112.344283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zoysa Ariyananda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, E. K.</span></span> <span> </span><span class="NLM_article-title">The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">13535</span>– <span class="NLM_lpage">13537</span>, <span class="refDoi"> DOI: 10.1021/ja303883c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303883c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=13535-13537&author=C.+L.+Grimesauthor=L.+De+Zoysa+Ariyanandaauthor=J.+E.+Melnykauthor=E.+K.+O%E2%80%99Shea&title=The+innate+immune+protein+Nod2+binds+directly+to+MDP%2C+a+bacterial+cell+wall+fragment&doi=10.1021%2Fja303883c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment</span></div><div class="casAuthors">Grimes, Catherine Leimkuhler; Ariyananda, Lushanti De Zoysa; Melnyk, James E.; O'Shea, Erin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13535-13537</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mammalian Nod2 is an intracellular protein that is implicated in the innate immune response to the bacterial cell wall and is assocd. with the development of Crohn's disease, Blau syndrome, and gastrointestinal cancers.  Nod2 is required for an immune response to muramyl dipeptide (MDP), an immunostimulatory fragment of bacterial cell wall, but it is not known whether MDP binds directly to Nod2.  We report the expression and purifn. of human Nod2 from insect cells.  Using novel MDP self-assembled monolayers (SAMs), we provide the first biochem. evidence for a direct, high-affinity interaction between Nod2 and MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_35GPZTPtLVg90H21EOLACvtfcHk0liihyTCWidAqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F&md5=9bb26db0105a836a5130c961622f4e34</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fja303883c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303883c%26sid%3Dliteratum%253Aachs%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26aulast%3DDe%2BZoysa%2BAriyananda%26aufirst%3DL.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DE.%2BK.%26atitle%3DThe%2520innate%2520immune%2520protein%2520Nod2%2520binds%2520directly%2520to%2520MDP%252C%2520a%2520bacterial%2520cell%2520wall%2520fragment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D13535%26epage%3D13537%26doi%3D10.1021%2Fja303883c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6897</span>– <span class="NLM_lpage">6918</span>, <span class="refDoi"> DOI: 10.1021/jm401841p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401841p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6897-6918&author=%C5%BD.+Jakopin&title=Nucleotide-binding+oligomerization+domain+%28NOD%29+inhibitors%3A+a+rational+approach+toward+inhibition+of+NOD+signaling+pathway&doi=10.1021%2Fjm401841p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401841p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401841p%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DNucleotide-binding%2520oligomerization%2520domain%2520%2528NOD%2529%2520inhibitors%253A%2520a%2520rational%2520approach%2520toward%2520inhibition%2520of%2520NOD%2520signaling%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6897%26epage%3D6918%26doi%3D10.1021%2Fjm401841p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamaillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegariu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span> <span> </span><span class="NLM_article-title">Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1126/science.1104911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1126%2Fscience.1104911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=15692051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=731-734&author=K.+S.+Kobayashiauthor=M.+Chamaillardauthor=Y.+Oguraauthor=O.+Henegariuauthor=N.+Inoharaauthor=G.+Nu%C3%B1ezauthor=R.+A.+Flavell&title=Nod2-dependent+regulation+of+innate+and+adaptive+immunity+in+the+intestinal+tract&doi=10.1126%2Fscience.1104911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract</span></div><div class="casAuthors">Kobayashi, Koichi S.; Chamaillard, Mathias; Ogura, Yasunori; Henegariu, Octavian; Inohara, Naohiro; Nunez, Gabriel; Flavell, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5710</span>),
    <span class="NLM_cas:pages">731-734</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The gene encoding the Nod2 protein is frequently mutated in Crohn's disease (CD) patients, although the physiol. function of Nod2 in the intestine remains elusive.  Here we show that protective immunity mediated by Nod2 recognition of bacterial muramyl dipeptide is abolished in Nod2-deficient mice.  These animals are susceptible to bacterial infection via the oral route but not through i.v. or peritoneal delivery.  Nod2 is required for the expression of a subgroup of intestinal anti-microbial peptides, known as cryptdins.  The Nod2 protein is thus a crit. regulator of bacterial immunity within the intestine, providing a possible mechanism for Nod2 mutations in CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAkDJ_MMpIXLVg90H21EOLACvtfcHk0lj_p94-oXAf5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wqtw%253D%253D&md5=288870c756e634bf9df3c15591fb259d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.1104911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1104911%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%2BS.%26aulast%3DChamaillard%26aufirst%3DM.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DHenegariu%26aufirst%3DO.%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26atitle%3DNod2-dependent%2520regulation%2520of%2520innate%2520and%2520adaptive%2520immunity%2520in%2520the%2520intestinal%2520tract%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D731%26epage%3D734%26doi%3D10.1126%2Fscience.1104911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvanantham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommerman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nod2-dependent Th2 polarization of antigen-specific immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">7925</span>– <span class="NLM_lpage">7935</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.181.11.7925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.181.11.7925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19017983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=7925-7935&author=J.+G.+Magalhaesauthor=J.+H.+Fritzauthor=L.+Le+Bourhisauthor=G.+Sellgeauthor=L.+H.+Travassosauthor=T.+Selvananthamauthor=S.+E.+Girardinauthor=J.+L.+Gommermanauthor=D.+J.+Philpott&title=Nod2-dependent+Th2+polarization+of+antigen-specific+immunity&doi=10.4049%2Fjimmunol.181.11.7925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity</span></div><div class="casAuthors">Magalhaes, Joao Gamelas; Fritz, Joerg H.; Le Bourhis, Lionel; Sellge, Gernot; Travassos, Leonardo H.; Selvanantham, Thirumahal; Girardin, Stephen E.; Gommerman, Jennifer L.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7925-7935</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">While a no. of microbial-assocd. mol. patterns have been known for decades to act as adjuvants, the mechanisms and the signaling pathways underlying their action have remained elusive.  Here, the authors examd. the unfolding of the adaptive immune response induced by Nod2 in vivo upon activation by its specific ligand, muramyl dipeptide, a component of peptidoglycan.  The authors' findings demonstrate that this bacterial sensor triggers a potent Ag-specific immune response with a Th2-type polarization profile, characterized by the induction of IL-4 and IL-5 by T cells and IgG1 Ab responses.  Nod2 was also crit. for the induction of both Th1- and Th2-type responses following costimulation with TLR agonists.  Importantly, the synergistic responses to Nod2 and TLR agonists seen in vivo were recapitulated by dendritic cells in vitro, suggesting that these cells likely play a central role in the integration of Nod2- and TLR-dependent signals for driving the adaptive immune response.  Taken together, the authors' results identify Nod2 as a crit. mediator of microbial-induced potentiation and polarization of Ag-dependent immunity.  Moreover, these findings affect the authors' understanding of Crohn's diseases pathogenesis, where lack of Nod2-dependent Th2 signaling in a subset of these patients might explain heightened Th1-mediated inflammation at the level of the intestinal mucosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJlqhZbkvAl7Vg90H21EOLACvtfcHk0liHTbyGNNx4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM&md5=d57612e894994da00c2cd14d5d578f54</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.11.7925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.11.7925%26sid%3Dliteratum%253Aachs%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DSellge%26aufirst%3DG.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DSelvanantham%26aufirst%3DT.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DGommerman%26aufirst%3DJ.%2BL.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNod2-dependent%2520Th2%2520polarization%2520of%2520antigen-specific%2520immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26spage%3D7925%26epage%3D7935%26doi%3D10.4049%2Fjimmunol.181.11.7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochereau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rességuier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutjahr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiraby, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perouzel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lioux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernejoul, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">5781</span>– <span class="NLM_lpage">5785</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1402184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.1402184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=25392526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2014&pages=5781-5785&author=V.+Pavotauthor=N.+Rochereauauthor=J.+Ress%C3%A9guierauthor=A.+Gutjahrauthor=C.+Geninauthor=G.+Tirabyauthor=E.+Perouzelauthor=T.+Liouxauthor=F.+Vernejoulauthor=B.+Verrierauthor=S.+Paul&title=Cutting+edge%3A+New+chimeric+NOD2%2FTLR2+adjuvant+drastically+increases+vaccine+immunogenicity&doi=10.4049%2Fjimmunol.1402184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity</span></div><div class="casAuthors">Pavot, Vincent; Rochereau, Nicolas; Resseguier, Julien; Gutjahr, Alice; Genin, Christian; Tiraby, Gerard; Perouzel, Eric; Lioux, Thierry; Vernejoul, Fabienne; Verrier, Bernard; Paul, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5781-5785</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">TLR ligands are crit. activators of innate immunity and are being developed as vaccine adjuvants.  However, their usefulness in conjunction with NOD-like receptor agonists remains poorly studied.  In this study, we evaluated a new ligand that targets both TLR2 and NOD2 receptors.  We assessed its ability to enhance dendritic cell maturation in vitro in addn. to improving systemic and mucosal immune responses in mice.  The chimeric NOD2/TLR2 ligand induced synergistic upregulation of dendritic cell maturation markers, costimulatory mols., and secretion of proinflammatory cytokines compared with combinations of sep. ligands.  Furthermore, when coadministered with biodegradable nanoparticles carrying a model Ag, the ligand was able to induce high Ag-specific IgA and IgG titers at both systemic and mucosal sites after parenteral immunizations.  These findings point out the potential utility of chimeric mols. TLR/NOD as adjuvants for vaccines to induce systemic and mucosal immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogfIIXnNf2VLVg90H21EOLACvtfcHk0liHTbyGNNx4Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegu7fE&md5=8e2e65ce220ea0d46e41fdc394537019</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1402184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1402184%26sid%3Dliteratum%253Aachs%26aulast%3DPavot%26aufirst%3DV.%26aulast%3DRochereau%26aufirst%3DN.%26aulast%3DRess%25C3%25A9guier%26aufirst%3DJ.%26aulast%3DGutjahr%26aufirst%3DA.%26aulast%3DGenin%26aufirst%3DC.%26aulast%3DTiraby%26aufirst%3DG.%26aulast%3DPerouzel%26aufirst%3DE.%26aulast%3DLioux%26aufirst%3DT.%26aulast%3DVernejoul%26aufirst%3DF.%26aulast%3DVerrier%26aufirst%3DB.%26aulast%3DPaul%26aufirst%3DS.%26atitle%3DCutting%2520edge%253A%2520New%2520chimeric%2520NOD2%252FTLR2%2520adjuvant%2520drastically%2520increases%2520vaccine%2520immunogenicity%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D193%26spage%3D5781%26epage%3D5785%26doi%3D10.4049%2Fjimmunol.1402184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uehori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shingai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seya, T.</span></span> <span> </span><span class="NLM_article-title">Dendritic cell maturation induced by muramy dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">7096</span>– <span class="NLM_lpage">7103</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.174.11.7096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.174.11.7096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=7096-7103&author=J.+Uehoriauthor=K.+Fukaseauthor=T.+Akazawaauthor=S.+Uematsuauthor=S.+Akiraauthor=K.+Funamiauthor=M.+Shingaiauthor=M.+Matsumotoauthor=I.+Azumaauthor=K.+Toyoshimaauthor=S.+Kusumotoauthor=T.+Seya&title=Dendritic+cell+maturation+induced+by+muramy+dipeptide+%28MDP%29+derivatives%3A+monoacylated+MDP+confers+TLR2%2FTLR4+activation&doi=10.4049%2Fjimmunol.174.11.7096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.174.11.7096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.174.11.7096%26sid%3Dliteratum%253Aachs%26aulast%3DUehori%26aufirst%3DJ.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DAkazawa%26aufirst%3DT.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DFunami%26aufirst%3DK.%26aulast%3DShingai%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DAzuma%26aufirst%3DI.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DSeya%26aufirst%3DT.%26atitle%3DDendritic%2520cell%2520maturation%2520induced%2520by%2520muramy%2520dipeptide%2520%2528MDP%2529%2520derivatives%253A%2520monoacylated%2520MDP%2520confers%2520TLR2%252FTLR4%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D7096%26epage%3D7103%26doi%3D10.4049%2Fjimmunol.174.11.7096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitting, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengin-Lecreulx, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caroff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaillon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adib-Conquy, M.</span></span> <span> </span><span class="NLM_article-title">Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and Nod1- and Nod2-activating agonists</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2459</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1002/eji.200526286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2Feji.200526286" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=2459-2470&author=J.+H.+Fritzauthor=S.+E.+Girardinauthor=C.+Fittingauthor=C.+Wertsauthor=D.+Mengin-Lecreulxauthor=M.+Caroffauthor=J.+M.+Cavaillonauthor=D.+J.+Philpottauthor=M.+Adib-Conquy&title=Synergistic+stimulation+of+human+monocytes+and+dendritic+cells+by+Toll-like+receptor+4+and+Nod1-+and+Nod2-activating+agonists&doi=10.1002%2Feji.200526286"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Feji.200526286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200526286%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DFitting%26aufirst%3DC.%26aulast%3DWerts%26aufirst%3DC.%26aulast%3DMengin-Lecreulx%26aufirst%3DD.%26aulast%3DCaroff%26aufirst%3DM.%26aulast%3DCavaillon%26aufirst%3DJ.%2BM.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DAdib-Conquy%26aufirst%3DM.%26atitle%3DSynergistic%2520stimulation%2520of%2520human%2520monocytes%2520and%2520dendritic%2520cells%2520by%2520Toll-like%2520receptor%25204%2520and%2520Nod1-%2520and%2520Nod2-activating%2520agonists%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2005%26volume%3D35%26spage%3D2459%26epage%3D2470%26doi%3D10.1002%2Feji.200526286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohteki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, H.</span></span> <span> </span><span class="NLM_article-title">Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7967</span>– <span class="NLM_lpage">7976</span>, <span class="refDoi"> DOI: 10.1128/IAI.73.12.7967-7976.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1128%2FIAI.73.12.7967-7976.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16299289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlersbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=7967-7976&author=H.+Tadaauthor=S.+Aibaauthor=K.+Shibataauthor=T.+Ohtekiauthor=H.+Takada&title=Synergistic+effect+of+Nod1+and+Nod2+agonists+with+toll-like+receptor+agonists+on+human+dendritic+cells+to+generate+interleukin-12+and+T+helper+type+1+cells&doi=10.1128%2FIAI.73.12.7967-7976.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells</span></div><div class="casAuthors">Tada, Hiroyuki; Aiba, Setsuya; Shibata, Ken-Ichiro; Ohteki, Toshiaki; Takada, Haruhiko</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7967-7976</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A synthetic Nod2 agonist, muramyldipeptide (MDP), and two Nod1 agonists, FK565 and FK156, mimic the bacterial peptidoglycan moiety and are powerful adjuvants that induce cell-mediated immunity, esp. delayed-type hypersensitivity.  In this study, we used human dendritic cell (DC) cultures to examine possible T helper type 1 (Th1) responses induced by MDP and FK565/156 in combination with various synthetic Toll-like receptor (TLR) agonists, including synthetic lipid A (TLR4 agonist), the synthetic triacyl lipopeptide Pam3CSSNA (TLR2 agonist), poly(I:C) (TLR3 agonist), and CpG DNA (TLR9 agonist).  Immature DCs derived from human monocytes expressed mRNAs for Nod1, Nod2, TLR2, TLR3, TLR4, and TLR9.  The stimulation of DCs with MDP and FK565 in combination with lipid A, poly(I:C), and CpG DNA, but not with Pam3CSSNA, synergistically induced interleukin-12 (IL-12) p70 and gamma interferon (IFN-γ), but not IL-18, in culture supernatants and induced IL-15 on the cell surface.  In correlation with the cytokine induction, an upregulation of the mRNA expression of these cytokine genes was obsd.  Notably, IL-12 p35 mRNA expression increased > 1000-fold upon stimulation with lipid A plus either MDP or FK565 compared with stimulation with each stimulant alone.  In contrast, for the expression of CD83 and costimulatory mols. such as CD40, CD80, and CD86, no synergistic effects were obsd. upon stimulation with Nod plus TLR agonists.  The culture supernatants of DCs stimulated with lipid A plus either MDP or FK565 activated human T cells to produce high levels of IFN-γ, and the activity was attributable to DC-derived IL-12.  These findings suggest that Nod1 and Nod2 agonists in combination with TLR3, TLR4, and TLR9 agonists synergistically induce IL-12 and IFN-γ prodn. in DCs to induce Th1-lineage immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Do-WJaMJBrVg90H21EOLACvtfcHk0lgGE0C2yMp0Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlersbbP&md5=54df8c2b0ed2f78c83967ab39da4212a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.12.7967-7976.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.12.7967-7976.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTada%26aufirst%3DH.%26aulast%3DAiba%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DOhteki%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DH.%26atitle%3DSynergistic%2520effect%2520of%2520Nod1%2520and%2520Nod2%2520agonists%2520with%2520toll-like%2520receptor%2520agonists%2520on%2520human%2520dendritic%2520cells%2520to%2520generate%2520interleukin-12%2520and%2520T%2520helper%2520type%25201%2520cells%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26spage%3D7967%26epage%3D7976%26doi%3D10.1128%2FIAI.73.12.7967-7976.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleinnijenhuis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preijers, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, L. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ifrim, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loenhout, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stunnenberg, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Meer, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Crevel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title">Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17537</span>– <span class="NLM_lpage">17542</span>, <span class="refDoi"> DOI: 10.1073/pnas.1202870109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1073%2Fpnas.1202870109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17537-17542&author=J.+Kleinnijenhuisauthor=J.+Quintinauthor=F.+Preijersauthor=L.+A.+B.+Joostenauthor=D.+C.+Ifrimauthor=S.+Saeedauthor=C.+Jacobsauthor=J.+van+Loenhoutauthor=D.+de+Jongauthor=H.+G.+Stunnenbergauthor=R.+J.+Xavierauthor=J.+W.+M.+van+der%0AMeerauthor=R.+van+Crevelauthor=M.+G.+Netea&title=Bacille+Calmette-Gu%C3%A9rin+induces+NOD2-dependent+nonspecific+protection+from+reinfection+via+epigenetic+reprogramming+of+monocytes&doi=10.1073%2Fpnas.1202870109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202870109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202870109%26sid%3Dliteratum%253Aachs%26aulast%3DKleinnijenhuis%26aufirst%3DJ.%26aulast%3DQuintin%26aufirst%3DJ.%26aulast%3DPreijers%26aufirst%3DF.%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DIfrim%26aufirst%3DD.%2BC.%26aulast%3DSaeed%26aufirst%3DS.%26aulast%3DJacobs%26aufirst%3DC.%26aulast%3Dvan%2BLoenhout%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DD.%26aulast%3DStunnenberg%26aufirst%3DH.%2BG.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26aulast%3Dvan%2BCrevel%26aufirst%3DR.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DBacille%2520Calmette-Gu%25C3%25A9rin%2520induces%2520NOD2-dependent%2520nonspecific%2520protection%2520from%2520reinfection%2520via%2520epigenetic%2520reprogramming%2520of%2520monocytes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D17537%26epage%3D17542%26doi%3D10.1073%2Fpnas.1202870109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Meer, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, L. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riksen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title">Trained immunity: a smart way to enhance innate immune defence</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.molimm.2015.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.molimm.2015.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=26597205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyrsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=40-44&author=J.+W.+M.+van%0Ader+Meerauthor=L.+A.+B.+Joostenauthor=N.+Riksenauthor=M.+G.+Netea&title=Trained+immunity%3A+a+smart+way+to+enhance+innate+immune+defence&doi=10.1016%2Fj.molimm.2015.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Trained immunity: A smart way to enhance innate immune defense</span></div><div class="casAuthors">van der Meer, Jos W. M.; Joosten, Leo A. B.; Riksen, Niels; Netea, Mihai G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-44</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The innate arm of the immune system is generally viewed as primitive and non-specific and - in contrast to the adaptive immune arm - not to possess memory.  However in plants and invertebrate animals that lack adaptive immunity, innate immunity will exhibit a prolonged enhanced functional state after adequate priming.  A similar enhancement of function of the innate immunity has occasionally been described in vertebrates, including humans.  Over the past few years the authors have studied this phenomenon in greater detail and the authors have coined the term 'Trained (innate) immunity' (TI).  TI can be induced by a variety of stimuli, of which the authors have studied BCG and β-glucan in greater detail.  The non-specific protective effects of BCG that have been obsd. in vaccination studies in the literature are probably due to TI.  Monocytes and macrophages are among the main cells of the innate immune arm that can be trained.  The authors have discovered that both BCG (via NOD2 signaling) and β-glucan (via dectin-1) induce epigenetic reprogramming, in particular stable changes in histone trimethylation at H3K4.  These epigenetic changes lead to cellular activation, enhanced cytokine prodn. and a change in the metabolic state of the cell with a shift from oxidative phosphorylation to aerobic glycolysis.  TI is not only important for host defense and vaccine responses, but most probably also for diseases like atherosclerosis.  Modulation of TI is a promising area for new treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotee2u4LPVarVg90H21EOLACvtfcHk0lhrzYa7ZyyLZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyrsbfM&md5=4077caa871aaa41c7e918dd39cbae5eb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2015.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2015.06.019%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DRiksen%26aufirst%3DN.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DTrained%2520immunity%253A%2520a%2520smart%2520way%2520to%2520enhance%2520innate%2520immune%2520defence%26jtitle%3DMol.%2520Immunol.%26date%3D2015%26volume%3D68%26spage%3D40%26epage%3D44%26doi%3D10.1016%2Fj.molimm.2015.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhães, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the therapeutic potential of NOD-like receptors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1038/nrd2783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnrd2783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19483708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=465-479&author=K.+Geddesauthor=J.+G.+Magalh%C3%A3esauthor=S.+E.+Girardin&title=Unleashing+the+therapeutic+potential+of+NOD-like+receptors&doi=10.1038%2Fnrd2783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the therapeutic potential of NOD-like receptors</span></div><div class="casAuthors">Geddes, Kaoru; Magalhaes, Joao G.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">465-479</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular sensors that have key roles in innate immunity and inflammation.  Whereas some NLRs, including NOD1, NOD2, NAIP (NLR family, apoptosis inhibitory protein) and NLRC4, detect conserved bacterial mol. signatures within the host cytosol, other members of this family sense 'danger signals', i.e., xenocompounds or mols. that when recognized alert the immune system of hazardous environments, perhaps independently of a microbial trigger.  In the past few years, remarkable progress has been made towards deciphering the role and the biol. of NLRs, which has shown that these innate immune sensors have pivotal roles in providing immunity to infection, adjuvanticity and inflammation.  Furthermore, several inflammatory disorders have been assocd. with mutations in human NLR genes.  Here, the authors discuss the effect that research on NLRs will have on vaccination, treatment of chronic inflammatory disorders and acute bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCvglqYhhnV7Vg90H21EOLACvtfcHk0lhrzYa7ZyyLZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D&md5=06a9045f6206702396cd920edf38649b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd2783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2783%26sid%3Dliteratum%253Aachs%26aulast%3DGeddes%26aufirst%3DK.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DJ.%2BG.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DUnleashing%2520the%2520therapeutic%2520potential%2520of%2520NOD-like%2520receptors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D465%26epage%3D479%26doi%3D10.1038%2Fnrd2783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciorbaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Minimal requirements for adjuvant activity of bacterial peptidoglycan derivatives</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(74)90458-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2F0006-291X%2874%2990458-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1974&pages=1317-1325&author=F.+Ellouzauthor=A.+Adamauthor=R.+Ciorbaruauthor=E.+Lederer&title=Minimal+requirements+for+adjuvant+activity+of+bacterial+peptidoglycan+derivatives&doi=10.1016%2F0006-291X%2874%2990458-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2874%2990458-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252874%252990458-6%26sid%3Dliteratum%253Aachs%26aulast%3DEllouz%26aufirst%3DF.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DCiorbaru%26aufirst%3DR.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMinimal%2520requirements%2520for%2520adjuvant%2520activity%2520of%2520bacterial%2520peptidoglycan%2520derivatives%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1974%26volume%3D59%26spage%3D1317%26epage%3D1325%26doi%3D10.1016%2F0006-291X%2874%2990458-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maisonneuve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertholet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gregorio, E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12294</span>– <span class="NLM_lpage">12299</span>, <span class="refDoi"> DOI: 10.1073/pnas.1400478111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1073%2Fpnas.1400478111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=25136133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12294-12299&author=C.+Maisonneuveauthor=S.+Bertholetauthor=D.+J.+Philpottauthor=E.+De+Gregorio&title=Unleashing+the+potential+of+NOD-+and+Toll-like+agonists+as+vaccine+adjuvants&doi=10.1073%2Fpnas.1400478111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants</span></div><div class="casAuthors">Maisonneuve, Charles; Bertholet, Sylvie; Philpott, Dana J.; De Gregorio, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12294-12299</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Innate immunity confers an immediate nonspecific mechanism of microbial recognition through germ line-encoded pattern recognition receptors (PRRs).  Of these, Toll-like receptors (TLRs) and nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) have shaped the authors' current understanding of innate regulation of adaptive immunity.  It is now recognized that PRRs are paramount in instructing an appropriate adaptive immune response.  Their ligands have been the focus of adjuvant research with the goal of generating modern vaccine combinations tailored to specific pathogens.  In this review the authors will highlight the recent findings in the field of adjuvant research with a particular focus on the potential of TLR and NLR ligands as adjuvants and their influence on adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Pm03irVncrVg90H21EOLACvtfcHk0lj4w9Zv79Z40w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM&md5=de6088e853b57a9f4d2d622e0a27a2c8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1400478111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1400478111%26sid%3Dliteratum%253Aachs%26aulast%3DMaisonneuve%26aufirst%3DC.%26aulast%3DBertholet%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DDe%2BGregorio%26aufirst%3DE.%26atitle%3DUnleashing%2520the%2520potential%2520of%2520NOD-%2520and%2520Toll-like%2520agonists%2520as%2520vaccine%2520adjuvants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12294%26epage%3D12299%26doi%3D10.1073%2Fpnas.1400478111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Modulating immunity as a therapy for bacterial infections</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnrmicro2745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=22421877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XktValu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=243-254&author=R.+E.+W.+Hancockauthor=A.+Nijnikauthor=D.+J.+Philpott&title=Modulating+immunity+as+a+therapy+for+bacterial+infections&doi=10.1038%2Fnrmicro2745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating immunity as a therapy for bacterial infections</span></div><div class="casAuthors">Hancock, Robert E. W.; Nijnik, Anastasia; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">243-254</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite our efforts to halt the increase and spread of antimicrobial resistance, bacteria continue to become less susceptible to antimicrobial drugs over time, and rates of discovery for new antibiotics are declining.  Thus, it is essential to explore new paradigms for anti-infective therapy.  One promising approach involves host-directed immunomodulatory therapies, whereby natural mechanisms in the host are exploited to enhance therapeutic benefit.  The objective is to initiate or enhance protective antimicrobial immunity while limiting inflammation-induced tissue injury.  A range of potential immune modulators have been proposed, including innate defense regulator peptides and agonists of innate immune components such as Toll-like receptors and NOD-like receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8BNxJiwdYerVg90H21EOLACvtfcHk0lg7ZHCp1ipATQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktValu70%253D&md5=8cc490e070e8f94adc62181b92b6d144</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2745%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26aulast%3DNijnik%26aufirst%3DA.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DModulating%2520immunity%2520as%2520a%2520therapy%2520for%2520bacterial%2520infections%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2012%26volume%3D10%26spage%3D243%26epage%3D254%26doi%3D10.1038%2Fnrmicro2745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Muramyl-peptides</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1351/pac198759030449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1351%2Fpac198759030449" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1987&pages=449-454&author=P.+Lefrancierauthor=E.+Lederer&title=Muramyl-peptides&doi=10.1351%2Fpac198759030449"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1351%2Fpac198759030449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac198759030449%26sid%3Dliteratum%253Aachs%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMuramyl-peptides%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1987%26volume%3D59%26spage%3D449%26epage%3D454%26doi%3D10.1351%2Fpac198759030449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">A novel immunostimulator, <i>N</i><sup>2</sup>-[α-<i>O</i>-benzyl-<i>N</i>-(acetylmuramyl)-<span class="smallcaps smallerCapital">l</span>-alanyl-<span class="smallcaps smallerCapital">d</span>-isoglutaminyl]-<i>N</i><sup>6</sup>-<i>trans</i>-(<i>m</i>-nitrocinnamoyl)-<span class="smallcaps smallerCapital">l</span>-lysine, and its adjuvancy on the hepatitis B surface antigen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5112</span>– <span class="NLM_lpage">5122</span>, <span class="refDoi"> DOI: 10.1021/jm0493313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0493313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5112-5122&author=H.-Z.+Yangauthor=S.+Xuauthor=X.-Y.+Liaoauthor=S.-D.+Zhangauthor=Z.-L.+Liangauthor=B.-H.+Liuauthor=J.-Y.+Baiauthor=C.+Jiangauthor=J.+Dingauthor=G.-F.+Chengauthor=G.+Liu&title=A+novel+immunostimulator%2C+N2-%5B%CE%B1-O-benzyl-N-%28acetylmuramyl%29-l-alanyl-d-isoglutaminyl%5D-N6-trans-%28m-nitrocinnamoyl%29-l-lysine%2C+and+its+adjuvancy+on+the+hepatitis+B+surface+antigen&doi=10.1021%2Fjm0493313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0493313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493313%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.-Z.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DX.-Y.%26aulast%3DZhang%26aufirst%3DS.-D.%26aulast%3DLiang%26aufirst%3DZ.-L.%26aulast%3DLiu%26aufirst%3DB.-H.%26aulast%3DBai%26aufirst%3DJ.-Y.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.-F.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DA%2520novel%2520immunostimulator%252C%2520N2-%255B%25CE%25B1-O-benzyl-N-%2528acetylmuramyl%2529-l-alanyl-d-isoglutaminyl%255D-N6-trans-%2528m-nitrocinnamoyl%2529-l-lysine%252C%2520and%2520its%2520adjuvancy%2520on%2520the%2520hepatitis%2520B%2520surface%2520antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5112%26epage%3D5122%26doi%3D10.1021%2Fjm0493313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel desmuramyldipeptide analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3762</span>– <span class="NLM_lpage">3777</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2011.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=21669478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3762-3777&author=%C5%BD.+Jakopinauthor=E.+Corsiniauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Design%2C+synthesis+and+biological+evaluation+of+novel+desmuramyldipeptide+analogs&doi=10.1016%2Fj.ejmech.2011.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel desmuramyldipeptide analogs</span></div><div class="casAuthors">Jakopin, Ziga; Corsini, Emanuela; Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3762-3777</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel desmuramyldipeptides have been designed and synthesized as part of the search for therapeutically useful muramyldipeptide (MDP) analogs.  Their immunomodulatory properties were initially assessed in vitro, evaluating their effect on lipopolysaccharide (LPS)-induced cytokine release in THP-1 cells.  Following the initial screening, selected compds. were further investigated for immunomodulatory properties using LPS and phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells.  The results confirmed the immunomodulatory properties of some of the synthesized desmuramyldipeptide analogs.  Taken together, the data confirmed the immunostimulatory effect of pyrido-fused [1,2]-benzisothiazole-contg. MDP deriv. I, while for indole-contg. MDP derivs. II and III, an immunosuppressive effect was obsd.  Further studies will be necessary to address their potential therapeutic use as immunomodulatory drugs, both as immunostimulants or antiinflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdf0ICGmE7rrVg90H21EOLACvtfcHk0lhhVX5eo9pccw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI&md5=0e658d046b6551ad97d9e5887bb960c8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DCorsini%26aufirst%3DE.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520desmuramyldipeptide%2520analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3762%26epage%3D3777%26doi%3D10.1016%2Fj.ejmech.2011.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Immunomodulatory properties of novel nucleotide oligomerization domain 2 (Nod2) agonistic desmuramyldipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6478</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.1021/jm300503b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300503b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6478-6488&author=%C5%BD.+Jakopinauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Immunomodulatory+properties+of+novel+nucleotide+oligomerization+domain+2+%28Nod2%29+agonistic+desmuramyldipeptides&doi=10.1021%2Fjm300503b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory Properties of Novel Nucleotide Oligomerization Domain 2 (Nod2) Agonistic Desmuramyldipeptides</span></div><div class="casAuthors">Jakopin, Ziga; Gobec, Martina; Mlinaric-Rascan, Irena; Sollner Dolenc, Marija</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6478-6488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a pressing need for the development of novel adjuvants for human use.  The minimal bioactive structure of bacterial peptidoglycan (PGN), muramyldipeptide (MDP), and its deriv. murabutide (MB) have long been known for their adjuvant activities.  For this reason, a series of novel desmuramyldipeptides have been designed and synthesized as part of our search for therapeutically useful MDP analogs.  Since nucleotide oligomerization domain 2 (Nod2) is a putative receptor for MDP, we used engineered HEK293 cells overexpressing Nod2 to screen and validate our compds. for their Nod2-agonist activity.  Their immunomodulatory properties were subsequently assessed in vitro by evaluating their effect on proinflammatory cytokine prodn. of phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells (PBMCs).  Herein, we present novel desmuramyldipeptides, the most active of them possessing immunoenhancing properties as a result of their potent Nod2-agonistic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwj-B62knTQ7Vg90H21EOLACvtfcHk0lhhVX5eo9pccw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D&md5=7da25625df463ffa238394773501767e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300503b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300503b%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DImmunomodulatory%2520properties%2520of%2520novel%2520nucleotide%2520oligomerization%2520domain%25202%2520%2528Nod2%2529%2520agonistic%2520desmuramyldipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6478%26epage%3D6488%26doi%3D10.1021%2Fjm300503b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Murabutide revisited: a review of its pleiotropic biological effects</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.2174/0929867311320160002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.2174%2F0929867311320160002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=23531213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=2068-2079&author=%C5%BD.+Jakopin&title=Murabutide+revisited%3A+a+review+of+its+pleiotropic+biological+effects&doi=10.2174%2F0929867311320160002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Murabutide revisited: a review of its pleiotropic biological effects</span></div><div class="casAuthors">Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2068-2079</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the great efforts put into their development, the list of clin. approved immunol. adjuvants is still very short.  Evolution of the knowledge of the immune system has enabled for rational design of novel adjuvants and has led to the conclusion that more than one type of adjuvant will be required.  Derivs. of muramyl dipeptide (MDP), the minimal immunomodulatory structure of bacterial cell wall peptidoglycan, have gained considerable attention in the past decades, because of their potent adjuvant effects.  Murabutide is a safe deriv. of MDP, which interacts with cells of the immune system, both innate and adaptive, and exerts its effect through activation of Nod2.  The transcriptional response of murabutide-stimulated macrophages revealed enhanced expression of genes coding for various proteins such as immune mediators and their receptors, transcription factors and kinases, ion channels/transporters and proteins involved in cell metabolic activity, thus reflecting a broad spectrum of biol. effects.  In addn. to its well recognized adjuvant effect, murabutide has also been shown to enhance the host's resistance against microbial infections, nonspecific resistance against tumors and the induction of cytokines and chemokines implicated in enhancing the immune response and hematopoesis.  This article provides an insight into the mechanism of action of murabutide and its interactions with the cells of the immune system in vitro and in vivo.  On account of its numerous biol. effects, murabutide has been the subject of several clin. studies.  Many of these have confirmed its potential to synergize with cytokines of therapeutic interest in potentiating the tumoricidal activity of macrophages or targeting chronic viral diseases, as well as reducing the cytokine dosage needed to achieve a therapeutic effect.  This review covers the findings of all relevant studies and focuses on the role of murabutide and its potential in the treatment of several microbial diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRI0UmLi-DrVg90H21EOLACvtfcHk0lgrpxLEy3eN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D&md5=519fd1fb58ae28d9da85019cfc765e61</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F0929867311320160002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320160002%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DMurabutide%2520revisited%253A%2520a%2520review%2520of%2520its%2520pleiotropic%2520biological%2520effects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D2068%26epage%3D2079%26doi%3D10.2174%2F0929867311320160002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">425</span>, <span class="refDoi"> DOI: 10.1007/s10719-007-9095-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1007%2Fs10719-007-9095-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=18161023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=415-425&author=X.+Liauthor=J.+Yuauthor=S.+Xuauthor=N.+Wangauthor=H.+Yangauthor=Z.+Yanauthor=G.+Chengauthor=G.+Liu&title=Chemical+conjugation+of+muramyl+dipeptide+and+paclitaxel+to+explore+the+combination+of+immunotherapy+and+chemotherapy+for+cancer&doi=10.1007%2Fs10719-007-9095-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer</span></div><div class="casAuthors">Li, Xuqin; Yu, Junli; Xu, Song; Wang, Nan; Yang, Hongzhen; Yan, Zheng; Cheng, Guifang; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-425</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Paclitaxel (Taxol) conjugated to muramyl dipeptide (MDP) is described.  Biol. testing showed that the conjugation of MDP at 2'-O-paclitaxel (2'-O-MTC-01) not only has antitumor activity, but also has immunoenhancement capacity.  Compared with paclitaxel or MDP alone or with a mixt. of paclitaxel + MDP, 2'-O-MTC-01 significantly increases the prodn. and expression of TNF-α and IL-12 from mouse peritoneal macrophages, which demonstrates a synergism of MDP and paclitaxel in one conjugated mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgQsSKmbICMLVg90H21EOLACvtfcHk0lgrpxLEy3eN-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVKqs74%253D&md5=ea2a28398e9dd6690b0cbd54c508b604</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10719-007-9095-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-007-9095-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DChemical%2520conjugation%2520of%2520muramyl%2520dipeptide%2520and%2520paclitaxel%2520to%2520explore%2520the%2520combination%2520of%2520immunotherapy%2520and%2520chemotherapy%2520for%2520cancer%26jtitle%3DGlycoconjugate%2520J.%26date%3D2008%26volume%3D25%26spage%3D415%26epage%3D425%26doi%3D10.1007%2Fs10719-007-9095-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pečar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štalc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraber-Herzog, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povšič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhadolc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hočevar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hönig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogi-Kohlenprath, R.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-{<i>trans</i>-[[2′(acetylamino)cyclohexyl]oxy]acetyl}-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1021/jm970509d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970509d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=530-539&author=D.+Kikeljauthor=S.+Pe%C4%8Darauthor=V.+Kotnikauthor=A.+%C5%A0talcauthor=B.+Wraber-Herzogauthor=S.+Sim%C4%8Di%C4%8Dauthor=A.+Ihanauthor=L.+Klamferauthor=L.+Pov%C5%A1i%C4%8Dauthor=R.+Grahekauthor=E.+Suhadolcauthor=M.+Ho%C4%8Devarauthor=H.+H%C3%B6nigauthor=R.+Rogi-Kohlenprath&title=N-%7Btrans-%5B%5B2%E2%80%B2%28acetylamino%29cyclohexyl%5Doxy%5Dacetyl%7D-L-alanyl-D-glutamic+acid%3A+a+novel+immunologically+active+carbocyclic+muramyl+dipeptide+analogue&doi=10.1021%2Fjm970509d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm970509d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970509d%26sid%3Dliteratum%253Aachs%26aulast%3DKikelj%26aufirst%3DD.%26aulast%3DPe%25C4%258Dar%26aufirst%3DS.%26aulast%3DKotnik%26aufirst%3DV.%26aulast%3D%25C5%25A0talc%26aufirst%3DA.%26aulast%3DWraber-Herzog%26aufirst%3DB.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DIhan%26aufirst%3DA.%26aulast%3DKlamfer%26aufirst%3DL.%26aulast%3DPov%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DGrahek%26aufirst%3DR.%26aulast%3DSuhadolc%26aufirst%3DE.%26aulast%3DHo%25C4%258Devar%26aufirst%3DM.%26aulast%3DH%25C3%25B6nig%26aufirst%3DH.%26aulast%3DRogi-Kohlenprath%26aufirst%3DR.%26atitle%3DN-%257Btrans-%255B%255B2%25E2%2580%25B2%2528acetylamino%2529cyclohexyl%255Doxy%255Dacetyl%257D-L-alanyl-D-glutamic%2520acid%253A%2520a%2520novel%2520immunologically%2520active%2520carbocyclic%2520muramyl%2520dipeptide%2520analogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D530%26epage%3D539%26doi%3D10.1021%2Fjm970509d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sollner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štalc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povšič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog-Wraber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosman, P.</span></span> <span> </span><span class="NLM_article-title">Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties</span>. <i>Agents Actions</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1007/BF01976220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1007%2FBF01976220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=8213354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1993&pages=273-280&author=M.+Sollnerauthor=V.+Kotnikauthor=A.+%C5%A0talcauthor=S.+Sim%C4%8Di%C4%8Dauthor=L.+Pov%C5%A1i%C4%8Dauthor=B.+Herzog-Wraberauthor=L.+Klampferauthor=A.+Ihanauthor=P.+Grosman&title=Apyrogenic+synthetic+desmuramyldipeptide%2C+LK-409%2C+with+immunomodulatory+properties&doi=10.1007%2FBF01976220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties</span></div><div class="casAuthors">Sollner, M.; Kotnik, V.; Pecar; Stalc, A.; Simcic, S.; Povsic, L.; Herzog-Wraber, B.; Klampfer, L.; Ihan, A.; Grosman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Agents and Actions</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">273-80</span>CODEN:
                <span class="NLM_cas:coden">AGACBH</span>;
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">The synthesis and some immunol. characteristics of a new desmuramyl dipeptide 7-oxooctanoyl-L-alanyl-D-isoglutamine (LK-409) are presented.  The effects of this compd. were compared with those of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).  The influence of LK-409 on the no. of B and T cells in spleen and the no. of peritoneal macrophages was studied; Jerne's plaque forming cells assay was performed to monitor the effect of B cell differentiation.  The blast transformation of T cells stimulated with Con A was used to detect the influences on T lymphocytes.  The activation of macrophages was studied as well.  In contrast to MDP, LK-409 was apyrogenic in the doses applied but had similar immunomodulatory properties.  Tested immunol. properties and the absence of pyrogenicity and low toxicity make LK-409 a candidate for an immunomodulatory drug and a model mol. suitable for studying and understanding the dual activity of the MDP and its analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQCbmK0ebCLVg90H21EOLACvtfcHk0ljoiIkdLLjRXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWjt7s%253D&md5=8d15bd07507b4a8acecd97d09c3516ff</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2FBF01976220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01976220%26sid%3Dliteratum%253Aachs%26aulast%3DSollner%26aufirst%3DM.%26aulast%3DKotnik%26aufirst%3DV.%26aulast%3D%25C5%25A0talc%26aufirst%3DA.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DPov%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DHerzog-Wraber%26aufirst%3DB.%26aulast%3DKlampfer%26aufirst%3DL.%26aulast%3DIhan%26aufirst%3DA.%26aulast%3DGrosman%26aufirst%3DP.%26atitle%3DApyrogenic%2520synthetic%2520desmuramyldipeptide%252C%2520LK-409%252C%2520with%2520immunomodulatory%2520properties%26jtitle%3DAgents%2520Actions%26date%3D1993%26volume%3D38%26spage%3D273%26epage%3D280%26doi%3D10.1007%2FBF01976220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Todate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Muramyl dipeptide-Lys stimulates the function of human dendritic cells</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=11698491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=723-729&author=A.+Todateauthor=T.+Sudaauthor=H.+Kuwataauthor=K.+Chidaauthor=H.+Nakamura&title=Muramyl+dipeptide-Lys+stimulates+the+function+of+human+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl dipeptide-Lys stimulates the function of human dendritic cells</span></div><div class="casAuthors">Todate, Akihito; Suda, Takafumi; Kuwata, Hiroshi; Chida, Kingo; Nakamura, Hirotoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">723-729</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP)-Lys (L18), a synthetic MDP analog derived from bacterial cell walls, has been reported to be a potent immunoadjuvant that enhances protective immunity against pathogens and tumors by stimulating immune-competent cells, such as monocytes and macrophages.  However, it is not known whether MDP-Lys modulates the function of dendritic cells (DCs), which are the most potent antigen-presenting cells and play a crucial role in initiating T cell-mediated immunity.  Therefore, we examd. the effects of MDP-Lys on the expression of surface mols., cytokine prodn., and antigen-presenting function of human DCs generated from peripheral blood cells in the presence of interleukin (IL)-4 and granulocyte-macrophage colony-stimulating factor.  We found that MDP-Lys markedly up-regulated the expression of CD80, CD83, CD86, and CD40, but not human leukocyte antigen-DR, and stimulated the prodn. of tumor necrosis factor-α, IL-6, IL-8, IL-10, and IL-12 (p40) by human DCs in a dose-dependent manner.  Furthermore, MDP-Lys-treated DCs showed enhanced antigen-presenting function compared with untreated DCs, as assessed by an allogeneic mixed lymphocyte reaction.  These results suggested that the immunoadjuvant activity of MDP-Lys in vivo is mediated, in part, by its stimulation of DC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVi5NO0qPVQLVg90H21EOLACvtfcHk0liKeLGq_w5nww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D&md5=0123eaf8d8f353ed56e2dd604b90afc4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTodate%26aufirst%3DA.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DH.%26aulast%3DChida%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DMuramyl%2520dipeptide-Lys%2520stimulates%2520the%2520function%2520of%2520human%2520dendritic%2520cells%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D70%26spage%3D723%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Level, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">826</span>– <span class="NLM_lpage">831</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1128%2FIAI.27.3.826-831.1980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=7380554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaL3cXksVemtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1980&pages=826-831&author=M.+A.+Parantauthor=F.+M.+Audibertauthor=L.+A.+Chedidauthor=M.+R.+Levelauthor=P.+L.+Lefrancierauthor=J.+P.+Choayauthor=E.+Lederer&title=Immunostimulant+activities+of+a+lipophilic+muramyl+dipeptide+derivative+and+of+desmuramyl+peptidolipid+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs</span></div><div class="casAuthors">Parant, Monique A.; Audibert, Francoise M.; Chedid, Louis A.; Level, Michel R.; Lefrancier, Pierre L.; Choay, Jean P.; Lederer, Edgar</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">826-31</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The immunostimulant properties of a new muramyl dipeptide (MDP) deriv. bearing a lipophilic moiety on the C-terminal end of the peptide chain are described.  It is shown, that 1,O-(acetylmuramyl-L-alanyl-D-isoglutamine-L-alanyl)-glycerol-3-mycolate had increased immunostimulant activity in comparison with MDP.  It induced hypersensitivity even when administered with an antigen in saline, and it gave higher protection against bacterial infections than did MDP.  The corresponding desmuramyl compd. 1,O-(L-alanyl-D-isoglutamine-L-alanyl-glycerol-3-mycolate, which had no activity in producing humoral antibodies was just as active as the muramic acid-contg. compd. in stimulating nonspecific resistance to bacterial infections.  It was not pyrogenic.  Modifications of the peptide moiety or the lipid moiety of this peptidolipid led to decrease, or even loss, of activity.  These results show the importance of the N-acetylmuramyl moiety in MDP for humoral antibody prodn.  The peptidolipid 1,O-(L-alanyl-D-isoglutamine-L-alanyl)-glycerol-3-mycolate is the first member of a new category of nonspecific immunostimulants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4chO2awCP4LVg90H21EOLACvtfcHk0liKeLGq_w5nww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXksVemtrg%253D&md5=ff6679a276700ea82b532b98e8db2bff</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FIAI.27.3.826-831.1980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.27.3.826-831.1980%26sid%3Dliteratum%253Aachs%26aulast%3DParant%26aufirst%3DM.%2BA.%26aulast%3DAudibert%26aufirst%3DF.%2BM.%26aulast%3DChedid%26aufirst%3DL.%2BA.%26aulast%3DLevel%26aufirst%3DM.%2BR.%26aulast%3DLefrancier%26aufirst%3DP.%2BL.%26aulast%3DChoay%26aufirst%3DJ.%2BP.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DImmunostimulant%2520activities%2520of%2520a%2520lipophilic%2520muramyl%2520dipeptide%2520derivative%2520and%2520of%2520desmuramyl%2520peptidolipid%2520analogs%26jtitle%3DInfect.%2520Immun.%26date%3D1980%26volume%3D27%26spage%3D826%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willems, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zom, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeuwenoord, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossendorp, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippov, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codée, J. D.</span></span> <span> </span><span class="NLM_article-title">Lipophilic muramyl dipeptide-antigen conjugates as immunostimulating agents</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2Fcmdc.201500196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=26059481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps12ru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=190-198&author=M.+M.+Willemsauthor=G.+G.+Zomauthor=N.+Meeuwenoordauthor=S.+Khanauthor=F.+Ossendorpauthor=H.+S.+Overkleeftauthor=G.+A.+van+der+Marelauthor=D.+V.+Filippovauthor=J.+D.+Cod%C3%A9e&title=Lipophilic+muramyl+dipeptide-antigen+conjugates+as+immunostimulating+agents&doi=10.1002%2Fcmdc.201500196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic muramyl dipeptide-antigen conjugates as immunostimulating agents</span></div><div class="casAuthors">Willems, Marian M. J. H. P.; Zom, Gijs G.; Meeuwenoord, Nico; Khan, Selina; Ossendorp, Ferry; Overkleeft, Herman S.; van der Marel, Gijsbert A.; Filippov, Dmitri V.; Codee, Jeroen D. C.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">190-198</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is the smallest peptidoglycan fragment capable of triggering the innate immune system through interaction with the intracellular NOD2 receptor.  To develop synthetic vaccine modalities composed of an antigenic entity (typically a small peptide) and a mol. adjuvant with well-defined activity, we previously assembled covalent MDP-antigen conjugates.  Although these were found to be capable of stimulating the NOD2 receptor and were processed by dendritic cells (DCs) leading to effective antigen presentation, DC maturation-required for an apt immune response-could not be achieved with these conjugates.  To improve the efficacy of these vaccine modalities, we equipped the MDP moiety with lipophilic tails, well-known modifications to enhance the immune-stimulatory activity of MDPs.  Herein we report the design and synthesis of a lipophilic MDP-antigen conjugate and show that it is a promising vaccine modality capable of stimulating the NOD2 receptor, maturing DCs, and delivering antigen cargo into the MHC-I cross-presentation pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgaDbNR6tWdbVg90H21EOLACvtfcHk0lh89uiytIVFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps12ru74%253D&md5=e4b4eb77478a257f7213f9ba11362c2d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500196%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DM.%2BM.%26aulast%3DZom%26aufirst%3DG.%2BG.%26aulast%3DMeeuwenoord%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DOssendorp%26aufirst%3DF.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DFilippov%26aufirst%3DD.%2BV.%26aulast%3DCod%25C3%25A9e%26aufirst%3DJ.%2BD.%26atitle%3DLipophilic%2520muramyl%2520dipeptide-antigen%2520conjugates%2520as%2520immunostimulating%2520agents%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D190%26epage%3D198%26doi%3D10.1002%2Fcmdc.201500196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4292</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.bmcl.2011.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=21683593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4292-4295&author=N.+Zhaoauthor=Y.+Maauthor=S.+Zhangauthor=X.+Fangauthor=Z.+Liangauthor=G.+Liu&title=New+muramyl+dipeptide+%28MDP%29+mimics+without+the+carbohydrate+moiety+as+potential+adjuvant+candidates+for+a+therapeutic+hepatitis+B+vaccine+%28HBV%29&doi=10.1016%2Fj.bmcl.2011.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)</span></div><div class="casAuthors">Zhao, Nan; Ma, Yao; Zhang, Shengmei; Fang, Xin; Liang, Zhenglun; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4292-4295</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new muramyl dipeptide (MDP) mimics were designed and synthesized via a solid-phase synthetic route.  Their adjuvant activities were evaluated ex vivo for investigation of the synergism of the S28-39 peptide, which is an MHC class I binding epitope of recombinant hepatitis B surface antigen (HBsAg) for both humans and mice.  Several compds. without the carbohydrate moiety exerted better adjuvanticity than the MDP-C that has been reported by the authors previously.  A primary screening test revealed that compds. 6, 14 and 16 exhibited stronger adjuvanticity compared with other MDP mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0n6Vaul0AJ7Vg90H21EOLACvtfcHk0lh89uiytIVFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D&md5=110f9bdbbcd8c37da8dfc295e4128dfe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DNew%2520muramyl%2520dipeptide%2520%2528MDP%2529%2520mimics%2520without%2520the%2520carbohydrate%2520moiety%2520as%2520potential%2520adjuvant%2520candidates%2520for%2520a%2520therapeutic%2520hepatitis%2520B%2520vaccine%2520%2528HBV%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4292%26epage%3D4295%26doi%3D10.1016%2Fj.bmcl.2011.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Structural requirements of acylated Gly-l-Ala-d-Glu analogs for activation of the innate immune receptor NOD2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2016.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=27039337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=1-12&author=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolencauthor=%C5%BD.+Jakopin&title=Structural+requirements+of+acylated+Gly-l-Ala-d-Glu+analogs+for+activation+of+the+innate+immune+receptor+NOD2&doi=10.1016%2Fj.ejmech.2016.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements of acylated Gly-L-Ala-D-Glu analogs for activation of the innate immune receptor NOD2</span></div><div class="casAuthors">Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The fragment of bacterial peptidoglycan muramyl dipeptide (MDP) has long been known for its adjuvant activity, however the underlying mechanism of this action has only recently been elucidated.  It is ascribed to its agonist action on the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2).  In spite of the pressing need for novel adjuvants for human use, this discovery is hampered, by not knowing the structural requirements underlying the immunostimulatory activity.  The authors have investigated how minor modifications of hit compd. acyl Gly-L-Ala-D-Glu deriv. I modulate the mol. recognition by NOD2.  A series of novel desmuramyldipeptides has been designed and synthesized leading to the identification of compd. 16, in which the sugar moiety is replaced by a 6-phenylindole moiety, that exhibits the strongest NOD2 activation to date sans the carbohydrate moiety.  The results have enabled a deeper understanding of the structural requirements of desmuramylpeptides for NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0x5MPpjFx7Vg90H21EOLACvtfcHk0lh89uiytIVFwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D&md5=7a990ab9f29e7802bd24bcb051c60bd4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DStructural%2520requirements%2520of%2520acylated%2520Gly-l-Ala-d-Glu%2520analogs%2520for%2520activation%2520of%2520the%2520innate%2520immune%2520receptor%2520NOD2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Functional and molecular expression of the proton-coupled oligopeptide transporters in spleen and macrophages from mouse and human</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1416</span>, <span class="refDoi"> DOI: 10.1021/mp300700p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300700p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1409-1416&author=D.+Sunauthor=Y.+Wangauthor=F.+Tanauthor=D.+Fangauthor=Y.+Huauthor=D.+E.+Smithauthor=H.+Jiang&title=Functional+and+molecular+expression+of+the+proton-coupled+oligopeptide+transporters+in+spleen+and+macrophages+from+mouse+and+human&doi=10.1021%2Fmp300700p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and Molecular Expression of the Proton-Coupled Oligopeptide Transporters in Spleen and Macrophages from Mouse and Human</span></div><div class="casAuthors">Sun, Dongli; Wang, Yuqing; Tan, Fuqing; Fang, Danbo; Hu, Yongjun; Smith, David E.; Jiang, Huidi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1409-1416</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this study was to det. the expression and function of proton-coupled oligopeptide transporters (POTs) in spleen and macrophages and their contribution to innate immune response induced by bacterial peptidomimetics γ-iE-DAP and MDP.  Quant. real-time PCR (qRT-PCR) and Western blot results revealed the mRNA and protein expression of PepT2, PhT1, and PhT2, but not PepT1, in the spleen of mice and humans.  In comparison to lymphocytes of the spleen, macrophages had higher transcript levels of PepT2 and PhT2.  The cellular uptake of Ala-Lys-AMCA in mouse splenic macrophages was pH-dependent with max. uptake at pH 6.0, and the kinetic parameters were Km = 75.5 μM and Vmax = 25.4 pmol/min per mg protein.  The uptake of Ala-Lys-AMCA by mouse splenic macrophages was not inhibited by histidine but was significantly inhibited by glycyl-sarcosine (GlySar) and carnosine, and by bacterial peptidomimetics γ-iE-DAP and MDP, ligands of nucleotide-binding oligomerization domain (NOD)-contg. proteins.  Carnosine and GlySar, but not histidine, attenuated the inflammatory response induced by γ-iE-DAP and MDP in mouse splenic macrophages.  Functional expression of POTs was also demonstrated in THP-1 cells, and dipeptides reduced the immune response induced by γ-iE-DAP.  In conclusion, these findings are novel by providing important information on the mol. and functional expression of POTs in the spleen.  Moreover, it appears that the PepT2-mediated uptake of γ-iE-DAP and MDP in macrophages further contributes to the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFoWVuJlfPJLVg90H21EOLACvtfcHk0lgldu9mKt2SEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCmsbg%253D&md5=1fbfdaa031d4a9b65bf4bfd7f107d17d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fmp300700p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300700p%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DFunctional%2520and%2520molecular%2520expression%2520of%2520the%2520proton-coupled%2520oligopeptide%2520transporters%2520in%2520spleen%2520and%2520macrophages%2520from%2520mouse%2520and%2520human%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1409%26epage%3D1416%26doi%3D10.1021%2Fmp300700p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakalarski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mazière, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumperman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delamarre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span> <span> </span><span class="NLM_article-title">Endosomes are specialized platforms for bacterial sensing and NOD2 signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1038/nature13133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnature13133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=24695226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=240-244&author=N.+Nakamuraauthor=J.+R.+Lillauthor=Q.+Phungauthor=Z.+Jiangauthor=C.+Bakalarskiauthor=A.+de+Mazi%C3%A8reauthor=J.+Klumpermanauthor=M.+Schlatterauthor=L.+Delamarreauthor=I.+Mellman&title=Endosomes+are+specialized+platforms+for+bacterial+sensing+and+NOD2+signalling&doi=10.1038%2Fnature13133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomes are specialized platforms for bacterial sensing and NOD2 signalling</span></div><div class="casAuthors">Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; de Maziere, Ann; Klumperman, Judith; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7499</span>),
    <span class="NLM_cas:pages">240-244</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The detection of microbial pathogens involves the recognition of conserved microbial components by host cell sensors such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs).  TLRs are membrane receptors that survey the extracellular environment for microbial infections, whereas NLRs are cytosolic complexes that detect microbial products that reach the cytosol.  Upon detection, both sensor classes trigger innate inflammatory responses and allow the engagement of adaptive immunity.  Endo-lysosomes are the entry sites for a variety of pathogens, and therefore the sites at which the immune system first senses their presence.  Pathogens internalized by endocytosis are well known to activate TLRs 3 and 7-9 that are localized to endocytic compartments and detect ligands present in the endosomal lumen.  Internalized pathogens also activate sensors in the cytosol such as NOD1 and NOD2 (ref. 2), indicating that endosomes also provide for the translocation of bacterial components across the endosomal membrane.  Despite the fact that NOD2 is well understood to have a key role in regulating innate immune responses and that mutations at the NOD2 locus are a common risk factor in inflammatory bowel disease and possibly other chronic inflammatory states, little is known about how its ligands escape from endosomes.  Here we show that two endo-lysosomal peptide transporters, SLC15A3 and SLC15A4, are preferentially expressed by dendritic cells, esp. after TLR stimulation.  The transporters mediate the egress of bacterially derived components, such as the NOD2 cognate ligand muramyl dipeptide (MDP), and are selectively required for NOD2 responses to endosomally derived MDP.  Enhanced expression of the transporters also generates endosomal membrane tubules characteristic of dendritic cells, which further enhanced the NOD2-dependent response to MDP.  Finally, sensing required the recruitment of NOD2 and its effector kinase RIPK2 to the endosomal membrane, possibly by forming a complex with SLC15A3 or SLC15A4.  Thus, dendritic cell endosomes are specialized platforms for both the lumenal and cytosolic sensing of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoppdcGuBL0_bVg90H21EOLACvtfcHk0lhK7B3f35VzRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D&md5=dd38ce753d9529651acea52f83a753b1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature13133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13133%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DPhung%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DBakalarski%26aufirst%3DC.%26aulast%3Dde%2BMazi%25C3%25A8re%26aufirst%3DA.%26aulast%3DKlumperman%26aufirst%3DJ.%26aulast%3DSchlatter%26aufirst%3DM.%26aulast%3DDelamarre%26aufirst%3DL.%26aulast%3DMellman%26aufirst%3DI.%26atitle%3DEndosomes%2520are%2520specialized%2520platforms%2520for%2520bacterial%2520sensing%2520and%2520NOD2%2520signalling%26jtitle%3DNature%26date%3D2014%26volume%3D509%26spage%3D240%26epage%3D244%26doi%3D10.1038%2Fnature13133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattoli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtal, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavricka, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">23818</span>– <span class="NLM_lpage">23829</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.033670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.M109.033670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19570976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=23818-23829&author=J.+Leeauthor=I.+Tattoliauthor=K.+A.+Wojtalauthor=S.+R.+Vavrickaauthor=D.+J.+Philpottauthor=S.+E.+Girardin&title=pH-dependent+internalization+of+muramyl+peptides+from+early+endosomes+enables+Nod1+and+Nod2+signaling&doi=10.1074%2Fjbc.M109.033670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling</span></div><div class="casAuthors">Lee, Jooeun; Tattoli, Ivan; Wojtal, Kacper A.; Vavricka, Stephan R.; Philpott, Dana J.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">23818-23829</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod1 and Nod2 are members of the Nod-like receptor family that detect intracellular bacterial peptidoglycan-derived muramyl peptides.  The biol. effects of muramyl peptides have been described for over three decades, but the mechanism underlying their internalization to the cytosol remains unclear.  Using the human epithelial cell line HEK293T as a model system, the authors demonstrate here that Nod1-activating ligands entered cells through endocytosis, most likely by the clathrin-coated pit pathway, as internalization was dynamin-dependent but not inhibited by methyl-β-cyclodextrin.  In the endocytic pathway, the cytosolic internalization of Nod1 ligands was pH-dependent, occurred prior to the acidification mediated by the vacuolar ATPase, and was optimal at pH ranging from 5.5 to 6.  Similarly, the Nod2 ligand MDP was internalized into host cytosol through a similar pathway with optimal pH for internalization ranging from 5.5 to 6.5.  Moreover, Nod1-activating muramyl peptides likely required processing by endosomal enzymes, prior to transport into the cytosol, suggesting the existence of a sterically gated endosomal transporter for Nod1 ligands.  In support for this, the authors identified a role for SLC15A4, an oligopeptide transporter expressed in early endosomes, in Nod1-dependent NF-κB signaling.  Interestingly, SLC15A4 expression was also up-regulated in colonic biopsies from patients with inflammatory bowel disease, a disorder assocd. with mutations in Nod1 and Nod2.  Together, the authors' results shed light on the mechanisms by which muramyl peptides get access to the host cytosol, where they are detected by Nod1 and Nod2, and might have implications for the understanding of human diseases, such as inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyr2dvGF25XrVg90H21EOLACvtfcHk0lhK7B3f35VzRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J&md5=ce9181846219003ee56b3c0e487d591c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033670%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTattoli%26aufirst%3DI.%26aulast%3DWojtal%26aufirst%3DK.%2BA.%26aulast%3DVavricka%26aufirst%3DS.%2BR.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DpH-dependent%2520internalization%2520of%2520muramyl%2520peptides%2520from%2520early%2520endosomes%2520enables%2520Nod1%2520and%2520Nod2%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D23818%26epage%3D23829%26doi%3D10.1074%2Fjbc.M109.033670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marina-García, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">4321</span>– <span class="NLM_lpage">4327</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.0802197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19299732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=4321-4327&author=N.+Marina-Garc%C3%ADaauthor=L.+Franchiauthor=Y.+G.+Kimauthor=Y.+Huauthor=D.+E.+Smithauthor=G.+J.+Boonsauthor=G.+Nu%C3%B1ez&title=Clathrin-+and+dynamin-dependent+endocytic+pathway+regulates+muramyl+dipeptide+internalization+and+NOD2+activation&doi=10.4049%2Fjimmunol.0802197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation</span></div><div class="casAuthors">Marina-Garcia, Noemi; Franchi, Luigi; Kim, Yun-Gi; Hu, Yonjun; Smith, David E.; Boons, Geert-Jan; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4321-4327</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP), the NOD2 agonist, induces NF-κB and MAPK activation leading to the prodn. of antimicrobial and proinflammatory mols.  MDP is internalized into acidified vesicles in macrophages.  However, the endocytic mechanism of MDP uptake that induces NOD2 signaling is unknown.  We now report the identification of an endocytosis pathway dependent on clathrin and dynamin that mediates MDP internalization and NOD2 activation.  Intracellular MDP uptake was inhibited by chlorpromazine, a drug that disrupts clathrin-dependent endocytosis, but not by compds. that block pinocytosis or cellular entry via scavenger or mannose receptors.  In contrast, MDP uptake and NOD2-dependent signaling were unimpaired in macrophages deficient in PepT1, a peptide transporter previously implicated in MDP internalization.  Both chlorpromazine and knockdown of clathrin expression by RNA interference attenuated MDP-induced NF-κB and MAPK activation.  Furthermore, MDP uptake and NOD2-dependent signaling were impaired by inhibition of dynamin, a GTPase required for budding of clathrin-coated vesicles from the plasma membrane.  Finally, bafilomycin A, a specific inhibitor of the vacuolar proton pump, blocked MDP accumulation in acidified vesicles and cytokine responses, suggesting that vacuolar maturation is important for MDP-induced NOD2 signaling.  These studies provide evidence for a clathrin- and dynamin-dependent endocytosis pathway that mediates MDP uptake and NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8_dCzxcnmtrVg90H21EOLACvtfcHk0lg4QespgPKIQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D&md5=7df403b628d10949d61a470550e7ae02</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802197%26sid%3Dliteratum%253Aachs%26aulast%3DMarina-Garc%25C3%25ADa%26aufirst%3DN.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DBoons%26aufirst%3DG.%2BJ.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DClathrin-%2520and%2520dynamin-dependent%2520endocytic%2520pathway%2520regulates%2520muramyl%2520dipeptide%2520internalization%2520and%2520NOD2%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D4321%26epage%3D4327%26doi%3D10.4049%2Fjimmunol.0802197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smrdel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabnar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Černe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrenšek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovačič, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogataj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urleb, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrhar, A.</span></span> <span> </span><span class="NLM_article-title">Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423, a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity</span>. <i>Drug Dev. Ind. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.3109/03639040902889814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.3109%2F03639040902889814" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1293-1304&author=P.+Smrdelauthor=I.+Grabnarauthor=I.+Locatelliauthor=M.+%C4%8Cerneauthor=S.+Andren%C5%A1ekauthor=N.+Kova%C4%8Di%C4%8Dauthor=A.+Kristlauthor=M.+Bogatajauthor=U.+Urlebauthor=A.+Mrhar&title=Physicochemical+and+preclinical+pharmacokinetic+and+toxicological+evaluation+of+LK-423%2C+a+new+phthalimido-desmuramyl-dipeptide+derivative+with+immunomodulating+activity&doi=10.3109%2F03639040902889814"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3109%2F03639040902889814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03639040902889814%26sid%3Dliteratum%253Aachs%26aulast%3DSmrdel%26aufirst%3DP.%26aulast%3DGrabnar%26aufirst%3DI.%26aulast%3DLocatelli%26aufirst%3DI.%26aulast%3D%25C4%258Cerne%26aufirst%3DM.%26aulast%3DAndren%25C5%25A1ek%26aufirst%3DS.%26aulast%3DKova%25C4%258Di%25C4%258D%26aufirst%3DN.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DBogataj%26aufirst%3DM.%26aulast%3DUrleb%26aufirst%3DU.%26aulast%3DMrhar%26aufirst%3DA.%26atitle%3DPhysicochemical%2520and%2520preclinical%2520pharmacokinetic%2520and%2520toxicological%2520evaluation%2520of%2520LK-423%252C%2520a%2520new%2520phthalimido-desmuramyl-dipeptide%2520derivative%2520with%2520immunomodulating%2520activity%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2009%26volume%3D35%26spage%3D1293%26epage%3D1304%26doi%3D10.3109%2F03639040902889814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varambally, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaiyan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span> <span> </span><span class="NLM_article-title">Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1084/jem.20051229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1084%2Fjem.20051229" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=203-213&author=J.+Masumotoauthor=K.+Yangauthor=S.+Varamballyauthor=M.+Hasegawaauthor=S.+A.+Tomlinsauthor=S.+Qiuauthor=Y.+Fujimotoauthor=A.+Kawasakiauthor=S.+J.+Fosterauthor=Y.+Horieauthor=T.+W.+Makauthor=G.+Nu%C3%B1ezauthor=A.+M.+Chinnaiyanauthor=K.+Fukaseauthor=N.+Inohara&title=Nod1+acts+as+an+intracellular+receptor+to+stimulate+chemokine+production+and+neutrophil+recruitment+in+vivo&doi=10.1084%2Fjem.20051229"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1084%2Fjem.20051229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20051229%26sid%3Dliteratum%253Aachs%26aulast%3DMasumoto%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DFujimoto%26aufirst%3DY.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DS.%2BJ.%26aulast%3DHorie%26aufirst%3DY.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInohara%26aufirst%3DN.%26atitle%3DNod1%2520acts%2520as%2520an%2520intracellular%2520receptor%2520to%2520stimulate%2520chemokine%2520production%2520and%2520neutrophil%2520recruitment%2520in%2520vivo%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D203%26epage%3D213%26doi%3D10.1084%2Fjem.20051229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodela, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazdovac, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.08.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2013.08.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=232-243&author=%C5%BD.+Jakopinauthor=M.+Gobecauthor=J.+Kodelaauthor=T.+Hazdovacauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Synthesis+of+conformationally+constrained+%CE%B3-D-glutamyl-meso-diaminopimelic+acid+derivatives+as+ligands+of+nucleotide-binding+oligomerization+domain+protein+1+%28Nod1%29&doi=10.1016%2Fj.ejmech.2013.08.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.08.022%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DJ.%26aulast%3DHazdovac%26aufirst%3DT.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520conformationally%2520constrained%2520%25CE%25B3-D-glutamyl-meso-diaminopimelic%2520acid%2520derivatives%2520as%2520ligands%2520of%2520nucleotide-binding%2520oligomerization%2520domain%2520protein%25201%2520%2528Nod1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D232%26epage%3D243%26doi%3D10.1016%2Fj.ejmech.2013.08.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity</span>. <i>Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1177/1753425912471691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1177%2F1753425912471691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=23339926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=493-503&author=S.+J.+Rubinoauthor=J.+G.+Magalhaesauthor=D.+Philpottauthor=G.+M.+Bahrauthor=D.+Blanotauthor=S.+E.+Girardin&title=Identification+of+a+synthetic+muramyl+peptide+derivative+with+enhanced+Nod2+stimulatory+capacity&doi=10.1177%2F1753425912471691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity</span></div><div class="casAuthors">Rubino, Stephen J.; Magalhaes, Joao G.; Philpott, Dana; Bahr, George M.; Blanot, Didier; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">493-503, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Muramyl peptides (MPs) represent the building blocks of bacterial peptidoglycan, a crit. component of bacterial cell walls.  MPs are well characterized for their immunomodulatory properties, and numerous studies have delineated the role of MPs or synthetic MP analogs in host defense, adjuvanticity and inflammation.  More recently, Nod1 and Nod2 have been identified as the host sensors for specific MPs and in particular, Nod2 was shown to detect muramyl dipeptide (MDP), a MP found in both Gram-pos. and Gram-neg. bacterial cell walls.  Because mutations in Nod2 are assocd. with the etiol. of Crohn's disease, there is a need to identify synthetic MP analogs that could potentiate Nod2-dependent immunity.  Here, we analyzed the Nod2-activating property of 36 MP analogs that had been tested previously for their adjuvanticity and anti-infectious activity.  Using a luciferase-based screen, we demonstrate that addn. of a Me group to the second amino acid of MDP generates a MDP deriv. with enhanced Nod2-activating capacity.  We further validated these results in murine macrophages, human dendritic cells and in vivo.  These results offer a basis for the rational development of synthetic MPs that could be used in the treatment of inflammatory disorders that have been assocd. with Nod2 dysfunction, such as Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2n3YBmuCU7Vg90H21EOLACvtfcHk0liMwlAKHAwXdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M&md5=5238da0a9a6bbf359078c44f9c84ae09</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1177%2F1753425912471691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912471691%26sid%3Dliteratum%253Aachs%26aulast%3DRubino%26aufirst%3DS.%2BJ.%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DPhilpott%26aufirst%3DD.%26aulast%3DBahr%26aufirst%3DG.%2BM.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DIdentification%2520of%2520a%2520synthetic%2520muramyl%2520peptide%2520derivative%2520with%2520enhanced%2520Nod2%2520stimulatory%2520capacity%26jtitle%3DInnate%2520Immun.%26date%3D2013%26volume%3D19%26spage%3D493%26epage%3D503%26doi%3D10.1177%2F1753425912471691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Muramyl peptides</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1007/BF00225295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1007%2FBF00225295" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1981&pages=27-47&author=A.+Adamauthor=J.-F.+Petitauthor=P.+Lefrancierauthor=E.+Lederer&title=Muramyl+peptides&doi=10.1007%2FBF00225295"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2FBF00225295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00225295%26sid%3Dliteratum%253Aachs%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DPetit%26aufirst%3DJ.-F.%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMuramyl%2520peptides%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D1981%26volume%3D41%26spage%3D27%26epage%3D47%26doi%3D10.1007%2FBF00225295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamet, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span> <span> </span><span class="NLM_article-title">Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1021/jm00343a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00343a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaL38XkslU%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=87-90&author=P.+Lefrancierauthor=M.+Derrienauthor=X.+Jametauthor=J.+Choay&title=Apyrogenic%2C+adjuvant-active+N-acetylmuramyl-dipeptides&doi=10.1021%2Fjm00343a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides</span></div><div class="casAuthors">Lefrancier, Pierre; Derrien, Marcel; Jamet, Xavier; Choay, Jean; Lederer, Edgar; Audibert, Francoise; Parant, Monique; Parant, Francine; Chedid, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-90</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Seven analogs I (R = alkyl) of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) were synthesized in which the D-isoglutaminyl residue was replaced by D-glutamine alkyl esters.  They are all adjuvant active; however, their i.v. injection does not induce a febrile response in rabbits at a dose of 10 mg/kg, in contrast to MDP in which the minimal pyrogenic dose is 25 μg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9wAiNEhILbVg90H21EOLACvtfcHk0ljiTuKH-v_lqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslU%253D&md5=6813ca9606d5a0e0e7822292aa305207</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00343a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00343a018%26sid%3Dliteratum%253Aachs%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DDerrien%26aufirst%3DM.%26aulast%3DJamet%26aufirst%3DX.%26aulast%3DChoay%26aufirst%3DJ.%26atitle%3DApyrogenic%252C%2520adjuvant-active%2520N-acetylmuramyl-dipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D87%26epage%3D90%26doi%3D10.1021%2Fjm00343a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeygunawardana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">5287</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1021/jm980424s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980424s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5287-5296&author=A.+T.+Dinkova-Kostovaauthor=C.+Abeygunawardanaauthor=P.+Talalay&title=Chemoprotective+properties+of+phenylpropenoids%2C+bis%28benzylidene%29cycloalkanones%2C+and+related+Michael+acceptors%3A+correlation+of+potencies+as+phase+2+enzyme+inducers+and+radical+scavengers&doi=10.1021%2Fjm980424s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm980424s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980424s%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DAbeygunawardana%26aufirst%3DC.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DChemoprotective%2520properties%2520of%2520phenylpropenoids%252C%2520bis%2528benzylidene%2529cycloalkanones%252C%2520and%2520related%2520Michael%2520acceptors%253A%2520correlation%2520of%2520potencies%2520as%2520phase%25202%2520enzyme%2520inducers%2520and%2520radical%2520scavengers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5287%26epage%3D5296%26doi%3D10.1021%2Fjm980424s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The ≫cyclopropyl fragment≪ is a versatile player that frequently appears in preclinical/clinical drug molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%89%ABcyclopropyl+fragment%E2%89%AA+is+a+versatile+player+that+frequently+appears+in+preclinical%2Fclinical+drug+molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2589%25ABcyclopropyl%2520fragment%25E2%2589%25AA%2520is%2520a%2520versatile%2520player%2520that%2520frequently%2520appears%2520in%2520preclinical%252Fclinical%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreteau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golič Grdadolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras-Martel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joris, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activitiy optimization with conformationally rigid analogues of D-glutamic acid</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2880</span>– <span class="NLM_lpage">2894</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2011.04.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2880-2894&author=I.+Sosi%C4%8Dauthor=H.+Barreteauauthor=M.+Sim%C4%8Di%C4%8Dauthor=R.+%C5%A0inkauthor=J.+Cesarauthor=A.+Zegaauthor=S.+Goli%C4%8D+Grdadolnikauthor=C.+Contreras-Martelauthor=A.+Dessenauthor=A.+Amorosoauthor=B.+Jorisauthor=D.+Blanotauthor=S.+Gobec&title=Second-generation+sulfonamide+inhibitors+of+D-glutamic+acid-adding+enzyme%3A+activitiy+optimization+with+conformationally+rigid+analogues+of+D-glutamic+acid&doi=10.1016%2Fj.ejmech.2011.04.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DBarreteau%26aufirst%3DH.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DM.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DCesar%26aufirst%3DJ.%26aulast%3DZega%26aufirst%3DA.%26aulast%3DGoli%25C4%258D%2BGrdadolnik%26aufirst%3DS.%26aulast%3DContreras-Martel%26aufirst%3DC.%26aulast%3DDessen%26aufirst%3DA.%26aulast%3DAmoroso%26aufirst%3DA.%26aulast%3DJoris%26aufirst%3DB.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DSecond-generation%2520sulfonamide%2520inhibitors%2520of%2520D-glutamic%2520acid-adding%2520enzyme%253A%2520activitiy%2520optimization%2520with%2520conformationally%2520rigid%2520analogues%2520of%2520D-glutamic%2520acid%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2880%26epage%3D2894%26doi%3D10.1016%2Fj.ejmech.2011.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Conjugate (MTC-220) of muramyl dipeptide analogue and paclitaxel prevents both tumor growth and metastasis in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2767</span>– <span class="NLM_lpage">2777</span>, <span class="refDoi"> DOI: 10.1021/jm101577z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101577z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1yrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2767-2777&author=Y.+Maauthor=N.+Zhaoauthor=G.+Liu&title=Conjugate+%28MTC-220%29+of+muramyl+dipeptide+analogue+and+paclitaxel+prevents+both+tumor+growth+and+metastasis+in+mice&doi=10.1021%2Fjm101577z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugate (MTC-220) of Muramyl Dipeptide Analogue and Paclitaxel Prevents Both Tumor Growth and Metastasis in Mice</span></div><div class="casAuthors">Ma, Yao; Zhao, Nan; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2767-2777</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A conjugate (MTC-220) of paclitaxel and a muramyl dipeptide analog, has been synthesized as a novel agent of dual antitumor growth and metastasis activities.  In vitro and in vivo tests show that 1 retains its ability to inhibit tumor growth.  It is superior to paclitaxel in its ability to prevent tumor metastasis in Lewis lung carcinoma and 4T1-tumor-bearing mice.  The present studies indicate that 1 suppresses myeloid derived suppressor cell accumulation in the spleen and bone marrow of tumor-bearing mice and also represses inflammatory cytokines in tumor tissue.  These results demonstrated that 1 could be a potential therapeutic and preventive agent for cancer growth and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqul89hIGvj2rVg90H21EOLACvtfcHk0ljz00DKBFSFsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1yrtbw%253D&md5=f0837c2efd6dfb917a0fffcbe7c7ef0d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm101577z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101577z%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DConjugate%2520%2528MTC-220%2529%2520of%2520muramyl%2520dipeptide%2520analogue%2520and%2520paclitaxel%2520prevents%2520both%2520tumor%2520growth%2520and%2520metastasis%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2767%26epage%3D2777%26doi%3D10.1021%2Fjm101577z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Antagonizing NOD2 signaling with conjugates of paclitaxel and muramyl dipeptide derivatives sensitizes paclitaxel therapy and significantly prevents tumor metastasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1219-1224&author=Y.+Dongauthor=S.+Wangauthor=C.+Wangauthor=Z.+Liauthor=Y.+Maauthor=G.+Liu&title=Antagonizing+NOD2+signaling+with+conjugates+of+paclitaxel+and+muramyl+dipeptide+derivatives+sensitizes+paclitaxel+therapy+and+significantly+prevents+tumor+metastasis&doi=10.1021%2Facs.jmedchem.6b01704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01704%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DAntagonizing%2520NOD2%2520signaling%2520with%2520conjugates%2520of%2520paclitaxel%2520and%2520muramyl%2520dipeptide%2520derivatives%2520sensitizes%2520paclitaxel%2520therapy%2520and%2520significantly%2520prevents%2520tumor%2520metastasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1219%26epage%3D1224%26doi%3D10.1021%2Facs.jmedchem.6b01704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit49b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1,4-benzodiazepine-2,5-dione (BZD) derivatives as dual nucleotide binding oligomerization domain containing 1/2 (NOD1/NOD2) antagonists sensitizing paclitaxel (PTX) to suppress Lewis lung carcinoma (LLC) growth in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5162</span>– <span class="NLM_lpage">5192</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5162-5192&author=S.+Wangauthor=Y.+Yangauthor=X.+Liauthor=Z.+Liuauthor=Y.+Wuauthor=G.+Siauthor=Y.+Taoauthor=N.+Zhaoauthor=X.+Huauthor=Y.+Maauthor=G.+Liu&title=Discovery+of+1%2C4-benzodiazepine-2%2C5-dione+%28BZD%29+derivatives+as+dual+nucleotide+binding+oligomerization+domain+containing+1%2F2+%28NOD1%2FNOD2%29+antagonists+sensitizing+paclitaxel+%28PTX%29+to+suppress+Lewis+lung+carcinoma+%28LLC%29+growth+in+vivo&doi=10.1021%2Facs.jmedchem.7b00608"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00608%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSi%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DDiscovery%2520of%25201%252C4-benzodiazepine-2%252C5-dione%2520%2528BZD%2529%2520derivatives%2520as%2520dual%2520nucleotide%2520binding%2520oligomerization%2520domain%2520containing%25201%252F2%2520%2528NOD1%252FNOD2%2529%2520antagonists%2520sensitizing%2520paclitaxel%2520%2528PTX%2529%2520to%2520suppress%2520Lewis%2520lung%2520carcinoma%2520%2528LLC%2529%2520growth%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5162%26epage%3D5192%26doi%3D10.1021%2Facs.jmedchem.7b00608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauro, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahnson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of muramyl dipeptide occurs in the leucine-rich repeat domain of Nod2</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=264-270&author=M.+L.+Lauroauthor=E.+A.+D%E2%80%99Ambrosioauthor=B.+J.+Bahnsonauthor=C.+L.+Grimes&title=Molecular+recognition+of+muramyl+dipeptide+occurs+in+the+leucine-rich+repeat+domain+of+Nod2&doi=10.1021%2Facsinfecdis.6b00154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2</span></div><div class="casAuthors">Lauro, Mackenzie L.; D'Ambrosio, Elizabeth A.; Bahnson, Brian J.; Grimes, Catherine Leimkuhler</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">264-270</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic mutations in the innate immune receptor nucleotide-binding oligomerization domain-contg. 2 (Nod2) have demonstrated increased susceptibility to Crohn's disease, an inflammatory bowel disease that is hypothesized to be accompanied by changes in the gut microbiota.  Nod2 responds to the presence of bacteria, specifically a fragment of the bacterial cell wall, muramyl dipeptide (MDP).  The proposed site of this interaction is the leucine-rich repeat (LRR) domain.  Surface plasmon resonance and mol. modeling were used to investigate the interaction of the LRR domain with MDP.  A functional and pure LRR domain was obtained from Escherichia coli expression in high yield.  The LRR domain binds to MDP with high affinity, with a KD of 212 ± 24 nM.  Crit. portions of the receptor were detd. by mutagenesis of putative binding residues.  Fragment anal. of MDP revealed that both the peptide and carbohydrate portion contribute to the binding interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUCvojsr_fLVg90H21EOLACvtfcHk0lhJggJIJEofZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN&md5=75ab3d912d40a9e0f1ab611d57cae68e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00154%26sid%3Dliteratum%253Aachs%26aulast%3DLauro%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DE.%2BA.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26atitle%3DMolecular%2520recognition%2520of%2520muramyl%2520dipeptide%2520occurs%2520in%2520the%2520leucine-rich%2520repeat%2520domain%2520of%2520Nod2%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D264%26epage%3D270%26doi%3D10.1021%2Facsinfecdis.6b00154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maekawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of NOD2 and its implications in human disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11813</span>, <span class="refDoi"> DOI: 10.1038/ncomms11813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fncomms11813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=27283905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11813&author=S.+Maekawaauthor=U.+Ohtoauthor=T.+Shibataauthor=K.+Miyakeauthor=T.+Shimizu&title=Crystal+structure+of+NOD2+and+its+implications+in+human+disease&doi=10.1038%2Fncomms11813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of NOD2 and its implications in human disease</span></div><div class="casAuthors">Maekawa, Sakiko; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11813</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg. protein 2 (NOD2), a member of the NOD-like receptors family, are crucial for innate immune responses.  Mutations of NOD2 have been assocd. with chronic inflammatory disorders such as Crohn's disease (CD), Blau syndrome (BS) and early-onset sarcoidosis (EOS), but little is known about its signalling mechanism and the role it plays in these diseases.  Here, we report the crystal structure of rabbit NOD2 in an ADP-bound state.  The structure reveals an inactive closed conformation in which the subdomains in the NOD domain are closely packed by ADP-mediated and inter-domain interactions.  Mapping of the BS- or EOS-assocd. gain-of-function mutations reveals that most of these mutations are located in the NOD subdomain interfaces, and are likely to disrupt the inner domain interactions, facilitating a conformational change to the active form.  Conversely, mutations assocd. with CD are distributed throughout the protein, some of which may affect oligomer formation and ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJqTm2zQOG7Vg90H21EOLACvtfcHk0lj5n-ezo2PM7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D&md5=ff4a78caf8d9e744e473b6767c9d8154</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fncomms11813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11813%26sid%3Dliteratum%253Aachs%26aulast%3DMaekawa%26aufirst%3DS.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DCrystal%2520structure%2520of%2520NOD2%2520and%2520its%2520implications%2520in%2520human%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11813%26doi%3D10.1038%2Fncomms11813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallal, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoute, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chordia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poore, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e69619</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0069619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1371%2Fjournal.pone.0069619" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e69619&author=D.+J.+Rickardauthor=C.+A.+Sehonauthor=V.+Kasparcovaauthor=L.+A.+Kallalauthor=X.+Zengauthor=M.+N.+Montouteauthor=T.+Chordiaauthor=D.+D.+Pooreauthor=H.+Liauthor=P.+M.+Eidamauthor=P.+A.+Haileauthor=J.+Yuauthor=J.+G.+Emeryauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Identification+of+benzimidazole+diamides+as+selective+inhibitors+of+the+nucleotide-binding+oligomerization+domain+2+%28NOD2%29+signaling+pathway&doi=10.1371%2Fjournal.pone.0069619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0069619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0069619%26sid%3Dliteratum%253Aachs%26aulast%3DRickard%26aufirst%3DD.%2BJ.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKallal%26aufirst%3DL.%2BA.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DMontoute%26aufirst%3DM.%2BN.%26aulast%3DChordia%26aufirst%3DT.%26aulast%3DPoore%26aufirst%3DD.%2BD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DHaile%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DEmery%26aufirst%3DJ.%2BG.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520benzimidazole%2520diamides%2520as%2520selective%2520inhibitors%2520of%2520the%2520nucleotide-binding%2520oligomerization%2520domain%25202%2520%2528NOD2%2529%2520signaling%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De69619%26doi%3D10.1371%2Fjournal.pone.0069619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merhi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devissaguet, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barratt, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">4483</span>– <span class="NLM_lpage">4488</span>, <span class="refDoi"> DOI: 10.1021/jm960147u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960147u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4483-4488&author=G.+Merhiauthor=J.-P.+Devissaguetauthor=G.+M.+Barratt&title=Synthesis+and+immunostimulating+properties+of+lipophilic+ester+and+ether+muramyl+peptide+derivatives&doi=10.1021%2Fjm960147u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm960147u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960147u%26sid%3Dliteratum%253Aachs%26aulast%3DMerhi%26aufirst%3DG.%26aulast%3DDevissaguet%26aufirst%3DJ.-P.%26aulast%3DBarratt%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520and%2520immunostimulating%2520properties%2520of%2520lipophilic%2520ester%2520and%2520ether%2520muramyl%2520peptide%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4483%26epage%3D4488%26doi%3D10.1021%2Fjm960147u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">The design and synthesis of Ala-Glu/iGln mimetics: heterocyclic building blocks for pseudopeptides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.tetlet.2014.12.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=504-506&author=%C5%BD.+Jakopin&title=The+design+and+synthesis+of+Ala-Glu%2FiGln+mimetics%3A+heterocyclic+building+blocks+for+pseudopeptides&doi=10.1016%2Fj.tetlet.2014.12.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520Ala-Glu%252FiGln%2520mimetics%253A%2520heterocyclic%2520building%2520blocks%2520for%2520pseudopeptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D504%26epage%3D506%26doi%3D10.1016%2Fj.tetlet.2014.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Markey, G. M.</span></span> <span> </span><span class="NLM_article-title">Carboxylesterase 1 (Ces1): from monocyte marker to major player</span>. <i>J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1136/jcp.2010.084657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1136%2Fjcp.2010.084657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=21177752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jvV2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2011&pages=107-109&author=G.+M.+Markey&title=Carboxylesterase+1+%28Ces1%29%3A+from+monocyte+marker+to+major+player&doi=10.1136%2Fjcp.2010.084657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylesterase 1 (Ces1): from monocyte marker to major player</span></div><div class="casAuthors">Markey Geraldine M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There are few, if any, enzymes that have been studied by, and have importance in, so many and varied disciplines as has monocyte esterase/Ces 1.  In this review its involvement in the fields of histochemistry, haematology, toxicology, pharmacology, therapeutics, and tumour cell killing, immune surveillance and malignant disease, is briefly described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwm-8zIl3llSCEBeYuoi7AfW6udTcc2eYnvDLuQgmVt7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jvV2ruw%253D%253D&md5=46b3c40f99d6bf82c765e7f009860f90</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1136%2Fjcp.2010.084657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.2010.084657%26sid%3Dliteratum%253Aachs%26aulast%3DMarkey%26aufirst%3DG.%2BM.%26atitle%3DCarboxylesterase%25201%2520%2528Ces1%2529%253A%2520from%2520monocyte%2520marker%2520to%2520major%2520player%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D2011%26volume%3D64%26spage%3D107%26epage%3D109%26doi%3D10.1136%2Fjcp.2010.084657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crow, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herring, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borazjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, M. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1801</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2009.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.bbalip.2009.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19761868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2msrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1801&publication_year=2010&pages=31-41&author=J.+A.+Crowauthor=K.+L.+Herringauthor=S.+Xieauthor=A.+Borazjaniauthor=P.+M.+Potterauthor=M.+K.+Ross&title=Inhibition+of+carboxylesterase+activity+of+THP1+monocytes%2Fmacrophages+and+recombinant+human+carboxylesterase+1+by+oxysterols+and+fatty+acids&doi=10.1016%2Fj.bbalip.2009.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids</span></div><div class="casAuthors">Crow, J. Allen; Herring, Katye L.; Xie, Shuqi; Borazjani, Abdolsamad; Potter, Philip M.; Ross, Matthew K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1801</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-41</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Two major isoforms of human carboxylesterases (CEs) are found in metabolically active tissues, CES1 and CES2.  These hydrolytic enzymes are involved in xenobiotic and endobiotic metab.  CES1 is abundantly expressed in human liver and monocytes/macrophages, including the THP1 cell line; CES2 is expressed in liver but not in monocytes/macrophages.  The cholesteryl ester hydrolysis activity in human macrophages has been attributed to CES1.  Here, the authors report the direct inhibitory effects of several endogenous oxysterols and fatty acids on the CE activity of THP1 monocytes/macrophages and recombinant human CES1 and CES2.  Using THP1 whole-cell lysates the authors found: 27-hydroxycholesterol (27-HC) is a potent inhibitor of carboxylesterase activity (IC50 = 33 nM); 24(S),25-epoxycholesterol had moderate inhibitory activity (IC50 = 8.1 μM); and cholesterol, 7-ketocholesterol, 22(R)-hydroxycholesterol, 24(S)-hydroxycholesterol, and 25-hydroxycholesterol each had little inhibitory activity.  27-HC was a partially noncompetitive inhibitor of recombinant CES1 (K iapp = 10 nM) and impaired intracellular CES1 activity following treatment of intact THP1 cells.  In contrast, recombinant CES2 activity was not inhibited by 27-HC, suggesting isoform-selective inhibition by 27-HC.  Furthermore, unsatd. fatty acids were better inhibitors of CES1 activity than satd. fatty acids, while CES2 activity was unaffected by any fatty acid.  Arachidonic acid (AA) was the most potent fatty acid inhibitor of recombinant CES1 and acted by a noncompetitive mechanism (K iapp = 1.7 μM); when not complexed to albumin, exogenous AA penetrated intact THP1 cells and inhibited CES1.  Inhibition results are discussed in light of recent structural models for CES1 that describe ligand binding sites sep. from the active site.  In addn., oxysterol-mediated inhibition of CES1 activity was demonstrated by pretreatment of human liver homogenates or intact THP1 cells with exogenous 27-HC, which resulted in significantly reduced hydrolysis of the pyrethroid insecticide bioresmethrin, a CES1-specific xenobiotic substrate.  Collectively, these findings suggest that CE activity of recombinant CES1, cell lysates, and intact cells can be impaired by naturally occurring lipids, which may compromise the ability of CES1 to both detoxify environmental pollutants and metabolize endogenous compds. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-TNn1baZIPrVg90H21EOLACvtfcHk0lj_1QbXxn7NSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2msrnP&md5=1f079899301896faed5fb87533d57c94</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2009.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2009.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DCrow%26aufirst%3DJ.%2BA.%26aulast%3DHerring%26aufirst%3DK.%2BL.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DBorazjani%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26aulast%3DRoss%26aufirst%3DM.%2BK.%26atitle%3DInhibition%2520of%2520carboxylesterase%2520activity%2520of%2520THP1%2520monocytes%252Fmacrophages%2520and%2520recombinant%2520human%2520carboxylesterase%25201%2520by%2520oxysterols%2520and%2520fatty%2520acids%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2010%26volume%3D1801%26spage%3D31%26epage%3D41%26doi%3D10.1016%2Fj.bbalip.2009.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delatour, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J.-M.</span></span> <span> </span><span class="NLM_article-title">In vitro hydrolysis and transesterification of CDP323, an α4β1/α4β7 integrin antagonist ester prodrug</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.054049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.113.054049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=153-161&author=H.+Chanteuxauthor=M.+Rosaauthor=C.+Delatourauthor=C.+Prakashauthor=S.+Smithauthor=J.-M.+Nicolas&title=In+vitro+hydrolysis+and+transesterification+of+CDP323%2C+an+%CE%B14%CE%B21%2F%CE%B14%CE%B27+integrin+antagonist+ester+prodrug&doi=10.1124%2Fdmd.113.054049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.054049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.054049%26sid%3Dliteratum%253Aachs%26aulast%3DChanteux%26aufirst%3DH.%26aulast%3DRosa%26aufirst%3DM.%26aulast%3DDelatour%26aufirst%3DC.%26aulast%3DPrakash%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DNicolas%26aufirst%3DJ.-M.%26atitle%3DIn%2520vitro%2520hydrolysis%2520and%2520transesterification%2520of%2520CDP323%252C%2520an%2520%25CE%25B14%25CE%25B21%252F%25CE%25B14%25CE%25B27%2520integrin%2520antagonist%2520ester%2520prodrug%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D153%26epage%3D161%26doi%3D10.1124%2Fdmd.113.054049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnet, K.</span></span> <span> </span><span class="NLM_article-title">the INDICES Consortium. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.113.053512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=126-133&author=R.+Thomsenauthor=H.+B.+Rasmussenauthor=K.+Linnet&title=the+INDICES+Consortium.+In+vitro+drug+metabolism+by+human+carboxylesterase+1%3A+focus+on+angiotensin-converting+enzyme+inhibitors&doi=10.1124%2Fdmd.113.053512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053512%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DR.%26aulast%3DRasmussen%26aufirst%3DH.%2BB.%26aulast%3DLinnet%26aufirst%3DK.%26atitle%3Dthe%2520INDICES%2520Consortium.%2520In%2520vitro%2520drug%2520metabolism%2520by%2520human%2520carboxylesterase%25201%253A%2520focus%2520on%2520angiotensin-converting%2520enzyme%2520inhibitors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D126%26epage%3D133%26doi%3D10.1124%2Fdmd.113.053512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taketani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, K.</span></span> <span> </span><span class="NLM_article-title">Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1734</span>– <span class="NLM_lpage">1741</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.009381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.106.009381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16837570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1734-1741&author=T.+Imaiauthor=M.+Taketaniauthor=M.+Shiiauthor=M.+Hosokawaauthor=K.+Chiba&title=Substrate+specificity+of+carboxylesterase+isozymes+and+their+contribution+to+hydrolase+activity+in+human+liver+and+small+intestine&doi=10.1124%2Fdmd.106.009381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine</span></div><div class="casAuthors">Imai, Teruko; Taketani, Megumi; Shii, Mayumi; Hosokawa, Masakiyo; Chiba, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1734-1741</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Hydrolase activity from human liver and small intestine microsomes was compared with that of recombinant human carboxylesterases, hCE-1 and hCE-2.  Although both hCE-1 and hCE-2 are present in human liver, the dominant component was found to be hCE-1, whereas the hydrolase activity of the human small intestine was found to be predominantly hCE-2.  HCE-2 has a limited ability to hydrolyze large acyl compd. substrates.  Interestingly, propranolol derivs., good substrates for hCE-2, were easily hydrolyzed by substitution of the Me group on the 2-position of the acyl moiety, but were barely hydrolyzed when the Me group was substituted on the 3-position.  These findings suggest that hCE-2 does not easily form acylated intermediates because of conformational interference in its active site.  In contrast, hCE-1 could hydrolyze a variety of substrates.  The hydrolytic activity of hCE-2 increased with increasing alc. chain length in benzoic acid deriv. substrates, whereas hCE-1 preferentially catalyzed the hydrolysis of substrates with short alc. chains.  Kinetic data showed that the detg. factor for the rate of hydrolysis of p-aminobenzoic acid esters was Vmax for hCE-1 and Km for hCE-2.  Furthermore, the addn. of hydrophobic alcs. to the reaction mixt. with p-aminobenzoic acid Pr ester induced high and low levels of transesterification by hCE-1 and hCE-2, resp.  When considering the substrate specificities of hCE-1, it is necessary to consider the transesterification ability of hCE-1, in addn. to the binding structure of the substrate in the active site of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_5Qby7_S88LVg90H21EOLACvtfcHk0lgo3JEoPMBD3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI&md5=b2d3c1d2aee89b647e1c8030daee8c3a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.009381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.009381%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26aulast%3DTaketani%26aufirst%3DM.%26aulast%3DShii%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26atitle%3DSubstrate%2520specificity%2520of%2520carboxylesterase%2520isozymes%2520and%2520their%2520contribution%2520to%2520hydrolase%2520activity%2520in%2520human%2520liver%2520and%2520small%2520intestine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1734%26epage%3D1741%26doi%3D10.1124%2Fdmd.106.009381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span> <span> </span><span class="NLM_article-title">Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1124/dmd.30.5.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.30.5.541" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=541-547&author=M.+Xieauthor=D.+Yangauthor=L.+Liuauthor=B.+Xueauthor=B.+Yan&title=Human+and+rodent+carboxylesterases%3A+immunorelatedness%2C+overlapping+substrate+specificity%2C+differential+sensitivity+to+serine+enzyme+inhibitors%2C+and+tumor-related+expression&doi=10.1124%2Fdmd.30.5.541"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.5.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.5.541%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DB.%26atitle%3DHuman%2520and%2520rodent%2520carboxylesterases%253A%2520immunorelatedness%252C%2520overlapping%2520substrate%2520specificity%252C%2520differential%2520sensitivity%2520to%2520serine%2520enzyme%2520inhibitors%252C%2520and%2520tumor-related%2520expression%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D541%26epage%3D547%26doi%3D10.1124%2Fdmd.30.5.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durland-Busbice, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinz-Taheny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantzig, A. H.</span></span> <span> </span><span class="NLM_article-title">Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1158%2F1078-0432.CCR-12-1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=23325581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1159-1168&author=S.+E.+Prattauthor=S.+Durland-Busbiceauthor=R.+L.+Shepardauthor=K.+Heinz-Tahenyauthor=P.+W.+Iversenauthor=A.+H.+Dantzig&title=Human+carboxylesterase-2+hydrolyzes+the+prodrug+of+gemcitabine+%28LY2334737%29+and+confers+prodrug+sensitivity+to+cancer+cells&doi=10.1158%2F1078-0432.CCR-12-1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells</span></div><div class="casAuthors">Pratt, Susan E.; Durland-Busbice, Sara; Shepard, Robert L.; Heinz-Taheny, Kathleen; Iversen, Philip W.; Dantzig, Anne H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1159-1168</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The oral prodrug of gemcitabine LY2334737 is cleaved systemically to gemcitabine; the mechanism responsible for hydrolysis is unknown.  LY2334737 cytotoxicity was tested in the NCI-60 panel; mining of microarray expression data identified carboxylesterase (CES) as a top hydrolase candidate.  Studies examd. whether CES is responsible for hydrolysis and whether cellular CES expression confers prodrug sensitivity.  Exptl. Design: Human recombinant CES isoenzymes were assayed for LY2334737 hydrolysis.  Stable CES-overexpressing HCT-116 transfectants and a SK-OV-3 knockdown were prepd.  Cell lines were tested for drug sensitivity and CES expression by quant. real time-PCR (qRT-PCR), Western blotting, and immunohistochem. staining.  Bystander cytotoxicity studies were conducted with GFP-tagged PC-3 cells as the reporter cell line.  Therapeutic response of the HCT-116 transfectants was evaluated in xenografts.  Results: Of 3 human CES isoenzymes tested, only CES2 hydrolyzed LY2334737.  Five cell lines that express CES2 responded to LY2334737 treatment.  LY2334737 was less cytotoxic to a SK-OV-3 CES2 knockdown than parental cells.  The drug response of CES2-transfected HCT-116 cells correlated with CES2 expression level.  Bystander studies showed statistically greater PC-3-GFP growth inhibition by LY2334737 when cells were cocultured with CES2 and not mock transfectants.  Oral treatment of xenograft models with 3.2 mg/kg LY2334737 once a day for 21 days showed greater tumor growth inhibition of CES2 transfectant than the mock transfectant (P ≤ 0.001).  Conclusions: CES2 is responsible for the slow hydrolysis of LY2334737.  Because intact prodrug circulates at high plasma levels after oral LY2334737 administration, improved response rates may be obsd. by tailoring LY2334737 treatment to patients with CES2 tumor expression.  Clin Cancer Res; 19(5); 1159-68. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM5cExv8fNIbVg90H21EOLACvtfcHk0lgo3JEoPMBD3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D&md5=37b16874ce4de70dea8a5e57f8aa8a0b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1184%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DS.%2BE.%26aulast%3DDurland-Busbice%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DR.%2BL.%26aulast%3DHeinz-Taheny%26aufirst%3DK.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DDantzig%26aufirst%3DA.%2BH.%26atitle%3DHuman%2520carboxylesterase-2%2520hydrolyzes%2520the%2520prodrug%2520of%2520gemcitabine%2520%2528LY2334737%2529%2520and%2520confers%2520prodrug%2520sensitivity%2520to%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D1159%26epage%3D1168%26doi%3D10.1158%2F1078-0432.CCR-12-1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maharana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, S. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (<i>Danio rerio</i>) NOD2: a molecular dynamics approach</span>. <i>J. Mol. Recognit.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1002/jmr.2357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2Fjmr.2357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=24700593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=260-275&author=J.+Maharanaauthor=M.+C.+Patraauthor=C.+D.+Deauthor=B.+R.+Sahooauthor=B.+K.+Beheraauthor=S.+Deauthor=S.+K.+Pradhan&title=Structural+insights+into+the+MDP+binding+and+CARD-CARD+interaction+in+zebrafish+%28Danio+rerio%29+NOD2%3A+a+molecular+dynamics+approach&doi=10.1002%2Fjmr.2357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (Danio rerio) NOD2: a molecular dynamics approach</span></div><div class="casAuthors">Maharana, Jitendra; Patra, Mahesh Chandra; De, Bidhan Chandra; Sahoo, Bikash Ranjan; Behera, Bijay Kumar; De, Sachinandan; Pradhan, Sukanta Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">260-275</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nucleotide binding and oligomerization domain (NOD2) is a key component of innate immunity that is highly specific for muramyl dipeptide (MDP)-a peptidoglycan component of bacterial cell wall.  MDP recognition by NOD2-leucine rich repeat (LRR) domain activates NF-κB signaling through a protein-protein interaction between caspase activating and recruitment domains (CARDs) of NOD2 and downstream receptor interacting and activating protein kinase 2 (RIP2).  Due to the lack of crystal/NMR structures, MDP recognition and CARD-CARD interaction are poorly understood.  Herein, we have predicted the probable MDP and CARD-CARD binding surfaces in zebrafish NOD2 (zNOD2) using various in silico methodologies.  The results show that the conserved residues Phe819, Phe871, Trp875, Trp929, Trp899, and Arg845 located at the concave face of zNOD2-LRR confer MDP recognition by hydrophobic and hydrogen bond (H-bond) interactions.  Mol. dynamics simulations reveal a stable assocn. between the electropos. surface on zNOD2-CARDa and the electroneg. surface on zRIP2-CARD reinforced mostly by H-bonds and electrostatic interactions.  Importantly, a 3.5 Å salt bridge is obsd. between Arg60 of zNOD2-CARDa and Asp494 of zRIP2-CARD.  Arg11 and Lys53 of zNOD2-CARDa and Ser498 and Glu508 of zRIP2-CARD are crit. residues for CARD-CARD interaction and NOD2 signaling.  The 2.7 Å H-bond between Lys104 of the linker and Glu508 of zRIP2-CARD suggests a possible role of the linker for shaping CARD-CARD interaction.  These findings are consistent with existing mutagenesis data.  We provide first insight into MDP recognition and CARD-CARD interaction in the zebrafish that will be useful to understand the mol. basis of NOD signaling in a broader perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT5a6yULpl1LVg90H21EOLACvtfcHk0ljuveMbZOS0aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlaksLc%253D&md5=9c39dbc6d9b2eb44994ddc41f6c70683</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fjmr.2357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.2357%26sid%3Dliteratum%253Aachs%26aulast%3DMaharana%26aufirst%3DJ.%26aulast%3DPatra%26aufirst%3DM.%2BC.%26aulast%3DDe%26aufirst%3DC.%2BD.%26aulast%3DSahoo%26aufirst%3DB.%2BR.%26aulast%3DBehera%26aufirst%3DB.%2BK.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DPradhan%26aufirst%3DS.%2BK.%26atitle%3DStructural%2520insights%2520into%2520the%2520MDP%2520binding%2520and%2520CARD-CARD%2520interaction%2520in%2520zebrafish%2520%2528Danio%2520rerio%2529%2520NOD2%253A%2520a%2520molecular%2520dynamics%2520approach%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2014%26volume%3D27%26spage%3D260%26epage%3D275%26doi%3D10.1002%2Fjmr.2357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asensio, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardá, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cañada, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Barbero, J.</span></span> <span> </span><span class="NLM_article-title">Carbohydrate-aromatic interactions</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1021/ar300024d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar300024d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=946-954&author=J.+L.+Asensioauthor=A.+Ard%C3%A1author=F.+J.+Ca%C3%B1adaauthor=J.+Jim%C3%A9nez-Barbero&title=Carbohydrate-aromatic+interactions&doi=10.1021%2Far300024d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-Aromatic Interactions</span></div><div class="casAuthors">Asensio, Juan Luis; Arda, Ana; Canada, Francisco Javier; Jimenez-Barbero, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">946-954</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The recognition of saccharides by proteins has far-reaching implications in biol., technol., and drug design.  Within the past two decades, researchers have directed considerable effort toward a detailed understanding of these processes.  Early crystallog. studies revealed, not surprisingly, that hydrogen-bonding interactions are usually involved in carbohydrate recognition.  But less expectedly, researchers obsd. that despite the highly hydrophilic character of most sugars, arom. rings of the receptor often play an important role in carbohydrate recognition.  With further research, scientists now accept that noncovalent interactions mediated by arom. rings are pivotal to sugar binding.  For example, arom. residues often stack against the faces of sugar pyranose rings in complexes between proteins and carbohydrates.  Such contacts typically involve two or three CH groups of the pyranoses and the π electron d. of the arom. ring (called CH/π bonds), and these interactions can exhibit a variety of geometries, with either parallel or nonparallel arrangements of the arom. and sugar units.  In this Account, we provide an overview of the structural and thermodn. features of protein-carbohydrate interactions, theor. and exptl. efforts to understand stacking in these complexes, and the implications of this understanding for chem. biol.  The interaction energy between different arom. rings and simple monosaccharides based on quantum mech. calcns. in the gas phase ranges from 3 to 6 kcal/mol range.  Exptl. values measured in water are somewhat smaller, approx. 1.5 kcal/mol for each interaction between a monosaccharide and an arom. ring.  This difference illustrates the dependence of these intermol. interactions on their context and shows that this stacking can be modulated by entropic and solvent effects.  Despite their relatively modest influence on the stability of carbohydrate/protein complexes, the arom. platforms play a major role in detg. the specificity of the mol. recognition process.  The recognition of carbohydrate/arom. interactions has prompted further anal. of the properties that influence them.  Using a variety of exptl. and theor. methods, researchers have worked to quantify carbohydrate/arom. stacking and identify the features that stabilize these complexes.  Researchers have used site-directed mutagenesis, org. synthesis, or both to incorporate modifications in the receptor or ligand and then quant. analyzed the structural and thermodn. features of these interactions.  Researchers have also synthesized and characterized artificial receptors and simple model systems, employing a reductionistic chem.-based strategy.  Finally, using quantum mechanics calcns., researchers have examd. the magnitude of each property's contribution to the interaction energy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIXOW5VJV3dLVg90H21EOLACvtfcHk0ljuveMbZOS0aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFeku78%253D&md5=eefd3c7ada7692abb8b123137fcedeb8</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Far300024d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far300024d%26sid%3Dliteratum%253Aachs%26aulast%3DAsensio%26aufirst%3DJ.%2BL.%26aulast%3DArd%25C3%25A1%26aufirst%3DA.%26aulast%3DCa%25C3%25B1ada%26aufirst%3DF.%2BJ.%26aulast%3DJim%25C3%25A9nez-Barbero%26aufirst%3DJ.%26atitle%3DCarbohydrate-aromatic%2520interactions%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2013%26volume%3D46%26spage%3D946%26epage%3D954%26doi%3D10.1021%2Far300024d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agirre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolfson, D. N.</span></span> <span> </span><span class="NLM_article-title">Carbohydrate-aromatic interactions in proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">15152</span>– <span class="NLM_lpage">15160</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b08424</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b08424" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=15152-15160&author=K.+L.+Hudsonauthor=G.+J.+Bartlettauthor=R.+C.+Diehlauthor=J.+Agirreauthor=T.+Gallagherauthor=L.+L.+Kiesslingauthor=D.+N.+Woolfson&title=Carbohydrate-aromatic+interactions+in+proteins&doi=10.1021%2Fjacs.5b08424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-Aromatic Interactions in Proteins</span></div><div class="casAuthors">Hudson, Kieran L.; Bartlett, Gail J.; Diehl, Roger C.; Agirre, Jon; Gallagher, Timothy; Kiessling, Laura L.; Woolfson, Derek N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">15152-15160</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-carbohydrate interactions play pivotal roles in health and disease.  However, defining and manipulating these interactions has been hindered by an incomplete understanding of the underlying fundamental forces.  To elucidate common and discriminating features in carbohydrate recognition, we have analyzed quant. X-ray crystal structures of proteins with noncovalently bound carbohydrates.  Within the carbohydrate-binding pockets, aliph. hydrophobic residues are disfavored, whereas arom. side chains are enriched.  The greatest preference is for tryptophan with an increased prevalence of 9-fold.  Variations in the spatial orientation of amino acids around different monosaccharides indicate specific carbohydrate C-H bonds interact preferentially with arom. residues.  These preferences are consistent with the electronic properties of both the carbohydrate C-H bonds and the arom. residues.  Those carbohydrates that present patches of electropos. saccharide C-H bonds engage more often in CH-π interactions involving electron-rich arom. partners.  These electronic effects are also manifested when carbohydrate-arom. interactions are monitored in soln.: NMR anal. indicates that indole favorably binds to electron-poor C-H bonds of model carbohydrates, and a clear linear free energy relationships with substituted indoles supports the importance of complementary electronic effects in driving protein-carbohydrate interactions.  Together, our data indicate that electrostatic and electronic complementarity between carbohydrates and arom. residues play key roles in driving protein-carbohydrate complexation.  Moreover, these weak noncovalent interactions influence which saccharide residues bind to proteins, and how they are positioned within carbohydrate-binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpGFFcCF0NrVg90H21EOLACvtfcHk0lhBBfP0K3TGjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fN&md5=6154734469d3617e0f2e744da3b4a1cb</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b08424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b08424%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DK.%2BL.%26aulast%3DBartlett%26aufirst%3DG.%2BJ.%26aulast%3DDiehl%26aufirst%3DR.%2BC.%26aulast%3DAgirre%26aufirst%3DJ.%26aulast%3DGallagher%26aufirst%3DT.%26aulast%3DKiessling%26aufirst%3DL.%2BL.%26aulast%3DWoolfson%26aufirst%3DD.%2BN.%26atitle%3DCarbohydrate-aromatic%2520interactions%2520in%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D15152%26epage%3D15160%26doi%3D10.1021%2Fjacs.5b08424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nopper, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craddock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivory, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passioura, T.</span></span> <span> </span><span class="NLM_article-title">Primary leukocyte screens for innate agonists</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1177/1087057109335325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1177%2F1087057109335325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19525489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVaksr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=723-730&author=A.+Goodchildauthor=N.+Nopperauthor=A.+Craddockauthor=T.+Lawauthor=A.+Kingauthor=G.+Fanningauthor=L.+Rivoryauthor=T.+Passioura&title=Primary+leukocyte+screens+for+innate+agonists&doi=10.1177%2F1087057109335325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Primary leukocyte screens for innate immune agonists</span></div><div class="casAuthors">Goodchild, Amber; Nopper, Nicole; Craddock, Alexis; Law, Tamara; King, Andrew; Fanning, Gregory; Rivory, Laurent; Passioura, Toby</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The innate immune system of mammals is a key defense mechanism against invading foreign pathogens.  Innate immune stimulants may have applications as vaccine adjuvants as well as in the treatment of cancer and some viral diseases, and clin. studies have been performed using agonists of Toll-like receptors (TLRs) 7, 8, and 9.  The high-throughput screens for such agonists have typically relied on the overexpression of a single TLR gene in an immortalized cell line and are inherently artificial systems that are restricted to the identification of agonists for a single receptor.  The authors describe 2 assays for the identification of immunostimulants that employ primary human leukocytes cocultured with hepatitis C virus (HCV) replicon-expressing cells.  In these assays, stimulation of innate immune pathways in leukocytes induces interferon (IFN) expression, which acts to inhibit HCV replication, providing a high-throughput and low-cost readout for leukocyte activation.  These assays are highly sensitive and provide a physiol. relevant system for the identification of a broad range of immunostimulant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcDOKkmsM6ILVg90H21EOLACvtfcHk0lgTJD3j5yb8yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVaksr%252FF&md5=e0ccf1f1f272b72f013156c195c95b7a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1177%2F1087057109335325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109335325%26sid%3Dliteratum%253Aachs%26aulast%3DGoodchild%26aufirst%3DA.%26aulast%3DNopper%26aufirst%3DN.%26aulast%3DCraddock%26aufirst%3DA.%26aulast%3DLaw%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DRivory%26aufirst%3DL.%26aulast%3DPassioura%26aufirst%3DT.%26atitle%3DPrimary%2520leukocyte%2520screens%2520for%2520innate%2520agonists%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2009%26volume%3D14%26spage%3D723%26epage%3D730%26doi%3D10.1177%2F1087057109335325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rostaing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkaczuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peres, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Préval, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohayon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbal, M.</span></span> <span> </span><span class="NLM_article-title">Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells</span>. <i>Cytometry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0320(19990401)35:4<318::AID-CYTO4>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10213197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK1MXisFaisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1999&pages=318-328&author=L.+Rostaingauthor=J.+Tkaczukauthor=M.+Durandauthor=C.+Peresauthor=D.+Durandauthor=C.+de+Pr%C3%A9valauthor=E.+Ohayonauthor=M.+Abbal&title=Kinetics+of+intracytoplasmic+Th1+and+Th2+cytokine+production+assessed+by+flow+cytometry+following+in+vitro+activation+of+peripheral+blood+mononuclear+cells&doi=10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells</span></div><div class="casAuthors">Rostaing, Lionel; Tkaczuk, Jean; Durand, Martine; Peres, Christine; Durand, Dominique; de Preval, Claude; Ohayon, Elie; Abbal, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">CYTODQ</span>;
        ISSN:<span class="NLM_cas:issn">0196-4763</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Std. cytokine detection methods are unable to det. which cells are the producing cells.  We report on the extent and under which conditions the multilabeling capability of flow cytometry (FCM) can bring new advances into the field.  Five different cytokines, interleukin-2 (IL-2), -4, -5, -10 and interferon-γ (IFN-γ), were assessed simultaneously under five ex vivo stimulation conditions in peripheral blood mononuclear cells from five healthy volunteers in a 5-day kinetic study.  A second group of 35 volunteers was assessed for IFN-γ and IL-2 prodn.  This study showed that (a) intracytoplasmic cytokines were almost undetectable within unstimulated cells, (b) intracytoplasmic cytokines were detected only in CD69(+) T lymphocytes, and (c) intracytoplasmic IL-2 and IFN-γ were dramatically upregulated after stimulation with phorbol myristate acetate (PMA)-ionomycin in a biphasic response or with PMA-phytohemagglutinin (one major peak only at 18 h) but to a lesser extent with other stimuli such as monoclonal antibodies.  Th2 cytokines were detected at a later time point and at lower levels.  PMA/ionomycin stimulation after 4 h and 18 h of culture in 35 other volunteers individualized several subgroups according to the frequency of IFN-γ- or IL-2-producing cells-IFN-γ delayed producers (n = 10/35), IFN-γ low producers (n = 8/35), and IL-2 delayed producers (n = 16/35)-as opposed to IFN-γ or IL-2 normal producers.  FCM appears to be a good tool to examine cell cytokine status in pathol. (allergy, autoimmune disease, etc.) provided that optimal stimulation conditions and multiple time-point cultures are used.  It also seems to be a relevant method to define new Th subsets further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR2oImGlDtaLVg90H21EOLACvtfcHk0lgTJD3j5yb8yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFaisLo%253D&md5=96061b0d762595b1a870ce08506a121e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0320%252819990401%252935%253A4%253C318%253A%253AAID-CYTO4%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DRostaing%26aufirst%3DL.%26aulast%3DTkaczuk%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DM.%26aulast%3DPeres%26aufirst%3DC.%26aulast%3DDurand%26aufirst%3DD.%26aulast%3Dde%2BPr%25C3%25A9val%26aufirst%3DC.%26aulast%3DOhayon%26aufirst%3DE.%26aulast%3DAbbal%26aufirst%3DM.%26atitle%3DKinetics%2520of%2520intracytoplasmic%2520Th1%2520and%2520Th2%2520cytokine%2520production%2520assessed%2520by%2520flow%2520cytometry%2520following%2520in%2520vitro%2520activation%2520of%2520peripheral%2520blood%2520mononuclear%2520cells%26jtitle%3DCytometry%26date%3D1999%26volume%3D35%26spage%3D318%26epage%3D328%26doi%3D10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauleau, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, P. J.</span></span> <span> </span><span class="NLM_article-title">Role of Nod2 in the response of macrophages to Toll-like receptor agonists</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7539</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.21.7531-7539.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1128%2FMCB.23.21.7531-7539.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=14560001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7531-7539&author=A.-L.+Pauleauauthor=P.+J.+Murray&title=Role+of+Nod2+in+the+response+of+macrophages+to+Toll-like+receptor+agonists&doi=10.1128%2FMCB.23.21.7531-7539.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Nod2 in the response of macrophages to toll-like receptor agonists</span></div><div class="casAuthors">Pauleau, Anne-Laure; Murray, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7539</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Nod2 (CARD15) is a macrophage-specific protein contg. two CARD domains, a large nucleotide binding domain and leucine-rich repeats.  Human genetic studies have linked mutations in NOD2/CARD15 with Crohn's disease, although the mechanisms involved are unknown.  However, Nod2 has been proposed to directly bind bacterial lipopolysaccharide (LPS) and subsequently act as an activator of NF-κB via the assocn. of the CARD domains with Rip2/RICK/CARDIAK.  This is hypothesized to constitute a pathogen recognition pathway distinct from Toll-like receptor 4-mediated recognition of LPS.  Using targeted mutagenesis, the authors introduced a mutation to delete the CARD domains of mouse Nod2.  Mice lacking Nod2 were indistinguishable from controls and showed no signs of intestinal pathol.  Macrophages responded normally to multiple Toll-like receptor agonists in terms of NF-κB target activation, mitogen-activated protein kinase activation, and cytokine secretion.  However, Nod2-/- mice were significantly protected in endotoxin challenge expts., and Nod2-/- macrophages were refractory to muramyl dipeptide stimulation.  These results argue that Nod2 does not play an essential, nonredundant role in the response of macrophages to bacterial products but rather plays unexpected roles in regulating systemic responses to pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriHdplUQMDi7Vg90H21EOLACvtfcHk0lgTJD3j5yb8yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOgsbs%253D&md5=f4f271383b1f6719cba5ab632edab843</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.21.7531-7539.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.21.7531-7539.2003%26sid%3Dliteratum%253Aachs%26aulast%3DPauleau%26aufirst%3DA.-L.%26aulast%3DMurray%26aufirst%3DP.%2BJ.%26atitle%3DRole%2520of%2520Nod2%2520in%2520the%2520response%2520of%2520macrophages%2520to%2520Toll-like%2520receptor%2520agonists%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D7531%26epage%3D7539%26doi%3D10.1128%2FMCB.23.21.7531-7539.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Meer, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of muramyl dipeptide stimulation of cytokine production by blood components</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2249.2009.03926.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1111%2Fj.1365-2249.2009.03926.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19438594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=428-433&author=J.+H.+M.+van%0Ader+Meerauthor=M.+G.+Neteaauthor=C.+A.+Dinarello&title=Modulation+of+muramyl+dipeptide+stimulation+of+cytokine+production+by+blood+components&doi=10.1111%2Fj.1365-2249.2009.03926.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of muramyl dipeptide stimulation of cytokine production by blood components</span></div><div class="casAuthors">van der Meer, J. H. M.; Netea, M. G.; Dinarello, C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-433</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is the minimal active fragment of peptidoglycan of the cell wall of Gram-pos. bacteria, with potential beneficial effects as a vaccine adjuvant.  Peptidoglycans and MDP are recognized by the intracellular receptor NOD2 (nucleotide-binding oligomerization domain 2), leading to prodn. of proinflammatory cytokines.  In the present study, it is shown that, despite stimulatory effects on isolated human mononuclear cells, MDP does not stimulate prodn. of tumor necrosis factor-α, interleukin-1β or interleukin-6 in a whole-blood assay.  However, MDP retains synergistic effects on lipopolysaccharide-induced cytokines in whole blood.  Screening tests of NOD2 function based on whole-blood stimulation should therefore employ strategies based on the synergistic effects of MDP on Toll-like receptor-induced cytokine prodn.  Plasma was not responsible for the inhibition of MDP in whole blood.  The inhibition of MDP stimulation was dependent upon cellular components, with erythrocyte-derived Hb and neutrophils collaborating in the inhibition of MDP effects in whole blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUdpMc135fu7Vg90H21EOLACvtfcHk0ljFfVItw8oC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D&md5=a6310bc3893e2094498393e42d080279</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2009.03926.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2009.03926.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DModulation%2520of%2520muramyl%2520dipeptide%2520stimulation%2520of%2520cytokine%2520production%2520by%2520blood%2520components%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2009%26volume%3D156%26spage%3D428%26epage%3D433%26doi%3D10.1111%2Fj.1365-2249.2009.03926.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Aulock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, C.</span></span> <span> </span><span class="NLM_article-title">MDP and other muropeptides – direct and synergistic effects on the immune system</span>. <i>J. Endotoxin Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1179/096805106X89044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1179%2F096805106X89044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16690010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=69-85&author=S.+Traubauthor=S.+von+Aulockauthor=T.+Hartungauthor=C.+Hermann&title=MDP+and+other+muropeptides+%E2%80%93+direct+and+synergistic+effects+on+the+immune+system&doi=10.1179%2F096805106X89044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">MDP and other muropeptides - direct and synergistic effects on the immune system</span></div><div class="casAuthors">Traub, Stephanie; von Aulock, Sonja; Hartung, Thomas; Hermann, Corinna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endotoxin Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-85</span>CODEN:
                <span class="NLM_cas:coden">JENREB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0519</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  Muropeptides are breakdown products of peptidoglycan (PGN) of Gram-neg. and Gram-pos. bacteria.  They are released during bacterial growth and division, as part of the host response by lysozyme and amidases, or upon antibiotic treatment.  After phagocytosis of bacteria or bacterial breakdown products by host immune cells, the muropeptides trigger intracellular signaling cascades, leading to altered gene expression and activation of the immune response.  Numerous muropeptides and derivs. have been synthesized chem. to characterize their immunostimulatory effects and adjuvant activity.  Muramyl dipeptide, a natural partial structure of PGN, is the minimal structure with adjuvant activity.  This review discusses the structure and occurrence of muropeptides and gives a broad overview of their inflammatory and adjuvant activity and the possible involvement of receptors in these responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEKqY15UjK3LVg90H21EOLACvtfcHk0ljFfVItw8oC9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D&md5=b10e36602d50c3022a76e7bf47b3d3e6</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1179%2F096805106X89044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F096805106X89044%26sid%3Dliteratum%253Aachs%26aulast%3DTraub%26aufirst%3DS.%26aulast%3Dvon%2BAulock%26aufirst%3DS.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHermann%26aufirst%3DC.%26atitle%3DMDP%2520and%2520other%2520muropeptides%2520%25E2%2580%2593%2520direct%2520and%2520synergistic%2520effects%2520on%2520the%2520immune%2520system%26jtitle%3DJ.%2520Endotoxin%2520Res.%26date%3D2006%26volume%3D12%26spage%3D69%26epage%3D85%26doi%3D10.1179%2F096805106X89044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukhvatulin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzharullaeva, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukhvatulina, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcheblyakov, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmarov, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolzhikova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanhope-Baker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naroditsky, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudkov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logunov, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gintsburg, A. L.</span></span> <span> </span><span class="NLM_article-title">Powerful complex immunoadjuvant based on synergistic effect of combined TLR4 and NOD2 activation significantly enhances magnitude of humoral and cellular adaptive immune responses</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e0155650</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0155650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1371%2Fjournal.pone.0155650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0155650&issue=5&author=A.+I.+Tukhvatulinauthor=A.+S.+Dzharullaevaauthor=N.+M.+Tukhvatulinaauthor=D.+V.+Shcheblyakovauthor=M.+M.+Shmarovauthor=I.+V.+Dolzhikovaauthor=P.+Stanhope-Bakerauthor=B.+S.+Naroditskyauthor=A.+V.+Gudkovauthor=D.+Y.+Logunovauthor=A.+L.+Gintsburg&title=Powerful+complex+immunoadjuvant+based+on+synergistic+effect+of+combined+TLR4+and+NOD2+activation+significantly+enhances+magnitude+of+humoral+and+cellular+adaptive+immune+responses&doi=10.1371%2Fjournal.pone.0155650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0155650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0155650%26sid%3Dliteratum%253Aachs%26aulast%3DTukhvatulin%26aufirst%3DA.%2BI.%26aulast%3DDzharullaeva%26aufirst%3DA.%2BS.%26aulast%3DTukhvatulina%26aufirst%3DN.%2BM.%26aulast%3DShcheblyakov%26aufirst%3DD.%2BV.%26aulast%3DShmarov%26aufirst%3DM.%2BM.%26aulast%3DDolzhikova%26aufirst%3DI.%2BV.%26aulast%3DStanhope-Baker%26aufirst%3DP.%26aulast%3DNaroditsky%26aufirst%3DB.%2BS.%26aulast%3DGudkov%26aufirst%3DA.%2BV.%26aulast%3DLogunov%26aufirst%3DD.%2BY.%26aulast%3DGintsburg%26aufirst%3DA.%2BL.%26atitle%3DPowerful%2520complex%2520immunoadjuvant%2520based%2520on%2520synergistic%2520effect%2520of%2520combined%2520TLR4%2520and%2520NOD2%2520activation%2520significantly%2520enhances%2520magnitude%2520of%2520humoral%2520and%2520cellular%2520adaptive%2520immune%2520responses%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D5%26spage%3De0155650%26doi%3D10.1371%2Fjournal.pone.0155650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span>; <span class="NLM_string-name">Mašek, J.</span>; <span class="NLM_string-name">Raška, M.</span>; <span class="NLM_string-name">Ledvina, M.</span></span> <span> </span><span class="NLM_article-title">Application of liposomes for construction of vaccines</span>. In  <i>Biomedical Science, Engineering and Technology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghista, D. N.</span></span>, Ed.; <span class="NLM_publisher-name">InTech</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">678</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.5772%2F21328" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=653-678&author=J.+Tur%C3%A1nek&author=J.+Ma%C5%A1ek&author=M.+Ra%C5%A1ka&author=M.+Ledvinaauthor=D.+N.+Ghista&title=Biomedical+Science%2C+Engineering+and+Technology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71a&amp;dbid=16384&amp;doi=10.5772%2F21328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F21328%26sid%3Dliteratum%253Aachs%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520liposomes%2520for%2520construction%2520of%2520vaccines%26btitle%3DBiomedical%2520Science%252C%2520Engineering%2520and%2520Technology%26aulast%3DGhista%26aufirst%3DD.%2BN.%26pub%3DInTech%26date%3D2012%26spage%3D653%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit71b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Effenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knötigova, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zyka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čelechovská, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartheldyová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubatka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudelka, Š.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukáč, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalová, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šaman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Křupka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkocziova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosztyu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šebela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drož, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hučko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanásová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledvina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span> <span> </span><span class="NLM_article-title">Nonpyrogenic molecular adjuvants based on norAbu-muramyldipeptide and norAbu-glucosaminyl muramyldipeptide: synthesis, molecular mechanisms of action, and biological activities in vitro and in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7745</span>– <span class="NLM_lpage">7763</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00593</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00593" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7745-7763&author=R.+Effenbergauthor=P.+T.+Kn%C3%B6tigovaauthor=D.+Zykaauthor=H.+%C4%8Celechovsk%C3%A1author=J.+Ma%C5%A1ekauthor=E.+Bartheldyov%C3%A1author=F.+Hubatkaauthor=%C5%A0.+Koudelkaauthor=R.+Luk%C3%A1%C4%8Dauthor=A.+Kovalov%C3%A1author=D.+%C5%A0amanauthor=M.+K%C5%99upkaauthor=L.+Barkocziovaauthor=P.+Kosztyuauthor=M.+%C5%A0ebelaauthor=L.+Dro%C5%BEauthor=M.+Hu%C4%8Dkoauthor=M.+Kan%C3%A1sov%C3%A1author=A.+D.+Millerauthor=M.+Ra%C5%A1kaauthor=M.+Ledvinaauthor=J.+Tur%C3%A1nek&title=Nonpyrogenic+molecular+adjuvants+based+on+norAbu-muramyldipeptide+and+norAbu-glucosaminyl+muramyldipeptide%3A+synthesis%2C+molecular+mechanisms+of+action%2C+and+biological+activities+in+vitro+and+in+vivo&doi=10.1021%2Facs.jmedchem.7b00593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71bR"><div class="casContent"><span class="casTitleNuber">71b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpyrogenic Molecular Adjuvants Based on norAbu-Muramyldipeptide and norAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo</span></div><div class="casAuthors">Effenberg, Roman; Turanek Knotigova, Pavlina; Zyka, Daniel; Celechovska, Hana; Masek, Josef; Bartheldyova, Eliska; Hubatka, Frantisek; Koudelka, Stepan; Lukac, Robert; Kovalova, Anna; Saman, David; Krupka, Michal; Barkocziova, Lucia; Kosztyu, Petr; Sebela, Marek; Droz, Ladislav; Hucko, Michal; Kanasova, Maria; Miller, Andrew D.; Raska, Milan; Ledvina, Miroslav; Turanek, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7745-7763</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acyl analogs of muramyldipeptide (MDP) (abbreviated N-L18 norAbuGMDP, N-B30 norAbuGMDP, norAbuMDP-Lys(L18), norAbuMDP-Lys(B30), norAbuGMDP-Lys(L18), norAbuGMDP-Lys(B30), B30 norAbuMDP, L18 norAbuMDP) are designed and synthesized comprising the normuramyl-L-α-aminobutanoyl (norAbu) structural moiety.  All new analogs show depressed pyrogenicity in both free (micellar) state and in liposomal formulations when tested in rabbits in vivo (s.c. and iv application).  New analogs are also shown to be selective activators of NOD2 and NLRP3 (inflammasome) in vitro but not NOD1.  Potencies of NOD2 and NLRP3 stimulation are found comparable with free MDP and other pos. controls.  Analogs are also demonstrated to be effective in stimulating cellular proliferation when the sera from mice are injected s.c. with individual liposome-loaded analogs, causing proliferation of bone marrow-derived GM-progenitors cells.  Importantly, vaccination nanoparticles prepd. from metallochelation liposomes, His-tagged antigen rOspA from Borrelia burgdorferi, and lipophilic analog norAbuMDP-Lys(B30) as adjuvant, are shown to provoke OspA-specific antibody responses with a strong Th1-bias (dominance of IgG2a response).  In contrast, the adjuvant effects of Alum or parent MDP show a strong Th2-bias (dominance of IgG1 response).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUp8pDHzdC7Vg90H21EOLACvtfcHk0lhRCUkghPvxig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF&md5=ca10207e03938dc2e1dd1400b79d38d8</span></div><a href="/servlet/linkout?suffix=cit71b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00593%26sid%3Dliteratum%253Aachs%26aulast%3DEffenberg%26aufirst%3DR.%26aulast%3DKn%25C3%25B6tigova%26aufirst%3DP.%2BT.%26aulast%3DZyka%26aufirst%3DD.%26aulast%3D%25C4%258Celechovsk%25C3%25A1%26aufirst%3DH.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DBartheldyov%25C3%25A1%26aufirst%3DE.%26aulast%3DHubatka%26aufirst%3DF.%26aulast%3DKoudelka%26aufirst%3D%25C5%25A0.%26aulast%3DLuk%25C3%25A1%25C4%258D%26aufirst%3DR.%26aulast%3DKovalov%25C3%25A1%26aufirst%3DA.%26aulast%3D%25C5%25A0aman%26aufirst%3DD.%26aulast%3DK%25C5%2599upka%26aufirst%3DM.%26aulast%3DBarkocziova%26aufirst%3DL.%26aulast%3DKosztyu%26aufirst%3DP.%26aulast%3D%25C5%25A0ebela%26aufirst%3DM.%26aulast%3DDro%25C5%25BE%26aufirst%3DL.%26aulast%3DHu%25C4%258Dko%26aufirst%3DM.%26aulast%3DKan%25C3%25A1sov%25C3%25A1%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DRa%25C5%25A1ka%26aufirst%3DM.%26aulast%3DLedvina%26aufirst%3DM.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DNonpyrogenic%2520molecular%2520adjuvants%2520based%2520on%2520norAbu-muramyldipeptide%2520and%2520norAbu-glucosaminyl%2520muramyldipeptide%253A%2520synthesis%252C%2520molecular%2520mechanisms%2520of%2520action%252C%2520and%2520biological%2520activities%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7745%26epage%3D7763%26doi%3D10.1021%2Facs.jmedchem.7b00593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alving, C. R.</span></span> <span> </span><span class="NLM_article-title">Liposomes as as carriers of antigens and adjuvants</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(91)90120-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2F0022-1759%2891%2990120-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1712030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK3MXkslylur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1991&pages=1-13&author=C.+R.+Alving&title=Liposomes+as+as+carriers+of+antigens+and+adjuvants&doi=10.1016%2F0022-1759%2891%2990120-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Liposomes as carriers of antigens and adjuvants</span></div><div class="casAuthors">Alving, Carl R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A review with 101 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9Z-KHYZEMrVg90H21EOLACvtfcHk0lhRCUkghPvxig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkslylur0%253D&md5=2a6a771f87da8765218ac6e38b6e4087</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2891%2990120-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252891%252990120-5%26sid%3Dliteratum%253Aachs%26aulast%3DAlving%26aufirst%3DC.%2BR.%26atitle%3DLiposomes%2520as%2520as%2520carriers%2520of%2520antigens%2520and%2520adjuvants%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1991%26volume%3D140%26spage%3D1%26epage%3D13%26doi%3D10.1016%2F0022-1759%2891%2990120-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG response to ovalbumin in mice</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2010.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.intimp.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=20403461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=751-759&author=L.+Habjanecauthor=B.+Halassyauthor=J.+Toma%C5%A1i%C4%87&title=Comparative+study+of+structurally+related+peptidoglycan+monomer+and+muramyl+dipeptide+on+humoral+IgG+response+to+ovalbumin+in+mice&doi=10.1016%2Fj.intimp.2010.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse</span></div><div class="casAuthors">Habjanec, Lidija; Halassy, Beata; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">751-759</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structurally related peptidoglycan monomer (PGM) and muramyl dipeptide (MDP) differ in several aspects of biol. activity but have in common immunostimulating properties.  Comparative study of the effects of these adjuvants on humoral IgG immune response specific for protein antigen ovalbumin (OVA) was carried out in two inbred mouse strains, CBA and NIH/OlaHsd, and their ability to modulate the bias of immune response towards Th1/Th2 was evaluated.  MDP had better adjuvant activity at some points than PGM, whereas both adjuvants stimulated Th2-biased immune response specific for OVA.  In comparison to Complete Freund's adjuvant (CFA), as a golden std. of adjuvant action, both PGM and MDP exhibited considerably lower activity.  Addn. of PGM to Incomplete Freund's adjuvant (IFA) on humoral immune response was studied also, and the effect of such adjuvant formulation was compared to the effect of CFA.  While CFA induced the switch towards Th1-biased immune response, the addn. of PGM into IFA did have no impact on modulating the immune response towards more pronounced Th2-type of immune response, defined by IFA itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEa9MV5PnV7bVg90H21EOLACvtfcHk0lh-2W8DooOeRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D&md5=0279f7b455963f0048e0d182805bd5f1</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DComparative%2520study%2520of%2520structurally%2520related%2520peptidoglycan%2520monomer%2520and%2520muramyl%2520dipeptide%2520on%2520humoral%2520IgG%2520response%2520to%2520ovalbumin%2520in%2520mice%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2010%26volume%3D10%26spage%3D751%26epage%3D759%26doi%3D10.1016%2Fj.intimp.2010.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Effect of liposomal formulations and immunostimulating peptidoglycan monomer (PGM) on the immune reaction to ovalbumin in mice</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1080/08982100500528537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1080%2F08982100500528537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16556546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD28XislCksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1-16&author=L.+Habjanecauthor=R.+Frkanecauthor=B.+Halassyauthor=J.+Toma%C5%A1i%C4%87&title=Effect+of+liposomal+formulations+and+immunostimulating+peptidoglycan+monomer+%28PGM%29+on+the+immune+reaction+to+ovalbumin+in+mice&doi=10.1080%2F08982100500528537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Liposomal Formulations and Immunostimulating Peptidoglycan Monomer (PGM) on the Immune Reaction to Ovalbumin in Mice</span></div><div class="casAuthors">Habjanec, Lidija; Frkanec, Ruza; Halassy, Beata; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The adjuvant activity of liposomes and immunostimulating peptidoglycan monomer (PGM) in different formulations has been studied in mice model using ovalbumin (OVA) as an antigen.  PGM is a natural compd. of bacterial origin with well-defined chem. structure: GlcNAc-MurNAc-l-Ala-d-isoGln-mesoDpm(eNH2)-d-Ala-d-Ala.  It is a non-toxic, non-pyrogenic, and water-sol. immunostimulator.  The aim of this study was to investigate the influence of different liposomal formulations of OVA, with or without PGM, on the prodn. of total IgG, as well as of IgG1 and IgG2a subclasses of OVA-specific antibodies (as indicators of Th2 and Th1 type of immune response, resp.).  CBA mice were immunized s.c. with OVA mixed with liposomes, OVA with PGM mixed with liposomes, OVA encapsulated into liposomes and OVA with PGM encapsulated into liposomes.  Control groups were OVA in saline, OVA with PGM in saline, and OVA in CFA/IFA adjuvant formulation.  The entrapment efficacy of OVA was monitored by HPLC method.  The adjuvant activity of the mixt. of OVA and empty liposomes, the mixt. of OVA, PGM, and liposomes and PGM encapsulated with OVA into liposomes on prodn. of total anti-OVA IgG was demonstrated.  The mixt. of PGM and liposomes exhibited additive immunostimulating effect on the prodn. of antigen-specific IgGs.  The anal. of IgG subclasses revealed that encapsulation of OVA into liposomes favors the stimulation of IgG2a antibodies, indicating the switch toward the Th1 type of immune response.  When encapsulated into liposomes or mixed with liposomes, PGM induced a switch from Th1 to Th2 type of immune response.  It could be concluded that appropriate formulations of antigen, PGM, and liposomes differently affect the humoral immune response and direct the switch in the type of immune response (Th1/Th2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol4pGRk6ZmWrVg90H21EOLACvtfcHk0lh-2W8DooOeRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislCksLY%253D&md5=9f6310327818b4024f1af15d538dbd35</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1080%2F08982100500528537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08982100500528537%26sid%3Dliteratum%253Aachs%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEffect%2520of%2520liposomal%2520formulations%2520and%2520immunostimulating%2520peptidoglycan%2520monomer%2520%2528PGM%2529%2520on%2520the%2520immune%2520reaction%2520to%2520ovalbumin%2520in%2520mice%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2006%26volume%3D16%26spage%3D1%26epage%3D16%26doi%3D10.1080%2F08982100500528537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relyveld, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindblad, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizzini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Efraim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, C. K.</span></span> <span> </span><span class="NLM_article-title">Adjuvants – a balance between toxicity and adjuvanticity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/0264-410X(93)90190-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2F0264-410X%2893%2990190-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=293-306&author=R.+K.+Guptaauthor=E.+H.+Relyveldauthor=E.+B.+Lindbladauthor=B.+Bizziniauthor=S.+Ben-Efraimauthor=C.+K.+Gupta&title=Adjuvants+%E2%80%93+a+balance+between+toxicity+and+adjuvanticity&doi=10.1016%2F0264-410X%2893%2990190-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F0264-410X%2893%2990190-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0264-410X%252893%252990190-9%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DRelyveld%26aufirst%3DE.%2BH.%26aulast%3DLindblad%26aufirst%3DE.%2BB.%26aulast%3DBizzini%26aufirst%3DB.%26aulast%3DBen-Efraim%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DC.%2BK.%26atitle%3DAdjuvants%2520%25E2%2580%2593%2520a%2520balance%2520between%2520toxicity%2520and%2520adjuvanticity%26jtitle%3DVaccine%26date%3D1993%26volume%3D11%26spage%3D293%26epage%3D306%26doi%3D10.1016%2F0264-410X%2893%2990190-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travaš, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstanović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy Špoljar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljevaković, Đ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Entrapment of peptidoglycans and adamantyltripeptides into liposomes: an HPLC assay for determination of encapsulation efficiency</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1081/LPR-120026452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1081%2FLPR-120026452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=14670233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=279-294&author=R.+Frkanecauthor=D.+Trava%C5%A1author=M.+Krstanovi%C4%87author=B.+Halassy+%C5%A0poljarauthor=%C4%90.+Ljevakovi%C4%87author=B.+Vrane%C5%A1i%C4%87author=L.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Entrapment+of+peptidoglycans+and+adamantyltripeptides+into+liposomes%3A+an+HPLC+assay+for+determination+of+encapsulation+efficiency&doi=10.1081%2FLPR-120026452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Entrapment of peptidoglycans and adamantyltripeptides into liposomes: An HPLC assay for determination of encapsulation efficiency</span></div><div class="casAuthors">Frkanec, Ruza; Travas, Dijana; Krstanovic, Marina; Spoljar, Beata Halassy; Ljevakovic, Durdica; Vranesic, Branka; Frkanec, Leo; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">279-294</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The encapsulation of different immunomodulating peptides, the peptidoglycan monomer, its semisynthetic derivs. (Adamant-1-yl)-acetyl-peptidoglycan monomer and Boc-Tyr-peptidoglycan monomer, resp., and of 2 diastereoisomers of adamantyltripeptides into the large neg. charged multilamellar liposomes was investigated.  The reproducible quant. method using HPLC was established for the detn. of the entrapped compds.  It was shown that the tested compds. could be efficiently incorporated into liposomes using either the film or modified film method.  The results confirmed that the peptidoglycans with lipophilic substituents and particularly the adamantyltripeptides were incorporated into liposomes with higher efficiency than the peptidoglycan monomer using either of the described methods.  Liposome prepns. were stable at 4°C up to 7 days as shown by minimal leaking of the entrapped material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1hI__p75OorVg90H21EOLACvtfcHk0lj2Pyl4tPN04A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D&md5=d7c820181996614dad55faa819effe09</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1081%2FLPR-120026452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FLPR-120026452%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTrava%25C5%25A1%26aufirst%3DD.%26aulast%3DKrstanovi%25C4%2587%26aufirst%3DM.%26aulast%3DHalassy%2B%25C5%25A0poljar%26aufirst%3DB.%26aulast%3DLjevakovi%25C4%2587%26aufirst%3D%25C4%2590.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEntrapment%2520of%2520peptidoglycans%2520and%2520adamantyltripeptides%2520into%2520liposomes%253A%2520an%2520HPLC%2520assay%2520for%2520determination%2520of%2520encapsulation%2520efficiency%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2003%26volume%3D13%26spage%3D279%26epage%3D294%26doi%3D10.1081%2FLPR-120026452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noethig Laslo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirosavljević, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1611</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/S0005-2736(03)00054-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2FS0005-2736%2803%2900054-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=12659960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1611&publication_year=2003&pages=187-196&author=R.+Frkanecauthor=V.+Noethig+Lasloauthor=B.+Vrane%C5%A1i%C4%87author=K.+Mirosavljevi%C4%87author=J.+Toma%C5%A1i%C4%87&title=A+spin+labelling+study+of+immunomodulating+peptidoglycan+monomer+and+adamantyltripeptides+entrapped+into+liposomes&doi=10.1016%2FS0005-2736%2803%2900054-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes</span></div><div class="casAuthors">Frkanec, Ruza; Noethig-Laslo, Vesna; Vranesic, Branka; Mirosavljevic, Krunoslav; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1611</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">187-196</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The interaction of immunostimulating compds., the peptidoglycan monomer (PGM) and structurally related adamantyltripeptides (AdTP1 and AdTP2), resp., with phospholipids in liposomal bilayers were investigated by ESR spectroscopy.  The fatty acids bearing the nitroxide spin label at different positions along the acyl chain were used to investigate the interaction of tested compds. with neg. charged multilamellar liposomes.  ESR spectra were studied at 290 and 310 K.  The entrapment of the adamantyltripeptides affected the motional properties of all spin labeled lipids, while the entrapment of PGM had no effect.  Spin labeled PGM was prepd. and the novel compd. bearing the spin label attached via the amino group of diaminopimelic acid was chromatog. purified and chem. characterized.  The rotational correlation time of the spin labeled mol. dissolved in buffer at pH 7.4 was studied as a function of temp.  The conformational change was obsd. above 300 K.  The same effect was obsd. with the spin labeled PGM incorporated into liposomes.  Such effect was not obsd. when the spin labeled PGM was studied at alk. pH, probably due to the hydrolysis of PGM mol.  The study of possible interaction with liposomal membrane is relevant to the use of tested compds. incorporated into liposomes, as adjuvants in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKdV2HeMqDUbVg90H21EOLACvtfcHk0lj2Pyl4tPN04A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D&md5=d85964e73e290fbc42df57e31045d890</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0005-2736%2803%2900054-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2736%252803%252900054-3%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DNoethig%2BLaslo%26aufirst%3DV.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DMirosavljevi%25C4%2587%26aufirst%3DK.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DA%2520spin%2520labelling%2520study%2520of%2520immunomodulating%2520peptidoglycan%2520monomer%2520and%2520adamantyltripeptides%2520entrapped%2520into%2520liposomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2003%26volume%3D1611%26spage%3D187%26epage%3D196%26doi%3D10.1016%2FS0005-2736%2803%2900054-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstanović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Adjuvant activity of peptidoglycan monomer and its metabolic products</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(02)00547-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2FS0264-410X%2802%2900547-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=971-976&author=B.+Halassyauthor=M.+Krstanovi%C4%87author=R.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Adjuvant+activity+of+peptidoglycan+monomer+and+its+metabolic+products&doi=10.1016%2FS0264-410X%2802%2900547-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2802%2900547-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252802%252900547-9%26sid%3Dliteratum%253Aachs%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DKrstanovi%25C4%2587%26aufirst%3DM.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DAdjuvant%2520activity%2520of%2520peptidoglycan%2520monomer%2520and%2520its%2520metabolic%2520products%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D971%26epage%3D976%26doi%3D10.1016%2FS0264-410X%2802%2900547-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span> <i>GAMESS interface, ChemBio3D Ultra 13.0, ChemBioOffice Ultra 13.0</i>; CambridgeSoft.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GAMESS+interface%2C+ChemBio3D+Ultra+13.0%2C+ChemBioOffice+Ultra+13.0%3B+CambridgeSoft."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGAMESS%2520interface%252C%2520ChemBio3D%2520Ultra%252013.0%252C%2520ChemBioOffice%2520Ultra%252013.0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span> <span> </span><span class="NLM_article-title">Merck molecular force field 0.1. Basis, form, scope, parameterization, and performance of MMFF94</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=490-519&author=T.+A.+Halgren&title=Merck+molecular+force+field+0.1.+Basis%2C+form%2C+scope%2C+parameterization%2C+and+performance+of+MMFF94&doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0ljsUDb4MeG5KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMerck%2520molecular%2520force%2520field%25200.1.%2520Basis%252C%2520form%252C%2520scope%252C%2520parameterization%252C%2520and%2520performance%2520of%2520MMFF94%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D519%26doi%3D10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lhJrvaGjaRIkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span> <i>GOLD Suite</i>, v5.4; The Cambridge Crystallographic Data Centre:
Cambridge, UK; <a href="http://www.ccdc.cam.ac.uk" class="extLink">www.ccdc.cam.ac.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GOLD+Suite%2C+v5.4%3B+The+Cambridge+Crystallographic+Data+Centre%3A%0ACambridge%2C+UK%3B+www.ccdc.cam.ac.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGOLD%2520Suite" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span> <i>PyMOL</i>; <span class="NLM_publisher-name">Delano Scientific
LLC</span>, <span class="NLM_publisher-loc">San Francisco, CA</span>; <a href="http://pymol.sourceforge.net" class="extLink">http://pymol.sourceforge.net</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+PyMOL%3B+Delano+Scientific%0ALLC%2C+San+Francisco%2C+CA%3B+http%3A%2F%2Fpymol.sourceforge.net."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPyMOL%26pub%3DDelano%2520Scientific%250ALLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49a','cit49b'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71a','cit71b'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 12 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samo Guzelj, Sanja Nabergoj, Martina Gobec, Stane Pajk, Veronika Klančič, Bram Slütter, Ruža Frkanec, Adela Štimac, Primož Šket, Janez Plavec, Irena Mlinarič-Raščan, <span class="NLM_string-name hlFld-ContribAuthor">Žiga Jakopin</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7809-7838. <a href="https://doi.org/10.1021/acs.jmedchem.1c00644" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00644</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00644&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00644%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BFine-Tuning%252Bof%252BDesmuramylpeptide%252BNOD2%252BAgonists%252BDefines%252BTheir%252BIn%252BVivo%252BAdjuvant%252BActivity%26aulast%3DGuzelj%26aufirst%3DSamo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08042021%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7809%26epage%3D7838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qian  Xu</span>, <span class="hlFld-ContribAuthor ">Hao  Deng</span>, <span class="hlFld-ContribAuthor ">Xiaoting  Li</span>, <span class="hlFld-ContribAuthor ">Zhe-Shan  Quan</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Amino Acids in the Structural Modification of Natural Products: A Review. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fchem.2021.650569" title="DOI URL">https://doi.org/10.3389/fchem.2021.650569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2021.650569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2021.650569%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DApplication%252Bof%252BAmino%252BAcids%252Bin%252Bthe%252BStructural%252BModification%252Bof%252BNatural%252BProducts%25253A%252BA%252BReview%26aulast%3DXu%26aufirst%3DQian%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Virgil  Schijns</span>, <span class="hlFld-ContribAuthor ">Dragomira  Majhen</span>, <span class="hlFld-ContribAuthor ">Peter  van der Ley</span>, <span class="hlFld-ContribAuthor ">Aneesh  Thakur</span>, <span class="hlFld-ContribAuthor ">Artur  Summerfield</span>, <span class="hlFld-ContribAuthor ">Rita  Berisio</span>, <span class="hlFld-ContribAuthor ">Cristina  Nativi</span>, <span class="hlFld-ContribAuthor ">Alberto  Fernández-Tejada</span>, <span class="hlFld-ContribAuthor ">Carmen  Alvarez-Dominguez</span>, <span class="hlFld-ContribAuthor ">Sveinbjörn  Gizurarson</span>, <span class="hlFld-ContribAuthor ">Alla  Zamyatina</span>, <span class="hlFld-ContribAuthor ">Antonio  Molinaro</span>, <span class="hlFld-ContribAuthor ">Camillo  Rosano</span>, <span class="hlFld-ContribAuthor ">Žiga  Jakopin</span>, <span class="hlFld-ContribAuthor ">Ihsan  Gursel</span>, <span class="hlFld-ContribAuthor ">Siobhán  McClean</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Vaccine Design in Times of Emerging Diseases: The Critical Choices of Immunological Correlates of Protection, Vaccine Antigen and Immunomodulation. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2021,</strong> <em>13 </em>
                                    (4)
                                     , 501. <a href="https://doi.org/10.3390/pharmaceutics13040501" title="DOI URL">https://doi.org/10.3390/pharmaceutics13040501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics13040501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics13040501%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DRational%252BVaccine%252BDesign%252Bin%252BTimes%252Bof%252BEmerging%252BDiseases%25253A%252BThe%252BCritical%252BChoices%252Bof%252BImmunological%252BCorrelates%252Bof%252BProtection%25252C%252BVaccine%252BAntigen%252Band%252BImmunomodulation%26aulast%3DSchijns%26aufirst%3DVirgil%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D4%26spage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleksandra  Maršavelski</span>, <span class="hlFld-ContribAuthor ">Marija  Paurević</span>, <span class="hlFld-ContribAuthor ">Rosana  Ribić</span>. </span><span class="cited-content_cbyCitation_article-title">Mannosylated adamantane-containing desmuramyl peptide recognition by the NOD2 receptor: a molecular dynamics study. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>140 </em><a href="https://doi.org/10.1039/D1OB00679G" title="DOI URL">https://doi.org/10.1039/D1OB00679G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1OB00679G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1OB00679G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DMannosylated%252Badamantane-containing%252Bdesmuramyl%252Bpeptide%252Brecognition%252Bby%252Bthe%252BNOD2%252Breceptor%25253A%252Ba%252Bmolecular%252Bdynamics%252Bstudy%26aulast%3DMar%25C5%25A1avelski%26aufirst%3DAleksandra%26date%3D2021%26date%3D2021%26volume%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei‐Chieh  Cheng</span>, <span class="hlFld-ContribAuthor ">Ting‐Yun  You</span>, <span class="hlFld-ContribAuthor ">Zhen‐Zhuo  Teo</span>, <span class="hlFld-ContribAuthor ">Ashik A.  Sayyad</span>, <span class="hlFld-ContribAuthor ">Jitendra  Maharana</span>, <span class="hlFld-ContribAuthor ">Chih‐Wei  Guo</span>, <span class="hlFld-ContribAuthor ">Pi‐Hui  Liang</span>, <span class="hlFld-ContribAuthor ">Chung‐Shun  Lin</span>, <span class="hlFld-ContribAuthor ">Fan‐Chun  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Further Insights on Structural Modifications of Muramyl Dipeptides to Study the Human NOD2 Stimulating Activity. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – An Asian Journal</span><span> <strong>2020,</strong> <em>15 </em>
                                    (22)
                                     , 3836-3844. <a href="https://doi.org/10.1002/asia.202001003" title="DOI URL">https://doi.org/10.1002/asia.202001003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.202001003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.202001003%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520An%2520Asian%2520Journal%26atitle%3DFurther%252BInsights%252Bon%252BStructural%252BModifications%252Bof%252BMuramyl%252BDipeptides%252Bto%252BStudy%252Bthe%252BHuman%252BNOD2%252BStimulating%252BActivity%26aulast%3DCheng%26aufirst%3DWei%25E2%2580%2590Chieh%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D22%26spage%3D3836%26epage%3D3844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mateja  Manček-Keber</span>, <span class="hlFld-ContribAuthor ">Rosana  Ribić</span>, <span class="hlFld-ContribAuthor ">Fernando  Chain</span>, <span class="hlFld-ContribAuthor ">Davy  Sinnaeve</span>, <span class="hlFld-ContribAuthor ">José C.  Martins</span>, <span class="hlFld-ContribAuthor ">Roman  Jerala</span>, <span class="hlFld-ContribAuthor ">Srđanka  Tomić</span>, <span class="hlFld-ContribAuthor ">Krisztina  Fehér</span>. </span><span class="cited-content_cbyCitation_article-title">Adamantane Containing Peptidoglycan Fragments Enhance RANTES and IL-6 Production in Lipopolysaccharide-Induced Macrophages. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (16)
                                     , 3707. <a href="https://doi.org/10.3390/molecules25163707" title="DOI URL">https://doi.org/10.3390/molecules25163707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25163707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25163707%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAdamantane%252BContaining%252BPeptidoglycan%252BFragments%252BEnhance%252BRANTES%252Band%252BIL-6%252BProduction%252Bin%252BLipopolysaccharide-Induced%252BMacrophages%26aulast%3DMan%25C4%258Dek-Keber%26aufirst%3DMateja%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D16%26spage%3D3707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samo  Guzelj</span>, <span class="hlFld-ContribAuthor ">Martina  Gobec</span>, <span class="hlFld-ContribAuthor ">Dunja  Urbančič</span>, <span class="hlFld-ContribAuthor ">Irena  Mlinarič-Raščan</span>, <span class="hlFld-ContribAuthor ">Emanuela  Corsini</span>, <span class="hlFld-ContribAuthor ">Žiga  Jakopin</span>. </span><span class="cited-content_cbyCitation_article-title">Structural features and functional activities of benzimidazoles as NOD2 antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112089. <a href="https://doi.org/10.1016/j.ejmech.2020.112089" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112089%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252Bfeatures%252Band%252Bfunctional%252Bactivities%252Bof%252Bbenzimidazoles%252Bas%252BNOD2%252Bantagonists%26aulast%3DGuzelj%26aufirst%3DSamo%26date%3D2020%26volume%3D190%26spage%3D112089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanja  Nabergoj</span>, <span class="hlFld-ContribAuthor ">Irena  Mlinarič‐Raščan</span>, <span class="hlFld-ContribAuthor ">Žiga  Jakopin</span>. </span><span class="cited-content_cbyCitation_article-title">Harnessing the untapped potential of nucleotide‐binding oligomerization domain ligands for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (5)
                                     , 1447-1484. <a href="https://doi.org/10.1002/med.21557" title="DOI URL">https://doi.org/10.1002/med.21557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21557%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHarnessing%252Bthe%252Buntapped%252Bpotential%252Bof%252Bnucleotide%2525E2%252580%252590binding%252Boligomerization%252Bdomain%252Bligands%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DNabergoj%26aufirst%3DSanja%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D5%26spage%3D1447%26epage%3D1484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakopin</span>, <span class="hlFld-ContribAuthor ">Corsini</span>. </span><span class="cited-content_cbyCitation_article-title">THP-1 Cells and Pro-inflammatory Cytokine Production: An in Vitro Tool for Functional Characterization of NOD1/NOD2 Antagonists. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (17)
                                     , 4265. <a href="https://doi.org/10.3390/ijms20174265" title="DOI URL">https://doi.org/10.3390/ijms20174265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20174265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20174265%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DTHP-1%252BCells%252Band%252BPro-inflammatory%252BCytokine%252BProduction%25253A%252BAn%252Bin%252BVitro%252BTool%252Bfor%252BFunctional%252BCharacterization%252Bof%252BNOD1%25252FNOD2%252BAntagonists%26aulast%3DJakopin%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D17%26spage%3D4265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elizabeth A.  D'Ambrosio</span>, <span class="hlFld-ContribAuthor ">Walter R.  Drake</span>, <span class="hlFld-ContribAuthor ">Siavash  Mashayekh</span>, <span class="hlFld-ContribAuthor ">Ophelia I.  Ukaegbu</span>, <span class="hlFld-ContribAuthor ">Ashley R.  Brown</span>, <span class="hlFld-ContribAuthor ">Catherine L.  Grimes</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the NOD-like receptors NOD1 and NOD2: A chemist’s perspective. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (10)
                                     , 1153-1161. <a href="https://doi.org/10.1016/j.bmcl.2019.03.010" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.03.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.03.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DModulation%252Bof%252Bthe%252BNOD-like%252Breceptors%252BNOD1%252Band%252BNOD2%25253A%252BA%252Bchemist%2525E2%252580%252599s%252Bperspective%26aulast%3DD%2527Ambrosio%26aufirst%3DElizabeth%2BA.%26date%3D2019%26volume%3D29%26issue%3D10%26spage%3D1153%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew E  Griffin</span>, <span class="hlFld-ContribAuthor ">Charles W  Hespen</span>, <span class="hlFld-ContribAuthor ">Yen‐Chih  Wang</span>, <span class="hlFld-ContribAuthor ">Howard C  Hang</span>. </span><span class="cited-content_cbyCitation_article-title">Translation of peptidoglycan metabolites into immunotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">Clinical & Translational Immunology</span><span> <strong>2019,</strong> <em>8 </em>
                                    (12)
                                     <a href="https://doi.org/10.1002/cti2.1095" title="DOI URL">https://doi.org/10.1002/cti2.1095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cti2.1095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcti2.1095%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520%2526%2520Translational%2520Immunology%26atitle%3DTranslation%252Bof%252Bpeptidoglycan%252Bmetabolites%252Binto%252Bimmunotherapeutics%26aulast%3DGriffin%26aufirst%3DMatthew%2BE%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosana  Ribić</span>, <span class="hlFld-ContribAuthor ">Ranko  Stojković</span>, <span class="hlFld-ContribAuthor ">Lidija  Milković</span>, <span class="hlFld-ContribAuthor ">Mariastefania  Antica</span>, <span class="hlFld-ContribAuthor ">Marko  Cigler</span>, <span class="hlFld-ContribAuthor ">Srđanka  Tomić</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of immunostimulating mannosylated desmuramyl peptides. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>15 </em>, 1805-1814. <a href="https://doi.org/10.3762/bjoc.15.174" title="DOI URL">https://doi.org/10.3762/bjoc.15.174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.15.174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.15.174%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bimmunostimulating%252Bmannosylated%252Bdesmuramyl%252Bpeptides%26aulast%3DRibi%25C4%2587%26aufirst%3DRosana%26date%3D2019%26date%3D2019%26volume%3D15%26spage%3D1805%26epage%3D1814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of acylated tripeptide analogs and structural modifications of leads <b>I</b> and <b>II</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Acylated Tripeptide Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Boc-<span class="smallcaps smallerCapital">l</span>-Val or Boc-<span class="smallcaps smallerCapital">l</span>-Phe, DCC, HOBt, DIPEA, DMAP, EtOAc; (ii) TFA/CH<sub>2</sub>Cl<sub>2</sub> (1:5); (iii) Boc-Gly, DCC, HOBt, DIPEA, DMAP, EtOAc; (iv) R′COOH, EDC, HOBt, DIPEA, DMAP, DMF. *a mixture of two diastereomers; <i>**</i>a mixture of four diastereomers.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Derivatives of Compound <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF; (ii) 1 M NaOH, EtOH, rt.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Exploration of the Chemical Space of <span class="smallcaps smallerCapital">d</span>-Glutamic Acid<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) <i>trans</i>-ferulic acid, EDC, HOBt, DIPEA, DMAP, DMF; (ii) 1 M NaOH, EtOH, rt; (iii) <b>1b</b>, EDC, HOBt, DIPEA, DMAP, DMF; (iv) ethyl isonipecotate or ethyl (1<i>R</i>,2<i>S</i>)-2-aminocyclohexane-1-carboxylate or ethyl (1<i>S</i>,2<i>S</i>)-2-aminocyclohexane-1-carboxylate, EDC, HOBt, DIPEA, DMAP, DMF; (v) <b>25b</b> or <b>26b</b> or <b>27b</b>, EDC, HOBt, DIPEA, DMAP, DMF. Constrained mimetics of <span class="smallcaps smallerCapital">d</span>-glutamic acid are highlighted in dashed red rectangles. Core structure of <b>9</b> is highlighted in dashed blue rectangles.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Effects of desmuramylpeptides <b>4</b>–<b>15</b> on NF-κB transcriptional activity. (B) Effects of desmuramylpeptides <b>16</b>, <b>17</b>, <b>22</b>–<b>24</b>, and <b>28</b>–<b>30</b> on NF-κB transcriptional activity. SEAP activities were measured in both NOD2-specific and NOD1-specific HEK-Blue cells after incubation for 18 h with compounds of interest (2 μM), MDP (2 μM), or C12-iE-DAP (100 nM). The data are shown relative to that of the control (NT). Columns represent the means of duplicates of three independent experiments. Error bars indicate ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Concentration-dependent activation of NOD2 by selected desmuramylpeptides and by MDP. SEAP activity was measured in NOD2-specific HEK-Blue cells after incubation for 18 h with MDP or with the compound of interest at concentrations ranging from 0.001 to 20 μM. Data points represent means of duplicates of three independent experiments; error bars indicate ± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Concentrations of compounds <b>9</b> and <b>17</b> in cell supernatant (CS) and cell lysate (LYS) determined in the cell uptake and stability experiment performed by 18 h incubations in the presence of 2 μM compound <b>9</b> (A) and 2 μM compound <b>17</b> (B) in cell incubation media. Dark gray bars represent compound <b>9</b>, and light gray bars represent compound <b>17</b>. Columns represent means of two independent experiments performed in duplicates. Error bars represent SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Predicted binding modes of (a) MDP (magenta sticks) and (b) <b>17</b> (green sticks) in the putative binding pocket on the concave surface of the LRR domain of NOD2 (PDB entry: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN">5IRN</a>). The protein is shown in surface presentation, and for clarity, only amino acid side chains interacting with the ligands are shown as gray sticks. Hydrogen bonds are shown as black dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effect of MDP and compound <b>9</b> on cytokine release in PBMCs. Cells were treated with 2 μM MDP or <b>9</b> in the presence or absence of 10 ng/mL LPS. Cytokine release was determined after 18 h. Columns represent means of duplicates ± SEM of two independent experiments (data are representative of two independent donors); *<i>p</i> < 0.05 vs untreated (NT) or LPS-treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/medium/jm-2017-010522_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Comparison of the adjuvant effects of MDP and <b>9</b> on the production of total anti-OVA IgGs in the sera of three experimental groups of NIH/OlaHsd female mice (<i>n</i> = 6) after the second booster. OVA in liposomes (50 μg of OVA in sterile PBS); OVA + MDP in liposomes (50 μg of OVA with 200 μg/mouse of MDP); OVA + <b>9</b> in liposomes (50 μg of OVA with 200 μg/mouse of <b>9</b>). ○ Denotes each mouse separately; −–– denotes group mean value; *<i>p</i> < 0.05 (Kruskal–Wallis ANOVA, followed by multiple Mann–Whitney U-nonparametric tests) in comparison to the group not treated by adjuvant or in comparison with the group connected with dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.7b01052/20180406/images/large/jm-2017-010522_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01052&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i68">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 83 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janeway, C. A.,  Jr</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medzhitov, R.</span></span> <span> </span><span class="NLM_article-title">Innate immune recognition</span>. <i>Annu. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1146/annurev.immunol.20.083001.084359</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1146%2Fannurev.immunol.20.083001.084359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=11861602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=197-216&author=C.+A.+Janewayauthor=R.+Medzhitov&title=Innate+immune+recognition&doi=10.1146%2Fannurev.immunol.20.083001.084359"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Innate immune recognition</span></div><div class="casAuthors">Janeway, Charles A., Jr.; Medzhitov, Ruslan</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197-216</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  The innate immune system is a universal and ancient form of host defense against infection.  Innate immune recognition relies on a limited no. of germline-encoded receptors.  These receptors evolved to recognize conserved products of microbial metab. produced by microbial pathogens, but not by the host.  Recognition of these mol. structures allows the immune system to distinguish infectious nonself from noninfectious self.  Toll-like receptors play a major role in pathogen recognition and initiation of inflammatory and immune responses.  Stimulation of Toll-like receptors by microbial products leads to the activation of signaling pathways that result in the induction of antimicrobial genes and inflammatory cytokines.  In addn., stimulation of Toll-like receptors triggers dendritic cell maturation and results in the induction of costimulatory mols. and increased antigen-presenting capacity.  Thus, microbial recognition by Toll-like receptors helps to direct adaptive immune responses to antigens derived from microbial pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Ee-TeDKpobVg90H21EOLACvtfcHk0lgQb7sx5GGYfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlWgt7Y%253D&md5=0c4bd7dbf690ad61e6b81324be227d8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.20.083001.084359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.20.083001.084359%26sid%3Dliteratum%253Aachs%26aulast%3DJaneway%26aufirst%3DC.%2BA.%26aulast%3DMedzhitov%26aufirst%3DR.%26atitle%3DInnate%2520immune%2520recognition%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D20%26spage%3D197%26epage%3D216%26doi%3D10.1146%2Fannurev.immunol.20.083001.084359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorbara, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croitoru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">NOD proteins: regulators of inflammation in health and disease</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1038/nri3565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnri3565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=24336102" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=9-23&author=D.+J.+Philpottauthor=M.+T.+Sorbaraauthor=S.+J.+Robertsonauthor=K.+Croitoruauthor=S.+E.+Girardin&title=NOD+proteins%3A+regulators+of+inflammation+in+health+and+disease&doi=10.1038%2Fnri3565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">NOD proteins: regulators of inflammation in health and disease</span></div><div class="casAuthors">Philpott, Dana J.; Sorbara, Matthew T.; Robertson, Susan J.; Croitoru, Kenneth; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-23</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Entry of bacteria into host cells is an important virulence mechanism.  Through peptidoglycan recognition, the nucleotide-binding oligomerization domain (NOD) proteins NOD1 and NOD2 enable detection of intracellular bacteria and promote their clearance through initiation of a pro-inflammatory transcriptional program and other host defense pathways, including autophagy.  Recent findings have expanded the scope of the cellular compartments monitored by NOD1 and NOD2 and have elucidated the signalling pathways that are triggered downstream of NOD activation.  In vivo, NOD1 and NOD2 have complex roles, both during bacterial infection and at homeostasis.  The assocn. of alleles that encode constitutively active or constitutively inactive forms of NOD2 with different diseases highlights this complexity and indicates that a balanced level of NOD signalling is crucial for the maintenance of immune homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHe0P1JHOtJ7Vg90H21EOLACvtfcHk0lgQb7sx5GGYfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFars7bO&md5=4de699679859f47003bceeea35012b34</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri3565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3565%26sid%3Dliteratum%253Aachs%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSorbara%26aufirst%3DM.%2BT.%26aulast%3DRobertson%26aufirst%3DS.%2BJ.%26aulast%3DCroitoru%26aufirst%3DK.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DNOD%2520proteins%253A%2520regulators%2520of%2520inflammation%2520in%2520health%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2014%26volume%3D14%26spage%3D9%26epage%3D23%26doi%3D10.1038%2Fnri3565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Caruso, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">NOD1 and NOD2: signaling, host defense, and inflammatory disease</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">908</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2014.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.immuni.2014.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=25526305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislyqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=898-908&author=R.+Carusoauthor=N.+Warnerauthor=N.+Inoharaauthor=G.+Nu%C3%B1ez&title=NOD1+and+NOD2%3A+signaling%2C+host+defense%2C+and+inflammatory+disease&doi=10.1016%2Fj.immuni.2014.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease</span></div><div class="casAuthors">Caruso, Roberta; Warner, Neil; Inohara, Naohiro; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">898-908</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The nucleotide-binding oligomerization domain (NOD) proteins NOD1 and NOD2, the founding members of the intracellular NOD-like receptor family, sense conserved motifs in bacterial peptidoglycan and induce proinflammatory and antimicrobial responses.  Here, we discuss recent developments about the mechanisms by which NOD1 and NOD2 are activated by bacterial ligands, the regulation of their signaling pathways, and their role in host defense and inflammatory disease.  Several routes for the entry of peptidoglycan ligands to the host cytosol to trigger activation of NOD1 and NOD2 have been elucidated.  Furthermore, genetic screens and biochem. analyses have revealed mechanisms that regulate NOD1 and NOD2 signaling.  Finally, recent studies have suggested several mechanisms to account for the link between NOD2 variants and susceptibility to Crohn's disease.  Further understanding of NOD1 and NOD2 should provide new insight into the pathogenesis of disease and the development of new strategies to treat inflammatory and infectious disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTC-ne46_MPrVg90H21EOLACvtfcHk0ljkIbeTSOQMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislyqsg%253D%253D&md5=da20e3b76c185e91da9168b011bc0b78</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2014.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2014.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DCaruso%26aufirst%3DR.%26aulast%3DWarner%26aufirst%3DN.%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DNOD1%2520and%2520NOD2%253A%2520signaling%252C%2520host%2520defense%252C%2520and%2520inflammatory%2520disease%26jtitle%3DImmunity%26date%3D2014%26volume%3D41%26spage%3D898%26epage%3D908%26doi%3D10.1016%2Fj.immuni.2014.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Proell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riedl, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rojas, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarzenbacher, R.</span></span> <span> </span><span class="NLM_article-title">The Nod-like receptor (NLR) family: a tale of similarities and differences</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">e2119</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0002119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1371%2Fjournal.pone.0002119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e2119&author=M.+Proellauthor=S.+J.+Riedlauthor=J.+H.+Fritzauthor=A.+M.+Rojasauthor=R.+Schwarzenbacher&title=The+Nod-like+receptor+%28NLR%29+family%3A+a+tale+of+similarities+and+differences&doi=10.1371%2Fjournal.pone.0002119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0002119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0002119%26sid%3Dliteratum%253Aachs%26aulast%3DProell%26aufirst%3DM.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DRojas%26aufirst%3DA.%2BM.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26atitle%3DThe%2520Nod-like%2520receptor%2520%2528NLR%2529%2520family%253A%2520a%2520tale%2520of%2520similarities%2520and%2520differences%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De2119%26doi%3D10.1371%2Fjournal.pone.0002119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boneca, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viala, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamaillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labigne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sansonetti, P. J.</span></span> <span> </span><span class="NLM_article-title">Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">8869</span>– <span class="NLM_lpage">8872</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200651200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.C200651200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=12527755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=8869-8872&author=S.+E.+Girardinauthor=I.+G.+Bonecaauthor=J.+Vialaauthor=M.+Chamaillardauthor=A.+Labigneauthor=G.+Thomasauthor=D.+J.+Philpottauthor=P.+J.+Sansonetti&title=Nod2+is+a+general+sensor+of+peptidoglycan+through+muramyl+dipeptide+%28MDP%29+detection&doi=10.1074%2Fjbc.C200651200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection</span></div><div class="casAuthors">Girardin, Stephen E.; Boneca, Ivo G.; Viala, Jerome; Chamaillard, Mathias; Labigne, Agnes; Thomas, Gilles; Philpott, Dana J.; Sansonetti, Philippe J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">8869-8872</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod2 activates the NF-κB pathway following intracellular stimulation by bacterial products.  Recently, mutations in Nod2 have been shown to be assocd. with Crohn's disease, suggesting a role for bacteria-host interactions in the etiol. of this disorder.  The authors show here that Nod2 is a general sensor of peptidoglycan through the recognition of muramyl dipeptide (MDP), the minimal bioactive peptidoglycan motif common to all bacteria.  Moreover, the 3020insC frameshift mutation, the most frequent Nod2 variant assocd. with Crohn's disease patients, fully abrogates Nod2-dependent detection of peptidoglycan and MDP.  Together, these results impact on the understanding of Crohn's disease development.  Addnl., the characterization of Nod2 as the first pathogen-recognition mol. that detects MDP will help to unravel the well known biol. activities of this immunomodulatory compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWOYkWjlEqR7Vg90H21EOLACvtfcHk0ljkIbeTSOQMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvVyqsbs%253D&md5=220b5b27786d90179dca20566d643bf6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200651200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200651200%26sid%3Dliteratum%253Aachs%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DBoneca%26aufirst%3DI.%2BG.%26aulast%3DViala%26aufirst%3DJ.%26aulast%3DChamaillard%26aufirst%3DM.%26aulast%3DLabigne%26aufirst%3DA.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DSansonetti%26aufirst%3DP.%2BJ.%26atitle%3DNod2%2520is%2520a%2520general%2520sensor%2520of%2520peptidoglycan%2520through%2520muramyl%2520dipeptide%2520%2528MDP%2529%2520detection%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D8869%26epage%3D8872%26doi%3D10.1074%2Fjbc.C200651200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontalba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutierrez, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crespo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Luna, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">Host recognition of bacterial muramyl dipeptide mediated through NOD2</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">5509</span>– <span class="NLM_lpage">5512</span>, <span class="refDoi"> DOI: 10.1074/jbc.C200673200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.C200673200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=5509-5512&author=N.+Inoharaauthor=Y.+Oguraauthor=A.+Fontalbaauthor=O.+Gutierrezauthor=F.+Ponsauthor=J.+Crespoauthor=K.+Fukaseauthor=S.+Inamuraauthor=S.+Kusumotoauthor=M.+Hashimotoauthor=S.+J.+Fosterauthor=A.+P.+Moranauthor=J.+L.+Fernandez-Lunaauthor=G.+Nu%C3%B1ez&title=Host+recognition+of+bacterial+muramyl+dipeptide+mediated+through+NOD2&doi=10.1074%2Fjbc.C200673200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.C200673200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.C200673200%26sid%3Dliteratum%253Aachs%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DFontalba%26aufirst%3DA.%26aulast%3DGutierrez%26aufirst%3DO.%26aulast%3DPons%26aufirst%3DF.%26aulast%3DCrespo%26aufirst%3DJ.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInamura%26aufirst%3DS.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DFoster%26aufirst%3DS.%2BJ.%26aulast%3DMoran%26aufirst%3DA.%2BP.%26aulast%3DFernandez-Luna%26aufirst%3DJ.%2BL.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DHost%2520recognition%2520of%2520bacterial%2520muramyl%2520dipeptide%2520mediated%2520through%2520NOD2%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D5509%26epage%3D5512%26doi%3D10.1074%2Fjbc.C200673200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howard, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monie, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, J. A.</span></span> <span> </span><span class="NLM_article-title">Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">23057</span>– <span class="NLM_lpage">23067</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.344283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.M112.344283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=22549783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=23057-23067&author=J.+Moauthor=J.+P.+Boyleauthor=C.+B.+Howardauthor=T.+P.+Monieauthor=B.+K.+Davisauthor=J.+A.+Duncan&title=Pathogen+sensing+by+nucleotide-binding+oligomerization+domain-containing+protein+2+%28NOD2%29+is+mediated+by+direct+binding+to+muramyl+dipeptide+and+ATP&doi=10.1074%2Fjbc.M112.344283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP</span></div><div class="casAuthors">Mo, Jinyao; Boyle, Joseph P.; Howard, Christopher B.; Monie, Tom P.; Davis, Beckley K.; Duncan, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">23057-23067</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nucleotide binding and oligomerization domain-contg. protein 2 (NOD2/Card15) is an intracellular protein that is involved in the recognition of bacterial cell wall-derived muramyl dipeptide.  Mutations in the gene encoding NOD2 are assocd. with inherited inflammatory disorders, including Crohn disease and Blau syndrome.  NOD2 is a member of the nucleotide-binding domain and leucine-rich repeat-contg. protein gene (NLR) family.  Nucleotide binding is thought to play a crit. role in signaling by NLR family members.  However, the mol. mechanisms underlying signal transduction by these proteins remain largely unknown.  Mutations in the nucleotide-binding domain of NOD2 have been shown to alter its signal transduction properties in response to muramyl dipeptide in cellular assays.  Using purified recombinant protein, we now demonstrate that NOD2 binds and hydrolyzes ATP.  Addnl., we have found that the purified recombinant protein is able to bind directly to muramyl dipeptide and can assoc. with known NOD2-interacting proteins in vitro.  Binding of NOD2 to muramyl dipeptide and homo-oligomerization of NOD2 are enhanced by ATP binding, suggesting a model of the mol. mechanism for signal transduction that involves binding of nucleotide followed by binding of muramyl dipeptide and oligomerization of NOD2 into a signaling complex.  These findings set the stage for further studies into the mol. mechanisms that underlie detection of muramyl dipeptide and assembly of NOD2-contg. signaling complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHB17K-Mn8MrVg90H21EOLACvtfcHk0liRbxkFwvjaJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptlWmt7g%253D&md5=79080d42bc5db467360658170bde4caf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.344283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.344283%26sid%3Dliteratum%253Aachs%26aulast%3DMo%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DHoward%26aufirst%3DC.%2BB.%26aulast%3DMonie%26aufirst%3DT.%2BP.%26aulast%3DDavis%26aufirst%3DB.%2BK.%26aulast%3DDuncan%26aufirst%3DJ.%2BA.%26atitle%3DPathogen%2520sensing%2520by%2520nucleotide-binding%2520oligomerization%2520domain-containing%2520protein%25202%2520%2528NOD2%2529%2520is%2520mediated%2520by%2520direct%2520binding%2520to%2520muramyl%2520dipeptide%2520and%2520ATP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D23057%26epage%3D23067%26doi%3D10.1074%2Fjbc.M112.344283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Zoysa Ariyananda, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, E. K.</span></span> <span> </span><span class="NLM_article-title">The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">13535</span>– <span class="NLM_lpage">13537</span>, <span class="refDoi"> DOI: 10.1021/ja303883c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja303883c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=13535-13537&author=C.+L.+Grimesauthor=L.+De+Zoysa+Ariyanandaauthor=J.+E.+Melnykauthor=E.+K.+O%E2%80%99Shea&title=The+innate+immune+protein+Nod2+binds+directly+to+MDP%2C+a+bacterial+cell+wall+fragment&doi=10.1021%2Fja303883c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment</span></div><div class="casAuthors">Grimes, Catherine Leimkuhler; Ariyananda, Lushanti De Zoysa; Melnyk, James E.; O'Shea, Erin K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">13535-13537</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mammalian Nod2 is an intracellular protein that is implicated in the innate immune response to the bacterial cell wall and is assocd. with the development of Crohn's disease, Blau syndrome, and gastrointestinal cancers.  Nod2 is required for an immune response to muramyl dipeptide (MDP), an immunostimulatory fragment of bacterial cell wall, but it is not known whether MDP binds directly to Nod2.  We report the expression and purifn. of human Nod2 from insect cells.  Using novel MDP self-assembled monolayers (SAMs), we provide the first biochem. evidence for a direct, high-affinity interaction between Nod2 and MDP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_35GPZTPtLVg90H21EOLACvtfcHk0liRbxkFwvjaJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFChtr3F&md5=9bb26db0105a836a5130c961622f4e34</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fja303883c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja303883c%26sid%3Dliteratum%253Aachs%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26aulast%3DDe%2BZoysa%2BAriyananda%26aufirst%3DL.%26aulast%3DMelnyk%26aufirst%3DJ.%2BE.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DE.%2BK.%26atitle%3DThe%2520innate%2520immune%2520protein%2520Nod2%2520binds%2520directly%2520to%2520MDP%252C%2520a%2520bacterial%2520cell%2520wall%2520fragment%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D13535%26epage%3D13537%26doi%3D10.1021%2Fja303883c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">6897</span>– <span class="NLM_lpage">6918</span>, <span class="refDoi"> DOI: 10.1021/jm401841p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401841p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6897-6918&author=%C5%BD.+Jakopin&title=Nucleotide-binding+oligomerization+domain+%28NOD%29+inhibitors%3A+a+rational+approach+toward+inhibition+of+NOD+signaling+pathway&doi=10.1021%2Fjm401841p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm401841p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401841p%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DNucleotide-binding%2520oligomerization%2520domain%2520%2528NOD%2529%2520inhibitors%253A%2520a%2520rational%2520approach%2520toward%2520inhibition%2520of%2520NOD%2520signaling%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6897%26epage%3D6918%26doi%3D10.1021%2Fjm401841p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamaillard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henegariu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flavell, R. A.</span></span> <span> </span><span class="NLM_article-title">Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">734</span>, <span class="refDoi"> DOI: 10.1126/science.1104911</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1126%2Fscience.1104911" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=15692051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpt1Wqtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=731-734&author=K.+S.+Kobayashiauthor=M.+Chamaillardauthor=Y.+Oguraauthor=O.+Henegariuauthor=N.+Inoharaauthor=G.+Nu%C3%B1ezauthor=R.+A.+Flavell&title=Nod2-dependent+regulation+of+innate+and+adaptive+immunity+in+the+intestinal+tract&doi=10.1126%2Fscience.1104911"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract</span></div><div class="casAuthors">Kobayashi, Koichi S.; Chamaillard, Mathias; Ogura, Yasunori; Henegariu, Octavian; Inohara, Naohiro; Nunez, Gabriel; Flavell, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5710</span>),
    <span class="NLM_cas:pages">731-734</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The gene encoding the Nod2 protein is frequently mutated in Crohn's disease (CD) patients, although the physiol. function of Nod2 in the intestine remains elusive.  Here we show that protective immunity mediated by Nod2 recognition of bacterial muramyl dipeptide is abolished in Nod2-deficient mice.  These animals are susceptible to bacterial infection via the oral route but not through i.v. or peritoneal delivery.  Nod2 is required for the expression of a subgroup of intestinal anti-microbial peptides, known as cryptdins.  The Nod2 protein is thus a crit. regulator of bacterial immunity within the intestine, providing a possible mechanism for Nod2 mutations in CD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAkDJ_MMpIXLVg90H21EOLACvtfcHk0lji9fHUWZ36eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wqtw%253D%253D&md5=288870c756e634bf9df3c15591fb259d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.1104911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1104911%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DK.%2BS.%26aulast%3DChamaillard%26aufirst%3DM.%26aulast%3DOgura%26aufirst%3DY.%26aulast%3DHenegariu%26aufirst%3DO.%26aulast%3DInohara%26aufirst%3DN.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DFlavell%26aufirst%3DR.%2BA.%26atitle%3DNod2-dependent%2520regulation%2520of%2520innate%2520and%2520adaptive%2520immunity%2520in%2520the%2520intestinal%2520tract%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D731%26epage%3D734%26doi%3D10.1126%2Fscience.1104911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Bourhis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellge, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travassos, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvanantham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gommerman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Nod2-dependent Th2 polarization of antigen-specific immunity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">7925</span>– <span class="NLM_lpage">7935</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.181.11.7925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.181.11.7925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19017983" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2008&pages=7925-7935&author=J.+G.+Magalhaesauthor=J.+H.+Fritzauthor=L.+Le+Bourhisauthor=G.+Sellgeauthor=L.+H.+Travassosauthor=T.+Selvananthamauthor=S.+E.+Girardinauthor=J.+L.+Gommermanauthor=D.+J.+Philpott&title=Nod2-dependent+Th2+polarization+of+antigen-specific+immunity&doi=10.4049%2Fjimmunol.181.11.7925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Nod2-Dependent Th2 Polarization of Antigen-Specific Immunity</span></div><div class="casAuthors">Magalhaes, Joao Gamelas; Fritz, Joerg H.; Le Bourhis, Lionel; Sellge, Gernot; Travassos, Leonardo H.; Selvanantham, Thirumahal; Girardin, Stephen E.; Gommerman, Jennifer L.; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7925-7935</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">While a no. of microbial-assocd. mol. patterns have been known for decades to act as adjuvants, the mechanisms and the signaling pathways underlying their action have remained elusive.  Here, the authors examd. the unfolding of the adaptive immune response induced by Nod2 in vivo upon activation by its specific ligand, muramyl dipeptide, a component of peptidoglycan.  The authors' findings demonstrate that this bacterial sensor triggers a potent Ag-specific immune response with a Th2-type polarization profile, characterized by the induction of IL-4 and IL-5 by T cells and IgG1 Ab responses.  Nod2 was also crit. for the induction of both Th1- and Th2-type responses following costimulation with TLR agonists.  Importantly, the synergistic responses to Nod2 and TLR agonists seen in vivo were recapitulated by dendritic cells in vitro, suggesting that these cells likely play a central role in the integration of Nod2- and TLR-dependent signals for driving the adaptive immune response.  Taken together, the authors' results identify Nod2 as a crit. mediator of microbial-induced potentiation and polarization of Ag-dependent immunity.  Moreover, these findings affect the authors' understanding of Crohn's diseases pathogenesis, where lack of Nod2-dependent Th2 signaling in a subset of these patients might explain heightened Th1-mediated inflammation at the level of the intestinal mucosa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJlqhZbkvAl7Vg90H21EOLACvtfcHk0lji9fHUWZ36eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2gsLzM&md5=d57612e894994da00c2cd14d5d578f54</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.181.11.7925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.181.11.7925%26sid%3Dliteratum%253Aachs%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DLe%2BBourhis%26aufirst%3DL.%26aulast%3DSellge%26aufirst%3DG.%26aulast%3DTravassos%26aufirst%3DL.%2BH.%26aulast%3DSelvanantham%26aufirst%3DT.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DGommerman%26aufirst%3DJ.%2BL.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DNod2-dependent%2520Th2%2520polarization%2520of%2520antigen-specific%2520immunity%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D181%26spage%3D7925%26epage%3D7935%26doi%3D10.4049%2Fjimmunol.181.11.7925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochereau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rességuier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutjahr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiraby, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perouzel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lioux, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vernejoul, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verrier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S.</span></span> <span> </span><span class="NLM_article-title">Cutting edge: New chimeric NOD2/TLR2 adjuvant drastically increases vaccine immunogenicity</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>193</i></span>,  <span class="NLM_fpage">5781</span>– <span class="NLM_lpage">5785</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1402184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.1402184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=25392526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVegu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2014&pages=5781-5785&author=V.+Pavotauthor=N.+Rochereauauthor=J.+Ress%C3%A9guierauthor=A.+Gutjahrauthor=C.+Geninauthor=G.+Tirabyauthor=E.+Perouzelauthor=T.+Liouxauthor=F.+Vernejoulauthor=B.+Verrierauthor=S.+Paul&title=Cutting+edge%3A+New+chimeric+NOD2%2FTLR2+adjuvant+drastically+increases+vaccine+immunogenicity&doi=10.4049%2Fjimmunol.1402184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: New Chimeric NOD2/TLR2 Adjuvant Drastically Increases Vaccine Immunogenicity</span></div><div class="casAuthors">Pavot, Vincent; Rochereau, Nicolas; Resseguier, Julien; Gutjahr, Alice; Genin, Christian; Tiraby, Gerard; Perouzel, Eric; Lioux, Thierry; Vernejoul, Fabienne; Verrier, Bernard; Paul, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5781-5785</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">TLR ligands are crit. activators of innate immunity and are being developed as vaccine adjuvants.  However, their usefulness in conjunction with NOD-like receptor agonists remains poorly studied.  In this study, we evaluated a new ligand that targets both TLR2 and NOD2 receptors.  We assessed its ability to enhance dendritic cell maturation in vitro in addn. to improving systemic and mucosal immune responses in mice.  The chimeric NOD2/TLR2 ligand induced synergistic upregulation of dendritic cell maturation markers, costimulatory mols., and secretion of proinflammatory cytokines compared with combinations of sep. ligands.  Furthermore, when coadministered with biodegradable nanoparticles carrying a model Ag, the ligand was able to induce high Ag-specific IgA and IgG titers at both systemic and mucosal sites after parenteral immunizations.  These findings point out the potential utility of chimeric mols. TLR/NOD as adjuvants for vaccines to induce systemic and mucosal immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogfIIXnNf2VLVg90H21EOLACvtfcHk0lji9fHUWZ36eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVegu7fE&md5=8e2e65ce220ea0d46e41fdc394537019</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1402184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1402184%26sid%3Dliteratum%253Aachs%26aulast%3DPavot%26aufirst%3DV.%26aulast%3DRochereau%26aufirst%3DN.%26aulast%3DRess%25C3%25A9guier%26aufirst%3DJ.%26aulast%3DGutjahr%26aufirst%3DA.%26aulast%3DGenin%26aufirst%3DC.%26aulast%3DTiraby%26aufirst%3DG.%26aulast%3DPerouzel%26aufirst%3DE.%26aulast%3DLioux%26aufirst%3DT.%26aulast%3DVernejoul%26aufirst%3DF.%26aulast%3DVerrier%26aufirst%3DB.%26aulast%3DPaul%26aufirst%3DS.%26atitle%3DCutting%2520edge%253A%2520New%2520chimeric%2520NOD2%252FTLR2%2520adjuvant%2520drastically%2520increases%2520vaccine%2520immunogenicity%26jtitle%3DJ.%2520Immunol.%26date%3D2014%26volume%3D193%26spage%3D5781%26epage%3D5785%26doi%3D10.4049%2Fjimmunol.1402184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uehori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akazawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uematsu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shingai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azuma, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyoshima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seya, T.</span></span> <span> </span><span class="NLM_article-title">Dendritic cell maturation induced by muramy dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">7096</span>– <span class="NLM_lpage">7103</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.174.11.7096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.174.11.7096" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2005&pages=7096-7103&author=J.+Uehoriauthor=K.+Fukaseauthor=T.+Akazawaauthor=S.+Uematsuauthor=S.+Akiraauthor=K.+Funamiauthor=M.+Shingaiauthor=M.+Matsumotoauthor=I.+Azumaauthor=K.+Toyoshimaauthor=S.+Kusumotoauthor=T.+Seya&title=Dendritic+cell+maturation+induced+by+muramy+dipeptide+%28MDP%29+derivatives%3A+monoacylated+MDP+confers+TLR2%2FTLR4+activation&doi=10.4049%2Fjimmunol.174.11.7096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.174.11.7096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.174.11.7096%26sid%3Dliteratum%253Aachs%26aulast%3DUehori%26aufirst%3DJ.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DAkazawa%26aufirst%3DT.%26aulast%3DUematsu%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DFunami%26aufirst%3DK.%26aulast%3DShingai%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DAzuma%26aufirst%3DI.%26aulast%3DToyoshima%26aufirst%3DK.%26aulast%3DKusumoto%26aufirst%3DS.%26aulast%3DSeya%26aufirst%3DT.%26atitle%3DDendritic%2520cell%2520maturation%2520induced%2520by%2520muramy%2520dipeptide%2520%2528MDP%2529%2520derivatives%253A%2520monoacylated%2520MDP%2520confers%2520TLR2%252FTLR4%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2005%26volume%3D174%26spage%3D7096%26epage%3D7103%26doi%3D10.4049%2Fjimmunol.174.11.7096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitting, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengin-Lecreulx, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caroff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaillon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adib-Conquy, M.</span></span> <span> </span><span class="NLM_article-title">Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and Nod1- and Nod2-activating agonists</span>. <i>Eur. J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2459</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1002/eji.200526286</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2Feji.200526286" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2005&pages=2459-2470&author=J.+H.+Fritzauthor=S.+E.+Girardinauthor=C.+Fittingauthor=C.+Wertsauthor=D.+Mengin-Lecreulxauthor=M.+Caroffauthor=J.+M.+Cavaillonauthor=D.+J.+Philpottauthor=M.+Adib-Conquy&title=Synergistic+stimulation+of+human+monocytes+and+dendritic+cells+by+Toll-like+receptor+4+and+Nod1-+and+Nod2-activating+agonists&doi=10.1002%2Feji.200526286"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Feji.200526286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Feji.200526286%26sid%3Dliteratum%253Aachs%26aulast%3DFritz%26aufirst%3DJ.%2BH.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26aulast%3DFitting%26aufirst%3DC.%26aulast%3DWerts%26aufirst%3DC.%26aulast%3DMengin-Lecreulx%26aufirst%3DD.%26aulast%3DCaroff%26aufirst%3DM.%26aulast%3DCavaillon%26aufirst%3DJ.%2BM.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DAdib-Conquy%26aufirst%3DM.%26atitle%3DSynergistic%2520stimulation%2520of%2520human%2520monocytes%2520and%2520dendritic%2520cells%2520by%2520Toll-like%2520receptor%25204%2520and%2520Nod1-%2520and%2520Nod2-activating%2520agonists%26jtitle%3DEur.%2520J.%2520Immunol.%26date%3D2005%26volume%3D35%26spage%3D2459%26epage%3D2470%26doi%3D10.1002%2Feji.200526286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiba, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohteki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, H.</span></span> <span> </span><span class="NLM_article-title">Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">7967</span>– <span class="NLM_lpage">7976</span>, <span class="refDoi"> DOI: 10.1128/IAI.73.12.7967-7976.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1128%2FIAI.73.12.7967-7976.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16299289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlersbbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2005&pages=7967-7976&author=H.+Tadaauthor=S.+Aibaauthor=K.+Shibataauthor=T.+Ohtekiauthor=H.+Takada&title=Synergistic+effect+of+Nod1+and+Nod2+agonists+with+toll-like+receptor+agonists+on+human+dendritic+cells+to+generate+interleukin-12+and+T+helper+type+1+cells&doi=10.1128%2FIAI.73.12.7967-7976.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic effect of Nod1 and Nod2 agonists with Toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells</span></div><div class="casAuthors">Tada, Hiroyuki; Aiba, Setsuya; Shibata, Ken-Ichiro; Ohteki, Toshiaki; Takada, Haruhiko</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">7967-7976</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A synthetic Nod2 agonist, muramyldipeptide (MDP), and two Nod1 agonists, FK565 and FK156, mimic the bacterial peptidoglycan moiety and are powerful adjuvants that induce cell-mediated immunity, esp. delayed-type hypersensitivity.  In this study, we used human dendritic cell (DC) cultures to examine possible T helper type 1 (Th1) responses induced by MDP and FK565/156 in combination with various synthetic Toll-like receptor (TLR) agonists, including synthetic lipid A (TLR4 agonist), the synthetic triacyl lipopeptide Pam3CSSNA (TLR2 agonist), poly(I:C) (TLR3 agonist), and CpG DNA (TLR9 agonist).  Immature DCs derived from human monocytes expressed mRNAs for Nod1, Nod2, TLR2, TLR3, TLR4, and TLR9.  The stimulation of DCs with MDP and FK565 in combination with lipid A, poly(I:C), and CpG DNA, but not with Pam3CSSNA, synergistically induced interleukin-12 (IL-12) p70 and gamma interferon (IFN-γ), but not IL-18, in culture supernatants and induced IL-15 on the cell surface.  In correlation with the cytokine induction, an upregulation of the mRNA expression of these cytokine genes was obsd.  Notably, IL-12 p35 mRNA expression increased > 1000-fold upon stimulation with lipid A plus either MDP or FK565 compared with stimulation with each stimulant alone.  In contrast, for the expression of CD83 and costimulatory mols. such as CD40, CD80, and CD86, no synergistic effects were obsd. upon stimulation with Nod plus TLR agonists.  The culture supernatants of DCs stimulated with lipid A plus either MDP or FK565 activated human T cells to produce high levels of IFN-γ, and the activity was attributable to DC-derived IL-12.  These findings suggest that Nod1 and Nod2 agonists in combination with TLR3, TLR4, and TLR9 agonists synergistically induce IL-12 and IFN-γ prodn. in DCs to induce Th1-lineage immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8Do-WJaMJBrVg90H21EOLACvtfcHk0liTkIicnQ21BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlersbbP&md5=54df8c2b0ed2f78c83967ab39da4212a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FIAI.73.12.7967-7976.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.73.12.7967-7976.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTada%26aufirst%3DH.%26aulast%3DAiba%26aufirst%3DS.%26aulast%3DShibata%26aufirst%3DK.%26aulast%3DOhteki%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DH.%26atitle%3DSynergistic%2520effect%2520of%2520Nod1%2520and%2520Nod2%2520agonists%2520with%2520toll-like%2520receptor%2520agonists%2520on%2520human%2520dendritic%2520cells%2520to%2520generate%2520interleukin-12%2520and%2520T%2520helper%2520type%25201%2520cells%26jtitle%3DInfect.%2520Immun.%26date%3D2005%26volume%3D73%26spage%3D7967%26epage%3D7976%26doi%3D10.1128%2FIAI.73.12.7967-7976.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kleinnijenhuis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preijers, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, L. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ifrim, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Loenhout, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stunnenberg, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xavier, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Meer, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Crevel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title">Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">17537</span>– <span class="NLM_lpage">17542</span>, <span class="refDoi"> DOI: 10.1073/pnas.1202870109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1073%2Fpnas.1202870109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=17537-17542&author=J.+Kleinnijenhuisauthor=J.+Quintinauthor=F.+Preijersauthor=L.+A.+B.+Joostenauthor=D.+C.+Ifrimauthor=S.+Saeedauthor=C.+Jacobsauthor=J.+van+Loenhoutauthor=D.+de+Jongauthor=H.+G.+Stunnenbergauthor=R.+J.+Xavierauthor=J.+W.+M.+van+der%0AMeerauthor=R.+van+Crevelauthor=M.+G.+Netea&title=Bacille+Calmette-Gu%C3%A9rin+induces+NOD2-dependent+nonspecific+protection+from+reinfection+via+epigenetic+reprogramming+of+monocytes&doi=10.1073%2Fpnas.1202870109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202870109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202870109%26sid%3Dliteratum%253Aachs%26aulast%3DKleinnijenhuis%26aufirst%3DJ.%26aulast%3DQuintin%26aufirst%3DJ.%26aulast%3DPreijers%26aufirst%3DF.%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DIfrim%26aufirst%3DD.%2BC.%26aulast%3DSaeed%26aufirst%3DS.%26aulast%3DJacobs%26aufirst%3DC.%26aulast%3Dvan%2BLoenhout%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DD.%26aulast%3DStunnenberg%26aufirst%3DH.%2BG.%26aulast%3DXavier%26aufirst%3DR.%2BJ.%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26aulast%3Dvan%2BCrevel%26aufirst%3DR.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DBacille%2520Calmette-Gu%25C3%25A9rin%2520induces%2520NOD2-dependent%2520nonspecific%2520protection%2520from%2520reinfection%2520via%2520epigenetic%2520reprogramming%2520of%2520monocytes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D17537%26epage%3D17542%26doi%3D10.1073%2Fpnas.1202870109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Meer, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joosten, L. A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riksen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title">Trained immunity: a smart way to enhance innate immune defence</span>. <i>Mol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">40</span>– <span class="NLM_lpage">44</span>, <span class="refDoi"> DOI: 10.1016/j.molimm.2015.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.molimm.2015.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=26597205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyrsbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2015&pages=40-44&author=J.+W.+M.+van%0Ader+Meerauthor=L.+A.+B.+Joostenauthor=N.+Riksenauthor=M.+G.+Netea&title=Trained+immunity%3A+a+smart+way+to+enhance+innate+immune+defence&doi=10.1016%2Fj.molimm.2015.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Trained immunity: A smart way to enhance innate immune defense</span></div><div class="casAuthors">van der Meer, Jos W. M.; Joosten, Leo A. B.; Riksen, Niels; Netea, Mihai G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">40-44</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The innate arm of the immune system is generally viewed as primitive and non-specific and - in contrast to the adaptive immune arm - not to possess memory.  However in plants and invertebrate animals that lack adaptive immunity, innate immunity will exhibit a prolonged enhanced functional state after adequate priming.  A similar enhancement of function of the innate immunity has occasionally been described in vertebrates, including humans.  Over the past few years the authors have studied this phenomenon in greater detail and the authors have coined the term 'Trained (innate) immunity' (TI).  TI can be induced by a variety of stimuli, of which the authors have studied BCG and β-glucan in greater detail.  The non-specific protective effects of BCG that have been obsd. in vaccination studies in the literature are probably due to TI.  Monocytes and macrophages are among the main cells of the innate immune arm that can be trained.  The authors have discovered that both BCG (via NOD2 signaling) and β-glucan (via dectin-1) induce epigenetic reprogramming, in particular stable changes in histone trimethylation at H3K4.  These epigenetic changes lead to cellular activation, enhanced cytokine prodn. and a change in the metabolic state of the cell with a shift from oxidative phosphorylation to aerobic glycolysis.  TI is not only important for host defense and vaccine responses, but most probably also for diseases like atherosclerosis.  Modulation of TI is a promising area for new treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotee2u4LPVarVg90H21EOLACvtfcHk0liTkIicnQ21BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyrsbfM&md5=4077caa871aaa41c7e918dd39cbae5eb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2015.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2015.06.019%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DJoosten%26aufirst%3DL.%2BA.%2BB.%26aulast%3DRiksen%26aufirst%3DN.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DTrained%2520immunity%253A%2520a%2520smart%2520way%2520to%2520enhance%2520innate%2520immune%2520defence%26jtitle%3DMol.%2520Immunol.%26date%3D2015%26volume%3D68%26spage%3D40%26epage%3D44%26doi%3D10.1016%2Fj.molimm.2015.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geddes, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhães, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the therapeutic potential of NOD-like receptors</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1038/nrd2783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnrd2783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19483708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=465-479&author=K.+Geddesauthor=J.+G.+Magalh%C3%A3esauthor=S.+E.+Girardin&title=Unleashing+the+therapeutic+potential+of+NOD-like+receptors&doi=10.1038%2Fnrd2783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the therapeutic potential of NOD-like receptors</span></div><div class="casAuthors">Geddes, Kaoru; Magalhaes, Joao G.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">465-479</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are a family of intracellular sensors that have key roles in innate immunity and inflammation.  Whereas some NLRs, including NOD1, NOD2, NAIP (NLR family, apoptosis inhibitory protein) and NLRC4, detect conserved bacterial mol. signatures within the host cytosol, other members of this family sense 'danger signals', i.e., xenocompounds or mols. that when recognized alert the immune system of hazardous environments, perhaps independently of a microbial trigger.  In the past few years, remarkable progress has been made towards deciphering the role and the biol. of NLRs, which has shown that these innate immune sensors have pivotal roles in providing immunity to infection, adjuvanticity and inflammation.  Furthermore, several inflammatory disorders have been assocd. with mutations in human NLR genes.  Here, the authors discuss the effect that research on NLRs will have on vaccination, treatment of chronic inflammatory disorders and acute bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCvglqYhhnV7Vg90H21EOLACvtfcHk0li6Ahx0euRgcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1aksL4%253D&md5=06a9045f6206702396cd920edf38649b</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd2783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2783%26sid%3Dliteratum%253Aachs%26aulast%3DGeddes%26aufirst%3DK.%26aulast%3DMagalh%25C3%25A3es%26aufirst%3DJ.%2BG.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DUnleashing%2520the%2520therapeutic%2520potential%2520of%2520NOD-like%2520receptors%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D465%26epage%3D479%26doi%3D10.1038%2Fnrd2783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellouz, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciorbaru, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Minimal requirements for adjuvant activity of bacterial peptidoglycan derivatives</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1317</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1016/0006-291X(74)90458-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2F0006-291X%2874%2990458-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1974&pages=1317-1325&author=F.+Ellouzauthor=A.+Adamauthor=R.+Ciorbaruauthor=E.+Lederer&title=Minimal+requirements+for+adjuvant+activity+of+bacterial+peptidoglycan+derivatives&doi=10.1016%2F0006-291X%2874%2990458-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2874%2990458-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252874%252990458-6%26sid%3Dliteratum%253Aachs%26aulast%3DEllouz%26aufirst%3DF.%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DCiorbaru%26aufirst%3DR.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMinimal%2520requirements%2520for%2520adjuvant%2520activity%2520of%2520bacterial%2520peptidoglycan%2520derivatives%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1974%26volume%3D59%26spage%3D1317%26epage%3D1325%26doi%3D10.1016%2F0006-291X%2874%2990458-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maisonneuve, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertholet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Gregorio, E.</span></span> <span> </span><span class="NLM_article-title">Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">12294</span>– <span class="NLM_lpage">12299</span>, <span class="refDoi"> DOI: 10.1073/pnas.1400478111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1073%2Fpnas.1400478111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=25136133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=12294-12299&author=C.+Maisonneuveauthor=S.+Bertholetauthor=D.+J.+Philpottauthor=E.+De+Gregorio&title=Unleashing+the+potential+of+NOD-+and+Toll-like+agonists+as+vaccine+adjuvants&doi=10.1073%2Fpnas.1400478111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants</span></div><div class="casAuthors">Maisonneuve, Charles; Bertholet, Sylvie; Philpott, Dana J.; De Gregorio, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">12294-12299</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  Innate immunity confers an immediate nonspecific mechanism of microbial recognition through germ line-encoded pattern recognition receptors (PRRs).  Of these, Toll-like receptors (TLRs) and nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) have shaped the authors' current understanding of innate regulation of adaptive immunity.  It is now recognized that PRRs are paramount in instructing an appropriate adaptive immune response.  Their ligands have been the focus of adjuvant research with the goal of generating modern vaccine combinations tailored to specific pathogens.  In this review the authors will highlight the recent findings in the field of adjuvant research with a particular focus on the potential of TLR and NLR ligands as adjuvants and their influence on adaptive immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2Pm03irVncrVg90H21EOLACvtfcHk0li6Ahx0euRgcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVarsLbM&md5=de6088e853b57a9f4d2d622e0a27a2c8</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1400478111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1400478111%26sid%3Dliteratum%253Aachs%26aulast%3DMaisonneuve%26aufirst%3DC.%26aulast%3DBertholet%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DDe%2BGregorio%26aufirst%3DE.%26atitle%3DUnleashing%2520the%2520potential%2520of%2520NOD-%2520and%2520Toll-like%2520agonists%2520as%2520vaccine%2520adjuvants%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D12294%26epage%3D12299%26doi%3D10.1073%2Fpnas.1400478111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nijnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span> <span> </span><span class="NLM_article-title">Modulating immunity as a therapy for bacterial infections</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnrmicro2745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=22421877" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XktValu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=243-254&author=R.+E.+W.+Hancockauthor=A.+Nijnikauthor=D.+J.+Philpott&title=Modulating+immunity+as+a+therapy+for+bacterial+infections&doi=10.1038%2Fnrmicro2745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating immunity as a therapy for bacterial infections</span></div><div class="casAuthors">Hancock, Robert E. W.; Nijnik, Anastasia; Philpott, Dana J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">243-254</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite our efforts to halt the increase and spread of antimicrobial resistance, bacteria continue to become less susceptible to antimicrobial drugs over time, and rates of discovery for new antibiotics are declining.  Thus, it is essential to explore new paradigms for anti-infective therapy.  One promising approach involves host-directed immunomodulatory therapies, whereby natural mechanisms in the host are exploited to enhance therapeutic benefit.  The objective is to initiate or enhance protective antimicrobial immunity while limiting inflammation-induced tissue injury.  A range of potential immune modulators have been proposed, including innate defense regulator peptides and agonists of innate immune components such as Toll-like receptors and NOD-like receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8BNxJiwdYerVg90H21EOLACvtfcHk0li6Ahx0euRgcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktValu70%253D&md5=8cc490e070e8f94adc62181b92b6d144</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2745%26sid%3Dliteratum%253Aachs%26aulast%3DHancock%26aufirst%3DR.%2BE.%2BW.%26aulast%3DNijnik%26aufirst%3DA.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26atitle%3DModulating%2520immunity%2520as%2520a%2520therapy%2520for%2520bacterial%2520infections%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2012%26volume%3D10%26spage%3D243%26epage%3D254%26doi%3D10.1038%2Fnrmicro2745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Muramyl-peptides</span>. <i>Pure Appl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">449</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1351/pac198759030449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1351%2Fpac198759030449" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1987&pages=449-454&author=P.+Lefrancierauthor=E.+Lederer&title=Muramyl-peptides&doi=10.1351%2Fpac198759030449"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1351%2Fpac198759030449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252Fpac198759030449%26sid%3Dliteratum%253Aachs%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMuramyl-peptides%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D1987%26volume%3D59%26spage%3D449%26epage%3D454%26doi%3D10.1351%2Fpac198759030449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">A novel immunostimulator, <i>N</i><sup>2</sup>-[α-<i>O</i>-benzyl-<i>N</i>-(acetylmuramyl)-<span class="smallcaps smallerCapital">l</span>-alanyl-<span class="smallcaps smallerCapital">d</span>-isoglutaminyl]-<i>N</i><sup>6</sup>-<i>trans</i>-(<i>m</i>-nitrocinnamoyl)-<span class="smallcaps smallerCapital">l</span>-lysine, and its adjuvancy on the hepatitis B surface antigen</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">5112</span>– <span class="NLM_lpage">5122</span>, <span class="refDoi"> DOI: 10.1021/jm0493313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0493313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=5112-5122&author=H.-Z.+Yangauthor=S.+Xuauthor=X.-Y.+Liaoauthor=S.-D.+Zhangauthor=Z.-L.+Liangauthor=B.-H.+Liuauthor=J.-Y.+Baiauthor=C.+Jiangauthor=J.+Dingauthor=G.-F.+Chengauthor=G.+Liu&title=A+novel+immunostimulator%2C+N2-%5B%CE%B1-O-benzyl-N-%28acetylmuramyl%29-l-alanyl-d-isoglutaminyl%5D-N6-trans-%28m-nitrocinnamoyl%29-l-lysine%2C+and+its+adjuvancy+on+the+hepatitis+B+surface+antigen&doi=10.1021%2Fjm0493313"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0493313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0493313%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.-Z.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DX.-Y.%26aulast%3DZhang%26aufirst%3DS.-D.%26aulast%3DLiang%26aufirst%3DZ.-L.%26aulast%3DLiu%26aufirst%3DB.-H.%26aulast%3DBai%26aufirst%3DJ.-Y.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DG.-F.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DA%2520novel%2520immunostimulator%252C%2520N2-%255B%25CE%25B1-O-benzyl-N-%2528acetylmuramyl%2529-l-alanyl-d-isoglutaminyl%255D-N6-trans-%2528m-nitrocinnamoyl%2529-l-lysine%252C%2520and%2520its%2520adjuvancy%2520on%2520the%2520hepatitis%2520B%2520surface%2520antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D5112%26epage%3D5122%26doi%3D10.1021%2Fjm0493313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel desmuramyldipeptide analogs</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3762</span>– <span class="NLM_lpage">3777</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2011.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=21669478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=3762-3777&author=%C5%BD.+Jakopinauthor=E.+Corsiniauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Design%2C+synthesis+and+biological+evaluation+of+novel+desmuramyldipeptide+analogs&doi=10.1016%2Fj.ejmech.2011.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel desmuramyldipeptide analogs</span></div><div class="casAuthors">Jakopin, Ziga; Corsini, Emanuela; Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3762-3777</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel desmuramyldipeptides have been designed and synthesized as part of the search for therapeutically useful muramyldipeptide (MDP) analogs.  Their immunomodulatory properties were initially assessed in vitro, evaluating their effect on lipopolysaccharide (LPS)-induced cytokine release in THP-1 cells.  Following the initial screening, selected compds. were further investigated for immunomodulatory properties using LPS and phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells.  The results confirmed the immunomodulatory properties of some of the synthesized desmuramyldipeptide analogs.  Taken together, the data confirmed the immunostimulatory effect of pyrido-fused [1,2]-benzisothiazole-contg. MDP deriv. I, while for indole-contg. MDP derivs. II and III, an immunosuppressive effect was obsd.  Further studies will be necessary to address their potential therapeutic use as immunomodulatory drugs, both as immunostimulants or antiinflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdf0ICGmE7rrVg90H21EOLACvtfcHk0lgHe_0KtEkPCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rt7vI&md5=0e658d046b6551ad97d9e5887bb960c8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DCorsini%26aufirst%3DE.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520desmuramyldipeptide%2520analogs%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D3762%26epage%3D3777%26doi%3D10.1016%2Fj.ejmech.2011.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Immunomodulatory properties of novel nucleotide oligomerization domain 2 (Nod2) agonistic desmuramyldipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6478</span>– <span class="NLM_lpage">6488</span>, <span class="refDoi"> DOI: 10.1021/jm300503b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300503b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6478-6488&author=%C5%BD.+Jakopinauthor=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Immunomodulatory+properties+of+novel+nucleotide+oligomerization+domain+2+%28Nod2%29+agonistic+desmuramyldipeptides&doi=10.1021%2Fjm300503b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory Properties of Novel Nucleotide Oligomerization Domain 2 (Nod2) Agonistic Desmuramyldipeptides</span></div><div class="casAuthors">Jakopin, Ziga; Gobec, Martina; Mlinaric-Rascan, Irena; Sollner Dolenc, Marija</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6478-6488</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a pressing need for the development of novel adjuvants for human use.  The minimal bioactive structure of bacterial peptidoglycan (PGN), muramyldipeptide (MDP), and its deriv. murabutide (MB) have long been known for their adjuvant activities.  For this reason, a series of novel desmuramyldipeptides have been designed and synthesized as part of our search for therapeutically useful MDP analogs.  Since nucleotide oligomerization domain 2 (Nod2) is a putative receptor for MDP, we used engineered HEK293 cells overexpressing Nod2 to screen and validate our compds. for their Nod2-agonist activity.  Their immunomodulatory properties were subsequently assessed in vitro by evaluating their effect on proinflammatory cytokine prodn. of phorbol 12-myristate 13-acetate (PMA)/ionomycin-stimulated human peripheral blood mononuclear cells (PBMCs).  Herein, we present novel desmuramyldipeptides, the most active of them possessing immunoenhancing properties as a result of their potent Nod2-agonistic effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwj-B62knTQ7Vg90H21EOLACvtfcHk0lgHe_0KtEkPCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovFaqt7g%253D&md5=7da25625df463ffa238394773501767e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300503b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300503b%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DImmunomodulatory%2520properties%2520of%2520novel%2520nucleotide%2520oligomerization%2520domain%25202%2520%2528Nod2%2529%2520agonistic%2520desmuramyldipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6478%26epage%3D6488%26doi%3D10.1021%2Fjm300503b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Murabutide revisited: a review of its pleiotropic biological effects</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2079</span>, <span class="refDoi"> DOI: 10.2174/0929867311320160002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.2174%2F0929867311320160002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=23531213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=2068-2079&author=%C5%BD.+Jakopin&title=Murabutide+revisited%3A+a+review+of+its+pleiotropic+biological+effects&doi=10.2174%2F0929867311320160002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Murabutide revisited: a review of its pleiotropic biological effects</span></div><div class="casAuthors">Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2068-2079</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite the great efforts put into their development, the list of clin. approved immunol. adjuvants is still very short.  Evolution of the knowledge of the immune system has enabled for rational design of novel adjuvants and has led to the conclusion that more than one type of adjuvant will be required.  Derivs. of muramyl dipeptide (MDP), the minimal immunomodulatory structure of bacterial cell wall peptidoglycan, have gained considerable attention in the past decades, because of their potent adjuvant effects.  Murabutide is a safe deriv. of MDP, which interacts with cells of the immune system, both innate and adaptive, and exerts its effect through activation of Nod2.  The transcriptional response of murabutide-stimulated macrophages revealed enhanced expression of genes coding for various proteins such as immune mediators and their receptors, transcription factors and kinases, ion channels/transporters and proteins involved in cell metabolic activity, thus reflecting a broad spectrum of biol. effects.  In addn. to its well recognized adjuvant effect, murabutide has also been shown to enhance the host's resistance against microbial infections, nonspecific resistance against tumors and the induction of cytokines and chemokines implicated in enhancing the immune response and hematopoesis.  This article provides an insight into the mechanism of action of murabutide and its interactions with the cells of the immune system in vitro and in vivo.  On account of its numerous biol. effects, murabutide has been the subject of several clin. studies.  Many of these have confirmed its potential to synergize with cytokines of therapeutic interest in potentiating the tumoricidal activity of macrophages or targeting chronic viral diseases, as well as reducing the cytokine dosage needed to achieve a therapeutic effect.  This review covers the findings of all relevant studies and focuses on the role of murabutide and its potential in the treatment of several microbial diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZRI0UmLi-DrVg90H21EOLACvtfcHk0ljHDbv5xGYarQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotl2isLo%253D&md5=519fd1fb58ae28d9da85019cfc765e61</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F0929867311320160002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867311320160002%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DMurabutide%2520revisited%253A%2520a%2520review%2520of%2520its%2520pleiotropic%2520biological%2520effects%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2013%26volume%3D20%26spage%3D2068%26epage%3D2079%26doi%3D10.2174%2F0929867311320160002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">425</span>, <span class="refDoi"> DOI: 10.1007/s10719-007-9095-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1007%2Fs10719-007-9095-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=18161023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVKqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2008&pages=415-425&author=X.+Liauthor=J.+Yuauthor=S.+Xuauthor=N.+Wangauthor=H.+Yangauthor=Z.+Yanauthor=G.+Chengauthor=G.+Liu&title=Chemical+conjugation+of+muramyl+dipeptide+and+paclitaxel+to+explore+the+combination+of+immunotherapy+and+chemotherapy+for+cancer&doi=10.1007%2Fs10719-007-9095-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical conjugation of muramyl dipeptide and paclitaxel to explore the combination of immunotherapy and chemotherapy for cancer</span></div><div class="casAuthors">Li, Xuqin; Yu, Junli; Xu, Song; Wang, Nan; Yang, Hongzhen; Yan, Zheng; Cheng, Guifang; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">415-425</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Paclitaxel (Taxol) conjugated to muramyl dipeptide (MDP) is described.  Biol. testing showed that the conjugation of MDP at 2'-O-paclitaxel (2'-O-MTC-01) not only has antitumor activity, but also has immunoenhancement capacity.  Compared with paclitaxel or MDP alone or with a mixt. of paclitaxel + MDP, 2'-O-MTC-01 significantly increases the prodn. and expression of TNF-α and IL-12 from mouse peritoneal macrophages, which demonstrates a synergism of MDP and paclitaxel in one conjugated mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgQsSKmbICMLVg90H21EOLACvtfcHk0ljHDbv5xGYarQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVKqs74%253D&md5=ea2a28398e9dd6690b0cbd54c508b604</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs10719-007-9095-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-007-9095-3%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYan%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DChemical%2520conjugation%2520of%2520muramyl%2520dipeptide%2520and%2520paclitaxel%2520to%2520explore%2520the%2520combination%2520of%2520immunotherapy%2520and%2520chemotherapy%2520for%2520cancer%26jtitle%3DGlycoconjugate%2520J.%26date%3D2008%26volume%3D25%26spage%3D415%26epage%3D425%26doi%3D10.1007%2Fs10719-007-9095-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikelj, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pečar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štalc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wraber-Herzog, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klamfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povšič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grahek, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suhadolc, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hočevar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hönig, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogi-Kohlenprath, R.</span></span> <span> </span><span class="NLM_article-title"><i>N</i>-{<i>trans</i>-[[2′(acetylamino)cyclohexyl]oxy]acetyl}-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">539</span>, <span class="refDoi"> DOI: 10.1021/jm970509d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970509d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=530-539&author=D.+Kikeljauthor=S.+Pe%C4%8Darauthor=V.+Kotnikauthor=A.+%C5%A0talcauthor=B.+Wraber-Herzogauthor=S.+Sim%C4%8Di%C4%8Dauthor=A.+Ihanauthor=L.+Klamferauthor=L.+Pov%C5%A1i%C4%8Dauthor=R.+Grahekauthor=E.+Suhadolcauthor=M.+Ho%C4%8Devarauthor=H.+H%C3%B6nigauthor=R.+Rogi-Kohlenprath&title=N-%7Btrans-%5B%5B2%E2%80%B2%28acetylamino%29cyclohexyl%5Doxy%5Dacetyl%7D-L-alanyl-D-glutamic+acid%3A+a+novel+immunologically+active+carbocyclic+muramyl+dipeptide+analogue&doi=10.1021%2Fjm970509d"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm970509d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970509d%26sid%3Dliteratum%253Aachs%26aulast%3DKikelj%26aufirst%3DD.%26aulast%3DPe%25C4%258Dar%26aufirst%3DS.%26aulast%3DKotnik%26aufirst%3DV.%26aulast%3D%25C5%25A0talc%26aufirst%3DA.%26aulast%3DWraber-Herzog%26aufirst%3DB.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DIhan%26aufirst%3DA.%26aulast%3DKlamfer%26aufirst%3DL.%26aulast%3DPov%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DGrahek%26aufirst%3DR.%26aulast%3DSuhadolc%26aufirst%3DE.%26aulast%3DHo%25C4%258Devar%26aufirst%3DM.%26aulast%3DH%25C3%25B6nig%26aufirst%3DH.%26aulast%3DRogi-Kohlenprath%26aufirst%3DR.%26atitle%3DN-%257Btrans-%255B%255B2%25E2%2580%25B2%2528acetylamino%2529cyclohexyl%255Doxy%255Dacetyl%257D-L-alanyl-D-glutamic%2520acid%253A%2520a%2520novel%2520immunologically%2520active%2520carbocyclic%2520muramyl%2520dipeptide%2520analogue%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D530%26epage%3D539%26doi%3D10.1021%2Fjm970509d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sollner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotnik, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Štalc, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Povšič, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzog-Wraber, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klampfer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosman, P.</span></span> <span> </span><span class="NLM_article-title">Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties</span>. <i>Agents Actions</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1007/BF01976220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1007%2FBF01976220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=8213354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVWjt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1993&pages=273-280&author=M.+Sollnerauthor=V.+Kotnikauthor=A.+%C5%A0talcauthor=S.+Sim%C4%8Di%C4%8Dauthor=L.+Pov%C5%A1i%C4%8Dauthor=B.+Herzog-Wraberauthor=L.+Klampferauthor=A.+Ihanauthor=P.+Grosman&title=Apyrogenic+synthetic+desmuramyldipeptide%2C+LK-409%2C+with+immunomodulatory+properties&doi=10.1007%2FBF01976220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Apyrogenic synthetic desmuramyldipeptide, LK-409, with immunomodulatory properties</span></div><div class="casAuthors">Sollner, M.; Kotnik, V.; Pecar; Stalc, A.; Simcic, S.; Povsic, L.; Herzog-Wraber, B.; Klampfer, L.; Ihan, A.; Grosman, P.</div><div class="citationInfo"><span class="NLM_cas:title">Agents and Actions</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">273-80</span>CODEN:
                <span class="NLM_cas:coden">AGACBH</span>;
        ISSN:<span class="NLM_cas:issn">0065-4299</span>.
    </div><div class="casAbstract">The synthesis and some immunol. characteristics of a new desmuramyl dipeptide 7-oxooctanoyl-L-alanyl-D-isoglutamine (LK-409) are presented.  The effects of this compd. were compared with those of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP).  The influence of LK-409 on the no. of B and T cells in spleen and the no. of peritoneal macrophages was studied; Jerne's plaque forming cells assay was performed to monitor the effect of B cell differentiation.  The blast transformation of T cells stimulated with Con A was used to detect the influences on T lymphocytes.  The activation of macrophages was studied as well.  In contrast to MDP, LK-409 was apyrogenic in the doses applied but had similar immunomodulatory properties.  Tested immunol. properties and the absence of pyrogenicity and low toxicity make LK-409 a candidate for an immunomodulatory drug and a model mol. suitable for studying and understanding the dual activity of the MDP and its analogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHQCbmK0ebCLVg90H21EOLACvtfcHk0lh6MLw8WRo-FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVWjt7s%253D&md5=8d15bd07507b4a8acecd97d09c3516ff</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2FBF01976220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01976220%26sid%3Dliteratum%253Aachs%26aulast%3DSollner%26aufirst%3DM.%26aulast%3DKotnik%26aufirst%3DV.%26aulast%3D%25C5%25A0talc%26aufirst%3DA.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DS.%26aulast%3DPov%25C5%25A1i%25C4%258D%26aufirst%3DL.%26aulast%3DHerzog-Wraber%26aufirst%3DB.%26aulast%3DKlampfer%26aufirst%3DL.%26aulast%3DIhan%26aufirst%3DA.%26aulast%3DGrosman%26aufirst%3DP.%26atitle%3DApyrogenic%2520synthetic%2520desmuramyldipeptide%252C%2520LK-409%252C%2520with%2520immunomodulatory%2520properties%26jtitle%3DAgents%2520Actions%26date%3D1993%26volume%3D38%26spage%3D273%26epage%3D280%26doi%3D10.1007%2FBF01976220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Todate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuwata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Muramyl dipeptide-Lys stimulates the function of human dendritic cells</span>. <i>J. Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">729</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=11698491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=723-729&author=A.+Todateauthor=T.+Sudaauthor=H.+Kuwataauthor=K.+Chidaauthor=H.+Nakamura&title=Muramyl+dipeptide-Lys+stimulates+the+function+of+human+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Muramyl dipeptide-Lys stimulates the function of human dendritic cells</span></div><div class="casAuthors">Todate, Akihito; Suda, Takafumi; Kuwata, Hiroshi; Chida, Kingo; Nakamura, Hirotoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">723-729</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP)-Lys (L18), a synthetic MDP analog derived from bacterial cell walls, has been reported to be a potent immunoadjuvant that enhances protective immunity against pathogens and tumors by stimulating immune-competent cells, such as monocytes and macrophages.  However, it is not known whether MDP-Lys modulates the function of dendritic cells (DCs), which are the most potent antigen-presenting cells and play a crucial role in initiating T cell-mediated immunity.  Therefore, we examd. the effects of MDP-Lys on the expression of surface mols., cytokine prodn., and antigen-presenting function of human DCs generated from peripheral blood cells in the presence of interleukin (IL)-4 and granulocyte-macrophage colony-stimulating factor.  We found that MDP-Lys markedly up-regulated the expression of CD80, CD83, CD86, and CD40, but not human leukocyte antigen-DR, and stimulated the prodn. of tumor necrosis factor-α, IL-6, IL-8, IL-10, and IL-12 (p40) by human DCs in a dose-dependent manner.  Furthermore, MDP-Lys-treated DCs showed enhanced antigen-presenting function compared with untreated DCs, as assessed by an allogeneic mixed lymphocyte reaction.  These results suggested that the immunoadjuvant activity of MDP-Lys in vivo is mediated, in part, by its stimulation of DC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVi5NO0qPVQLVg90H21EOLACvtfcHk0lh6MLw8WRo-FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVKlsLg%253D&md5=0123eaf8d8f353ed56e2dd604b90afc4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTodate%26aufirst%3DA.%26aulast%3DSuda%26aufirst%3DT.%26aulast%3DKuwata%26aufirst%3DH.%26aulast%3DChida%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DMuramyl%2520dipeptide-Lys%2520stimulates%2520the%2520function%2520of%2520human%2520dendritic%2520cells%26jtitle%3DJ.%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D70%26spage%3D723%26epage%3D729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parant, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audibert, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chedid, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Level, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">826</span>– <span class="NLM_lpage">831</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1128%2FIAI.27.3.826-831.1980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=7380554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaL3cXksVemtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1980&pages=826-831&author=M.+A.+Parantauthor=F.+M.+Audibertauthor=L.+A.+Chedidauthor=M.+R.+Levelauthor=P.+L.+Lefrancierauthor=J.+P.+Choayauthor=E.+Lederer&title=Immunostimulant+activities+of+a+lipophilic+muramyl+dipeptide+derivative+and+of+desmuramyl+peptidolipid+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs</span></div><div class="casAuthors">Parant, Monique A.; Audibert, Francoise M.; Chedid, Louis A.; Level, Michel R.; Lefrancier, Pierre L.; Choay, Jean P.; Lederer, Edgar</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">826-31</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The immunostimulant properties of a new muramyl dipeptide (MDP) deriv. bearing a lipophilic moiety on the C-terminal end of the peptide chain are described.  It is shown, that 1,O-(acetylmuramyl-L-alanyl-D-isoglutamine-L-alanyl)-glycerol-3-mycolate had increased immunostimulant activity in comparison with MDP.  It induced hypersensitivity even when administered with an antigen in saline, and it gave higher protection against bacterial infections than did MDP.  The corresponding desmuramyl compd. 1,O-(L-alanyl-D-isoglutamine-L-alanyl-glycerol-3-mycolate, which had no activity in producing humoral antibodies was just as active as the muramic acid-contg. compd. in stimulating nonspecific resistance to bacterial infections.  It was not pyrogenic.  Modifications of the peptide moiety or the lipid moiety of this peptidolipid led to decrease, or even loss, of activity.  These results show the importance of the N-acetylmuramyl moiety in MDP for humoral antibody prodn.  The peptidolipid 1,O-(L-alanyl-D-isoglutamine-L-alanyl)-glycerol-3-mycolate is the first member of a new category of nonspecific immunostimulants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4chO2awCP4LVg90H21EOLACvtfcHk0lh6MLw8WRo-FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXksVemtrg%253D&md5=ff6679a276700ea82b532b98e8db2bff</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FIAI.27.3.826-831.1980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.27.3.826-831.1980%26sid%3Dliteratum%253Aachs%26aulast%3DParant%26aufirst%3DM.%2BA.%26aulast%3DAudibert%26aufirst%3DF.%2BM.%26aulast%3DChedid%26aufirst%3DL.%2BA.%26aulast%3DLevel%26aufirst%3DM.%2BR.%26aulast%3DLefrancier%26aufirst%3DP.%2BL.%26aulast%3DChoay%26aufirst%3DJ.%2BP.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DImmunostimulant%2520activities%2520of%2520a%2520lipophilic%2520muramyl%2520dipeptide%2520derivative%2520and%2520of%2520desmuramyl%2520peptidolipid%2520analogs%26jtitle%3DInfect.%2520Immun.%26date%3D1980%26volume%3D27%26spage%3D826%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willems, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zom, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meeuwenoord, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ossendorp, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overkleeft, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Marel, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippov, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codée, J. D.</span></span> <span> </span><span class="NLM_article-title">Lipophilic muramyl dipeptide-antigen conjugates as immunostimulating agents</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">190</span>– <span class="NLM_lpage">198</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201500196</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2Fcmdc.201500196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=26059481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXps12ru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=190-198&author=M.+M.+Willemsauthor=G.+G.+Zomauthor=N.+Meeuwenoordauthor=S.+Khanauthor=F.+Ossendorpauthor=H.+S.+Overkleeftauthor=G.+A.+van+der+Marelauthor=D.+V.+Filippovauthor=J.+D.+Cod%C3%A9e&title=Lipophilic+muramyl+dipeptide-antigen+conjugates+as+immunostimulating+agents&doi=10.1002%2Fcmdc.201500196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Lipophilic muramyl dipeptide-antigen conjugates as immunostimulating agents</span></div><div class="casAuthors">Willems, Marian M. J. H. P.; Zom, Gijs G.; Meeuwenoord, Nico; Khan, Selina; Ossendorp, Ferry; Overkleeft, Herman S.; van der Marel, Gijsbert A.; Filippov, Dmitri V.; Codee, Jeroen D. C.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">190-198</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is the smallest peptidoglycan fragment capable of triggering the innate immune system through interaction with the intracellular NOD2 receptor.  To develop synthetic vaccine modalities composed of an antigenic entity (typically a small peptide) and a mol. adjuvant with well-defined activity, we previously assembled covalent MDP-antigen conjugates.  Although these were found to be capable of stimulating the NOD2 receptor and were processed by dendritic cells (DCs) leading to effective antigen presentation, DC maturation-required for an apt immune response-could not be achieved with these conjugates.  To improve the efficacy of these vaccine modalities, we equipped the MDP moiety with lipophilic tails, well-known modifications to enhance the immune-stimulatory activity of MDPs.  Herein we report the design and synthesis of a lipophilic MDP-antigen conjugate and show that it is a promising vaccine modality capable of stimulating the NOD2 receptor, maturing DCs, and delivering antigen cargo into the MHC-I cross-presentation pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgaDbNR6tWdbVg90H21EOLACvtfcHk0lilIjPukJO-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXps12ru74%253D&md5=e4b4eb77478a257f7213f9ba11362c2d</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201500196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201500196%26sid%3Dliteratum%253Aachs%26aulast%3DWillems%26aufirst%3DM.%2BM.%26aulast%3DZom%26aufirst%3DG.%2BG.%26aulast%3DMeeuwenoord%26aufirst%3DN.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DOssendorp%26aufirst%3DF.%26aulast%3DOverkleeft%26aufirst%3DH.%2BS.%26aulast%3Dvan%2Bder%2BMarel%26aufirst%3DG.%2BA.%26aulast%3DFilippov%26aufirst%3DD.%2BV.%26aulast%3DCod%25C3%25A9e%26aufirst%3DJ.%2BD.%26atitle%3DLipophilic%2520muramyl%2520dipeptide-antigen%2520conjugates%2520as%2520immunostimulating%2520agents%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D190%26epage%3D198%26doi%3D10.1002%2Fcmdc.201500196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">4292</span>– <span class="NLM_lpage">4295</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.05.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.bmcl.2011.05.056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=21683593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4292-4295&author=N.+Zhaoauthor=Y.+Maauthor=S.+Zhangauthor=X.+Fangauthor=Z.+Liangauthor=G.+Liu&title=New+muramyl+dipeptide+%28MDP%29+mimics+without+the+carbohydrate+moiety+as+potential+adjuvant+candidates+for+a+therapeutic+hepatitis+B+vaccine+%28HBV%29&doi=10.1016%2Fj.bmcl.2011.05.056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">New muramyl dipeptide (MDP) mimics without the carbohydrate moiety as potential adjuvant candidates for a therapeutic hepatitis B vaccine (HBV)</span></div><div class="casAuthors">Zhao, Nan; Ma, Yao; Zhang, Shengmei; Fang, Xin; Liang, Zhenglun; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4292-4295</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of new muramyl dipeptide (MDP) mimics were designed and synthesized via a solid-phase synthetic route.  Their adjuvant activities were evaluated ex vivo for investigation of the synergism of the S28-39 peptide, which is an MHC class I binding epitope of recombinant hepatitis B surface antigen (HBsAg) for both humans and mice.  Several compds. without the carbohydrate moiety exerted better adjuvanticity than the MDP-C that has been reported by the authors previously.  A primary screening test revealed that compds. 6, 14 and 16 exhibited stronger adjuvanticity compared with other MDP mimics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0n6Vaul0AJ7Vg90H21EOLACvtfcHk0lilIjPukJO-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFWrsLs%253D&md5=110f9bdbbcd8c37da8dfc295e4128dfe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.05.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.05.056%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DNew%2520muramyl%2520dipeptide%2520%2528MDP%2529%2520mimics%2520without%2520the%2520carbohydrate%2520moiety%2520as%2520potential%2520adjuvant%2520candidates%2520for%2520a%2520therapeutic%2520hepatitis%2520B%2520vaccine%2520%2528HBV%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4292%26epage%3D4295%26doi%3D10.1016%2Fj.bmcl.2011.05.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">Structural requirements of acylated Gly-l-Ala-d-Glu analogs for activation of the innate immune receptor NOD2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.03.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2016.03.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=27039337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2016&pages=1-12&author=M.+Gobecauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolencauthor=%C5%BD.+Jakopin&title=Structural+requirements+of+acylated+Gly-l-Ala-d-Glu+analogs+for+activation+of+the+innate+immune+receptor+NOD2&doi=10.1016%2Fj.ejmech.2016.03.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements of acylated Gly-L-Ala-D-Glu analogs for activation of the innate immune receptor NOD2</span></div><div class="casAuthors">Gobec, Martina; Mlinaric-Rascan, Irena; Dolenc, Marija Sollner; Jakopin, Ziga</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The fragment of bacterial peptidoglycan muramyl dipeptide (MDP) has long been known for its adjuvant activity, however the underlying mechanism of this action has only recently been elucidated.  It is ascribed to its agonist action on the nucleotide-binding oligomerization domain-contg. protein 2 (NOD2).  In spite of the pressing need for novel adjuvants for human use, this discovery is hampered, by not knowing the structural requirements underlying the immunostimulatory activity.  The authors have investigated how minor modifications of hit compd. acyl Gly-L-Ala-D-Glu deriv. I modulate the mol. recognition by NOD2.  A series of novel desmuramyldipeptides has been designed and synthesized leading to the identification of compd. 16, in which the sugar moiety is replaced by a 6-phenylindole moiety, that exhibits the strongest NOD2 activation to date sans the carbohydrate moiety.  The results have enabled a deeper understanding of the structural requirements of desmuramylpeptides for NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0x5MPpjFx7Vg90H21EOLACvtfcHk0lilIjPukJO-DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlt1Kkurw%253D&md5=7a990ab9f29e7802bd24bcb051c60bd4</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.03.030%26sid%3Dliteratum%253Aachs%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DStructural%2520requirements%2520of%2520acylated%2520Gly-l-Ala-d-Glu%2520analogs%2520for%2520activation%2520of%2520the%2520innate%2520immune%2520receptor%2520NOD2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D116%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.ejmech.2016.03.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span> <span> </span><span class="NLM_article-title">Functional and molecular expression of the proton-coupled oligopeptide transporters in spleen and macrophages from mouse and human</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1409</span>– <span class="NLM_lpage">1416</span>, <span class="refDoi"> DOI: 10.1021/mp300700p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300700p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtVCmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1409-1416&author=D.+Sunauthor=Y.+Wangauthor=F.+Tanauthor=D.+Fangauthor=Y.+Huauthor=D.+E.+Smithauthor=H.+Jiang&title=Functional+and+molecular+expression+of+the+proton-coupled+oligopeptide+transporters+in+spleen+and+macrophages+from+mouse+and+human&doi=10.1021%2Fmp300700p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Functional and Molecular Expression of the Proton-Coupled Oligopeptide Transporters in Spleen and Macrophages from Mouse and Human</span></div><div class="casAuthors">Sun, Dongli; Wang, Yuqing; Tan, Fuqing; Fang, Danbo; Hu, Yongjun; Smith, David E.; Jiang, Huidi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1409-1416</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The aim of this study was to det. the expression and function of proton-coupled oligopeptide transporters (POTs) in spleen and macrophages and their contribution to innate immune response induced by bacterial peptidomimetics γ-iE-DAP and MDP.  Quant. real-time PCR (qRT-PCR) and Western blot results revealed the mRNA and protein expression of PepT2, PhT1, and PhT2, but not PepT1, in the spleen of mice and humans.  In comparison to lymphocytes of the spleen, macrophages had higher transcript levels of PepT2 and PhT2.  The cellular uptake of Ala-Lys-AMCA in mouse splenic macrophages was pH-dependent with max. uptake at pH 6.0, and the kinetic parameters were Km = 75.5 μM and Vmax = 25.4 pmol/min per mg protein.  The uptake of Ala-Lys-AMCA by mouse splenic macrophages was not inhibited by histidine but was significantly inhibited by glycyl-sarcosine (GlySar) and carnosine, and by bacterial peptidomimetics γ-iE-DAP and MDP, ligands of nucleotide-binding oligomerization domain (NOD)-contg. proteins.  Carnosine and GlySar, but not histidine, attenuated the inflammatory response induced by γ-iE-DAP and MDP in mouse splenic macrophages.  Functional expression of POTs was also demonstrated in THP-1 cells, and dipeptides reduced the immune response induced by γ-iE-DAP.  In conclusion, these findings are novel by providing important information on the mol. and functional expression of POTs in the spleen.  Moreover, it appears that the PepT2-mediated uptake of γ-iE-DAP and MDP in macrophages further contributes to the innate immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFoWVuJlfPJLVg90H21EOLACvtfcHk0ljG0gqC3PRs_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtVCmsbg%253D&md5=1fbfdaa031d4a9b65bf4bfd7f107d17d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fmp300700p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300700p%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DF.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DJiang%26aufirst%3DH.%26atitle%3DFunctional%2520and%2520molecular%2520expression%2520of%2520the%2520proton-coupled%2520oligopeptide%2520transporters%2520in%2520spleen%2520and%2520macrophages%2520from%2520mouse%2520and%2520human%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1409%26epage%3D1416%26doi%3D10.1021%2Fmp300700p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phung, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakalarski, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mazière, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klumperman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlatter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delamarre, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mellman, I.</span></span> <span> </span><span class="NLM_article-title">Endosomes are specialized platforms for bacterial sensing and NOD2 signalling</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>509</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">244</span>, <span class="refDoi"> DOI: 10.1038/nature13133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fnature13133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=24695226" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=509&publication_year=2014&pages=240-244&author=N.+Nakamuraauthor=J.+R.+Lillauthor=Q.+Phungauthor=Z.+Jiangauthor=C.+Bakalarskiauthor=A.+de+Mazi%C3%A8reauthor=J.+Klumpermanauthor=M.+Schlatterauthor=L.+Delamarreauthor=I.+Mellman&title=Endosomes+are+specialized+platforms+for+bacterial+sensing+and+NOD2+signalling&doi=10.1038%2Fnature13133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomes are specialized platforms for bacterial sensing and NOD2 signalling</span></div><div class="casAuthors">Nakamura, Norihiro; Lill, Jennie R.; Phung, Qui; Jiang, Zhaoshi; Bakalarski, Corey; de Maziere, Ann; Klumperman, Judith; Schlatter, Megan; Delamarre, Lelia; Mellman, Ira</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">509</span>
        (<span class="NLM_cas:issue">7499</span>),
    <span class="NLM_cas:pages">240-244</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The detection of microbial pathogens involves the recognition of conserved microbial components by host cell sensors such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs).  TLRs are membrane receptors that survey the extracellular environment for microbial infections, whereas NLRs are cytosolic complexes that detect microbial products that reach the cytosol.  Upon detection, both sensor classes trigger innate inflammatory responses and allow the engagement of adaptive immunity.  Endo-lysosomes are the entry sites for a variety of pathogens, and therefore the sites at which the immune system first senses their presence.  Pathogens internalized by endocytosis are well known to activate TLRs 3 and 7-9 that are localized to endocytic compartments and detect ligands present in the endosomal lumen.  Internalized pathogens also activate sensors in the cytosol such as NOD1 and NOD2 (ref. 2), indicating that endosomes also provide for the translocation of bacterial components across the endosomal membrane.  Despite the fact that NOD2 is well understood to have a key role in regulating innate immune responses and that mutations at the NOD2 locus are a common risk factor in inflammatory bowel disease and possibly other chronic inflammatory states, little is known about how its ligands escape from endosomes.  Here we show that two endo-lysosomal peptide transporters, SLC15A3 and SLC15A4, are preferentially expressed by dendritic cells, esp. after TLR stimulation.  The transporters mediate the egress of bacterially derived components, such as the NOD2 cognate ligand muramyl dipeptide (MDP), and are selectively required for NOD2 responses to endosomally derived MDP.  Enhanced expression of the transporters also generates endosomal membrane tubules characteristic of dendritic cells, which further enhanced the NOD2-dependent response to MDP.  Finally, sensing required the recruitment of NOD2 and its effector kinase RIPK2 to the endosomal membrane, possibly by forming a complex with SLC15A3 or SLC15A4.  Thus, dendritic cell endosomes are specialized platforms for both the lumenal and cytosolic sensing of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoppdcGuBL0_bVg90H21EOLACvtfcHk0ljG0gqC3PRs_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1Wqsrw%253D&md5=dd38ce753d9529651acea52f83a753b1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature13133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13133%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DN.%26aulast%3DLill%26aufirst%3DJ.%2BR.%26aulast%3DPhung%26aufirst%3DQ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DBakalarski%26aufirst%3DC.%26aulast%3Dde%2BMazi%25C3%25A8re%26aufirst%3DA.%26aulast%3DKlumperman%26aufirst%3DJ.%26aulast%3DSchlatter%26aufirst%3DM.%26aulast%3DDelamarre%26aufirst%3DL.%26aulast%3DMellman%26aufirst%3DI.%26atitle%3DEndosomes%2520are%2520specialized%2520platforms%2520for%2520bacterial%2520sensing%2520and%2520NOD2%2520signalling%26jtitle%3DNature%26date%3D2014%26volume%3D509%26spage%3D240%26epage%3D244%26doi%3D10.1038%2Fnature13133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tattoli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojtal, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vavricka, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">23818</span>– <span class="NLM_lpage">23829</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.033670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1074%2Fjbc.M109.033670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19570976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=23818-23829&author=J.+Leeauthor=I.+Tattoliauthor=K.+A.+Wojtalauthor=S.+R.+Vavrickaauthor=D.+J.+Philpottauthor=S.+E.+Girardin&title=pH-dependent+internalization+of+muramyl+peptides+from+early+endosomes+enables+Nod1+and+Nod2+signaling&doi=10.1074%2Fjbc.M109.033670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">pH-dependent Internalization of Muramyl Peptides from Early Endosomes Enables Nod1 and Nod2 Signaling</span></div><div class="casAuthors">Lee, Jooeun; Tattoli, Ivan; Wojtal, Kacper A.; Vavricka, Stephan R.; Philpott, Dana J.; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">23818-23829</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Nod1 and Nod2 are members of the Nod-like receptor family that detect intracellular bacterial peptidoglycan-derived muramyl peptides.  The biol. effects of muramyl peptides have been described for over three decades, but the mechanism underlying their internalization to the cytosol remains unclear.  Using the human epithelial cell line HEK293T as a model system, the authors demonstrate here that Nod1-activating ligands entered cells through endocytosis, most likely by the clathrin-coated pit pathway, as internalization was dynamin-dependent but not inhibited by methyl-β-cyclodextrin.  In the endocytic pathway, the cytosolic internalization of Nod1 ligands was pH-dependent, occurred prior to the acidification mediated by the vacuolar ATPase, and was optimal at pH ranging from 5.5 to 6.  Similarly, the Nod2 ligand MDP was internalized into host cytosol through a similar pathway with optimal pH for internalization ranging from 5.5 to 6.5.  Moreover, Nod1-activating muramyl peptides likely required processing by endosomal enzymes, prior to transport into the cytosol, suggesting the existence of a sterically gated endosomal transporter for Nod1 ligands.  In support for this, the authors identified a role for SLC15A4, an oligopeptide transporter expressed in early endosomes, in Nod1-dependent NF-κB signaling.  Interestingly, SLC15A4 expression was also up-regulated in colonic biopsies from patients with inflammatory bowel disease, a disorder assocd. with mutations in Nod1 and Nod2.  Together, the authors' results shed light on the mechanisms by which muramyl peptides get access to the host cytosol, where they are detected by Nod1 and Nod2, and might have implications for the understanding of human diseases, such as inflammatory bowel disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyr2dvGF25XrVg90H21EOLACvtfcHk0ljG0gqC3PRs_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWqt73J&md5=ce9181846219003ee56b3c0e487d591c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.033670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.033670%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTattoli%26aufirst%3DI.%26aulast%3DWojtal%26aufirst%3DK.%2BA.%26aulast%3DVavricka%26aufirst%3DS.%2BR.%26aulast%3DPhilpott%26aufirst%3DD.%2BJ.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DpH-dependent%2520internalization%2520of%2520muramyl%2520peptides%2520from%2520early%2520endosomes%2520enables%2520Nod1%2520and%2520Nod2%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D23818%26epage%3D23829%26doi%3D10.1074%2Fjbc.M109.033670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marina-García, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franchi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boons, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span> <span> </span><span class="NLM_article-title">Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and NOD2 activation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>182</i></span>,  <span class="NLM_fpage">4321</span>– <span class="NLM_lpage">4327</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0802197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.4049%2Fjimmunol.0802197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19299732" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=182&publication_year=2009&pages=4321-4327&author=N.+Marina-Garc%C3%ADaauthor=L.+Franchiauthor=Y.+G.+Kimauthor=Y.+Huauthor=D.+E.+Smithauthor=G.+J.+Boonsauthor=G.+Nu%C3%B1ez&title=Clathrin-+and+dynamin-dependent+endocytic+pathway+regulates+muramyl+dipeptide+internalization+and+NOD2+activation&doi=10.4049%2Fjimmunol.0802197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Clathrin- and Dynamin-Dependent Endocytic Pathway Regulates Muramyl Dipeptide Internalization and NOD2 Activation</span></div><div class="casAuthors">Marina-Garcia, Noemi; Franchi, Luigi; Kim, Yun-Gi; Hu, Yonjun; Smith, David E.; Boons, Geert-Jan; Nunez, Gabriel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">182</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4321-4327</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP), the NOD2 agonist, induces NF-κB and MAPK activation leading to the prodn. of antimicrobial and proinflammatory mols.  MDP is internalized into acidified vesicles in macrophages.  However, the endocytic mechanism of MDP uptake that induces NOD2 signaling is unknown.  We now report the identification of an endocytosis pathway dependent on clathrin and dynamin that mediates MDP internalization and NOD2 activation.  Intracellular MDP uptake was inhibited by chlorpromazine, a drug that disrupts clathrin-dependent endocytosis, but not by compds. that block pinocytosis or cellular entry via scavenger or mannose receptors.  In contrast, MDP uptake and NOD2-dependent signaling were unimpaired in macrophages deficient in PepT1, a peptide transporter previously implicated in MDP internalization.  Both chlorpromazine and knockdown of clathrin expression by RNA interference attenuated MDP-induced NF-κB and MAPK activation.  Furthermore, MDP uptake and NOD2-dependent signaling were impaired by inhibition of dynamin, a GTPase required for budding of clathrin-coated vesicles from the plasma membrane.  Finally, bafilomycin A, a specific inhibitor of the vacuolar proton pump, blocked MDP accumulation in acidified vesicles and cytokine responses, suggesting that vacuolar maturation is important for MDP-induced NOD2 signaling.  These studies provide evidence for a clathrin- and dynamin-dependent endocytosis pathway that mediates MDP uptake and NOD2 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8_dCzxcnmtrVg90H21EOLACvtfcHk0lgetpRgGs2yfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVSjurk%253D&md5=7df403b628d10949d61a470550e7ae02</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0802197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0802197%26sid%3Dliteratum%253Aachs%26aulast%3DMarina-Garc%25C3%25ADa%26aufirst%3DN.%26aulast%3DFranchi%26aufirst%3DL.%26aulast%3DKim%26aufirst%3DY.%2BG.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DD.%2BE.%26aulast%3DBoons%26aufirst%3DG.%2BJ.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26atitle%3DClathrin-%2520and%2520dynamin-dependent%2520endocytic%2520pathway%2520regulates%2520muramyl%2520dipeptide%2520internalization%2520and%2520NOD2%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D182%26spage%3D4321%26epage%3D4327%26doi%3D10.4049%2Fjimmunol.0802197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smrdel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grabnar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Černe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrenšek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovačič, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogataj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urleb, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrhar, A.</span></span> <span> </span><span class="NLM_article-title">Physicochemical and preclinical pharmacokinetic and toxicological evaluation of LK-423, a new phthalimido-desmuramyl-dipeptide derivative with immunomodulating activity</span>. <i>Drug Dev. Ind. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1293</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.3109/03639040902889814</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.3109%2F03639040902889814" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2009&pages=1293-1304&author=P.+Smrdelauthor=I.+Grabnarauthor=I.+Locatelliauthor=M.+%C4%8Cerneauthor=S.+Andren%C5%A1ekauthor=N.+Kova%C4%8Di%C4%8Dauthor=A.+Kristlauthor=M.+Bogatajauthor=U.+Urlebauthor=A.+Mrhar&title=Physicochemical+and+preclinical+pharmacokinetic+and+toxicological+evaluation+of+LK-423%2C+a+new+phthalimido-desmuramyl-dipeptide+derivative+with+immunomodulating+activity&doi=10.3109%2F03639040902889814"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3109%2F03639040902889814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F03639040902889814%26sid%3Dliteratum%253Aachs%26aulast%3DSmrdel%26aufirst%3DP.%26aulast%3DGrabnar%26aufirst%3DI.%26aulast%3DLocatelli%26aufirst%3DI.%26aulast%3D%25C4%258Cerne%26aufirst%3DM.%26aulast%3DAndren%25C5%25A1ek%26aufirst%3DS.%26aulast%3DKova%25C4%258Di%25C4%258D%26aufirst%3DN.%26aulast%3DKristl%26aufirst%3DA.%26aulast%3DBogataj%26aufirst%3DM.%26aulast%3DUrleb%26aufirst%3DU.%26aulast%3DMrhar%26aufirst%3DA.%26atitle%3DPhysicochemical%2520and%2520preclinical%2520pharmacokinetic%2520and%2520toxicological%2520evaluation%2520of%2520LK-423%252C%2520a%2520new%2520phthalimido-desmuramyl-dipeptide%2520derivative%2520with%2520immunomodulating%2520activity%26jtitle%3DDrug%2520Dev.%2520Ind.%2520Pharm.%26date%3D2009%26volume%3D35%26spage%3D1293%26epage%3D1304%26doi%3D10.3109%2F03639040902889814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masumoto, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varambally, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomlins, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuñez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaiyan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukase, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inohara, N.</span></span> <span> </span><span class="NLM_article-title">Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>203</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1084/jem.20051229</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1084%2Fjem.20051229" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=203-213&author=J.+Masumotoauthor=K.+Yangauthor=S.+Varamballyauthor=M.+Hasegawaauthor=S.+A.+Tomlinsauthor=S.+Qiuauthor=Y.+Fujimotoauthor=A.+Kawasakiauthor=S.+J.+Fosterauthor=Y.+Horieauthor=T.+W.+Makauthor=G.+Nu%C3%B1ezauthor=A.+M.+Chinnaiyanauthor=K.+Fukaseauthor=N.+Inohara&title=Nod1+acts+as+an+intracellular+receptor+to+stimulate+chemokine+production+and+neutrophil+recruitment+in+vivo&doi=10.1084%2Fjem.20051229"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1084%2Fjem.20051229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20051229%26sid%3Dliteratum%253Aachs%26aulast%3DMasumoto%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DK.%26aulast%3DVarambally%26aufirst%3DS.%26aulast%3DHasegawa%26aufirst%3DM.%26aulast%3DTomlins%26aufirst%3DS.%2BA.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DFujimoto%26aufirst%3DY.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DS.%2BJ.%26aulast%3DHorie%26aufirst%3DY.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DNu%25C3%25B1ez%26aufirst%3DG.%26aulast%3DChinnaiyan%26aufirst%3DA.%2BM.%26aulast%3DFukase%26aufirst%3DK.%26aulast%3DInohara%26aufirst%3DN.%26atitle%3DNod1%2520acts%2520as%2520an%2520intracellular%2520receptor%2520to%2520stimulate%2520chemokine%2520production%2520and%2520neutrophil%2520recruitment%2520in%2520vivo%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D203%26epage%3D213%26doi%3D10.1084%2Fjem.20051229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodela, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hazdovac, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mlinarič-Raščan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sollner Dolenc, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of conformationally constrained γ-D-glutamyl-meso-diaminopimelic acid derivatives as ligands of nucleotide-binding oligomerization domain protein 1 (Nod1)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.08.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2013.08.022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=232-243&author=%C5%BD.+Jakopinauthor=M.+Gobecauthor=J.+Kodelaauthor=T.+Hazdovacauthor=I.+Mlinari%C4%8D-Ra%C5%A1%C4%8Danauthor=M.+Sollner+Dolenc&title=Synthesis+of+conformationally+constrained+%CE%B3-D-glutamyl-meso-diaminopimelic+acid+derivatives+as+ligands+of+nucleotide-binding+oligomerization+domain+protein+1+%28Nod1%29&doi=10.1016%2Fj.ejmech.2013.08.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.08.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.08.022%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26aulast%3DGobec%26aufirst%3DM.%26aulast%3DKodela%26aufirst%3DJ.%26aulast%3DHazdovac%26aufirst%3DT.%26aulast%3DMlinari%25C4%258D-Ra%25C5%25A1%25C4%258Dan%26aufirst%3DI.%26aulast%3DSollner%2BDolenc%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520conformationally%2520constrained%2520%25CE%25B3-D-glutamyl-meso-diaminopimelic%2520acid%2520derivatives%2520as%2520ligands%2520of%2520nucleotide-binding%2520oligomerization%2520domain%2520protein%25201%2520%2528Nod1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D69%26spage%3D232%26epage%3D243%26doi%3D10.1016%2Fj.ejmech.2013.08.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rubino, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magalhaes, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahr, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardin, S. E.</span></span> <span> </span><span class="NLM_article-title">Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity</span>. <i>Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1177/1753425912471691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1177%2F1753425912471691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=23339926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=493-503&author=S.+J.+Rubinoauthor=J.+G.+Magalhaesauthor=D.+Philpottauthor=G.+M.+Bahrauthor=D.+Blanotauthor=S.+E.+Girardin&title=Identification+of+a+synthetic+muramyl+peptide+derivative+with+enhanced+Nod2+stimulatory+capacity&doi=10.1177%2F1753425912471691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity</span></div><div class="casAuthors">Rubino, Stephen J.; Magalhaes, Joao G.; Philpott, Dana; Bahr, George M.; Blanot, Didier; Girardin, Stephen E.</div><div class="citationInfo"><span class="NLM_cas:title">Innate Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">493-503, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">IINMCB</span>;
        ISSN:<span class="NLM_cas:issn">1753-4259</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Muramyl peptides (MPs) represent the building blocks of bacterial peptidoglycan, a crit. component of bacterial cell walls.  MPs are well characterized for their immunomodulatory properties, and numerous studies have delineated the role of MPs or synthetic MP analogs in host defense, adjuvanticity and inflammation.  More recently, Nod1 and Nod2 have been identified as the host sensors for specific MPs and in particular, Nod2 was shown to detect muramyl dipeptide (MDP), a MP found in both Gram-pos. and Gram-neg. bacterial cell walls.  Because mutations in Nod2 are assocd. with the etiol. of Crohn's disease, there is a need to identify synthetic MP analogs that could potentiate Nod2-dependent immunity.  Here, we analyzed the Nod2-activating property of 36 MP analogs that had been tested previously for their adjuvanticity and anti-infectious activity.  Using a luciferase-based screen, we demonstrate that addn. of a Me group to the second amino acid of MDP generates a MDP deriv. with enhanced Nod2-activating capacity.  We further validated these results in murine macrophages, human dendritic cells and in vivo.  These results offer a basis for the rational development of synthetic MPs that could be used in the treatment of inflammatory disorders that have been assocd. with Nod2 dysfunction, such as Crohn's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB2n3YBmuCU7Vg90H21EOLACvtfcHk0lhnv13EiBwGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1aksr7M&md5=5238da0a9a6bbf359078c44f9c84ae09</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1177%2F1753425912471691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1753425912471691%26sid%3Dliteratum%253Aachs%26aulast%3DRubino%26aufirst%3DS.%2BJ.%26aulast%3DMagalhaes%26aufirst%3DJ.%2BG.%26aulast%3DPhilpott%26aufirst%3DD.%26aulast%3DBahr%26aufirst%3DG.%2BM.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DGirardin%26aufirst%3DS.%2BE.%26atitle%3DIdentification%2520of%2520a%2520synthetic%2520muramyl%2520peptide%2520derivative%2520with%2520enhanced%2520Nod2%2520stimulatory%2520capacity%26jtitle%3DInnate%2520Immun.%26date%3D2013%26volume%3D19%26spage%3D493%26epage%3D503%26doi%3D10.1177%2F1753425912471691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adam, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petit, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, E.</span></span> <span> </span><span class="NLM_article-title">Muramyl peptides</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">47</span>, <span class="refDoi"> DOI: 10.1007/BF00225295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1007%2FBF00225295" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1981&pages=27-47&author=A.+Adamauthor=J.-F.+Petitauthor=P.+Lefrancierauthor=E.+Lederer&title=Muramyl+peptides&doi=10.1007%2FBF00225295"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2FBF00225295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00225295%26sid%3Dliteratum%253Aachs%26aulast%3DAdam%26aufirst%3DA.%26aulast%3DPetit%26aufirst%3DJ.-F.%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DLederer%26aufirst%3DE.%26atitle%3DMuramyl%2520peptides%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D1981%26volume%3D41%26spage%3D27%26epage%3D47%26doi%3D10.1007%2FBF00225295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lefrancier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derrien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamet, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choay, J.</span></span> <span> </span><span class="NLM_article-title">Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1021/jm00343a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00343a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaL38XkslU%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=87-90&author=P.+Lefrancierauthor=M.+Derrienauthor=X.+Jametauthor=J.+Choay&title=Apyrogenic%2C+adjuvant-active+N-acetylmuramyl-dipeptides&doi=10.1021%2Fjm00343a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Apyrogenic, adjuvant-active N-acetylmuramyl-dipeptides</span></div><div class="casAuthors">Lefrancier, Pierre; Derrien, Marcel; Jamet, Xavier; Choay, Jean; Lederer, Edgar; Audibert, Francoise; Parant, Monique; Parant, Francine; Chedid, Louis</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">87-90</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Seven analogs I (R = alkyl) of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) were synthesized in which the D-isoglutaminyl residue was replaced by D-glutamine alkyl esters.  They are all adjuvant active; however, their i.v. injection does not induce a febrile response in rabbits at a dose of 10 mg/kg, in contrast to MDP in which the minimal pyrogenic dose is 25 μg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT9wAiNEhILbVg90H21EOLACvtfcHk0lhnv13EiBwGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XkslU%253D&md5=6813ca9606d5a0e0e7822292aa305207</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm00343a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00343a018%26sid%3Dliteratum%253Aachs%26aulast%3DLefrancier%26aufirst%3DP.%26aulast%3DDerrien%26aufirst%3DM.%26aulast%3DJamet%26aufirst%3DX.%26aulast%3DChoay%26aufirst%3DJ.%26atitle%3DApyrogenic%252C%2520adjuvant-active%2520N-acetylmuramyl-dipeptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D87%26epage%3D90%26doi%3D10.1021%2Fjm00343a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abeygunawardana, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">5287</span>– <span class="NLM_lpage">5296</span>, <span class="refDoi"> DOI: 10.1021/jm980424s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm980424s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=5287-5296&author=A.+T.+Dinkova-Kostovaauthor=C.+Abeygunawardanaauthor=P.+Talalay&title=Chemoprotective+properties+of+phenylpropenoids%2C+bis%28benzylidene%29cycloalkanones%2C+and+related+Michael+acceptors%3A+correlation+of+potencies+as+phase+2+enzyme+inducers+and+radical+scavengers&doi=10.1021%2Fjm980424s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm980424s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980424s%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DAbeygunawardana%26aufirst%3DC.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DChemoprotective%2520properties%2520of%2520phenylpropenoids%252C%2520bis%2528benzylidene%2529cycloalkanones%252C%2520and%2520related%2520Michael%2520acceptors%253A%2520correlation%2520of%2520potencies%2520as%2520phase%25202%2520enzyme%2520inducers%2520and%2520radical%2520scavengers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D5287%26epage%3D5296%26doi%3D10.1021%2Fjm980424s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talele, T. T.</span></span> <span> </span><span class="NLM_article-title">The ≫cyclopropyl fragment≪ is a versatile player that frequently appears in preclinical/clinical drug molecules</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8712</span>– <span class="NLM_lpage">8756</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00472</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00472" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8712-8756&author=T.+T.+Talele&title=The+%E2%89%ABcyclopropyl+fragment%E2%89%AA+is+a+versatile+player+that+frequently+appears+in+preclinical%2Fclinical+drug+molecules&doi=10.1021%2Facs.jmedchem.6b00472"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26aulast%3DTalele%26aufirst%3DT.%2BT.%26atitle%3DThe%2520%25E2%2589%25ABcyclopropyl%2520fragment%25E2%2589%25AA%2520is%2520a%2520versatile%2520player%2520that%2520frequently%2520appears%2520in%2520preclinical%252Fclinical%2520drug%2520molecules%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8712%26epage%3D8756%26doi%3D10.1021%2Facs.jmedchem.6b00472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sosič, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barreteau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simčič, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šink, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zega, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golič Grdadolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Contreras-Martel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joris, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobec, S.</span></span> <span> </span><span class="NLM_article-title">Second-generation sulfonamide inhibitors of D-glutamic acid-adding enzyme: activitiy optimization with conformationally rigid analogues of D-glutamic acid</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">2880</span>– <span class="NLM_lpage">2894</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.ejmech.2011.04.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=2880-2894&author=I.+Sosi%C4%8Dauthor=H.+Barreteauauthor=M.+Sim%C4%8Di%C4%8Dauthor=R.+%C5%A0inkauthor=J.+Cesarauthor=A.+Zegaauthor=S.+Goli%C4%8D+Grdadolnikauthor=C.+Contreras-Martelauthor=A.+Dessenauthor=A.+Amorosoauthor=B.+Jorisauthor=D.+Blanotauthor=S.+Gobec&title=Second-generation+sulfonamide+inhibitors+of+D-glutamic+acid-adding+enzyme%3A+activitiy+optimization+with+conformationally+rigid+analogues+of+D-glutamic+acid&doi=10.1016%2Fj.ejmech.2011.04.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DSosi%25C4%258D%26aufirst%3DI.%26aulast%3DBarreteau%26aufirst%3DH.%26aulast%3DSim%25C4%258Di%25C4%258D%26aufirst%3DM.%26aulast%3D%25C5%25A0ink%26aufirst%3DR.%26aulast%3DCesar%26aufirst%3DJ.%26aulast%3DZega%26aufirst%3DA.%26aulast%3DGoli%25C4%258D%2BGrdadolnik%26aufirst%3DS.%26aulast%3DContreras-Martel%26aufirst%3DC.%26aulast%3DDessen%26aufirst%3DA.%26aulast%3DAmoroso%26aufirst%3DA.%26aulast%3DJoris%26aufirst%3DB.%26aulast%3DBlanot%26aufirst%3DD.%26aulast%3DGobec%26aufirst%3DS.%26atitle%3DSecond-generation%2520sulfonamide%2520inhibitors%2520of%2520D-glutamic%2520acid-adding%2520enzyme%253A%2520activitiy%2520optimization%2520with%2520conformationally%2520rigid%2520analogues%2520of%2520D-glutamic%2520acid%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D2880%26epage%3D2894%26doi%3D10.1016%2Fj.ejmech.2011.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Conjugate (MTC-220) of muramyl dipeptide analogue and paclitaxel prevents both tumor growth and metastasis in mice</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">2767</span>– <span class="NLM_lpage">2777</span>, <span class="refDoi"> DOI: 10.1021/jm101577z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101577z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjt1yrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2767-2777&author=Y.+Maauthor=N.+Zhaoauthor=G.+Liu&title=Conjugate+%28MTC-220%29+of+muramyl+dipeptide+analogue+and+paclitaxel+prevents+both+tumor+growth+and+metastasis+in+mice&doi=10.1021%2Fjm101577z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugate (MTC-220) of Muramyl Dipeptide Analogue and Paclitaxel Prevents Both Tumor Growth and Metastasis in Mice</span></div><div class="casAuthors">Ma, Yao; Zhao, Nan; Liu, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2767-2777</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A conjugate (MTC-220) of paclitaxel and a muramyl dipeptide analog, has been synthesized as a novel agent of dual antitumor growth and metastasis activities.  In vitro and in vivo tests show that 1 retains its ability to inhibit tumor growth.  It is superior to paclitaxel in its ability to prevent tumor metastasis in Lewis lung carcinoma and 4T1-tumor-bearing mice.  The present studies indicate that 1 suppresses myeloid derived suppressor cell accumulation in the spleen and bone marrow of tumor-bearing mice and also represses inflammatory cytokines in tumor tissue.  These results demonstrated that 1 could be a potential therapeutic and preventive agent for cancer growth and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqul89hIGvj2rVg90H21EOLACvtfcHk0lhHlajbA-R-2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjt1yrtbw%253D&md5=f0837c2efd6dfb917a0fffcbe7c7ef0d</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm101577z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101577z%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DConjugate%2520%2528MTC-220%2529%2520of%2520muramyl%2520dipeptide%2520analogue%2520and%2520paclitaxel%2520prevents%2520both%2520tumor%2520growth%2520and%2520metastasis%2520in%2520mice%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2767%26epage%3D2777%26doi%3D10.1021%2Fjm101577z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Antagonizing NOD2 signaling with conjugates of paclitaxel and muramyl dipeptide derivatives sensitizes paclitaxel therapy and significantly prevents tumor metastasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1219</span>– <span class="NLM_lpage">1224</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01704</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01704" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1219-1224&author=Y.+Dongauthor=S.+Wangauthor=C.+Wangauthor=Z.+Liauthor=Y.+Maauthor=G.+Liu&title=Antagonizing+NOD2+signaling+with+conjugates+of+paclitaxel+and+muramyl+dipeptide+derivatives+sensitizes+paclitaxel+therapy+and+significantly+prevents+tumor+metastasis&doi=10.1021%2Facs.jmedchem.6b01704"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01704%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DAntagonizing%2520NOD2%2520signaling%2520with%2520conjugates%2520of%2520paclitaxel%2520and%2520muramyl%2520dipeptide%2520derivatives%2520sensitizes%2520paclitaxel%2520therapy%2520and%2520significantly%2520prevents%2520tumor%2520metastasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1219%26epage%3D1224%26doi%3D10.1021%2Facs.jmedchem.6b01704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit49b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 1,4-benzodiazepine-2,5-dione (BZD) derivatives as dual nucleotide binding oligomerization domain containing 1/2 (NOD1/NOD2) antagonists sensitizing paclitaxel (PTX) to suppress Lewis lung carcinoma (LLC) growth in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5162</span>– <span class="NLM_lpage">5192</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00608</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00608" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5162-5192&author=S.+Wangauthor=Y.+Yangauthor=X.+Liauthor=Z.+Liuauthor=Y.+Wuauthor=G.+Siauthor=Y.+Taoauthor=N.+Zhaoauthor=X.+Huauthor=Y.+Maauthor=G.+Liu&title=Discovery+of+1%2C4-benzodiazepine-2%2C5-dione+%28BZD%29+derivatives+as+dual+nucleotide+binding+oligomerization+domain+containing+1%2F2+%28NOD1%2FNOD2%29+antagonists+sensitizing+paclitaxel+%28PTX%29+to+suppress+Lewis+lung+carcinoma+%28LLC%29+growth+in+vivo&doi=10.1021%2Facs.jmedchem.7b00608"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00608%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DSi%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DDiscovery%2520of%25201%252C4-benzodiazepine-2%252C5-dione%2520%2528BZD%2529%2520derivatives%2520as%2520dual%2520nucleotide%2520binding%2520oligomerization%2520domain%2520containing%25201%252F2%2520%2528NOD1%252FNOD2%2529%2520antagonists%2520sensitizing%2520paclitaxel%2520%2528PTX%2529%2520to%2520suppress%2520Lewis%2520lung%2520carcinoma%2520%2528LLC%2529%2520growth%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5162%26epage%3D5192%26doi%3D10.1021%2Facs.jmedchem.7b00608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lauro, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ambrosio, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bahnson, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimes, C. L.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition of muramyl dipeptide occurs in the leucine-rich repeat domain of Nod2</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">264</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=264-270&author=M.+L.+Lauroauthor=E.+A.+D%E2%80%99Ambrosioauthor=B.+J.+Bahnsonauthor=C.+L.+Grimes&title=Molecular+recognition+of+muramyl+dipeptide+occurs+in+the+leucine-rich+repeat+domain+of+Nod2&doi=10.1021%2Facsinfecdis.6b00154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2</span></div><div class="casAuthors">Lauro, Mackenzie L.; D'Ambrosio, Elizabeth A.; Bahnson, Brian J.; Grimes, Catherine Leimkuhler</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">264-270</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Genetic mutations in the innate immune receptor nucleotide-binding oligomerization domain-contg. 2 (Nod2) have demonstrated increased susceptibility to Crohn's disease, an inflammatory bowel disease that is hypothesized to be accompanied by changes in the gut microbiota.  Nod2 responds to the presence of bacteria, specifically a fragment of the bacterial cell wall, muramyl dipeptide (MDP).  The proposed site of this interaction is the leucine-rich repeat (LRR) domain.  Surface plasmon resonance and mol. modeling were used to investigate the interaction of the LRR domain with MDP.  A functional and pure LRR domain was obtained from Escherichia coli expression in high yield.  The LRR domain binds to MDP with high affinity, with a KD of 212 ± 24 nM.  Crit. portions of the receptor were detd. by mutagenesis of putative binding residues.  Fragment anal. of MDP revealed that both the peptide and carbohydrate portion contribute to the binding interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUCvojsr_fLVg90H21EOLACvtfcHk0lgKstvonqg6HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtbzN&md5=75ab3d912d40a9e0f1ab611d57cae68e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00154%26sid%3Dliteratum%253Aachs%26aulast%3DLauro%26aufirst%3DM.%2BL.%26aulast%3DD%25E2%2580%2599Ambrosio%26aufirst%3DE.%2BA.%26aulast%3DBahnson%26aufirst%3DB.%2BJ.%26aulast%3DGrimes%26aufirst%3DC.%2BL.%26atitle%3DMolecular%2520recognition%2520of%2520muramyl%2520dipeptide%2520occurs%2520in%2520the%2520leucine-rich%2520repeat%2520domain%2520of%2520Nod2%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D264%26epage%3D270%26doi%3D10.1021%2Facsinfecdis.6b00154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maekawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of NOD2 and its implications in human disease</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">11813</span>, <span class="refDoi"> DOI: 10.1038/ncomms11813</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1038%2Fncomms11813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=27283905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=11813&author=S.+Maekawaauthor=U.+Ohtoauthor=T.+Shibataauthor=K.+Miyakeauthor=T.+Shimizu&title=Crystal+structure+of+NOD2+and+its+implications+in+human+disease&doi=10.1038%2Fncomms11813"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of NOD2 and its implications in human disease</span></div><div class="casAuthors">Maekawa, Sakiko; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11813</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nucleotide-binding oligomerization domain-contg. protein 2 (NOD2), a member of the NOD-like receptors family, are crucial for innate immune responses.  Mutations of NOD2 have been assocd. with chronic inflammatory disorders such as Crohn's disease (CD), Blau syndrome (BS) and early-onset sarcoidosis (EOS), but little is known about its signalling mechanism and the role it plays in these diseases.  Here, we report the crystal structure of rabbit NOD2 in an ADP-bound state.  The structure reveals an inactive closed conformation in which the subdomains in the NOD domain are closely packed by ADP-mediated and inter-domain interactions.  Mapping of the BS- or EOS-assocd. gain-of-function mutations reveals that most of these mutations are located in the NOD subdomain interfaces, and are likely to disrupt the inner domain interactions, facilitating a conformational change to the active form.  Conversely, mutations assocd. with CD are distributed throughout the protein, some of which may affect oligomer formation and ligand binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJqTm2zQOG7Vg90H21EOLACvtfcHk0lgKstvonqg6HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslyltLg%253D&md5=ff4a78caf8d9e744e473b6767c9d8154</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fncomms11813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms11813%26sid%3Dliteratum%253Aachs%26aulast%3DMaekawa%26aufirst%3DS.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DCrystal%2520structure%2520of%2520NOD2%2520and%2520its%2520implications%2520in%2520human%2520disease%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D11813%26doi%3D10.1038%2Fncomms11813" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rickard, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallal, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montoute, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chordia, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poore, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haile, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emery, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Identification of benzimidazole diamides as selective inhibitors of the nucleotide-binding oligomerization domain 2 (NOD2) signaling pathway</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e69619</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0069619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1371%2Fjournal.pone.0069619" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e69619&author=D.+J.+Rickardauthor=C.+A.+Sehonauthor=V.+Kasparcovaauthor=L.+A.+Kallalauthor=X.+Zengauthor=M.+N.+Montouteauthor=T.+Chordiaauthor=D.+D.+Pooreauthor=H.+Liauthor=P.+M.+Eidamauthor=P.+A.+Haileauthor=J.+Yuauthor=J.+G.+Emeryauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Identification+of+benzimidazole+diamides+as+selective+inhibitors+of+the+nucleotide-binding+oligomerization+domain+2+%28NOD2%29+signaling+pathway&doi=10.1371%2Fjournal.pone.0069619"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0069619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0069619%26sid%3Dliteratum%253Aachs%26aulast%3DRickard%26aufirst%3DD.%2BJ.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKallal%26aufirst%3DL.%2BA.%26aulast%3DZeng%26aufirst%3DX.%26aulast%3DMontoute%26aufirst%3DM.%2BN.%26aulast%3DChordia%26aufirst%3DT.%26aulast%3DPoore%26aufirst%3DD.%2BD.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DHaile%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DJ.%26aulast%3DEmery%26aufirst%3DJ.%2BG.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520benzimidazole%2520diamides%2520as%2520selective%2520inhibitors%2520of%2520the%2520nucleotide-binding%2520oligomerization%2520domain%25202%2520%2528NOD2%2529%2520signaling%2520pathway%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26spage%3De69619%26doi%3D10.1371%2Fjournal.pone.0069619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merhi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devissaguet, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barratt, G. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and immunostimulating properties of lipophilic ester and ether muramyl peptide derivatives</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">4483</span>– <span class="NLM_lpage">4488</span>, <span class="refDoi"> DOI: 10.1021/jm960147u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960147u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=4483-4488&author=G.+Merhiauthor=J.-P.+Devissaguetauthor=G.+M.+Barratt&title=Synthesis+and+immunostimulating+properties+of+lipophilic+ester+and+ether+muramyl+peptide+derivatives&doi=10.1021%2Fjm960147u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm960147u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960147u%26sid%3Dliteratum%253Aachs%26aulast%3DMerhi%26aufirst%3DG.%26aulast%3DDevissaguet%26aufirst%3DJ.-P.%26aulast%3DBarratt%26aufirst%3DG.%2BM.%26atitle%3DSynthesis%2520and%2520immunostimulating%2520properties%2520of%2520lipophilic%2520ester%2520and%2520ether%2520muramyl%2520peptide%2520derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D4483%26epage%3D4488%26doi%3D10.1021%2Fjm960147u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakopin, Ž.</span></span> <span> </span><span class="NLM_article-title">The design and synthesis of Ala-Glu/iGln mimetics: heterocyclic building blocks for pseudopeptides</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.tetlet.2014.12.035" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=504-506&author=%C5%BD.+Jakopin&title=The+design+and+synthesis+of+Ala-Glu%2FiGln+mimetics%3A+heterocyclic+building+blocks+for+pseudopeptides&doi=10.1016%2Fj.tetlet.2014.12.035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DJakopin%26aufirst%3D%25C5%25BD.%26atitle%3DThe%2520design%2520and%2520synthesis%2520of%2520Ala-Glu%252FiGln%2520mimetics%253A%2520heterocyclic%2520building%2520blocks%2520for%2520pseudopeptides%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26spage%3D504%26epage%3D506%26doi%3D10.1016%2Fj.tetlet.2014.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Markey, G. M.</span></span> <span> </span><span class="NLM_article-title">Carboxylesterase 1 (Ces1): from monocyte marker to major player</span>. <i>J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1136/jcp.2010.084657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1136%2Fjcp.2010.084657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=21177752" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A280%3ADC%252BC3M7jvV2ruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2011&pages=107-109&author=G.+M.+Markey&title=Carboxylesterase+1+%28Ces1%29%3A+from+monocyte+marker+to+major+player&doi=10.1136%2Fjcp.2010.084657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxylesterase 1 (Ces1): from monocyte marker to major player</span></div><div class="casAuthors">Markey Geraldine M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">107-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There are few, if any, enzymes that have been studied by, and have importance in, so many and varied disciplines as has monocyte esterase/Ces 1.  In this review its involvement in the fields of histochemistry, haematology, toxicology, pharmacology, therapeutics, and tumour cell killing, immune surveillance and malignant disease, is briefly described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRwm-8zIl3llSCEBeYuoi7AfW6udTcc2eZr_QoQtsdbBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7jvV2ruw%253D%253D&md5=46b3c40f99d6bf82c765e7f009860f90</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1136%2Fjcp.2010.084657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjcp.2010.084657%26sid%3Dliteratum%253Aachs%26aulast%3DMarkey%26aufirst%3DG.%2BM.%26atitle%3DCarboxylesterase%25201%2520%2528Ces1%2529%253A%2520from%2520monocyte%2520marker%2520to%2520major%2520player%26jtitle%3DJ.%2520Clin.%2520Pathol.%26date%3D2011%26volume%3D64%26spage%3D107%26epage%3D109%26doi%3D10.1136%2Fjcp.2010.084657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crow, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herring, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borazjani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, M. K.</span></span> <span> </span><span class="NLM_article-title">Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids</span>. <i>Biochim. Biophys. Acta, Mol. Cell Biol. Lipids</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1801</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">41</span>, <span class="refDoi"> DOI: 10.1016/j.bbalip.2009.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.bbalip.2009.09.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19761868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsV2msrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1801&publication_year=2010&pages=31-41&author=J.+A.+Crowauthor=K.+L.+Herringauthor=S.+Xieauthor=A.+Borazjaniauthor=P.+M.+Potterauthor=M.+K.+Ross&title=Inhibition+of+carboxylesterase+activity+of+THP1+monocytes%2Fmacrophages+and+recombinant+human+carboxylesterase+1+by+oxysterols+and+fatty+acids&doi=10.1016%2Fj.bbalip.2009.09.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids</span></div><div class="casAuthors">Crow, J. Allen; Herring, Katye L.; Xie, Shuqi; Borazjani, Abdolsamad; Potter, Philip M.; Ross, Matthew K.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1801</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-41</span>CODEN:
                <span class="NLM_cas:coden">BBMLFG</span>;
        ISSN:<span class="NLM_cas:issn">1388-1981</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Two major isoforms of human carboxylesterases (CEs) are found in metabolically active tissues, CES1 and CES2.  These hydrolytic enzymes are involved in xenobiotic and endobiotic metab.  CES1 is abundantly expressed in human liver and monocytes/macrophages, including the THP1 cell line; CES2 is expressed in liver but not in monocytes/macrophages.  The cholesteryl ester hydrolysis activity in human macrophages has been attributed to CES1.  Here, the authors report the direct inhibitory effects of several endogenous oxysterols and fatty acids on the CE activity of THP1 monocytes/macrophages and recombinant human CES1 and CES2.  Using THP1 whole-cell lysates the authors found: 27-hydroxycholesterol (27-HC) is a potent inhibitor of carboxylesterase activity (IC50 = 33 nM); 24(S),25-epoxycholesterol had moderate inhibitory activity (IC50 = 8.1 μM); and cholesterol, 7-ketocholesterol, 22(R)-hydroxycholesterol, 24(S)-hydroxycholesterol, and 25-hydroxycholesterol each had little inhibitory activity.  27-HC was a partially noncompetitive inhibitor of recombinant CES1 (K iapp = 10 nM) and impaired intracellular CES1 activity following treatment of intact THP1 cells.  In contrast, recombinant CES2 activity was not inhibited by 27-HC, suggesting isoform-selective inhibition by 27-HC.  Furthermore, unsatd. fatty acids were better inhibitors of CES1 activity than satd. fatty acids, while CES2 activity was unaffected by any fatty acid.  Arachidonic acid (AA) was the most potent fatty acid inhibitor of recombinant CES1 and acted by a noncompetitive mechanism (K iapp = 1.7 μM); when not complexed to albumin, exogenous AA penetrated intact THP1 cells and inhibited CES1.  Inhibition results are discussed in light of recent structural models for CES1 that describe ligand binding sites sep. from the active site.  In addn., oxysterol-mediated inhibition of CES1 activity was demonstrated by pretreatment of human liver homogenates or intact THP1 cells with exogenous 27-HC, which resulted in significantly reduced hydrolysis of the pyrethroid insecticide bioresmethrin, a CES1-specific xenobiotic substrate.  Collectively, these findings suggest that CE activity of recombinant CES1, cell lysates, and intact cells can be impaired by naturally occurring lipids, which may compromise the ability of CES1 to both detoxify environmental pollutants and metabolize endogenous compds. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-TNn1baZIPrVg90H21EOLACvtfcHk0lhMZ5WMs2851Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsV2msrnP&md5=1f079899301896faed5fb87533d57c94</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bbalip.2009.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbalip.2009.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DCrow%26aufirst%3DJ.%2BA.%26aulast%3DHerring%26aufirst%3DK.%2BL.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DBorazjani%26aufirst%3DA.%26aulast%3DPotter%26aufirst%3DP.%2BM.%26aulast%3DRoss%26aufirst%3DM.%2BK.%26atitle%3DInhibition%2520of%2520carboxylesterase%2520activity%2520of%2520THP1%2520monocytes%252Fmacrophages%2520and%2520recombinant%2520human%2520carboxylesterase%25201%2520by%2520oxysterols%2520and%2520fatty%2520acids%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Biol.%2520Lipids%26date%3D2010%26volume%3D1801%26spage%3D31%26epage%3D41%26doi%3D10.1016%2Fj.bbalip.2009.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chanteux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delatour, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prakash, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J.-M.</span></span> <span> </span><span class="NLM_article-title">In vitro hydrolysis and transesterification of CDP323, an α4β1/α4β7 integrin antagonist ester prodrug</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">161</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.054049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.113.054049" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=153-161&author=H.+Chanteuxauthor=M.+Rosaauthor=C.+Delatourauthor=C.+Prakashauthor=S.+Smithauthor=J.-M.+Nicolas&title=In+vitro+hydrolysis+and+transesterification+of+CDP323%2C+an+%CE%B14%CE%B21%2F%CE%B14%CE%B27+integrin+antagonist+ester+prodrug&doi=10.1124%2Fdmd.113.054049"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.054049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.054049%26sid%3Dliteratum%253Aachs%26aulast%3DChanteux%26aufirst%3DH.%26aulast%3DRosa%26aufirst%3DM.%26aulast%3DDelatour%26aufirst%3DC.%26aulast%3DPrakash%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DS.%26aulast%3DNicolas%26aufirst%3DJ.-M.%26atitle%3DIn%2520vitro%2520hydrolysis%2520and%2520transesterification%2520of%2520CDP323%252C%2520an%2520%25CE%25B14%25CE%25B21%252F%25CE%25B14%25CE%25B27%2520integrin%2520antagonist%2520ester%2520prodrug%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D153%26epage%3D161%26doi%3D10.1124%2Fdmd.113.054049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linnet, K.</span></span> <span> </span><span class="NLM_article-title">the INDICES Consortium. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.113.053512" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2014&pages=126-133&author=R.+Thomsenauthor=H.+B.+Rasmussenauthor=K.+Linnet&title=the+INDICES+Consortium.+In+vitro+drug+metabolism+by+human+carboxylesterase+1%3A+focus+on+angiotensin-converting+enzyme+inhibitors&doi=10.1124%2Fdmd.113.053512"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053512%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DR.%26aulast%3DRasmussen%26aufirst%3DH.%2BB.%26aulast%3DLinnet%26aufirst%3DK.%26atitle%3Dthe%2520INDICES%2520Consortium.%2520In%2520vitro%2520drug%2520metabolism%2520by%2520human%2520carboxylesterase%25201%253A%2520focus%2520on%2520angiotensin-converting%2520enzyme%2520inhibitors%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2014%26volume%3D42%26spage%3D126%26epage%3D133%26doi%3D10.1124%2Fdmd.113.053512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taketani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shii, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosokawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiba, K.</span></span> <span> </span><span class="NLM_article-title">Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1734</span>– <span class="NLM_lpage">1741</span>, <span class="refDoi"> DOI: 10.1124/dmd.106.009381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.106.009381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16837570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1734-1741&author=T.+Imaiauthor=M.+Taketaniauthor=M.+Shiiauthor=M.+Hosokawaauthor=K.+Chiba&title=Substrate+specificity+of+carboxylesterase+isozymes+and+their+contribution+to+hydrolase+activity+in+human+liver+and+small+intestine&doi=10.1124%2Fdmd.106.009381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine</span></div><div class="casAuthors">Imai, Teruko; Taketani, Megumi; Shii, Mayumi; Hosokawa, Masakiyo; Chiba, Kan</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1734-1741</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Hydrolase activity from human liver and small intestine microsomes was compared with that of recombinant human carboxylesterases, hCE-1 and hCE-2.  Although both hCE-1 and hCE-2 are present in human liver, the dominant component was found to be hCE-1, whereas the hydrolase activity of the human small intestine was found to be predominantly hCE-2.  HCE-2 has a limited ability to hydrolyze large acyl compd. substrates.  Interestingly, propranolol derivs., good substrates for hCE-2, were easily hydrolyzed by substitution of the Me group on the 2-position of the acyl moiety, but were barely hydrolyzed when the Me group was substituted on the 3-position.  These findings suggest that hCE-2 does not easily form acylated intermediates because of conformational interference in its active site.  In contrast, hCE-1 could hydrolyze a variety of substrates.  The hydrolytic activity of hCE-2 increased with increasing alc. chain length in benzoic acid deriv. substrates, whereas hCE-1 preferentially catalyzed the hydrolysis of substrates with short alc. chains.  Kinetic data showed that the detg. factor for the rate of hydrolysis of p-aminobenzoic acid esters was Vmax for hCE-1 and Km for hCE-2.  Furthermore, the addn. of hydrophobic alcs. to the reaction mixt. with p-aminobenzoic acid Pr ester induced high and low levels of transesterification by hCE-1 and hCE-2, resp.  When considering the substrate specificities of hCE-1, it is necessary to consider the transesterification ability of hCE-1, in addn. to the binding structure of the substrate in the active site of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_5Qby7_S88LVg90H21EOLACvtfcHk0li96DqSAdeq_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCltbvI&md5=b2d3c1d2aee89b647e1c8030daee8c3a</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fdmd.106.009381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.106.009381%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26aulast%3DTaketani%26aufirst%3DM.%26aulast%3DShii%26aufirst%3DM.%26aulast%3DHosokawa%26aufirst%3DM.%26aulast%3DChiba%26aufirst%3DK.%26atitle%3DSubstrate%2520specificity%2520of%2520carboxylesterase%2520isozymes%2520and%2520their%2520contribution%2520to%2520hydrolase%2520activity%2520in%2520human%2520liver%2520and%2520small%2520intestine%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1734%26epage%3D1741%26doi%3D10.1124%2Fdmd.106.009381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, B.</span></span> <span> </span><span class="NLM_article-title">Human and rodent carboxylesterases: immunorelatedness, overlapping substrate specificity, differential sensitivity to serine enzyme inhibitors, and tumor-related expression</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">547</span>, <span class="refDoi"> DOI: 10.1124/dmd.30.5.541</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1124%2Fdmd.30.5.541" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2002&pages=541-547&author=M.+Xieauthor=D.+Yangauthor=L.+Liuauthor=B.+Xueauthor=B.+Yan&title=Human+and+rodent+carboxylesterases%3A+immunorelatedness%2C+overlapping+substrate+specificity%2C+differential+sensitivity+to+serine+enzyme+inhibitors%2C+and+tumor-related+expression&doi=10.1124%2Fdmd.30.5.541"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fdmd.30.5.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.30.5.541%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DB.%26atitle%3DHuman%2520and%2520rodent%2520carboxylesterases%253A%2520immunorelatedness%252C%2520overlapping%2520substrate%2520specificity%252C%2520differential%2520sensitivity%2520to%2520serine%2520enzyme%2520inhibitors%252C%2520and%2520tumor-related%2520expression%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2002%26volume%3D30%26spage%3D541%26epage%3D547%26doi%3D10.1124%2Fdmd.30.5.541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durland-Busbice, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shepard, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinz-Taheny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iversen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dantzig, A. H.</span></span> <span> </span><span class="NLM_article-title">Human carboxylesterase-2 hydrolyzes the prodrug of gemcitabine (LY2334737) and confers prodrug sensitivity to cancer cells</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1168</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-1184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1158%2F1078-0432.CCR-12-1184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=23325581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1159-1168&author=S.+E.+Prattauthor=S.+Durland-Busbiceauthor=R.+L.+Shepardauthor=K.+Heinz-Tahenyauthor=P.+W.+Iversenauthor=A.+H.+Dantzig&title=Human+carboxylesterase-2+hydrolyzes+the+prodrug+of+gemcitabine+%28LY2334737%29+and+confers+prodrug+sensitivity+to+cancer+cells&doi=10.1158%2F1078-0432.CCR-12-1184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells</span></div><div class="casAuthors">Pratt, Susan E.; Durland-Busbice, Sara; Shepard, Robert L.; Heinz-Taheny, Kathleen; Iversen, Philip W.; Dantzig, Anne H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1159-1168</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The oral prodrug of gemcitabine LY2334737 is cleaved systemically to gemcitabine; the mechanism responsible for hydrolysis is unknown.  LY2334737 cytotoxicity was tested in the NCI-60 panel; mining of microarray expression data identified carboxylesterase (CES) as a top hydrolase candidate.  Studies examd. whether CES is responsible for hydrolysis and whether cellular CES expression confers prodrug sensitivity.  Exptl. Design: Human recombinant CES isoenzymes were assayed for LY2334737 hydrolysis.  Stable CES-overexpressing HCT-116 transfectants and a SK-OV-3 knockdown were prepd.  Cell lines were tested for drug sensitivity and CES expression by quant. real time-PCR (qRT-PCR), Western blotting, and immunohistochem. staining.  Bystander cytotoxicity studies were conducted with GFP-tagged PC-3 cells as the reporter cell line.  Therapeutic response of the HCT-116 transfectants was evaluated in xenografts.  Results: Of 3 human CES isoenzymes tested, only CES2 hydrolyzed LY2334737.  Five cell lines that express CES2 responded to LY2334737 treatment.  LY2334737 was less cytotoxic to a SK-OV-3 CES2 knockdown than parental cells.  The drug response of CES2-transfected HCT-116 cells correlated with CES2 expression level.  Bystander studies showed statistically greater PC-3-GFP growth inhibition by LY2334737 when cells were cocultured with CES2 and not mock transfectants.  Oral treatment of xenograft models with 3.2 mg/kg LY2334737 once a day for 21 days showed greater tumor growth inhibition of CES2 transfectant than the mock transfectant (P ≤ 0.001).  Conclusions: CES2 is responsible for the slow hydrolysis of LY2334737.  Because intact prodrug circulates at high plasma levels after oral LY2334737 administration, improved response rates may be obsd. by tailoring LY2334737 treatment to patients with CES2 tumor expression.  Clin Cancer Res; 19(5); 1159-68. ©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM5cExv8fNIbVg90H21EOLACvtfcHk0li96DqSAdeq_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFekt7k%253D&md5=37b16874ce4de70dea8a5e57f8aa8a0b</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-1184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-1184%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DS.%2BE.%26aulast%3DDurland-Busbice%26aufirst%3DS.%26aulast%3DShepard%26aufirst%3DR.%2BL.%26aulast%3DHeinz-Taheny%26aufirst%3DK.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DDantzig%26aufirst%3DA.%2BH.%26atitle%3DHuman%2520carboxylesterase-2%2520hydrolyzes%2520the%2520prodrug%2520of%2520gemcitabine%2520%2528LY2334737%2529%2520and%2520confers%2520prodrug%2520sensitivity%2520to%2520cancer%2520cells%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D1159%26epage%3D1168%26doi%3D10.1158%2F1078-0432.CCR-12-1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maharana, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahoo, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behera, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, S. K.</span></span> <span> </span><span class="NLM_article-title">Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (<i>Danio rerio</i>) NOD2: a molecular dynamics approach</span>. <i>J. Mol. Recognit.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1002/jmr.2357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2Fjmr.2357" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=24700593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltlaksLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=260-275&author=J.+Maharanaauthor=M.+C.+Patraauthor=C.+D.+Deauthor=B.+R.+Sahooauthor=B.+K.+Beheraauthor=S.+Deauthor=S.+K.+Pradhan&title=Structural+insights+into+the+MDP+binding+and+CARD-CARD+interaction+in+zebrafish+%28Danio+rerio%29+NOD2%3A+a+molecular+dynamics+approach&doi=10.1002%2Fjmr.2357"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the MDP binding and CARD-CARD interaction in zebrafish (Danio rerio) NOD2: a molecular dynamics approach</span></div><div class="casAuthors">Maharana, Jitendra; Patra, Mahesh Chandra; De, Bidhan Chandra; Sahoo, Bikash Ranjan; Behera, Bijay Kumar; De, Sachinandan; Pradhan, Sukanta Kumar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Recognition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">260-275</span>CODEN:
                <span class="NLM_cas:coden">JMORE4</span>;
        ISSN:<span class="NLM_cas:issn">0952-3499</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Nucleotide binding and oligomerization domain (NOD2) is a key component of innate immunity that is highly specific for muramyl dipeptide (MDP)-a peptidoglycan component of bacterial cell wall.  MDP recognition by NOD2-leucine rich repeat (LRR) domain activates NF-κB signaling through a protein-protein interaction between caspase activating and recruitment domains (CARDs) of NOD2 and downstream receptor interacting and activating protein kinase 2 (RIP2).  Due to the lack of crystal/NMR structures, MDP recognition and CARD-CARD interaction are poorly understood.  Herein, we have predicted the probable MDP and CARD-CARD binding surfaces in zebrafish NOD2 (zNOD2) using various in silico methodologies.  The results show that the conserved residues Phe819, Phe871, Trp875, Trp929, Trp899, and Arg845 located at the concave face of zNOD2-LRR confer MDP recognition by hydrophobic and hydrogen bond (H-bond) interactions.  Mol. dynamics simulations reveal a stable assocn. between the electropos. surface on zNOD2-CARDa and the electroneg. surface on zRIP2-CARD reinforced mostly by H-bonds and electrostatic interactions.  Importantly, a 3.5 Å salt bridge is obsd. between Arg60 of zNOD2-CARDa and Asp494 of zRIP2-CARD.  Arg11 and Lys53 of zNOD2-CARDa and Ser498 and Glu508 of zRIP2-CARD are crit. residues for CARD-CARD interaction and NOD2 signaling.  The 2.7 Å H-bond between Lys104 of the linker and Glu508 of zRIP2-CARD suggests a possible role of the linker for shaping CARD-CARD interaction.  These findings are consistent with existing mutagenesis data.  We provide first insight into MDP recognition and CARD-CARD interaction in the zebrafish that will be useful to understand the mol. basis of NOD signaling in a broader perspective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT5a6yULpl1LVg90H21EOLACvtfcHk0lib1z2pJ5iLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltlaksLc%253D&md5=9c39dbc6d9b2eb44994ddc41f6c70683</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2Fjmr.2357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjmr.2357%26sid%3Dliteratum%253Aachs%26aulast%3DMaharana%26aufirst%3DJ.%26aulast%3DPatra%26aufirst%3DM.%2BC.%26aulast%3DDe%26aufirst%3DC.%2BD.%26aulast%3DSahoo%26aufirst%3DB.%2BR.%26aulast%3DBehera%26aufirst%3DB.%2BK.%26aulast%3DDe%26aufirst%3DS.%26aulast%3DPradhan%26aufirst%3DS.%2BK.%26atitle%3DStructural%2520insights%2520into%2520the%2520MDP%2520binding%2520and%2520CARD-CARD%2520interaction%2520in%2520zebrafish%2520%2528Danio%2520rerio%2529%2520NOD2%253A%2520a%2520molecular%2520dynamics%2520approach%26jtitle%3DJ.%2520Mol.%2520Recognit.%26date%3D2014%26volume%3D27%26spage%3D260%26epage%3D275%26doi%3D10.1002%2Fjmr.2357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asensio, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardá, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cañada, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Barbero, J.</span></span> <span> </span><span class="NLM_article-title">Carbohydrate-aromatic interactions</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">954</span>, <span class="refDoi"> DOI: 10.1021/ar300024d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar300024d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFeku78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=946-954&author=J.+L.+Asensioauthor=A.+Ard%C3%A1author=F.+J.+Ca%C3%B1adaauthor=J.+Jim%C3%A9nez-Barbero&title=Carbohydrate-aromatic+interactions&doi=10.1021%2Far300024d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-Aromatic Interactions</span></div><div class="casAuthors">Asensio, Juan Luis; Arda, Ana; Canada, Francisco Javier; Jimenez-Barbero, Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">946-954</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The recognition of saccharides by proteins has far-reaching implications in biol., technol., and drug design.  Within the past two decades, researchers have directed considerable effort toward a detailed understanding of these processes.  Early crystallog. studies revealed, not surprisingly, that hydrogen-bonding interactions are usually involved in carbohydrate recognition.  But less expectedly, researchers obsd. that despite the highly hydrophilic character of most sugars, arom. rings of the receptor often play an important role in carbohydrate recognition.  With further research, scientists now accept that noncovalent interactions mediated by arom. rings are pivotal to sugar binding.  For example, arom. residues often stack against the faces of sugar pyranose rings in complexes between proteins and carbohydrates.  Such contacts typically involve two or three CH groups of the pyranoses and the π electron d. of the arom. ring (called CH/π bonds), and these interactions can exhibit a variety of geometries, with either parallel or nonparallel arrangements of the arom. and sugar units.  In this Account, we provide an overview of the structural and thermodn. features of protein-carbohydrate interactions, theor. and exptl. efforts to understand stacking in these complexes, and the implications of this understanding for chem. biol.  The interaction energy between different arom. rings and simple monosaccharides based on quantum mech. calcns. in the gas phase ranges from 3 to 6 kcal/mol range.  Exptl. values measured in water are somewhat smaller, approx. 1.5 kcal/mol for each interaction between a monosaccharide and an arom. ring.  This difference illustrates the dependence of these intermol. interactions on their context and shows that this stacking can be modulated by entropic and solvent effects.  Despite their relatively modest influence on the stability of carbohydrate/protein complexes, the arom. platforms play a major role in detg. the specificity of the mol. recognition process.  The recognition of carbohydrate/arom. interactions has prompted further anal. of the properties that influence them.  Using a variety of exptl. and theor. methods, researchers have worked to quantify carbohydrate/arom. stacking and identify the features that stabilize these complexes.  Researchers have used site-directed mutagenesis, org. synthesis, or both to incorporate modifications in the receptor or ligand and then quant. analyzed the structural and thermodn. features of these interactions.  Researchers have also synthesized and characterized artificial receptors and simple model systems, employing a reductionistic chem.-based strategy.  Finally, using quantum mechanics calcns., researchers have examd. the magnitude of each property's contribution to the interaction energy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIXOW5VJV3dLVg90H21EOLACvtfcHk0lib1z2pJ5iLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFeku78%253D&md5=eefd3c7ada7692abb8b123137fcedeb8</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Far300024d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far300024d%26sid%3Dliteratum%253Aachs%26aulast%3DAsensio%26aufirst%3DJ.%2BL.%26aulast%3DArd%25C3%25A1%26aufirst%3DA.%26aulast%3DCa%25C3%25B1ada%26aufirst%3DF.%2BJ.%26aulast%3DJim%25C3%25A9nez-Barbero%26aufirst%3DJ.%26atitle%3DCarbohydrate-aromatic%2520interactions%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2013%26volume%3D46%26spage%3D946%26epage%3D954%26doi%3D10.1021%2Far300024d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartlett, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agirre, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallagher, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiessling, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolfson, D. N.</span></span> <span> </span><span class="NLM_article-title">Carbohydrate-aromatic interactions in proteins</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">15152</span>– <span class="NLM_lpage">15160</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b08424</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b08424" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=15152-15160&author=K.+L.+Hudsonauthor=G.+J.+Bartlettauthor=R.+C.+Diehlauthor=J.+Agirreauthor=T.+Gallagherauthor=L.+L.+Kiesslingauthor=D.+N.+Woolfson&title=Carbohydrate-aromatic+interactions+in+proteins&doi=10.1021%2Fjacs.5b08424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-Aromatic Interactions in Proteins</span></div><div class="casAuthors">Hudson, Kieran L.; Bartlett, Gail J.; Diehl, Roger C.; Agirre, Jon; Gallagher, Timothy; Kiessling, Laura L.; Woolfson, Derek N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">15152-15160</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein-carbohydrate interactions play pivotal roles in health and disease.  However, defining and manipulating these interactions has been hindered by an incomplete understanding of the underlying fundamental forces.  To elucidate common and discriminating features in carbohydrate recognition, we have analyzed quant. X-ray crystal structures of proteins with noncovalently bound carbohydrates.  Within the carbohydrate-binding pockets, aliph. hydrophobic residues are disfavored, whereas arom. side chains are enriched.  The greatest preference is for tryptophan with an increased prevalence of 9-fold.  Variations in the spatial orientation of amino acids around different monosaccharides indicate specific carbohydrate C-H bonds interact preferentially with arom. residues.  These preferences are consistent with the electronic properties of both the carbohydrate C-H bonds and the arom. residues.  Those carbohydrates that present patches of electropos. saccharide C-H bonds engage more often in CH-π interactions involving electron-rich arom. partners.  These electronic effects are also manifested when carbohydrate-arom. interactions are monitored in soln.: NMR anal. indicates that indole favorably binds to electron-poor C-H bonds of model carbohydrates, and a clear linear free energy relationships with substituted indoles supports the importance of complementary electronic effects in driving protein-carbohydrate interactions.  Together, our data indicate that electrostatic and electronic complementarity between carbohydrates and arom. residues play key roles in driving protein-carbohydrate complexation.  Moreover, these weak noncovalent interactions influence which saccharide residues bind to proteins, and how they are positioned within carbohydrate-binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpGFFcCF0NrVg90H21EOLACvtfcHk0lib1z2pJ5iLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVaht7fN&md5=6154734469d3617e0f2e744da3b4a1cb</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b08424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b08424%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DK.%2BL.%26aulast%3DBartlett%26aufirst%3DG.%2BJ.%26aulast%3DDiehl%26aufirst%3DR.%2BC.%26aulast%3DAgirre%26aufirst%3DJ.%26aulast%3DGallagher%26aufirst%3DT.%26aulast%3DKiessling%26aufirst%3DL.%2BL.%26aulast%3DWoolfson%26aufirst%3DD.%2BN.%26atitle%3DCarbohydrate-aromatic%2520interactions%2520in%2520proteins%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26spage%3D15152%26epage%3D15160%26doi%3D10.1021%2Fjacs.5b08424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodchild, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nopper, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craddock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivory, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passioura, T.</span></span> <span> </span><span class="NLM_article-title">Primary leukocyte screens for innate agonists</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">723</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1177/1087057109335325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1177%2F1087057109335325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19525489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVaksr%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=723-730&author=A.+Goodchildauthor=N.+Nopperauthor=A.+Craddockauthor=T.+Lawauthor=A.+Kingauthor=G.+Fanningauthor=L.+Rivoryauthor=T.+Passioura&title=Primary+leukocyte+screens+for+innate+agonists&doi=10.1177%2F1087057109335325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Primary leukocyte screens for innate immune agonists</span></div><div class="casAuthors">Goodchild, Amber; Nopper, Nicole; Craddock, Alexis; Law, Tamara; King, Andrew; Fanning, Gregory; Rivory, Laurent; Passioura, Toby</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">723-730</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The innate immune system of mammals is a key defense mechanism against invading foreign pathogens.  Innate immune stimulants may have applications as vaccine adjuvants as well as in the treatment of cancer and some viral diseases, and clin. studies have been performed using agonists of Toll-like receptors (TLRs) 7, 8, and 9.  The high-throughput screens for such agonists have typically relied on the overexpression of a single TLR gene in an immortalized cell line and are inherently artificial systems that are restricted to the identification of agonists for a single receptor.  The authors describe 2 assays for the identification of immunostimulants that employ primary human leukocytes cocultured with hepatitis C virus (HCV) replicon-expressing cells.  In these assays, stimulation of innate immune pathways in leukocytes induces interferon (IFN) expression, which acts to inhibit HCV replication, providing a high-throughput and low-cost readout for leukocyte activation.  These assays are highly sensitive and provide a physiol. relevant system for the identification of a broad range of immunostimulant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcDOKkmsM6ILVg90H21EOLACvtfcHk0lib1z2pJ5iLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVaksr%252FF&md5=e0ccf1f1f272b72f013156c195c95b7a</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1177%2F1087057109335325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109335325%26sid%3Dliteratum%253Aachs%26aulast%3DGoodchild%26aufirst%3DA.%26aulast%3DNopper%26aufirst%3DN.%26aulast%3DCraddock%26aufirst%3DA.%26aulast%3DLaw%26aufirst%3DT.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DRivory%26aufirst%3DL.%26aulast%3DPassioura%26aufirst%3DT.%26atitle%3DPrimary%2520leukocyte%2520screens%2520for%2520innate%2520agonists%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2009%26volume%3D14%26spage%3D723%26epage%3D730%26doi%3D10.1177%2F1087057109335325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rostaing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tkaczuk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peres, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durand, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Préval, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohayon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbal, M.</span></span> <span> </span><span class="NLM_article-title">Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells</span>. <i>Cytometry</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0320(19990401)35:4<318::AID-CYTO4>3.0.CO;2-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10213197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK1MXisFaisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1999&pages=318-328&author=L.+Rostaingauthor=J.+Tkaczukauthor=M.+Durandauthor=C.+Peresauthor=D.+Durandauthor=C.+de+Pr%C3%A9valauthor=E.+Ohayonauthor=M.+Abbal&title=Kinetics+of+intracytoplasmic+Th1+and+Th2+cytokine+production+assessed+by+flow+cytometry+following+in+vitro+activation+of+peripheral+blood+mononuclear+cells&doi=10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells</span></div><div class="casAuthors">Rostaing, Lionel; Tkaczuk, Jean; Durand, Martine; Peres, Christine; Durand, Dominique; de Preval, Claude; Ohayon, Elie; Abbal, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">CYTODQ</span>;
        ISSN:<span class="NLM_cas:issn">0196-4763</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Std. cytokine detection methods are unable to det. which cells are the producing cells.  We report on the extent and under which conditions the multilabeling capability of flow cytometry (FCM) can bring new advances into the field.  Five different cytokines, interleukin-2 (IL-2), -4, -5, -10 and interferon-γ (IFN-γ), were assessed simultaneously under five ex vivo stimulation conditions in peripheral blood mononuclear cells from five healthy volunteers in a 5-day kinetic study.  A second group of 35 volunteers was assessed for IFN-γ and IL-2 prodn.  This study showed that (a) intracytoplasmic cytokines were almost undetectable within unstimulated cells, (b) intracytoplasmic cytokines were detected only in CD69(+) T lymphocytes, and (c) intracytoplasmic IL-2 and IFN-γ were dramatically upregulated after stimulation with phorbol myristate acetate (PMA)-ionomycin in a biphasic response or with PMA-phytohemagglutinin (one major peak only at 18 h) but to a lesser extent with other stimuli such as monoclonal antibodies.  Th2 cytokines were detected at a later time point and at lower levels.  PMA/ionomycin stimulation after 4 h and 18 h of culture in 35 other volunteers individualized several subgroups according to the frequency of IFN-γ- or IL-2-producing cells-IFN-γ delayed producers (n = 10/35), IFN-γ low producers (n = 8/35), and IL-2 delayed producers (n = 16/35)-as opposed to IFN-γ or IL-2 normal producers.  FCM appears to be a good tool to examine cell cytokine status in pathol. (allergy, autoimmune disease, etc.) provided that optimal stimulation conditions and multiple time-point cultures are used.  It also seems to be a relevant method to define new Th subsets further.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR2oImGlDtaLVg90H21EOLACvtfcHk0liPImcohEIIAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXisFaisLo%253D&md5=96061b0d762595b1a870ce08506a121e</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0320%252819990401%252935%253A4%253C318%253A%253AAID-CYTO4%253E3.0.CO%253B2-4%26sid%3Dliteratum%253Aachs%26aulast%3DRostaing%26aufirst%3DL.%26aulast%3DTkaczuk%26aufirst%3DJ.%26aulast%3DDurand%26aufirst%3DM.%26aulast%3DPeres%26aufirst%3DC.%26aulast%3DDurand%26aufirst%3DD.%26aulast%3Dde%2BPr%25C3%25A9val%26aufirst%3DC.%26aulast%3DOhayon%26aufirst%3DE.%26aulast%3DAbbal%26aufirst%3DM.%26atitle%3DKinetics%2520of%2520intracytoplasmic%2520Th1%2520and%2520Th2%2520cytokine%2520production%2520assessed%2520by%2520flow%2520cytometry%2520following%2520in%2520vitro%2520activation%2520of%2520peripheral%2520blood%2520mononuclear%2520cells%26jtitle%3DCytometry%26date%3D1999%26volume%3D35%26spage%3D318%26epage%3D328%26doi%3D10.1002%2F%28SICI%291097-0320%2819990401%2935%3A4%3C318%3A%3AAID-CYTO4%3E3.0.CO%3B2-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pauleau, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, P. J.</span></span> <span> </span><span class="NLM_article-title">Role of Nod2 in the response of macrophages to Toll-like receptor agonists</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7539</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.21.7531-7539.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1128%2FMCB.23.21.7531-7539.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=14560001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOgsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7531-7539&author=A.-L.+Pauleauauthor=P.+J.+Murray&title=Role+of+Nod2+in+the+response+of+macrophages+to+Toll-like+receptor+agonists&doi=10.1128%2FMCB.23.21.7531-7539.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Role of Nod2 in the response of macrophages to toll-like receptor agonists</span></div><div class="casAuthors">Pauleau, Anne-Laure; Murray, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7539</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Nod2 (CARD15) is a macrophage-specific protein contg. two CARD domains, a large nucleotide binding domain and leucine-rich repeats.  Human genetic studies have linked mutations in NOD2/CARD15 with Crohn's disease, although the mechanisms involved are unknown.  However, Nod2 has been proposed to directly bind bacterial lipopolysaccharide (LPS) and subsequently act as an activator of NF-κB via the assocn. of the CARD domains with Rip2/RICK/CARDIAK.  This is hypothesized to constitute a pathogen recognition pathway distinct from Toll-like receptor 4-mediated recognition of LPS.  Using targeted mutagenesis, the authors introduced a mutation to delete the CARD domains of mouse Nod2.  Mice lacking Nod2 were indistinguishable from controls and showed no signs of intestinal pathol.  Macrophages responded normally to multiple Toll-like receptor agonists in terms of NF-κB target activation, mitogen-activated protein kinase activation, and cytokine secretion.  However, Nod2-/- mice were significantly protected in endotoxin challenge expts., and Nod2-/- macrophages were refractory to muramyl dipeptide stimulation.  These results argue that Nod2 does not play an essential, nonredundant role in the response of macrophages to bacterial products but rather plays unexpected roles in regulating systemic responses to pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriHdplUQMDi7Vg90H21EOLACvtfcHk0liPImcohEIIAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOgsbs%253D&md5=f4f271383b1f6719cba5ab632edab843</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.21.7531-7539.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.21.7531-7539.2003%26sid%3Dliteratum%253Aachs%26aulast%3DPauleau%26aufirst%3DA.-L.%26aulast%3DMurray%26aufirst%3DP.%2BJ.%26atitle%3DRole%2520of%2520Nod2%2520in%2520the%2520response%2520of%2520macrophages%2520to%2520Toll-like%2520receptor%2520agonists%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D7531%26epage%3D7539%26doi%3D10.1128%2FMCB.23.21.7531-7539.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Meer, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinarello, C. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of muramyl dipeptide stimulation of cytokine production by blood components</span>. <i>Clin. Exp. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>156</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2249.2009.03926.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1111%2Fj.1365-2249.2009.03926.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=19438594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=428-433&author=J.+H.+M.+van%0Ader+Meerauthor=M.+G.+Neteaauthor=C.+A.+Dinarello&title=Modulation+of+muramyl+dipeptide+stimulation+of+cytokine+production+by+blood+components&doi=10.1111%2Fj.1365-2249.2009.03926.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of muramyl dipeptide stimulation of cytokine production by blood components</span></div><div class="casAuthors">van der Meer, J. H. M.; Netea, M. G.; Dinarello, C. A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical and Experimental Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-433</span>CODEN:
                <span class="NLM_cas:coden">CEXIAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-9104</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Muramyl dipeptide (MDP) is the minimal active fragment of peptidoglycan of the cell wall of Gram-pos. bacteria, with potential beneficial effects as a vaccine adjuvant.  Peptidoglycans and MDP are recognized by the intracellular receptor NOD2 (nucleotide-binding oligomerization domain 2), leading to prodn. of proinflammatory cytokines.  In the present study, it is shown that, despite stimulatory effects on isolated human mononuclear cells, MDP does not stimulate prodn. of tumor necrosis factor-α, interleukin-1β or interleukin-6 in a whole-blood assay.  However, MDP retains synergistic effects on lipopolysaccharide-induced cytokines in whole blood.  Screening tests of NOD2 function based on whole-blood stimulation should therefore employ strategies based on the synergistic effects of MDP on Toll-like receptor-induced cytokine prodn.  Plasma was not responsible for the inhibition of MDP in whole blood.  The inhibition of MDP stimulation was dependent upon cellular components, with erythrocyte-derived Hb and neutrophils collaborating in the inhibition of MDP effects in whole blood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUdpMc135fu7Vg90H21EOLACvtfcHk0liPImcohEIIAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnslWis7c%253D&md5=a6310bc3893e2094498393e42d080279</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2249.2009.03926.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2249.2009.03926.x%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BMeer%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26aulast%3DDinarello%26aufirst%3DC.%2BA.%26atitle%3DModulation%2520of%2520muramyl%2520dipeptide%2520stimulation%2520of%2520cytokine%2520production%2520by%2520blood%2520components%26jtitle%3DClin.%2520Exp.%2520Immunol.%26date%3D2009%26volume%3D156%26spage%3D428%26epage%3D433%26doi%3D10.1111%2Fj.1365-2249.2009.03926.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traub, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Aulock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, C.</span></span> <span> </span><span class="NLM_article-title">MDP and other muropeptides – direct and synergistic effects on the immune system</span>. <i>J. Endotoxin Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1179/096805106X89044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1179%2F096805106X89044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16690010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=69-85&author=S.+Traubauthor=S.+von+Aulockauthor=T.+Hartungauthor=C.+Hermann&title=MDP+and+other+muropeptides+%E2%80%93+direct+and+synergistic+effects+on+the+immune+system&doi=10.1179%2F096805106X89044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">MDP and other muropeptides - direct and synergistic effects on the immune system</span></div><div class="casAuthors">Traub, Stephanie; von Aulock, Sonja; Hartung, Thomas; Hermann, Corinna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Endotoxin Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">69-85</span>CODEN:
                <span class="NLM_cas:coden">JENREB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0519</span>.
    
            (<span class="NLM_cas:orgname">Maney Publishing</span>)
        </div><div class="casAbstract">A review.  Muropeptides are breakdown products of peptidoglycan (PGN) of Gram-neg. and Gram-pos. bacteria.  They are released during bacterial growth and division, as part of the host response by lysozyme and amidases, or upon antibiotic treatment.  After phagocytosis of bacteria or bacterial breakdown products by host immune cells, the muropeptides trigger intracellular signaling cascades, leading to altered gene expression and activation of the immune response.  Numerous muropeptides and derivs. have been synthesized chem. to characterize their immunostimulatory effects and adjuvant activity.  Muramyl dipeptide, a natural partial structure of PGN, is the minimal structure with adjuvant activity.  This review discusses the structure and occurrence of muropeptides and gives a broad overview of their inflammatory and adjuvant activity and the possible involvement of receptors in these responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEKqY15UjK3LVg90H21EOLACvtfcHk0lhdSCQT2sHjyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksVWgsrk%253D&md5=b10e36602d50c3022a76e7bf47b3d3e6</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1179%2F096805106X89044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1179%252F096805106X89044%26sid%3Dliteratum%253Aachs%26aulast%3DTraub%26aufirst%3DS.%26aulast%3Dvon%2BAulock%26aufirst%3DS.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHermann%26aufirst%3DC.%26atitle%3DMDP%2520and%2520other%2520muropeptides%2520%25E2%2580%2593%2520direct%2520and%2520synergistic%2520effects%2520on%2520the%2520immune%2520system%26jtitle%3DJ.%2520Endotoxin%2520Res.%26date%3D2006%26volume%3D12%26spage%3D69%26epage%3D85%26doi%3D10.1179%2F096805106X89044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tukhvatulin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dzharullaeva, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukhvatulina, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcheblyakov, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmarov, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolzhikova, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanhope-Baker, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naroditsky, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudkov, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logunov, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gintsburg, A. L.</span></span> <span> </span><span class="NLM_article-title">Powerful complex immunoadjuvant based on synergistic effect of combined TLR4 and NOD2 activation significantly enhances magnitude of humoral and cellular adaptive immune responses</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">e0155650</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0155650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1371%2Fjournal.pone.0155650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0155650&issue=5&author=A.+I.+Tukhvatulinauthor=A.+S.+Dzharullaevaauthor=N.+M.+Tukhvatulinaauthor=D.+V.+Shcheblyakovauthor=M.+M.+Shmarovauthor=I.+V.+Dolzhikovaauthor=P.+Stanhope-Bakerauthor=B.+S.+Naroditskyauthor=A.+V.+Gudkovauthor=D.+Y.+Logunovauthor=A.+L.+Gintsburg&title=Powerful+complex+immunoadjuvant+based+on+synergistic+effect+of+combined+TLR4+and+NOD2+activation+significantly+enhances+magnitude+of+humoral+and+cellular+adaptive+immune+responses&doi=10.1371%2Fjournal.pone.0155650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0155650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0155650%26sid%3Dliteratum%253Aachs%26aulast%3DTukhvatulin%26aufirst%3DA.%2BI.%26aulast%3DDzharullaeva%26aufirst%3DA.%2BS.%26aulast%3DTukhvatulina%26aufirst%3DN.%2BM.%26aulast%3DShcheblyakov%26aufirst%3DD.%2BV.%26aulast%3DShmarov%26aufirst%3DM.%2BM.%26aulast%3DDolzhikova%26aufirst%3DI.%2BV.%26aulast%3DStanhope-Baker%26aufirst%3DP.%26aulast%3DNaroditsky%26aufirst%3DB.%2BS.%26aulast%3DGudkov%26aufirst%3DA.%2BV.%26aulast%3DLogunov%26aufirst%3DD.%2BY.%26aulast%3DGintsburg%26aufirst%3DA.%2BL.%26atitle%3DPowerful%2520complex%2520immunoadjuvant%2520based%2520on%2520synergistic%2520effect%2520of%2520combined%2520TLR4%2520and%2520NOD2%2520activation%2520significantly%2520enhances%2520magnitude%2520of%2520humoral%2520and%2520cellular%2520adaptive%2520immune%2520responses%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D5%26spage%3De0155650%26doi%3D10.1371%2Fjournal.pone.0155650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span>; <span class="NLM_string-name">Mašek, J.</span>; <span class="NLM_string-name">Raška, M.</span>; <span class="NLM_string-name">Ledvina, M.</span></span> <span> </span><span class="NLM_article-title">Application of liposomes for construction of vaccines</span>. In  <i>Biomedical Science, Engineering and Technology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghista, D. N.</span></span>, Ed.; <span class="NLM_publisher-name">InTech</span>, <span class="NLM_year">2012</span>; pp  <span class="NLM_fpage">653</span>– <span class="NLM_lpage">678</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.5772%2F21328" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=653-678&author=J.+Tur%C3%A1nek&author=J.+Ma%C5%A1ek&author=M.+Ra%C5%A1ka&author=M.+Ledvinaauthor=D.+N.+Ghista&title=Biomedical+Science%2C+Engineering+and+Technology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71a&amp;dbid=16384&amp;doi=10.5772%2F21328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252F21328%26sid%3Dliteratum%253Aachs%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DApplication%2520of%2520liposomes%2520for%2520construction%2520of%2520vaccines%26btitle%3DBiomedical%2520Science%252C%2520Engineering%2520and%2520Technology%26aulast%3DGhista%26aufirst%3DD.%2BN.%26pub%3DInTech%26date%3D2012%26spage%3D653%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit71b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Effenberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knötigova, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zyka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Čelechovská, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mašek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartheldyová, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubatka, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudelka, Š.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukáč, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovalová, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šaman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Křupka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barkocziova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosztyu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šebela, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drož, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hučko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanásová, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raška, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledvina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turánek, J.</span></span> <span> </span><span class="NLM_article-title">Nonpyrogenic molecular adjuvants based on norAbu-muramyldipeptide and norAbu-glucosaminyl muramyldipeptide: synthesis, molecular mechanisms of action, and biological activities in vitro and in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7745</span>– <span class="NLM_lpage">7763</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00593</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00593" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7745-7763&author=R.+Effenbergauthor=P.+T.+Kn%C3%B6tigovaauthor=D.+Zykaauthor=H.+%C4%8Celechovsk%C3%A1author=J.+Ma%C5%A1ekauthor=E.+Bartheldyov%C3%A1author=F.+Hubatkaauthor=%C5%A0.+Koudelkaauthor=R.+Luk%C3%A1%C4%8Dauthor=A.+Kovalov%C3%A1author=D.+%C5%A0amanauthor=M.+K%C5%99upkaauthor=L.+Barkocziovaauthor=P.+Kosztyuauthor=M.+%C5%A0ebelaauthor=L.+Dro%C5%BEauthor=M.+Hu%C4%8Dkoauthor=M.+Kan%C3%A1sov%C3%A1author=A.+D.+Millerauthor=M.+Ra%C5%A1kaauthor=M.+Ledvinaauthor=J.+Tur%C3%A1nek&title=Nonpyrogenic+molecular+adjuvants+based+on+norAbu-muramyldipeptide+and+norAbu-glucosaminyl+muramyldipeptide%3A+synthesis%2C+molecular+mechanisms+of+action%2C+and+biological+activities+in+vitro+and+in+vivo&doi=10.1021%2Facs.jmedchem.7b00593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71bR"><div class="casContent"><span class="casTitleNuber">71b</span><div class="casTitle"><span class="NLM_cas:atitle">Nonpyrogenic Molecular Adjuvants Based on norAbu-Muramyldipeptide and norAbu-Glucosaminyl Muramyldipeptide: Synthesis, Molecular Mechanisms of Action, and Biological Activities in Vitro and in Vivo</span></div><div class="casAuthors">Effenberg, Roman; Turanek Knotigova, Pavlina; Zyka, Daniel; Celechovska, Hana; Masek, Josef; Bartheldyova, Eliska; Hubatka, Frantisek; Koudelka, Stepan; Lukac, Robert; Kovalova, Anna; Saman, David; Krupka, Michal; Barkocziova, Lucia; Kosztyu, Petr; Sebela, Marek; Droz, Ladislav; Hucko, Michal; Kanasova, Maria; Miller, Andrew D.; Raska, Milan; Ledvina, Miroslav; Turanek, Jaroslav</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7745-7763</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acyl analogs of muramyldipeptide (MDP) (abbreviated N-L18 norAbuGMDP, N-B30 norAbuGMDP, norAbuMDP-Lys(L18), norAbuMDP-Lys(B30), norAbuGMDP-Lys(L18), norAbuGMDP-Lys(B30), B30 norAbuMDP, L18 norAbuMDP) are designed and synthesized comprising the normuramyl-L-α-aminobutanoyl (norAbu) structural moiety.  All new analogs show depressed pyrogenicity in both free (micellar) state and in liposomal formulations when tested in rabbits in vivo (s.c. and iv application).  New analogs are also shown to be selective activators of NOD2 and NLRP3 (inflammasome) in vitro but not NOD1.  Potencies of NOD2 and NLRP3 stimulation are found comparable with free MDP and other pos. controls.  Analogs are also demonstrated to be effective in stimulating cellular proliferation when the sera from mice are injected s.c. with individual liposome-loaded analogs, causing proliferation of bone marrow-derived GM-progenitors cells.  Importantly, vaccination nanoparticles prepd. from metallochelation liposomes, His-tagged antigen rOspA from Borrelia burgdorferi, and lipophilic analog norAbuMDP-Lys(B30) as adjuvant, are shown to provoke OspA-specific antibody responses with a strong Th1-bias (dominance of IgG2a response).  In contrast, the adjuvant effects of Alum or parent MDP show a strong Th2-bias (dominance of IgG1 response).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGUp8pDHzdC7Vg90H21EOLACvtfcHk0lhmMJBZhTgRQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurzF&md5=ca10207e03938dc2e1dd1400b79d38d8</span></div><a href="/servlet/linkout?suffix=cit71b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00593%26sid%3Dliteratum%253Aachs%26aulast%3DEffenberg%26aufirst%3DR.%26aulast%3DKn%25C3%25B6tigova%26aufirst%3DP.%2BT.%26aulast%3DZyka%26aufirst%3DD.%26aulast%3D%25C4%258Celechovsk%25C3%25A1%26aufirst%3DH.%26aulast%3DMa%25C5%25A1ek%26aufirst%3DJ.%26aulast%3DBartheldyov%25C3%25A1%26aufirst%3DE.%26aulast%3DHubatka%26aufirst%3DF.%26aulast%3DKoudelka%26aufirst%3D%25C5%25A0.%26aulast%3DLuk%25C3%25A1%25C4%258D%26aufirst%3DR.%26aulast%3DKovalov%25C3%25A1%26aufirst%3DA.%26aulast%3D%25C5%25A0aman%26aufirst%3DD.%26aulast%3DK%25C5%2599upka%26aufirst%3DM.%26aulast%3DBarkocziova%26aufirst%3DL.%26aulast%3DKosztyu%26aufirst%3DP.%26aulast%3D%25C5%25A0ebela%26aufirst%3DM.%26aulast%3DDro%25C5%25BE%26aufirst%3DL.%26aulast%3DHu%25C4%258Dko%26aufirst%3DM.%26aulast%3DKan%25C3%25A1sov%25C3%25A1%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DRa%25C5%25A1ka%26aufirst%3DM.%26aulast%3DLedvina%26aufirst%3DM.%26aulast%3DTur%25C3%25A1nek%26aufirst%3DJ.%26atitle%3DNonpyrogenic%2520molecular%2520adjuvants%2520based%2520on%2520norAbu-muramyldipeptide%2520and%2520norAbu-glucosaminyl%2520muramyldipeptide%253A%2520synthesis%252C%2520molecular%2520mechanisms%2520of%2520action%252C%2520and%2520biological%2520activities%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7745%26epage%3D7763%26doi%3D10.1021%2Facs.jmedchem.7b00593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alving, C. R.</span></span> <span> </span><span class="NLM_article-title">Liposomes as as carriers of antigens and adjuvants</span>. <i>J. Immunol. Methods</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>140</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/0022-1759(91)90120-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2F0022-1759%2891%2990120-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1712030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK3MXkslylur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=1991&pages=1-13&author=C.+R.+Alving&title=Liposomes+as+as+carriers+of+antigens+and+adjuvants&doi=10.1016%2F0022-1759%2891%2990120-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Liposomes as carriers of antigens and adjuvants</span></div><div class="casAuthors">Alving, Carl R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    </div><div class="casAbstract">A review with 101 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO9Z-KHYZEMrVg90H21EOLACvtfcHk0lhmMJBZhTgRQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXkslylur0%253D&md5=2a6a771f87da8765218ac6e38b6e4087</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2F0022-1759%2891%2990120-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-1759%252891%252990120-5%26sid%3Dliteratum%253Aachs%26aulast%3DAlving%26aufirst%3DC.%2BR.%26atitle%3DLiposomes%2520as%2520as%2520carriers%2520of%2520antigens%2520and%2520adjuvants%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D1991%26volume%3D140%26spage%3D1%26epage%3D13%26doi%3D10.1016%2F0022-1759%2891%2990120-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG response to ovalbumin in mice</span>. <i>Int. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">751</span>– <span class="NLM_lpage">759</span>, <span class="refDoi"> DOI: 10.1016/j.intimp.2010.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2Fj.intimp.2010.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=20403461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=751-759&author=L.+Habjanecauthor=B.+Halassyauthor=J.+Toma%C5%A1i%C4%87&title=Comparative+study+of+structurally+related+peptidoglycan+monomer+and+muramyl+dipeptide+on+humoral+IgG+response+to+ovalbumin+in+mice&doi=10.1016%2Fj.intimp.2010.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of structurally related peptidoglycan monomer and muramyl dipeptide on humoral IgG immune response to ovalbumin in mouse</span></div><div class="casAuthors">Habjanec, Lidija; Halassy, Beata; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">751-759</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structurally related peptidoglycan monomer (PGM) and muramyl dipeptide (MDP) differ in several aspects of biol. activity but have in common immunostimulating properties.  Comparative study of the effects of these adjuvants on humoral IgG immune response specific for protein antigen ovalbumin (OVA) was carried out in two inbred mouse strains, CBA and NIH/OlaHsd, and their ability to modulate the bias of immune response towards Th1/Th2 was evaluated.  MDP had better adjuvant activity at some points than PGM, whereas both adjuvants stimulated Th2-biased immune response specific for OVA.  In comparison to Complete Freund's adjuvant (CFA), as a golden std. of adjuvant action, both PGM and MDP exhibited considerably lower activity.  Addn. of PGM to Incomplete Freund's adjuvant (IFA) on humoral immune response was studied also, and the effect of such adjuvant formulation was compared to the effect of CFA.  While CFA induced the switch towards Th1-biased immune response, the addn. of PGM into IFA did have no impact on modulating the immune response towards more pronounced Th2-type of immune response, defined by IFA itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEa9MV5PnV7bVg90H21EOLACvtfcHk0lhmMJBZhTgRQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVagtr8%253D&md5=0279f7b455963f0048e0d182805bd5f1</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2010.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2010.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DComparative%2520study%2520of%2520structurally%2520related%2520peptidoglycan%2520monomer%2520and%2520muramyl%2520dipeptide%2520on%2520humoral%2520IgG%2520response%2520to%2520ovalbumin%2520in%2520mice%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2010%26volume%3D10%26spage%3D751%26epage%3D759%26doi%3D10.1016%2Fj.intimp.2010.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Habjanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Effect of liposomal formulations and immunostimulating peptidoglycan monomer (PGM) on the immune reaction to ovalbumin in mice</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1080/08982100500528537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1080%2F08982100500528537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=16556546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD28XislCksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1-16&author=L.+Habjanecauthor=R.+Frkanecauthor=B.+Halassyauthor=J.+Toma%C5%A1i%C4%87&title=Effect+of+liposomal+formulations+and+immunostimulating+peptidoglycan+monomer+%28PGM%29+on+the+immune+reaction+to+ovalbumin+in+mice&doi=10.1080%2F08982100500528537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Liposomal Formulations and Immunostimulating Peptidoglycan Monomer (PGM) on the Immune Reaction to Ovalbumin in Mice</span></div><div class="casAuthors">Habjanec, Lidija; Frkanec, Ruza; Halassy, Beata; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">The adjuvant activity of liposomes and immunostimulating peptidoglycan monomer (PGM) in different formulations has been studied in mice model using ovalbumin (OVA) as an antigen.  PGM is a natural compd. of bacterial origin with well-defined chem. structure: GlcNAc-MurNAc-l-Ala-d-isoGln-mesoDpm(eNH2)-d-Ala-d-Ala.  It is a non-toxic, non-pyrogenic, and water-sol. immunostimulator.  The aim of this study was to investigate the influence of different liposomal formulations of OVA, with or without PGM, on the prodn. of total IgG, as well as of IgG1 and IgG2a subclasses of OVA-specific antibodies (as indicators of Th2 and Th1 type of immune response, resp.).  CBA mice were immunized s.c. with OVA mixed with liposomes, OVA with PGM mixed with liposomes, OVA encapsulated into liposomes and OVA with PGM encapsulated into liposomes.  Control groups were OVA in saline, OVA with PGM in saline, and OVA in CFA/IFA adjuvant formulation.  The entrapment efficacy of OVA was monitored by HPLC method.  The adjuvant activity of the mixt. of OVA and empty liposomes, the mixt. of OVA, PGM, and liposomes and PGM encapsulated with OVA into liposomes on prodn. of total anti-OVA IgG was demonstrated.  The mixt. of PGM and liposomes exhibited additive immunostimulating effect on the prodn. of antigen-specific IgGs.  The anal. of IgG subclasses revealed that encapsulation of OVA into liposomes favors the stimulation of IgG2a antibodies, indicating the switch toward the Th1 type of immune response.  When encapsulated into liposomes or mixed with liposomes, PGM induced a switch from Th1 to Th2 type of immune response.  It could be concluded that appropriate formulations of antigen, PGM, and liposomes differently affect the humoral immune response and direct the switch in the type of immune response (Th1/Th2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol4pGRk6ZmWrVg90H21EOLACvtfcHk0lgyax0EGnXuyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XislCksLY%253D&md5=9f6310327818b4024f1af15d538dbd35</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1080%2F08982100500528537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08982100500528537%26sid%3Dliteratum%253Aachs%26aulast%3DHabjanec%26aufirst%3DL.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEffect%2520of%2520liposomal%2520formulations%2520and%2520immunostimulating%2520peptidoglycan%2520monomer%2520%2528PGM%2529%2520on%2520the%2520immune%2520reaction%2520to%2520ovalbumin%2520in%2520mice%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2006%26volume%3D16%26spage%3D1%26epage%3D16%26doi%3D10.1080%2F08982100500528537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relyveld, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindblad, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bizzini, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Efraim, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, C. K.</span></span> <span> </span><span class="NLM_article-title">Adjuvants – a balance between toxicity and adjuvanticity</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1016/0264-410X(93)90190-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2F0264-410X%2893%2990190-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=293-306&author=R.+K.+Guptaauthor=E.+H.+Relyveldauthor=E.+B.+Lindbladauthor=B.+Bizziniauthor=S.+Ben-Efraimauthor=C.+K.+Gupta&title=Adjuvants+%E2%80%93+a+balance+between+toxicity+and+adjuvanticity&doi=10.1016%2F0264-410X%2893%2990190-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2F0264-410X%2893%2990190-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0264-410X%252893%252990190-9%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DR.%2BK.%26aulast%3DRelyveld%26aufirst%3DE.%2BH.%26aulast%3DLindblad%26aufirst%3DE.%2BB.%26aulast%3DBizzini%26aufirst%3DB.%26aulast%3DBen-Efraim%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DC.%2BK.%26atitle%3DAdjuvants%2520%25E2%2580%2593%2520a%2520balance%2520between%2520toxicity%2520and%2520adjuvanticity%26jtitle%3DVaccine%26date%3D1993%26volume%3D11%26spage%3D293%26epage%3D306%26doi%3D10.1016%2F0264-410X%2893%2990190-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travaš, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstanović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halassy Špoljar, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ljevaković, Đ.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Entrapment of peptidoglycans and adamantyltripeptides into liposomes: an HPLC assay for determination of encapsulation efficiency</span>. <i>J. Liposome Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1081/LPR-120026452</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1081%2FLPR-120026452" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=14670233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=279-294&author=R.+Frkanecauthor=D.+Trava%C5%A1author=M.+Krstanovi%C4%87author=B.+Halassy+%C5%A0poljarauthor=%C4%90.+Ljevakovi%C4%87author=B.+Vrane%C5%A1i%C4%87author=L.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Entrapment+of+peptidoglycans+and+adamantyltripeptides+into+liposomes%3A+an+HPLC+assay+for+determination+of+encapsulation+efficiency&doi=10.1081%2FLPR-120026452"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Entrapment of peptidoglycans and adamantyltripeptides into liposomes: An HPLC assay for determination of encapsulation efficiency</span></div><div class="casAuthors">Frkanec, Ruza; Travas, Dijana; Krstanovic, Marina; Spoljar, Beata Halassy; Ljevakovic, Durdica; Vranesic, Branka; Frkanec, Leo; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Liposome Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3&4</span>),
    <span class="NLM_cas:pages">279-294</span>CODEN:
                <span class="NLM_cas:coden">JLREE7</span>;
        ISSN:<span class="NLM_cas:issn">0898-2104</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The encapsulation of different immunomodulating peptides, the peptidoglycan monomer, its semisynthetic derivs. (Adamant-1-yl)-acetyl-peptidoglycan monomer and Boc-Tyr-peptidoglycan monomer, resp., and of 2 diastereoisomers of adamantyltripeptides into the large neg. charged multilamellar liposomes was investigated.  The reproducible quant. method using HPLC was established for the detn. of the entrapped compds.  It was shown that the tested compds. could be efficiently incorporated into liposomes using either the film or modified film method.  The results confirmed that the peptidoglycans with lipophilic substituents and particularly the adamantyltripeptides were incorporated into liposomes with higher efficiency than the peptidoglycan monomer using either of the described methods.  Liposome prepns. were stable at 4°C up to 7 days as shown by minimal leaking of the entrapped material.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1hI__p75OorVg90H21EOLACvtfcHk0lgyax0EGnXuyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1Cgs70%253D&md5=d7c820181996614dad55faa819effe09</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1081%2FLPR-120026452&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FLPR-120026452%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DTrava%25C5%25A1%26aufirst%3DD.%26aulast%3DKrstanovi%25C4%2587%26aufirst%3DM.%26aulast%3DHalassy%2B%25C5%25A0poljar%26aufirst%3DB.%26aulast%3DLjevakovi%25C4%2587%26aufirst%3D%25C4%2590.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DFrkanec%26aufirst%3DL.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DEntrapment%2520of%2520peptidoglycans%2520and%2520adamantyltripeptides%2520into%2520liposomes%253A%2520an%2520HPLC%2520assay%2520for%2520determination%2520of%2520encapsulation%2520efficiency%26jtitle%3DJ.%2520Liposome%2520Res.%26date%3D2003%26volume%3D13%26spage%3D279%26epage%3D294%26doi%3D10.1081%2FLPR-120026452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noethig Laslo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vranešić, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirosavljević, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes</span>. <i>Biochim. Biophys. Acta, Biomembr.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1611</i></span>,  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">196</span>, <span class="refDoi"> DOI: 10.1016/S0005-2736(03)00054-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2FS0005-2736%2803%2900054-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=12659960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1611&publication_year=2003&pages=187-196&author=R.+Frkanecauthor=V.+Noethig+Lasloauthor=B.+Vrane%C5%A1i%C4%87author=K.+Mirosavljevi%C4%87author=J.+Toma%C5%A1i%C4%87&title=A+spin+labelling+study+of+immunomodulating+peptidoglycan+monomer+and+adamantyltripeptides+entrapped+into+liposomes&doi=10.1016%2FS0005-2736%2803%2900054-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A spin labelling study of immunomodulating peptidoglycan monomer and adamantyltripeptides entrapped into liposomes</span></div><div class="casAuthors">Frkanec, Ruza; Noethig-Laslo, Vesna; Vranesic, Branka; Mirosavljevic, Krunoslav; Tomasic, Jelka</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1611</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">187-196</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The interaction of immunostimulating compds., the peptidoglycan monomer (PGM) and structurally related adamantyltripeptides (AdTP1 and AdTP2), resp., with phospholipids in liposomal bilayers were investigated by ESR spectroscopy.  The fatty acids bearing the nitroxide spin label at different positions along the acyl chain were used to investigate the interaction of tested compds. with neg. charged multilamellar liposomes.  ESR spectra were studied at 290 and 310 K.  The entrapment of the adamantyltripeptides affected the motional properties of all spin labeled lipids, while the entrapment of PGM had no effect.  Spin labeled PGM was prepd. and the novel compd. bearing the spin label attached via the amino group of diaminopimelic acid was chromatog. purified and chem. characterized.  The rotational correlation time of the spin labeled mol. dissolved in buffer at pH 7.4 was studied as a function of temp.  The conformational change was obsd. above 300 K.  The same effect was obsd. with the spin labeled PGM incorporated into liposomes.  Such effect was not obsd. when the spin labeled PGM was studied at alk. pH, probably due to the hydrolysis of PGM mol.  The study of possible interaction with liposomal membrane is relevant to the use of tested compds. incorporated into liposomes, as adjuvants in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKdV2HeMqDUbVg90H21EOLACvtfcHk0lhrr4nGgD22bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlWqt7o%253D&md5=d85964e73e290fbc42df57e31045d890</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0005-2736%2803%2900054-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0005-2736%252803%252900054-3%26sid%3Dliteratum%253Aachs%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DNoethig%2BLaslo%26aufirst%3DV.%26aulast%3DVrane%25C5%25A1i%25C4%2587%26aufirst%3DB.%26aulast%3DMirosavljevi%25C4%2587%26aufirst%3DK.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DA%2520spin%2520labelling%2520study%2520of%2520immunomodulating%2520peptidoglycan%2520monomer%2520and%2520adamantyltripeptides%2520entrapped%2520into%2520liposomes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2003%26volume%3D1611%26spage%3D187%26epage%3D196%26doi%3D10.1016%2FS0005-2736%2803%2900054-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halassy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krstanović, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frkanec, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomašić, J.</span></span> <span> </span><span class="NLM_article-title">Adjuvant activity of peptidoglycan monomer and its metabolic products</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1016/S0264-410X(02)00547-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1016%2FS0264-410X%2802%2900547-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2003&pages=971-976&author=B.+Halassyauthor=M.+Krstanovi%C4%87author=R.+Frkanecauthor=J.+Toma%C5%A1i%C4%87&title=Adjuvant+activity+of+peptidoglycan+monomer+and+its+metabolic+products&doi=10.1016%2FS0264-410X%2802%2900547-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0264-410X%2802%2900547-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0264-410X%252802%252900547-9%26sid%3Dliteratum%253Aachs%26aulast%3DHalassy%26aufirst%3DB.%26aulast%3DKrstanovi%25C4%2587%26aufirst%3DM.%26aulast%3DFrkanec%26aufirst%3DR.%26aulast%3DToma%25C5%25A1i%25C4%2587%26aufirst%3DJ.%26atitle%3DAdjuvant%2520activity%2520of%2520peptidoglycan%2520monomer%2520and%2520its%2520metabolic%2520products%26jtitle%3DVaccine%26date%3D2003%26volume%3D21%26spage%3D971%26epage%3D976%26doi%3D10.1016%2FS0264-410X%2802%2900547-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span> <i>GAMESS interface, ChemBio3D Ultra 13.0, ChemBioOffice Ultra 13.0</i>; CambridgeSoft.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GAMESS+interface%2C+ChemBio3D+Ultra+13.0%2C+ChemBioOffice+Ultra+13.0%3B+CambridgeSoft."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGAMESS%2520interface%252C%2520ChemBio3D%2520Ultra%252013.0%252C%2520ChemBioOffice%2520Ultra%252013.0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span> <span> </span><span class="NLM_article-title">Merck molecular force field 0.1. Basis, form, scope, parameterization, and performance of MMFF94</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">490</span>– <span class="NLM_lpage">519</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1996&pages=490-519&author=T.+A.+Halgren&title=Merck+molecular+force+field+0.1.+Basis%2C+form%2C+scope%2C+parameterization%2C+and+performance+of+MMFF94&doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94</span></div><div class="casAuthors">Halgren, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5 & 6</span>),
    <span class="NLM_cas:pages">490-519</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">This article introduces MMFF94, the initial published version of the Merck mol. force field (MMFF).  It describes the objectives set for MMFF, the form it takes, and the range of systems to which it applies.  This study also outlines the methodol. employed in parameterizing MMFF94 and summarizes its performance in reproducing computational and exptl. data.  Though similar to MM3 in some respects, MMFF94 differs in ways intended to facilitate application to condensed-phase processes in mol.-dynamics simulations.  Indeed, MMFF94 seeks to achieve MM3-like accuracy for small mols. in a combined "org./protein" force field that is equally applicable to proteins and other systems of biol. significance.  A second distinguishing feature is that the core protion of MMFF94 has primarily been derived from high-quality computational data-ca. 500 mol. structures optimized at the HF/6-31G* level, 475 structures optimized at the MP2/6-31G* level, 380 MP2/6-31* structures evaluated at a defined approxn. to the MP4SDQ/TZP level, and 1450 structures partly derived from MP2/6-31G* geometries and evaluated at the MP2/TZP level.  A third distinguishing feature is that MMFF94 has been parameterized for a wide variety of chem. systems of interest to org. and combinations of functional groups for which little, if any, useful exptl. data are available.  The methodol. used in parameterizing MMFF94 represents a fourth distinguishing feature.  Rather than using the common "functional group" approach, nearly all MMFF parameters have been detd. in a mutually consistent fashion from the full set of available computational data.  MMFF94 reproduces the computational data used in its parameterization very well.  In addn., MMFF94 reproduces exptl. bond lengths (0.014 Å root mean square [rms]), bond angles (1.2° rms), vibrational frequencies (61 cm-1 rms), conformational energies (0.38 kcal/mol rms), and rotational barriers (0.39 kcal/mol rms) very nearly as well as does MM3 for comparable systems.  MMFF94 also describes intermol. interactions in hydrogen-bonded systems in a way that closely parallels that given by the highly regarded OPLS force field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzCYfKnN83rVg90H21EOLACvtfcHk0lhrr4nGgD22bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVGmsbk%253D&md5=56fb073477b4f49d1dfbd786fc56a480</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-987X%2528199604%252917%253A5%252F6%253C490%253A%253AAID-JCC1%253E3.0.CO%253B2-P%26sid%3Dliteratum%253Aachs%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26atitle%3DMerck%2520molecular%2520force%2520field%25200.1.%2520Basis%252C%2520form%252C%2520scope%252C%2520parameterization%252C%2520and%2520performance%2520of%2520MMFF94%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D1996%26volume%3D17%26spage%3D490%26epage%3D519%26doi%3D10.1002%2F%28SICI%291096-987X%28199604%2917%3A5%2F6%3C490%3A%3AAID-JCC1%3E3.0.CO%3B2-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willett, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leach, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R.</span></span> <span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">727</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1996.0897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking&doi=10.1006%2Fjmbi.1996.0897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lhtb7YxyJlbMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748%26doi%3D10.1006%2Fjmbi.1996.0897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span> <i>GOLD Suite</i>, v5.4; The Cambridge Crystallographic Data Centre:
Cambridge, UK; <a href="http://www.ccdc.cam.ac.uk" class="extLink">www.ccdc.cam.ac.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+GOLD+Suite%2C+v5.4%3B+The+Cambridge+Crystallographic+Data+Centre%3A%0ACambridge%2C+UK%3B+www.ccdc.cam.ac.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DGOLD%2520Suite" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span> <i>PyMOL</i>; <span class="NLM_publisher-name">Delano Scientific
LLC</span>, <span class="NLM_publisher-loc">San Francisco, CA</span>; <a href="http://pymol.sourceforge.net" class="extLink">http://pymol.sourceforge.net</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+PyMOL%3B+Delano+Scientific%0ALLC%2C+San+Francisco%2C+CA%3B+http%3A%2F%2Fpymol.sourceforge.net."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DPyMOL%26pub%3DDelano%2520Scientific%250ALLC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN','PDB','5IRN'); return false;">PDB: 5IRN</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i64"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01052">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_36070"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01052">10.1021/acs.jmedchem.7b01052</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_001.csv">CSV</a>)</p></li><li><p class="inline">Synthesis details for compounds <b>1a</b>–<b>1c</b>, <b>25a</b>–<b>b</b>, <b>26a</b>–<b>b</b>, and <b>27a</b>–<b>b</b>; analytical data/characterization of intermediate compounds <b>3a</b>–<b>b</b>, <b>18</b>–<b>21</b>, <b>25a</b>, <b>26a</b>, and <b>27a</b>; Supporting Schemes, Figures, and Tables; experimental procedure for molecular dynamics simulation; experimental procedure for bacterial endotoxin test; <sup>1</sup>H and <sup>13</sup>C NMR spectra of representative tested compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf">PDF</a>)</p></li><li><p class="inline">PDB-ID code of file used for docking experiments: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5IRN">5IRN</a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_003.zip">ZIP</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_001.csv">jm7b01052_si_001.csv (1.7 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_002.pdf">jm7b01052_si_002.pdf (8.64 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01052/suppl_file/jm7b01052_si_003.zip">jm7b01052_si_003.zip (916.69 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01052&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01052%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01052" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997ae17b551969","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
